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There are two sections to this research dissertation. Part one includes syntheses of 
fused-ring heterocycles derived from thiazole, oxazole, benzoxazole and benzothiazole 
derivatives and trifluoroacetylations of in situ generated N-methyl cyclic ketene-N,O/S-
acetals. Attempted functionalized polymer syntheses from plant-derived 5-(hydroxy-
methyl)furfural are discussed in part two.   
Three 2-methylthiazoles, 2,4,5-trimethyloxazole, 2-methylbenzoxazole and 2-
methyl-benzothiazole were each reacted with benzoyl chloride in 
acetonitrile/triethylamine to generate benzyl-vinyl esters. Base hydrolysis of these 
benzyl-vinyl esters formed 2-(heterocyclic)-1-phenylethenols which exist in both keto-
enol tautomeric forms. These tautomers were used as starting materials for fused-ring 
heterocycle syntheses. 
Each tautomeric pair react with dimethyl acetylenedicarboxylate in methanol 
giving the 5,6-ring-fused 8-benzoyl-5-oxo-5H-thiazolo-, 8-benzoyl-5-oxo-5H-oxazolo-, 
4-benzoyl-1-oxo-1H-benzo[4,5]oxazolo- and 4-benzoyl-1-oxo-1H-benzo[4,5]thiazolo 
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[3,2-a]pyridinecarboxylate derivatives. Two novel 5,7-ring-fused 9-benzoyl-2,3-
dimethyl-5,6-dihydrothiazolo- and 9-benzoyl-2,3-dimethyl-5,6-dihydrooxazolo[3,2-a] 
azepine-5,6,7,8-tetracarboxylates formed when the tautomers formed from 2,4,5-
trimethyl thiazole and 2,4,5-trimethyl oxazole were reacted with DMADC. 
These tautomers react with 1,3-diacid chlorides in acetonitrile/triethylamine 
affording the 5,6-ring-fused 8-benzoyl-6,6-dialkyl-6H-thiazolo- and 8-benzoyl-6,6-
dimethy-6H-oxazolo-, 4-benzoyl-2,2-dimethyl-1H-benzo[4,5]thiazolo- and 4-benzoyl-
2,2-dimethyl-1H-benzo[4,5]oxazolo[3,2,-a]pyridinedione derivatives. Functionalized 5,6-
ring-fused 8-benzoyl-6H-thiazolo- and 8-benzoyl-6H-oxazolo[3,2-f]pyrimidine-5,7-
diones, and 4-benzoyl-1H-benzo[4,5]thiazolo- and 4-benzoyl-1H-benzo[4,5]oxazolo[3,2-
c]pyrimidine-1,3(2H)-diones formed reacting the tautomers with N-chlorocarbonyl 
isocyanate in THF/triethylamine.  
Significant ring size and substituent effects were observed in trifluoroacetylations 
of in situ-generated cyclic ketene-N,O/S acetals. In situ-generated 3,4,4-trimethyl-2-
methylene-oxazolidine, 3-methyl-2-methylene-oxazolidine and 3-methyl-2-methylene-
1,3-oxazinane each formed β,β-bistrifluoroacetylated products. However, 3-methyl-2-
methylene-oxazolidine also afforded a -lactam by an iodide-catalyzed rearrangement of 
its β,β-bistrifluoroacetylated derivative. In situ-generated 3-methyl-2-methylene-
thiazolidine gave both β-mono- and β,β-bistrifluoroacetylation products.  
5-(Hydroxymethyl)furfural synthesized from sucrose was converted to 2,5-
bis(hydroxymethyl)furan (2,5-BHMF). 7-Oxanorbornene-type Diels-Alder adducts 
synthesized from 2,5-BHMF were used as monomers for both ring opening metathesis 
polymerizations (ROMPs) and polycondensations. ROMP, followed by polycondensation 
or vise versa were expected to give highly functionalized cross-linked polymers. ROMP 
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of the monomers using three Grubbs’ 1st, 2nd and 3rd generation catalysts were 
unsuccessful due to the presence of hydroxymethyl groups at one or both bridgeheads 
that could coordinate Ruthenium. With one bridgehead methyl present ROMP proceeded. 
Low molecular weight polyesters were synthesized via polycondensation. One was cross-
linked using ROMP, but not to its gel point. 
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Figure 1.1 Ketene-O,O-, N,N-, N,O- and N,S-acetals  
 
CHAPTER I
GENERAL INTRODUCTION AND RESEARCH GOALS
1.1 General introduction 
Acylic ketene-O,O-, N,N-, N,O- and N,S-acetals 1-4 (Figure 1.1) and their 
corresponding cyclic ketene acetals (CKAs) 5-8 (Figure 1.2) are reactive functional 
classes of organic compounds.  
CKAs contain a nucleophilic exocyclic methylene carbon (defined as the -
carbon in this dissertation, see Figure 1.2) attached to a carbon in a ring with two adjacent 
heteroatoms such as O, N or S. The -carbon of both acyclic and cyclic ketene-O,O-, 
N,N-, N,O- and N,S-acetals exhibits a significant nucleophilicity due to resonance 
electron donation from both heteroatoms. Resonance structures of cyclic ketene-O,O-, 
N,N-, N,O- and N,S-acetals are depicted in Figure 1.2.  
1 
 
  Figure 1.2 Resonance structures of cyclic ketene acetals
 
Ketene-O,O-acetals 1 and 5, and ketene-N,N-acetals 2 and 6 are “double vinyl 
ethers” and “double enamines”, respectively. Ketene-N,O-acetals 3 and 7 have both vinyl 
ether and enamine activity simultaneously. Ketene-N,S-acetals 4 and 8 share vinyl 
thioether and enamine structural motifs simultaneously in one compound. 
Vinyl ethers and enamines are well known as nucleophiles. They react with 
electrophiles via cation or zwitterion intermediates as depicted in Scheme 1.1. The 
stability of these cation or zwitterion intermediates is partially reflected in the 
corresponding transition states leading to them, thereby lowering the activation barriers to 









Scheme 1.1 Reactions of vinyl ethers, enamines and ketene-N,O-, N,S-, N,N-acetals 
with electrophiles
Cyclic ketene-O,O-, N,N-, N,O- and N,S-acetals have gained much attention due 
to their significant synthetic potential, especially for the synthesis of a wide variety of 
heterocyclic compounds.1-7 Synthesis of CKAs, and their reactions and applications in the 
preparation of heterocyclic compounds are discussed in this general introduction. CKA 
chemistry recently explored by the Pittman group is emphasized in this chapter to provide 
background information that related to the research work in this dissertation.  
1.1.1 Synthesis of CKAs
McElvain and coworkers reported the first acyclic ketene-O,O-, N,O- and N,N-
acetal preparations in the 1930s and 1940s.8-10 In 1948 they reported making the first 
cyclic ketene-O,O-acetals 19 by reacting 1,1-dimethoxy-2-halo-ethanes, or its 2-
substituted derivatives, with diols 17.11 Acetyl exchange between 16 and 17, followed by 
dehydrohalogenation of the corresponding halogenated intermediates 18, afforded cyclic 
ketene-O,O-acetals 19. This method was later modified by other groups. 12-18 Use of 
Dowex (H+) resins as acid catalysts in the acetal exchange step is commonly used for 




   Scheme 1.2 First synthesis of cyclic ketene-O,O-acetals 1911 
 




The first synthesis of a cyclic-ketene-N,O-acetal was published by Myers et al in 
1972.19 Two methods (Paths A and B) were reported by Mayer et al to make the six-
membered ring cyclic-ketene-N,O-acetal 24 starting from 2,4,4,6-tetramethyl-1,3-oxazine 
20 as depicted in Scheme 1.30. Path (b), which involves N-methylation, followed by 
deprotonation was extensively applied later in the synthesis of a wide variety of N-methyl 
cyclic ketene-N,X-acetals (X = N, O, S) by other research groups.20-24 
Scheme 1.3 First syntheses of a cyclic ketene-N,O-acetals19 
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28: R = H 30: R = H 32: R = H 
29: R = CH3 31: R = CH3 33: R = CH3 
Scheme 1.5 First synthesis of cyclic ketene-N,S-acetals21 
 
 
The first cyclic ketene-N,N-acetal synthesis and isolation only occurred by 1987 
in the work of Gruseck and coworkers.20 N-Methyl cyclic ketene-N,N-acetal 27 was 
achieved by reacting 1,2-dimethylimidazoline 25 with methyl iodide, followed by the 
deprotonation of 26 using NaH (Scheme 1.4). Pittman and co-workers used a similar 
method for the preparation of a series of cyclic ketene-N,X-acetals (X = N, S).21,5 
Syntheses of cyclic ketene-N,S-acetals as such 32 and 33, first appeared in the literature
are depicted in Scheme 1.5.21 
Pittman and co-workers reported a convenient method for the in situ preparation 
of cyclic ketene-N,X-acetals (X = O, S, N) and their reactions with various mono-, and di-
electrophiles.4-7,21,22 This provided a key advantage. These reactive species did not have 
to be isolated and purified before using them in further synthetic reactions. For example, 













by treatment with benzoyl chloride in the presence of triethylamine.21a This reaction 
presumably takes place via an in situ generated N-acylated cyclic ketene-N,S-acetal 
intermediate 34. The nucleophilic attack by electron rich -carbon on the second 
equivalent of acid chloride produces 35. Reactions of in situ generated cyclic ketene-N,X-
acetals (X = O, S, N) are discussed in more detail in later sections. 
Scheme 1.6 Reactions of in situ generated cyclic ketene-N,S-acetals with acid 
chlorides21a 
Lee and co-workers very recently reported a high yield preparation of cyclic 
ketene-N,X-acetals (X = O, S, N) 38 with two electron withdrawing groups on the -
carbon from ketene-S,S-acetal 36 and various binucleophiles 37 in aqueous medium in
the absence of any acid/base catalysts (Scheme 1.7).23 
Scheme 1.7 Synthesis of cyclic ketene-N,X-acetals (O, S, N) from ketene-S,S-acetals23 
6 
                                            
  




Scheme 1.8 Synthesis of the first benzothiazole-based cyclic ketene-N,S-acetal27 
 
 




Cyclic ketene-N,X-acetals (X = S, O, N) derived from aromatic heterocycles such 
as imidazoles, thiazoles, oxazoles, benzoxazoles, benzothiazoles and benzimidazoles are 
also interesting building blocks for synthesizing novel heterocycles.6,24-26 However, only 
a few reports exist on the synthesis of  cyclic ketene-N,X-acetals (X = S, O, N) from
aromatic precursors.27,28 In 1925, synthesis of the benzothiazole-based cyclic ketene 
acetal 40 was first reported by Konig and co-workers (Scheme 1.8).27 Aromatic 
heterocycle-based CKA 40 was synthesized by methylation of 2-methylbenzothiazole 39 
and the proton loss at 200 C. 
The first synthesis of a benzimidazole-based cyclic ketene-N,N-acetal was 
reported in 1959 (Scheme 1.9).28 Methylation of 2-methylbenzimidazole 41 using 
Me2SO4 and Na2CO3 in MeOH afforded 1,2-dimethylbenzimidazole 42. Further 
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1.1.2 Reactions of CKAs
The nucleophilicity of the cyclic ketene acetal -carbon and the stability of the 
resulting intermediate’s cationic center facilitate electrophilic attack at the -position as 
initially introduced on pages 1-3. Example electrophiles include a proton, mono-
electrophiles such as acid chlorides, isocyanates and isothiocyanates, and bis-
electrophiles such as 1,3-diacid chlorides, N-chlorocarbonyl isocyanates, N-
chlorosulfonyl isocyanates and electrophilic olefins such as ,-unsaturated carboxylic 
acid derivatives, aldehydes and ketones. 
1.1.2.1 Protonation of CKAs and subsequent reactions of their cationic intermediates
Protonation of cyclic ketene-O,O-acetals’ -carbon form stable  cyclic dioxonium
ions 45. These cations are ambident electrophiles. They are susceptible to nucleophilic 
attack at three possible positions as depicted in Scheme 1.10.11,29-32 Nucleophiles such as 
water, alcohols or carboxylic aids can attack at the carbon bearing positive charge (path 
a) or at the back side of the two carbons next to two oxygen atoms (paths b and c). 
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a b O R1 R2
HY cO O O O b 
O Yn 46b 
R1 R2n R1 n R2 c 
O R2 R144 45 
O Y 46c R1,R2 = H, alkyl or Ph; Y = OH, OR or OAc; n = 0,1 or 2 n 
Scheme 1.10 Ambident nature of cyclic ketene-O,O-acetals to nucleophilic attack after 
protonation11,29-32 
 
      
 
Pittman and co-workers extensively explored the chemistry of five, six and seven-
membered cyclic ketene-O,O-acetals.17,18,31-33 Zhu et al. reported a regioselective 
synthetic method for preparation of monoacetylated diols 47 by direct hydrolysis of 
CKAs 44 with water on the acidic surface of alumina (Scheme 1.11).31 Later, Wu et al. 
reported regioselective formation of mixed diesters, 48 and 49, by reactions of CKAs 44 
with carboxylic acids such as propionic acid, trimethylacetic acid and benzoic acid 
(Scheme 1.9).32 Cyclic ketene-O,O-acetals must be added to a stirred solution of excess 
carboxylic acid in THF to minimize cationic polymerization which can occur when cyclic 
dioxonium ions are present with CKAs in solution.30 
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R1 = H or Me; R2 = H, Me, t-Bu or Ph;  R =  Me, Et, t-Bu or Ph; n = 0, 1 or 2 





Cyclic ketene-O,O-acetals are very electron rich vinyl monomers. They have the 
possibility of undergoing 1,2-vinyl addition chain polymerization or ring-opening 
polymerization.11,17,18,33,34 Radical initiated polymerizations, first studied by Bailey and
co-workers, were sluggish and ultimately not useful.34 This method produced low 
molecular weight polymers. However, cationic homo- and co-polymerizations of five, six 
and seven-membered cyclic ketene-O,O-acetals can be very fast and were exploited by 
Pittman’s group.17,18,33 Effects of the ring size, different substituents on the ring, different 
cationic initiators and reaction conditions on reactivities of cyclic ketene-O,O-acetals 
have been studied. 
Possible 1,2-vinyl addition and ring-opening polymerization pathways of cyclic 
ketene-O,O-acetals initiated cationically are shown in Scheme 1.12.11, 17,18,33 1,2-Vinyl 
polymerization occurs by the addition of CKA monomer 44 to the resulting dioxonium





   
             














































































I = Cationic initiator 
R1 = H or Me;  R2 = H, Me, t-Bu or Ph; n = 0, 1 or 2 
Scheme 1.12 Three possible pathways for polymerization of cyclic ketene-O,O-acetals
by cationic initiation18,33f
CKA monomer 44 at one of the two carbons next to two oxygen atoms in the dioxonium 
ions 50 (path b) or isomerization to the ring-opened cation 55 followed by addition of 
another CKA monomer 44 (path c) to form 54. 
11 
 
        
 
 


















   58 
Acid initiators: 
BF3.Et2O, H2SO4, HCl,H3PO4, CdCl2, ZnCl2, 
NiCl2, FeCl3, AlCl3, HI, HF, ect. 
Scheme 1.13 Degradation of poly(cyclic ketene acetals) in the presence of Lewis or 
protonic acid11,17,33a,35
 
1,2-Vinyl polymers of cyclic ketene acetals, cationically initiated employing 
Lewis acids and protonic acids, were reported to be easily degraded during the 
polymerization or after work up when traces of acid remained present (Scheme 
1.13).11,17,33a,33b,35 Zhu and co-workers reported the successful cationic 1,2-vinyl addition 
polymerization of CKAs using heterogenized H2SO4-supported on activated carbon-
black. This led to stable ring-retained solid polymers.33a,c,d,g,i The use of immobilized acid 
catalysts allowed successful isolation of these polymers (see 56, Scheme 1.13).    
N-Methyl cyclic ketene-N,O-acetals undergo ring-opening by carboxylic acids to 
form amidoesters 61 and 62 (Scheme 1.14).21b This reactivity resembles that of cyclic 
ketene-O,O-acetals (Scheme 1.11). N-Methyl cyclic ketene-N,O-acetals can also react via 
ring-opening with nitrophenol and arylthiols to give amidoaryl ethers 63 and amidoaryl 
thioethers 64, respectively.22 The oxazolinium cation intermediate 60 that forms upon 
protonation of N-methyl cyclic ketene-N,O-acetal 59 undergoes ring-opening by the 
conjugate bases of carboxylic acids, nitrophenol and arylthiols. Pittman and co-workers 
reported these ring-opening reactions for both five- and six-membered cyclic ketene-N,O-
acetals.22 Selected examples are summarized in Scheme 1.14.
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Scheme 1.14 Ring-opening reactions of N-methyl cyclic ketene-N,O-acetals with 









1.1.2.2 Reactions of CKAs with other mono-electrophiles 
Cyclic ketene-N,X-acetals (X = O, S, N) react with various other mono-
electrophiles including aliphatic and aryl acid chlorides, aryl isocyanates, and vinyl and 
aryl isothiocyanates.4,5,7,21,22,36-41 Selected examples are discussed in this section.
1.1.2.2.1 Reactions with aliphatic and aryl acid chlorides 
Acylation reactions of non-aromatic and aromatic cyclic ketene-N,X-acetals (X = 
O, S, N) with acid chlorides were explored by many research groups.4,5,7,21a,36-41  In most
cases acylation reactions led to formation of a new CKA compound. For example, 
reaction of N-methyl cyclic ketene-N,X-acetals (X = O and S) 33 and 65 with both aryl 
and aliphatic acid chlorides afforded N-methyl--keto cyclic ketene-N,X -acetals (X = O













CH2 RR Cl 
H3C H3CEt3N, THF N X N X 
rt, 20 min 
R = alkyl, aryl 33: X= S 66: X= S
65: X= O 67: X= O 
Scheme 1.15 Reactions of N-methyl cyclic ketene-N,X-acetals with both aryl and 
aliphatic acid chlorides21a,4b 
 
 
As shown in Scheme 1.6 under the synthesis of CKAs, nucleophilic -carbon of 
in situ generated N-acylated cyclic ketene-N,S-acetal intermediate 34 underwent further 
acylation to afford N-acyl--keto cyclic ketene-N,S-acetal 35.21a 
N-Benzoylated cyclic ketene-N,O-acetal intermediate 71, generated in situ starting 
from 2,4,4-trimethyl-2-oxazoline 68, afforded N-benzoyl--keto cyclic ketene-N,O-acetal 
74 (Scheme 1.16).36 However, the corresponding reaction of 2-methyloxazoline 69 and 2-
methyloxazine 70 afforded ring-opened vinyl ester imides 76 and 78 via tris-N,C,O-
benzoylation, followed by nucleophilic ring-opening by chloride. The double de-
benzoylation of 76 using KOH in methanol, followed by ring closure, gave mono-
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Scheme 1.16 Reaction of in situ generated cyclic ketene-N,O-acetals with benzoyl 
chloride36 
 
Ye et al. reported reactions of aroyl chlorides with in situ generated N-acyl cyclic 
ketene-N,N-acetals 82 and 83 (Scheme 1.17).5 2-Methylimidazoline 80 reacted with 
excess aryl chlorides in the presence of triethylamine forming the tris-aroylated N,N-
diacyl--keto-cyclic ketene-N,N-acetals 85 via the progressively aroylated intermediates 
82 and 84. In contrast to the five-membered ring imidazoline 80, its six-membered ring 
analog 81 afforded only N,N-diaroyl cyclic ketene-N,N-acetal 86. The six-membered ring 
in CKA 86 is more flexible than the five-membered ring in CKA 84. Therefore, the steric 
hindrance between the methylene group and the N-substituents of 86 can be easily 
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Scheme 1.17 Reactions of in situ generated cyclic ketene-N,N-acetals with aroyl 
chloride5 
 
two nitrogen lone pairs with the carbon-carbon -bond, hence reducing (relative to 84) 
the electron donation from the nitrogen to the exocyclic double bond. This, in turn, 
reduces the nucleophilicity of the -carbon of 86 more than 84. Therefore, less 
nucleophilic 86 does not undergo third aroylation to form 87.5 
1,2-Dimethylimidazoline 25 and its six-membered ring analog 88 also reacted 
differently with aroyl chlorides.5 1,2-Dimethylimidazoline 25 formed the ring-opened 
(Z)-vinyl benzoates 93 via several steps, including N,C and O-benzoylations (Scheme 
1.18). However, 88 gave ring-retained N-aroyl N-methyl ,-dioxo cyclic ketene-N,N-
acetals 96 under the same reaction conditions. CKAs 89 and 90 were intermediates in 
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Reactions summarized in Schemes 1.6 and Schemes 1.15 - 1.18 emphasize the 
fact that variations in the hetero atoms, the ring size and the substituents on the ring can 
drastically change the reaction outcomes of cyclic ketene-N,X-acetals (X = O, S, N) with 
electrophiles. 
Aroylations of aromatic heterocycles were also broadly explored by many 
research groups.37-41 N-Acylated imidazole enol-ester 99 formed when 2-methylimidazole 
97 reacted with acid chlorides in the presence of Et3N in acetonitrile (Scheme 1.19).37 
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alkylated 2-methylimidazole derivative 98 with acid chlorides under the same reaction 
conditions (Scheme 1.19).37-42 
Pittman and co-workers group reported aroylation reactions of 2-methylthiazole 
102, 2,4,5-trimethylthiazole 103 and 2,4,5-trimethylozaxole 104 with various aroyl 
chlorides. These reactions also produced the enol-esters 105-107 (Scheme 1.20) through 
double benzoylation.40 2-Methylbenzoxazole 108, 2-methylbenzothiazole 39 and 2-
methyl-benzimidazole 41 afforded enol-esters 109-111 when treated with benzoyl 






Scheme 1.21 Reactions of 2-methylbenzoxazole, 2-methylbenzothiazole and 2-




Scheme 1.20 Double aroylation reactions of 2-methylthiazole, 2,4,5-trimethylthiazole 
and 2,4,5-trimethylozaxole with benzoyl chloride40 
 
 
Products formed in aroylations of these aromatic heterocycles were different than 
that observed for non-aromatic heterocycles (Schemes 1.6 and Schemes 1.15-1.18 vs 
Schemes 1.19-1.21). These observations indicate that non-aromatic oxazolines, oxazines, 
thiazolines and imidazolines, and aromatic oxazoles, thiazoles, imidazoles and their 
benzo-derivatives have different reactivities. Aromatic heterocycles react with acid 
chlorides in the presence of a base, like their non-aromatic counterparts also take place 
via cyclic ketene-N,X-acetal (X= N, O and S) intermediates (see 114 in Scheme 1.22).40,42 
However, the formation of cyclic ketene-N,X-acetal (X= N, O and S) intermediates from 
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aromatic heterocycles leads to the loss of a portion of this aromaticity.42 This could 
contribute to their different reactivities.  
1.1.2.2.2 Reactions with isocyanates and isothiocyanates 
Reactions of cyclic ketene-N,X-acetals (X = O, S, N) with mono-electrophiles 
such as aryl isocyanates, vinyl isocyanates and aryl isothiocyanates also formed a wide 
variety of products substituted at the -carbon.7,45-48 For example, N-methyl cyclic 
ketene-N,X-acetals (X = O and S) 33 and 65, each with two hydrogens on the -carbon, 
formed only the mono--substituted products 115 and 116, respectively, when reacted 
with such aryl isothiocyanates. Examples are summarized in Scheme 1.23. The same
results were observed even at higher temperature or using excess aryl isothiocyanates. 
Reactions of 33 and 65 with vinyl isocyanate also afforded only the mono--substituted 
products 117 and 118, respectively.43,44 
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 Scheme 1.23 Example reactions of N-methyl cyclic ketene-N,X-acetals (X = O and S), 






N-Methyl cyclic ketene-N,S-acetal 32 reacted with excess aryl isocyanates form
,-disubstituted product 126 as shown in Scheme 1.24. These reactions proceed via two 
different zwitterionic intermediates 120 and 124. N-Methyl cyclic ketene-N,O-acetal 119 
also behaved similarly. Di-substituted products 126 and 127 are highly polarized push-
pull alkenes.43 Push-pull systems are formed when two equivalents of an electrophile, 
like an isocyanate, replaces both hydrogens at the -carbon with two electron 
withdrawing groups.45,46 The nitrogen, sulfur and oxygen are electron donating and in 
conjugation with the new -carbon substituents (Structure 128 and 129 in Scheme 1.24). 
Similar results were observed with the six-membered ring analog of 119.43,44 If the charge 
separation is large enough, rotation by up to 90 can occur about the central carbon-
carbon bond to generate a bisected molecular geometry with zwitterionic character.45,46 
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Scheme 1.24 Reactions of N-methyl cyclic ketene-N,X-acetals (X = O and S), with two






N-Methyl cyclic ketene-N,O-acetals 130 and 131, with two methyl substituents on 
the -carbon, formed spirobicyclic 5/6 and 6/6-membered ring compounds 136 and 137
when these were reacted with isocyanates (Scheme 1.25) at room temperature in either 
THF or CH2Cl2.
45 CKAs 130 and 131 react with the first equivalent of aryl isocyanate to 
form the zwitterionic intermediates 132 and 133, respectively. Absence of hydrogens on 
the -carbon prevents transfer of a -carbon’s proton to the nitrogen. Hence, the 
zwitterionic intermediates 132 and 133 react with a second aryl isocyanate equivalent to 
generate the second zwitterionic intermediates 134 and 135, respectively. Intramolecular 
nucleophilic attack of 134 and 135 then gave spirobicyclic 5/6 and 6/6-membered ring 





Scheme 1.25 Reactions of N-methyl ketene-N,X-acetals (X = O and S) with two methyl 
substituents on the -carbon, with aryl isocyanates43,44
 
   
 
 
   
     
Five- and six-membered ring N-methyl cyclic ketene-N,O-acetals 119 and 141, 
generated in situ from N-methylated iodide salts 139 and 140, respectively, afforded ,-
bis(N-arylamido) lactams 146 and 147 (Scheme 1.26). These reactions take place via 
iodide-catalyzed rearrangement of ,-bis(N-arylamido) cyclic ketene-N,O-acetals 127 
and 145. However, the N-methylated iodide salt 138 of 2,4,4-trimethyl-2-oxazoline 68, 
exclusively gave the ring-retained ,-bis(N-arylamido) cyclic ketene-N,O- acetal 144 
under the same reaction conditions. The steric hindrance generated by dimethyl 
substitution at the C4 of 144 retards the iodide-catalyzed rearrangement that happens with 
less sterically hindered 127 and 145. In every case, the cyclic ketene acetals 65, 119 and 










Scheme 1.26 Synthesis of ,-bis(N-arylamido) lactams via iodide-catalyzed 
rearrangement of ,-bis(N-arylamido) cyclic ketene-N,O- acetals7 
Reaction between 2-methyloxazoline 69 and phenyl isocyanate afforded 2-
(bisphenylcarbamoyl)methylene-1,3-oxazolidine 150 as the major product at the room
temperature and small amounts of 3-phenylcarbamoyl-2-(phenylcarbamoyl)methylene-
1,3-oxazolidine 149 (Scheme 1.27). However, compound 149 was isolated as the only 
product at 0 C. It was proposed that 149 was formed from 148 and then thermally 
rearranged to give 150.47 
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   Scheme 1.28 Reactions of N,N-dimethyl cyclic ketene-N,N-acetals with isocyanates45,46 
 
 





Syntheses of highly polarized push-pull alkenes from N,N-dimethyl cyclic ketene-
N,N-acetals 152 were also reported by Pittman and co-workers (Scheme 1.28).45,46 
Nitrogen is a stronger electron donor than sulfur or oxygen. The double enamine 
functions of N,N-dimethyl cyclic ketene-N,N-acetals 152 provide electron donation 
towards the two ,-disubstituted amide functions in 153 (Scheme 1.28). An X-ray 
crystal structure showed the exocyclic double bond elongation which is a characteristic of 
push-pull conjugated systems.45,46 
2-Methylimidazoline 80 and 1,2-dimethylimidazoline 25, unlike 151, formed 5,6- 
ring-fused pyrimidinediones 154 and 155, respectively, when reacted with aryl isocyanate 
(Scheme 1.29). Their six-membered ring analogs also behaved similarly.48,22 
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1.1.2.3 Reactions of CKAs with bis-electrophiles 
Cyclic ketene-N,X-acetals (X = O, S, N) can be very useful building blocks for 
the synthesis of highly functionalized fused-ring heterocycles.1-4,6,49-54  This possibility 
has provided a driving force for the recent increase in CKA research activity. Reactions 
of CKAs with bis-electrophiles such as 1,3-diacid chlorides, N-chlorocarbonyl 
isocyanates and electrophilic olefins  provide a synthetic route for fused-ring heterocycle 
synthesis. 
1.1.2.3.1 Reactions of CKAs with 1,3-diacid chlorides and N-chlorocarbonyl 
isocyanates 
Cyclization reactions starting from 2-alkylthiazolines and 2-alkyloxazolines with 
1,3-diacid chlorides and N-chlorocarbonyl isocyanates were reported.4 Two such 
examples are depicted in Scheme 1.30 using 2-ethyl-2-oxazoline. These reactions 
proceed via N-acyl cyclic ketene-N,X-acetal (X = O, S) intermediates 157 and 159,
formed by an initial nucleophilic attack by nitrogen (Scheme 1.30). Since the -carbon of 
the resultant CKAs 157 and 159 are nucleophilic due to the electron donation from both 
N and S/O, their -carbons perform intramolecular nucleophic attacks on the side chains’ 




 Scheme 1.30 Cyclization reactions of 2-ethyl-2-oxazoline 156 with 1,3-diacid chlorides 





Ye and co-workers achieved an efficient synthesis of highly functionalized 1,8-
naphthyridinetetraones 163 (Scheme 1.31). These products consist of three fused-rings.49 
This synthesis took place by tandem cyclization reactions proceeding via in situ
generated CKA intermediates 162 as shown in Scheme 1.31. The final products 163 are 
examples where the -carbons of the cyclic ketene-N,N-acetal intermediates become








Scheme 1.31 Tandem cyclization reactions of 2-methylimidazoline with 1,3-diacid  
chlorides49 
2-Alkylimidazoles and 2-methylbenzimidazole, aromatic analogs of 2-
methylimidazoline 80, behaved differently than 80 when reacted with various 1,3-diacid 
chlorides (Scheme 1.32).6 For example, 2-methylimidazole 93 generated a wide range of 
fused-ring heterocycles 164-167 compared to its non-aromatic analog,  
2-methylimidazoline (Scheme 1.31), under the same reaction conditions.6 
2-Ethylimidazole, 2-isopropylimidazole and 2-methylbenzimidazole also formed fused-






Scheme 1.32 Reactions of 2-methylimidazole with 1,3-diacid chlorides6 
1.1.2.3.2 Reactions of CKAs with electrophilic olefins 
Reactions of CKAs with ,-unsaturated carboxylic acid derivatives, aldehydes 
and ketones are also useful in the synthesis of fused-ring heterocycles.3,26,50-55 A few such 
reactions are summarized in this section. 
,-Alkyne type esters such as dimethyl acetylenedicarboxylate (DMADC) and 
methyl propiolate, and ,-unsaturated esters such as methyl acrylate are useful 









making of a series of fused-heterocyclic compounds by reacting cyclic ketene-N,X-
acetals (X = N, O, S) with ,-alkyne type and ,-unsaturated esters.50-54 Some
examples are depicted in Scheme 1.33. These reactions take place via nucleophilic attack 
by the -carbon of the cyclic ketene-N,X-acetals (X = N, O, S) 168-169 on the 
electrophilic olefin or alkyne, followed by cyclocondensation via nucleophilic attack by 
the ring nitrogen at carbonyl carbon. This pathway produced fused heterocycles 171-178. 
Scheme 1.33 Examples of 5,6-ring-fused heterocycles synthesis via reactions of cyclic 
ketene-N,X-acetals (X = NH, O, S) with ,-alkyne type and ,-
unsaturated esters51-53 
Reactions of CKAs 179 with propenoyl chloride afforded the -lactam-fused-ring 
heterocycles 181.54 Nucleophilic attack by the CKAs’ -carbon was followed by nitrogen 











In summary, syntheses and reactions of non-aromatic cyclic ketene-O,O-, N,N-, 
N,O- and N,S-acetals were broadly explored by many research groups. As described 
above, cyclic ketene acetals are an important class of organic compounds for novel 
heterocyclic compound synthesis, especially fused-ring systems. However, the chemistry 
of CKAs derived from aromatic analogs has not yet widely explored. Imidazolines, 
oxazolines, thiazolines, imidazoles, oxazoles, thiazoles, benzimidazoles, and 
benzothiazoles are useful starting materials for the synthesis of CKAs and the exploration 
of their chemistry. New chemistry can be achieved by varying the heteroatoms in the 
ring, substituents, ring size and also using aromatic or non-aromatic precursors for CKA 
generation. 
1.2 Research Goals
Even though, there are many reports on heterocycle syntheses from non-aromatic 
CKAs and their precursors such as imidazolines, oxazolines, thiazolines and oxazines, the 
use of their aromatic analogs has not been as widely explored. Research work described 
in the first part of this dissertation (Chapters II-IV) is a continuation of the Pittman group 
research on using CKAs for novel reaction development.4-7,17,18,21,22,30-33,36,40,45-47,49 Major





acetals in the synthesis of highly functionalized novel heterocycles based on thiazoles, 
oxazoles, benzoxazoles and benzothiazoles and (2) study the use of the highly 
electrophilic trifluoroacetic anhydride in trifluoroacetylations of in situ generated N-
methyl cyclic ketene-N,X-acetals (X= O, S). This research helps to further develop CKAs 
synthetic methodology. 
The synthesis of enol-esters (benzyl vinyl-esters) starting from oxazoles and 
thiazoles via their corresponding CKAs intermediates (See Scheme 1.20) were reported 
by the Pittman group.40 Our hypothesis was that these enol-esters could be used as 
precursors for syntheses of highly functionalized fused-ring systems. These postulated 
synthetic pathways are summarized in Scheme 1.35.  
Enol-esters formed from aroyl chlorides reacting with 2-methylthiazoles or 2-
methyloxazole would first be hydrolyzed to afford the corresponding tautomeric keto-
enol products. Then these equilibrating tautomers were envisioned to react with ,-
alkynyl esters (DMADC and methyl propiolate) and 1,3-dielectrophiles (such as 2,2-
disubstituted-1,3-diacid chlorides and N-chlorocarbonyl isocyanate) to generate the 
highly functionalized fused-ring systems shown. In fact, this work was then successfully 
carried out. Next these ideas were further extended to 2-methylbenzoxazole and 2-








Scheme 1.35 Postulated synthetic pathways of highly functionalized fused-ring systems
As described in Chapter I, cyclic ketene-N,X-acetals (X= O, S, N) exhibited 
different reactivities with mono-electrophiles such as acid chlorides and aryl isocyanates. 
Ring size, substituents and heteroatoms on the ring, and the method by which CKAs were 
made all could change the reactivity of CKAs (Schemes 1.6, 1.15-1.1.18, 1.24-1.29). 
Trifluoroacetic anhydride is a stronger mono-electrophile compared to benzoyl chloride. 
Trifluoroacetylations of 2-methyloxazoline, 2,4,4-trimethyloxazoline, 2-methyloxazine 
and 2-methylthiazoline were initiated in our laboratory.55 It is important to explore the 
behavior of in situ generated N-methyl cyclic ketene-N,X-acetals (X = O, S) when this
strong electrophile is used. Do these reactions give -mono-substituted products or ,-





Trifluoroacetylations of in situ generated N-methyl cyclic ketene-N,X-acetals (X= O, S) 
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SYNTHESIS OF ENOL-ESTERS FROM THIAZOLES, OXAZOLES, 
BENZOXAZOLES, BENZOTHIAZOLES: THEIR  
TAUTOMERIC HYDROLYSIS PRODUCTS
2.1 Introduction 
Reactions of aromatic heterocycles; imidazoles, oxazoles, thiazoles, 
benzimidazoles, benzothiazoles and benzoxazoles with acid chlorides in the presence of a 
base were reported to give enol-esters (vinyl-esters) as described in the Chapter I 
(Schemes 1.19-1.21).37-41 These enol-esters can be hydrolyzed to the corresponding 2-
heterocyclic-1-phenylethenols (heterocycles include imidazoles, oxazoles, thiazoles, 
benzimidazoles, benzothiazoles and benzoxazoles). For example, Macco et al. and Kolker 
et al. reported that acid hydrolysis of 1-benzoyl-2-(2-phenyl-2-benzoyloxyvinyl) 
imidazole 99 gave (Z)-2-(1H-imidazol-2-yl)-1-phenylethenol, which exists as the keto-




  Scheme 2.2 Preparation of enol-esters of thiazoles and oxazoles40 
 
 
In this chapter, synthesis of analogous enol-esters of oxazoles, thiazoles, 
benzothiazoles and benzoxazoles, and their base hydrolysis will be discussed. Variable 
temperature NMR experiments in CDCl3, NMR experiments in more polar (deuterated 
DMSO) and less polar (deuterated benzene) solvents, and computational experiments will 
be discussed to explain behavior of structurally related equilibrating tautomers from 
thiazoles, oxazoles, benzoxazoles and benzothiazoles. Six tautomeric pairs of such enol-
esters were also used as starting reagents for syntheses of highly functionalized fused-
ring heterocycles. This synthetic work will be discussed in Chapters 3 and 4. 
2.2 Results and Discussions 
2-Methylthiazole 102, 2,4,5-trimethylthiazole 103, 2-methyloxazole 104, 2-
methylbenzoxazole 108 and 2-methylbenzothiazole 39 were reacted with benzoyl 
chloride in the presence of triethylamine (Et3N) in refluxing acetonitrile to afford 
corresponding enol-esters 105, 106, 107, 109 and 110, respectively (Schemes 2.2 and 
2.3).40,41 These five syntheses were reproduced from earlier work40,41 and the new 
preparation of 184 from 2,4,-dimethylthiazole 183 (Scheme 2.2) was completed in this 
dissertation to provide six model enol-esters as starting materials for hydrolysis.  
36 
 





  Scheme 2.4 Key steps in the proposed route for the formation of enol-ester 10540
Key steps in the proposed route for the formation of enol-esters are depicted in 
Scheme 2.4 considering 105 as the example.40 These enol-ester syntheses are thought to 
proceed by N-benzoylation followed by proton loss from the C2 methyl group of the 
resulting cation to generate an intermediate cyclic ketene acetal 185a. Then 185a
undergoes C-benzoylation to give intermediate 185b. Intramolecular de-N-





The enol-ester preparations are summarized in Table 2.1. All the reactions gave 
moderate to good yields. It has been demonstrated that the (Z)-isomer of enol-esters were 
exclusively formed from benzoylations of aromatic heterocycles.40 This type of reaction 
does not occur with 2-methyl oxazolines or thiazolines.21,36 All structures were 
characterized by 1H, 13C and DEPT NMR, and IR spectroscopy, and their melting points. 
Complete characterizations of all these compounds are given in the experimental section. 

































Table 2.1 Preparation of enol-esters from 2-methyl-substituted thiazoles, oxazole,  
benzothiazole and benzoxazolea 
























N S 7 66 
H3C CH3 







N O 7 79 
H3C CH3 













   
 
 



















a Reactions were carried out in refluxing MeCN with mole ratios of 102-104, 108, 39 and 
183:PhCOCl:Et3N = 1:3:3.6-3.7. 


































Figure 2.3 1H NMR spectrum (600 MHz, CDCl3) of (Z)-2-(benzo[d]oxazol-2-yl)-1-









Figure 2.4 13C and DEPT 135 NMR spectrum (150 MHz, CDCl3) of (Z)-2-







Enol-esters 105, 184, 106, 107, 109 and 110 were then hydrolyzed using KOH in 
anhydrous methanol to their tautomeric keto/enol products 194-199 (Schemes 2.5 and 
2.6). 
Scheme 2.5 Hydrolysis of the enol-esters derived from 2-methylthiazoles 102, 183 and 
103, and 2-methyloxazole 104 







                                                         Enol tautomer  Keto tautomer  Enaminone tautomer 
Scheme 2.6 Hydrolysis of the enol-esters derived from 2-methylbenzoxazole 108 and 
2-methylbenzothiazole 39 
Hydrolyzed products were characterized by 1H, 13C and DEPT 135 NMR, and IR 
spectroscopy, and also by melting points. Two sets of signals were observed in 1H and 
13C NMR spectra of all hydrolyzed products from 105-107, 109, 110 and 184 in CDCl3 at 
20 C. In addition to the methylene proton signals of the keto forms (4.38-4.81 ppm), 
vinyl proton signals of the enol form (5.98-6.35 ppm) were observed in the 1H NMR 
spectra of the each hydrolyzed product. The 1H NMR spectra of the hydrolyzed products 
of 105, 106, 109, 110 and 184 contain broad downfield signals (12.62-13.91 ppm) except 
in the hydrolyzed product from 107. These NMR spectral data indicate that all the 
hydrolyzed products contain two tautomers.  
Each hydrolysis product can have enol, keto and enaminone tautomeric forms as 
shown in Schemes 2.5 and 2.6. The presence of the methylene proton signals (4.38-4.81 
ppm) confirmed that each of the hydrolyzed products contained the corresponding keto 
tautomer, 194b-199b. This was further confirmed by the presence of distinct carbonyl 
carbon signals between 192.38 and 194.79 ppm.  
1H NMR chemical shift values are not sufficient to distinguish the enol and 










Figure 2.5 Selected 1H and 13C NMR chemical shifts of enol tautomers 198a and 
199a, keto tautomers 198b and 199b, and enaminone tautomers 199c and
20026,56
previously been definitively assigned. Enol and enaminone tautomers contain OH and 
NH functions, respectively. Hydrogen bonded OH and NH proton signals are 
broadened and appear far downfield. Further, both enol and enaminone tautomers contain 
a vinyl hydrogen which can appear between 5.98 - 6.35 ppm. However, 13C NMR data 
can be used to differentiate the enol and enaminone forms.26,56 The enolic carbon 
(=COH) of the enol tautomer and the carbonyl carbon (C=O) of the enaminone 
tautomer have distinct chemical shifts and define if one or both of these tautomers are 
present. 1H and 13C NMR data of enol tautomers 198a and 199a, keto tautomers 198b
and 199b, and enaminone tautomers 199c and 200 appear in the literature and selected 









The carbonyl carbons of enaminones 199c and 200 appear about 14.6 ppm and 
9.7 ppm, respectively, upfield of the keto tautomer 199b which appears at 194.1 ppm. 
However, enolic carbons (=COH) of enol tautomers 198a and 199a appear further 
upfield (163.5 and 166.3 ppm) than the carbonyl carbons of the corresponding enaminone 
tautomers. The absence of 13C NMR responses in 170-190 ppm region for the hydrolysis 
products of 109 and 110 (Scheme 2.5) excluded the presence of the corresponding 
enaminone forms 198c and 199c, respectively, and confirmed the presence of the enol 
forms 198a and 199a, respectively. 13C NMR spectra of the hydrolysis products of 105-
107 and 184 also did not have peaks in 170-190 ppm region. Therefore, all their 
hydrolysis products contain only keto and enol tautomers in CDCl3. Complete 
experimental details and characterizations of 194a,b-199a,b are given in the experimental 
section. 1H and 13C NMR spectra of tautomers 196a,b and 199a,b are depicted in Figures 






                                      
 
 
                       
  
 
196a 196b =CH 
CH2 
OH 
Figure 2.6 1H NMR spectrum (600 MHz, CDCl3 at 20 C) of the tautomers (Z)-2-(4,5-
dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-
















Figure 2.7 13C and DEPT 135 NMR spectra (150 MHz, CDCl3 at 20 C) of the 
tautomers (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-














                             
 
Figure 2.8 1H NMR spectrum (600 MHz, CDCl3 at 20 C) of the tautomers (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-yl)-










     
 




Figure 2.9 13C and DEPT 135 NMR spectra (150 MHz, CDCl3 at 20 C) of the 
tautomers (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-




























                    
 
  
Table 2.2 Keto-enol tautomeric ratios of 194a,b-199a,ba in CDCl3 solution at 20 oC 
and their isolated yields 
Entry Reactant Product 
























































































O Ph Ph Ph 
H H H 



























S 1.63 : 1 92 
a Reactions were carried out in anhydrous MeOH for 24 h at room temperature. 
  Concentrations of tautomers’ in CDCl3 were approximately in the range of 0.184 - 0.186 
M. 
b Ratios determined by NMR spectral integrations. Enol:keto ratios were calculated based 
on =CH peak area of enol per one methylene proton of the keto tautomer. 
c % Yields were calculated based on the theoretical yields considering corresponding 
enol-esters 105-107, 109, 110 and 184 as the limiting reagent. The keto:enol ratios in the 
solids are not known and could be significantly different from the solution values given 
in this table.
Hydrolysis of enol-esters 105, 184, 106, 107, 109 and 110 afforded the 
corresponding keto-enol tautomers 194a,b-199a,b, respectively, in moderate to good 
yields (Entries 1-6 in Table 2.2). Hydrolysis of (Z)-1-phenyl-2-(thiazol-2-yl)vinyl 
benzoate 105 afforded (Z)-1-phenyl-2-(thiazol-2-yl)ethenol 194a and 1-phenyl-2-
(thiazol-2-yl)ethanone 194b in excellent yield in a 1:2.0 ratio in CDCl3 (Entry 1 in Table 
2.2). Hydrolysis of both (Z)-2-(4-methylthiazol-2-yl)-1-phenylvinyl benzoate 184 and 






methylthiazol-2-yl)-1-phenylethanone 195b and 2-(4,5-dimethylthiazol-2-yl)-1-
phenylethanone 196b, respectively, as the major tautomers along with their enol forms 
(Entries 2 and 3 in Table 2.2). 2-(4,5-Dimethyloxazol-2-yl)-1-phenylethanone 197b was 
observed as the major tautomer present in the isolated hydrolyzed product from (Z)-2-
(4,5-dimethyloxazol-2-yl)-1-phenylvinyl benzoate 107. In contrast to thiazole- and 
oxazole-based enol-esters, the hydrolysis of (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylvinyl 
benzoate 109 and (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylvinyl benzoate 110 generated 
their enol forms, (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylethenol 199a, respectively, as the major tautomers. Even 
though, both keto and enol tautomers are present in CDCl3, in the solid state these results 
could be different. Either one tautomer or mixture of two or all three tautomers may be
present in the solid state. IR spectral data of tautomers 194-199 might be used to identify 
the possible tautomers present in the solid state.  
None of the IR spectra shows characteristic bands for OH or NH functions. Bands 
that correspond to OH and NH functions may broaden and hence disappear or be very 
difficult to detect due to strong intra- and intermolecular hydrogen bonding. Further, 
there are not any strong bands above 1700 cm-1 which correspond to the C=O functions 
of keto tautomers. There are several strong IR bands between 1700 cm-1 and 1500 cm-1. 
These bands may represent conjugated and hydrogen bonded carbonyl or C=N stretching 
frequencies and also symmetric and unsymmetric phenyl ring breathing modes.  
Therefore, it was very difficult to make definitive conclusions about the tautomeric forms 
that are present in the solid sate of hydrolyzed products 194-199. 
Variable temperature NMR studies were performed to confirm that these 








(G) is a function of TS, if S is zero, G will be constant with temperature. 
However, if S is not zero this factor leads to a temperature dependence of G. The 
change of the keto to enol ratio with temperature variation allows for the determination of
whether G is temperature dependent. The 1H NMR spectra of the six tautomers were 
obtained in CDCl3 at -50 C and 50 C, in addition to 20 C, to examine how the 
keto/enol ratio changes. All NMR tubes were kept in a -50 C cold acetone bath and 50 
C hot water bath for approximately 2 to 2.5 h before placing it inside the magnet at those 
same temperatures. About 5-10 minutes were allowed for temperature equilibrium to be 
established at both -50 C and 50 C before acquiring the spectra in each case.  
Enol/keto ratios were calculated as follows. First, the integrated areas of the 
methylene proton (CH2) of the keto tautomers were set at two and then the enol vinyl 
protons (=CH) peak areas were determined for each pair of tautomers. The keto CH2 
represents two protons per molecule and the enol =CH represents one proton per 
molecule. Therefore, half of the integrated area of the keto form was divided by the 
integrated area of the enol form to calculate the ratio between enol and keto forms.  
The equilibrium constant (Keq) was defined as [enol]/[keto] for all six pairs of 
tautomers 194-199. Therefore, the equilibrium favors the keto form when Keq is less than 
one. G is a positive value when the keto form predominates. When Keq is greater than 
one, G is negative and the equilibrium favors the enol form. The tautomer population 

























Table 2.3 Population ratios, Keq and G values for 194a and 194b at -50 C, 20 C 


















kJ mol-1 kcal mol-1 
1 -50 C 1 2.22 0.45 1.48 0.35 
2 20 C 1 2.00 0.50 1.69 0.40 
3 50 C 1 2.08 0.48 1.97 0.47 
Table 2.4 Population ratios, Keq and G values for 195a and 195b at -50 C, 20 C 












G = -RT lnKeq 
kJ mol-1 kcal mol-1 
1 -50 C 1 1.47 0.68 0.72 0.17 
2 20 C 1 1.32 0.76 0.69 0.16 














Table 2.5 Population ratios, Keq and G values for 196a and 196b at -50 C, 20 C 











G = -RT lnKeq 
196a 196b
kJ mol-1 kcal mol-1 
1 -50 C 1 1.64 0.61 0.92 0.22 
2 20 C 1 1.41 0.71 0.83 0.20 
3 50 C 1 1.43 0.70 0.96 0.23 
Since the population differences between the keto and enol tautomers were very 
small for all three cases 194, 195 and 196, the G values were also small. Therefore, the 
change of tautomer ratios with temperature is very small and the accuracy of the 
integration measurements limits how clearly trends with temperature can be resolved. 
The rate at which the tautomers interconvert was slow enough on the NMR time scale to 
observe both tautomers independently in the spectra at each temperature. The keto 
tautomer, 194b, 195b and 196b, was the prevalent species present for all three tautomer 
pairs. The keto tautomers were only slightly favored by 0.40 kcal mol-1 (Entry 2 in Table 
2.3), 0.16 kcal mol-1 (Entry 2 in Table 2.4), and 0.20 kcal mol-1 (Entry 2 in Table 2.5), 
respectively, at 20 C. As temperature drops, the population of the more stable 
tautomeric form should increase. At -50 C, all three equilibria have shifted further 
towards the corresponding predominant keto forms 194b (Entry 1 in Table 2.3), 195b
(Entry 1 in Table 2.4) and 196b (Entry 1 in Table 2.5). The keto forms are more stable 
tautomers in CDCl3 in each of these three cases. At 50 C the population of the keto 









   
 
compared to that at 20 C. However, in all three cases, the measured population of keto 
forms increased slightly at 50 C versus that at 20 C [See (Entry 3 in Table 2.3), (Entry 
3 in Table 2.4) and (Entry 3 in Table 2.5)]. This illustrates the difficulty of accurately 
measuring small changes in relative populations by 1H NMR spectral integrations. 1H 
NMR spectra of 196a and 196b in CDCl3 at -50 C and 50 C are depicted in Figures 




Figure 2.10 1H NMR spectrum (600 MHz, CDCl3 at -50 C) of tautomers (Z)-2-(4,5-
dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-dimethylthiazol-2-



























Figure 2.11 1H NMR spectrum (600 MHz, CDCl3 at 50 C) of the tautomers (Z)-2-(4,5-
dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-dimethylthiazol-2-
yl)-1-phenylethanone 196b in a1:1.43 mole ratio, respectively 
Table 2.6 Population ratios, Keq and G values for 197a and 197b at -50 C, 20 C 













G = -RT lnKeq 
kJ mol-1 kcal mol-1 
1 -50 C 1 6.67 0.15 3.52 0.84 
2 20 C 1 3.57 0.28 3.10 0.74 















          
 






The population difference between the keto 197b and enol 197a was much higher 
than that of thiazole analogs 194-196 at 20 C (Entry 2 in Table 2.6 vs Entry 2 in Tables 
2.3-2.5). Equilibrium favored the keto form 197b by a G value of 0.74 kcal mol-1 at 20 
C. This significant population difference allows the 197a/197b mole ratio trend with 
temperature to be clearly determined using the limited accuracy of 1H NMR integration. 
The larger G value leads to larger absolute differences in the keto and enol 
populations. At a comparable NMR integration accuracy, these larger population 
differences are not masked by the errors in the ratios caused by integration errors. At -50 
C, the equilibrium has shifted further towards the keto form 197b (Entry 1 in Table 2.6). 
At 50 C, the population of the more stable keto form 197b has further decreased (Entry 
3 in Table 2.6). 
Table 2.7 Population ratios, Keq and G values for 198a and 198b at -50 C, 20 C 


















G = -RT lnKeq 
kJ mol-1 kcal mol-1 
1 -50 C 1.16 1 1.16 -0.28 -0.07 
2 20 C 1.06 1 1.06 -0.14 -0.03 
3 50 C 1.05 1 1.05 -0.13 -0.03 
In contrast to the keto-enol tautomers of thiazole and oxazole derivatives 194-197, 
the enol form 198a was the major tautomer of the benzoxazole derivative 198 present in 

































Thus, G has a very small absolute value. When the keto-enol ratio is this close to one, 
the relative values of G are very sensitive to small errors in integration. At all 
temperatures the more stable enol form 198a was slightly favored and at the lowest 
temperature (-50 C) it was only favored over the keto form by 1.16:1 (Entry1 in Table 
2.7). The relative effect on the G values is huge with the energy gap more than 
doubling from 50 C to -50 C. However, the absolute change in G is very small (0.04 
kcal mol-1). 
Table 2.8 Population ratios, Keq and G values for 199a and 199b at -50 C, 20 C 



















G = -RT lnKeq 
kJ mol-1 kcal mol-1 
1 -50 C 1.97 1 1.97 -1.26 -0.30 
2 20 C 1.63 1 1.63 -1.19 -0.28 
3 50 C 1.42 1 1.42 -0.94 -0.22 
The benzothiazole tautomer equilibration between 199a and 199b also favored the 
enol form. Going from 50 C to -50 C the equilibrium increasingly favored the enol 
form 199a (Entries 1 and 3 in Table 2.8) confirming that it is the more stable tautomer in 
CDCl3. 
1H NMR spectra of equilibrating tautomers 199a and 199b in CDCl3 at -50 C 









                               
Clearly, the six enol tautomers 194a-199a are in equilibrium with their 
corresponding keto tautomers 194b-199b in CDCl3. In any other solvent, in the gas phase 




Figure 2.12 1H NMR spectrum (600 MHz, CDCl3 at -50 C) of the tautomers (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-yl)-













Figure 2.13 1H NMR spectrum (600 MHz, CDCl3 at 50 C) of the tautomers (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-yl)-
1-phenylethanone 199b in a 1.42:1 mole ratio, respectively 
The keto-enol tautomeric ratios were determined in both a more polar solvent 
(DMSO-d6) and a less polar solvent (C6D6) than CDCl3. DFT and MP2 calculations (gas 
phase) were also performed for enol, keto and enaminone tautomers of thiazole, oxazole, 
benzoxazole and benzothiazole derivatives 194-199. DFT and MP2 calculations were 
performed using 6-31++g-dp57 and cc-pvtz58 basis sets, respectively. Calculations probe 
the structure of a molecule in a vacuum or gas phase, where no perturbations exist from 
other molecules in the surroundings. Lauren Stutts who worked jointly with Dr. Debbie J. 












Calculated gas phase energies, energy differences and dipole moments of keto, enol and 
enaminone tautomers of 194 are summarized in Table 2.9.  
Table 2.9 Calculated gas phase energies, energy differences and dipole moments of 
194a- 194c using DFT and MP2 methodsa 
Ph Ph Ph 
H H H 
HO O O 









(× 105 kcal mol-1) 




0 4.72 3.33 
3 Dipole moment () 
(Debyes) 
1.36 2.84 2.76 
4 
Energy 
(× 105 kcal mol-1) 




0 8.88 6.41 
6 Dipole moment () 
(Debyes) 
2.41 2.50 4.29 
a Calculations were performed at 298 K 
b 6-31++g-dp used as the basis set 
c cc-pvtz used as the basis set 
Both DFT and MP2 computational studies predicted that enol 194a is the most 
stable tautomeric form in the gas phase (Entries 1 and 4 in Table 2.9). Therefore, the enol 
would be predicted to be the most populated form in the gas phase. The calculated E 
between the enol 194a and keto tautomer 194b is significantly different in the MP2 
calculation than that in the DFT calculation. However, the stability order is predicted to 
be the same by both methods. The enaminone’s stability is closer to that of the keto form. 


















corresponding enol and enaminone since it has the highest dipole moment (Entry 3 in 
Table 2.9). However, MP2 method predicts that the enaminone form 194c is more polar 
than either enol or keto forms (Entry 6 in Table 2.9).  Both theoretical levels show that 
the enol tautomer 194a is least polar. The dipole moments predicted from both levels of 
theory suggested that dissolving 194 in a polar solvent will shift the gas phase tautomer 
populations more toward the more polar keto and enaminone forms, barring any 
hydrogen bonding in solution. How do these predicted properties compare with NMR 
experiments in different solvents? The population ratios of keto, enol and enaminone 
tautomers of 194 in CDCl3, DMSO-d6 and C6H6 from 1H NMR integrations are 
summarized in Table 2.10. Keq and G of 194a and 194b in CDCl3, C6D6 and DMSO-d6 
at 20 C are given in Table 2.11. 
Table 2.10 Population ratios of 194a-194c in CDCl3, C6D6 and DMSO-d6 at 20 C from
1H NMR integrations 

























DFT = 2.76 
MP2 = 2.41 MP2 = 2.50 MP2 = 4.29 
1 CDCl3 4.8 1.04 1 2.00 -
2 C6D6 2.3 0 1 0.55 -














Table 2.11 Keq and G for the equilibrium between 194a and 194b in CDCl3, C6D6 




G = -RT lnKeq 
keto  kJ mol-1 kcal mol-1 
1 CDCl3 0.50 1.69 0.40 
2 C6D6 1.82 -1.46 -0.35 
3 DMSO-d6 0.76 0.67 0.16 
In CDCl3, the keto form 194b predominated over the enol and no enaminone was 
seen (Entry 1 in Table 2.10). This implies that the keto form is more polar than 
corresponding enol and that the enol, which is predicted to be more stable at DFT and 
MP2 levels, is less stabilized by CDCl3 solvation than the keto form. The least polar enol 
tautomer, as expected, predominated in less polar C6D6 (Entry 2 in Table 2.10) which is 
consistent with the dipole moments calculated by DFT and MP2 methods (Entries 3 and 6 
Table 2.9) 
Enol tautomer 194a is predicted to be 4.72 and 8.88 kcal mol-1 more stable than 
keto tautomer in DFT and MP2 calculations, respectively (Entries 2 and 5 in Table 2.9). 
In less polar C6D6, the equilibrium constant (Keq = 1.82) favors the enol form 194a, 
which corresponds to a G value of only -0.35 kcal mol-1. However, in CDCl3, the Keq, 
0.50, favors the keto form. Based on this Keq, G = 0.40 kcal mol-1. The relative gas 
phase energies (calculated) must now be compared to the relative energies in CDCl3 
(experimental from NMR). A comparison of energy differences of tautomers 194 in gas 
phase using DFT theory and in CDCl3 from experiments allows one to compare the 
relative solvation energies. The relative energy lowering by solvation are shown in Figure 





kcal mol-1 than the enol form in CDCl3. This shows that the solvation energy the released 
when the keto form is dissolved in CDCl3 compensates for and even overcomes the 
inherent lower energy of the enol tautomer in the gas phase. This solvation stabilizes the 
keto form more in CDCl3 relative to the solvation stabilization of the enol. In other 
words, solvation stabilizes both tautomers, but it stabilizes the more polar keto tautomer 
by a larger amount. This differential stabilization shifts the equilibrium in the gas phase, 







Figure 2.14 Energy differences between the tautomers of 194 in the gas phase (DFT) 
and in CDCl3 solution showing the relative solvation energies of these 
tautomers upon dissolving them into CDCl3 
DMSO-d6 is highly polar with a dielectric constant of 46.7 and dipole moment of 
almost 4 Debyes. All three tautomeric forms of 194 were seen (Entry 3 in Table 2.10). 
The keto form 194b is still has the highest population followed by the enol 194a and the 
enaminone 194b forms. The large dipole moment of DMSO favors tautomers with larger 
dipole moments. However, the dimethyl sulfoxide oxygen has a significant amount of 
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negative charge and should be a superb hydrogen bond acceptor. Hydrogen bonding 
favors both enol 194a and enaminone 194b forms as shown in Figure 2.15. 
The relative solvation of the three 194 tautomers is shown in Figure 2.17 using 
the relative gas phase energies calculated at the DFT 6-31++g-dp level basis set and the 
relative solution phase energies from NMR measurements of the tautomer populations in 
DMSO. Again, the absolute solvation energies are unknown but the tautomer ratios show 
that all three tautomers have similar energies in DMSO-d6. Both keto and enaminone 
tautomers have greater solvation energies than the enol form. The keto form is more 
solvated than the enol form by 4.88 kcal mol-1, while the enaminone is more 
exothermically solvated by 3.47 kcal mol-1. This is consistent with a greater hydrogen-
bonding contribution from DMSO-d6 to solvation for the enaminone than for the enol. Of 
course, the interpretations of the diagrams in Figure 2.14 and 2.16 depend on the 








Figure 2.16 Energy differences between the tautomers of 194 in the gas phase (DFT) 
and in DMSO-d6 solution showing the relative solvation energies of these 
tautomers upon dissolving into DMSO-d6 
Table 2.12 summarizes the gas phase calculated energies, energy differences and 
dipole moments of 195a-195c using DFT and MP2 methods. 195 differs from 194 by 












   
Table 2.12 Calculated gas phase energies, energy differences and dipole moments of 




















(× 105 kcal mol-1) 








1.08 2.61 3.01 
4 
Energy 
(× 105 kcal mol-1) 








1.76 2.24 3.18 
a Calculations were performed at 298 K 
b 6-31++g-dp used as the basis set 
c cc-pvtz used as the basis set 
The enol 195a is the most stable tautomer according to both DFT and MP2 
calculations (Entries 1 and 4 in Table 2.12). It is predicted to be 4.88 kcal mol-1 and 4.87 
kcal mol-1 more stable than the keto form 195b according to DFT and MP2 methods, 
respectively (Entries 2 and 5 in Table 2.12). The predicted E between the enol 195a and 
enaminone 195c tautomers is significantly different in MP2 calculations (7.69 kcal mol-1) 
and the stability order between keto and enaminone forms has also reversed, with the 
enaminone 2.82 kcal mol-1 less stable than the keto form. Both methods also predicted 
enaminone tautomer 195c as the most polar, followed by the keto 195b and then the enol 

























Table 2.13 Population ratios of 195a-195c in CDCl3, C6D6 and DMSO-d6 at 20 C from













DFT = 1.08 














DFT = 3.01 
MP2 = 3.18
1 CDCl3 4.8 1.04 1 1.32 -
2 C6D6 2.3 0 1 0.32 -
3 DMSO-d6 46.7 3.96 1 0.52 0.13 
Table 2.14 Keq and G for the equilibrium between 195a and 195b in CDCl3 and C6D6 




G = -RT lnKeq 
keto  kJ mol-1 kcal mol-1 
1 CDCl3 0.76 0.69 0.16 
2 C6D6 3.13 -2.78 -0.66 
3 DMSO-d6 1.92 -1.59 -0.38 
As discussed above, the enol 195a is predicted to be the most stable tautomer. 
Hence, it is the predicted to be most populated form in the gas phase. However, in CDCl3 
the keto tautomer 195b was more populated than enol form (Entry 1 in Table 2.13). The 
equilibrium constant (Keq = 0.76) favors the keto tautomer 195b by a G value of 0.16 
kcal mol-1 in CDCl3 (Entry 1 in Table 2.14). The solvation energy released, when the keto 
form is dissolved in moderately polar CDCl3, stabilizes the keto form. Therefore, using 
the same type of energy diagram as was applied for 194 in Figure 2.14, we can predict 






form 195a when employing the DFT calculations for the gas phase. In C6D6, this 
approach also predicts that the keto tautomer 195b is still more exothermically solvated
than the enol 195a, but only by 4.22 kcal mol-1. This amount of solvation still leaves the 
enol slightly more stable in C6D6, so it predominates. The enol tautomer 195a was also 
predicted to be the least polar tautomer in the gas phase. 
All three tautomeric forms were seen in the very polar DMSO-d6 (Entry 3 in 
Table 2.13) as in the case for the equilibrating tautomers of 194 (Entry 3 in Table 2.10). 
Theoretical calculations of the dipole moments of the 195 tautomers predicted that in a 
polar solvent the gas phase equilibrium should shift from the enol 195a towards both keto 
195b and enaminone 195c forms. The enol form 195a is the most populated form in 
DMSO-d6 followed by the keto and then the enaminone. However, compared to the gas 
phase populations, the equilibria are clearly shifted more towards the keto and enaminone 
forms in DMSO-d6. This is in contrast to the population order seen with the equilibrating 
tautomers of 194 (Entry 3 in Table 2.10). The energy diagram in Figure 2.17 shows that 
the keto 195b and the enaminone 195c are only 4.5 kcal mol-1 and 1.23 kcal mol-1, 
respectively, more exothermically solvated than the enol 195a in DMSO-d6. These 
solvation energy differences still leave the enol form more stable than the keto and 
enaminone forms. Hydrogen bonding (illustrated in Figure 2.15 on page 70) stabilizes 
both enol 195a and enaminone 195c forms. Therefore, both enol and enaminone 
tautomers had the lower energies and the population of 195a predominated. Again, 
differential solvation stabilizations have affected in the change in populations of 






Figure 2.17 Energy differences between the tautomers of 195 in the gas phase (DFT) 
and in DMSO-d6 solution showing the relative solvation energies of these 










Table 2.15 Calculated gas phase energies, energy differences and dipole moments of 




















(× 105 kcal mol-1) 
-6.4722864 -6.4723765 -6.4723307 
2 DFTb E 
(kcal mol-1) 




2.44 3.22 3.73 
4 
Energy 
(× 105 kcal mol-1) 
-6.4609011 -6.4609795 -6.4608976 
5 MP2c E 
(kcal mol-1) 




2.07 3.04 3.82 
a Calculations were performed at 298 K 
b 6-31++g-dp used as the basis set 
c cc-pvtz used as the basis set 
The keto tautomer 196b is the most stable and the enol tautomer 196a is the least 
stable form in the gas phase according to DFT calculations (Entry 1 in Table 2.15). The 
MP2 level calculations also show the keto form is most stable but the enaminone is least 
stable (Entry 4 in Table 2.15). These stability orders differ from those found for the close 
structural analogs 194a-c and 195a-c, where the only structural differences are a 
hydrogen has replaced a methyl at both C-4 and C-5, and only C-5, respectively of the 
ring. In both 194 and 195 the corresponding enol tautomer was predicted to be the most 
stable (Tables 2.9 and 2.12). Enaminone 196c is more stable than the enol form 196a by 
4.43 kcal mol-1 (DFT) (Entry 2 in Table 2.15). However, the MP2 method predicts the 



























and enaminone energy levels are closer than that predicted by the DFT method. The
enaminone form 196c is the most polar form (the largest dipole moment) according to 
both DFT and MP2 calculations (Entries 3 and 6 in Table 2.15). The enol form 196a is 
predicted to be the least polar similar to the equilibrating tautomers of 194 (Table 2.9) 
and 195 (Table 2.12). 
Table 2.16 Population ratios of 196a-196c in CDCl3, C6D6 and DMSO- d6 at 20 C 













DFT = 2.44 














DFT = 3.73 
MP2 = 3.82
1 CDCl3 4.8 1.04 1 1.41 -
2 C6D6 2.3 0 1 0.27 -
3 DMSO-d6 46.7 3.96 1 0.78 0.59 
Table 2.17 Keq and G for the equilibrium between 196a and 196b in CDCl3, C6D6 




G = -RTlnKeq 
keto  kJ mol-1 kcal mol-1 
1 CDCl3 0.71 0.83 0.20 
2 C6D6 3.70 -3.19 -0.76 
3 DMSO-d6 1.28 -0.60 -0.14 
The keto form 196b was predicted to be 9.01 and 7.84 kcal mol-1 more stable than 






2.15). This keto tautomer 196b also predominated over the enol form 196a in CDCl3 
(Entry 1 in Table 2.16). Based on the population ratio between 196a and 196b, the 
equilibrium constant, 0.71, favored the keto tautomer, which corresponds to a G value 
of only 0.20 kcal mol-1 (Entry 1 in Table 2.17). The keto tautomer is predicted to be more 
favored in the gas phase. Therefore, using these values, one concluded that the enol 
tautomer is more exothermically solvated in C6D6 than the more polar keto tautomer. The 
enol is more exothermically solvated than the keto form by 8.81 kcal mol-1 in CDCl3 
based on DFT gas phase calculations and the G values from NMR integration (Figure 
2.18). However, the most stable keto form still remains as the predominant species. The 
enol 196a is the least stable tautomer in the gas phase (Entries 2 and 5 in Table 2.15). 
Further, the enol was predicted to be the least polar tautomer in the gas phase. Therefore, 
the equilibrium should shift towards the enol in non polar C6D6. As expected, the enol is 
the most solvated tautomer in C6D6 which is predicted by comparing the relative gas 
phase energies calculated by DFT method and the relative solution phase energies from 
the NMR measurements of the tautomer populations in C6D6. The [enol]/[keto] 
equilibrium constant (Keq = 3.70) in C6D6  significantly favored the enol form (Entry 2 in 







Figure 2.18 Energy differences between the tautomers of 196 in the gas phase (DFT) 
and in CDCl3 solution showing the relative solvation energies of these 
tautomers upon dissolving them into CDCl3 
In the polar DMSO-d6, the enol 196a is the most stable tautomer by a small 
amount and hence it is the most abundant form compared to the keto and enaminone 
forms (Entry 3 in Table 2.16). It is slightly favored by 0.14 and 0.30 kcal mol-1 over the 
keto 196b and enaminone 196c tautomers, respectively. The enol is 9.01 kcal mol-1 less 
stable than the keto form according to the DFT method. Combining this with the 0.14 
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kcal mol-1 greater stability of the enol in DMSO-d6, it is 9.15 kcal mol
-1 more
exotherically solvated than the more polar keto form as depicted in Figure 2.19. This 
differential solvation is likely to be due, in part, to hydrogen bonding of the enol to 
DMSO-d6. The enaminone form is also more exothermically solvated than the keto form
despite being 0.16 kcal mol-1 less stable than the keto form in DMSO-d6 (Figure 2.19). 
Hydrogen bonding of both enol and enaminone tautomers to the DMSO-d6 contributes to 
the stronger solvation of these two species relative to the keto tautomer.
The presence of the three enaminone tautomers 194c-196c in DMSO-d6 (and only 
in DMSO-d6 ) was confirmed by observing its resonances in 
1H and 13C NMR spectra. 
The appearance of new proton signals for an NH (11.62-12.77 ppm) and a vinyl proton 
(5.91-6.29 ppm) in their respective 1H NMR spectra, and a carbonyl carbon signal 
between 190-170 ppm in their 13C NMR spectra in DMSO-d6 confirmed the presence of 
the enaminone tautomer.  1H and 13C NMR spectra of equilibrating tautomers 196a-196c
in DMSO-d6 are depicted in Figures 2.20 and 2.21, respectively. Figures 2.22 and 2.23 







Figure 2.19 Energy differences between the tautomers of 196 in the gas phase (DFT) 
and in DMSO-d6 solution showing the relative solvation energies of these 
tautomers upon dissolving into DMSO-d6 
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Figure 2.20 1H NMR spectrum (600 MHz, DMSO-d6 at 20 C) of the tautomers (Z)-2-
(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a, 2-(4,5-dimethylthiazol-2-
yl)-1-phenylethanone 196b and (E)-2-(4,5-dimethylthiazol-2(3H)-ylidene)-
1-phenylethanone 196c in a 1:0.78:0.59 mole ratio, respectively 
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Figure 2.21 13C NMR spectrum (150 MHz, DMSO-d6 at 20 C) of the tautomers (Z)-2-
(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a, 2-(4,5-dimethylthiazol-2-
yl)-1-phenylethanone 196b and (E)-2-(4,5-dimethylthiazol-2(3H)-ylidene)-













Figure 2.22 1H NMR spectrum (600 MHz, C6D6 at 20 
C) of the tautomers (Z)-2-(4,5-
dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-dimethylthiazol-2-












Figure 2.23 DEPT NMR spectrum (150 MHz, C6D6 at 20 C) of the tautomers (Z)-2-
(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-













Table 2.18 Calculated gas phase energies, energy differences and dipole moments of 
197a-197c using DFT and MP2 methodsa 
Ph Ph Ph 
H H H 
HO O O 
H 








(× 105 kcal mol-1) 








2.02 2.60 4.51 
4 
Energy 
(× 105 kcal mol-1) 








2.36 2.34 4.43 
a Calculations were performed at 298 K 
b 6-31++g-dp used as the basis set 
c cc-pvtz used as the basis set 
The enol form 197a is predicted to be the most stable tautomer in the gas phase by 
both DFT and MP2 methods (Entries 1 and 4 in Table 2.18). The energies calculated by 
DFT method for the keto 197b and the enaminone 197c forms are very close to each 
other (Entry 2 in Table 2.18). However, the MP2 calculations predicted that the keto form 
is 4.51 kcal mol-1 more stable than the enaminone form (Entry 5 in Table 2.18). Both 
calculation methods predicted the enaminone 197c as the most polar tautomer in the gas 
phase (Entries 3 and 6 in Table 2.18). The calculated dipole moments of the enol 197a 






















Table 2.19 Population ratios of 197a-197c in CDCl3, C6D6 and DMSO-d6 at 20 C from




























DFT = 4.51 
MP2 = 4.43 
1 CDCl3 4.8 1.04 1 3.57 -
2 C6D6 2.3 0 1 0.83 -
3 DMSO- d6 46.7 3.96 1 2.22 0.67 
Table 2.20 Keq and G for the equilibrium between 197a and 197b in CDCl3, C6D6 




G = -RTlnKeq 
keto  kJ mol-1 kcal mol-1 
1 CDCl3 0.28 3.10 0.74 
2 C6D6 1.20 -0.44 -0.11 
3 DMSO- d6 0.45 1.95 0.47 
Only the keto 197b and enol 197a oxazole-containing tautomers were observed in 
1H NMR spectrum in CDCl3 (Entry  1 in Table 2.19) analogous to equilibrating tautomers 
of thiazole derivatives, 194-196. In contrast to the gas phase results, the keto form was 
more stable than the enol form in CDCl3. The keto form was favored by the equilibrium 
constant (K  eq.= 0.28), corresponding to a G value of 0.74 kcal mol-1 (Entry  1 in Table 
2.20). Solvation has stabilized the keto form by a total of 4.79 kcal mol-1 more than the 
enol form. Thus, the equilibrium in the gas phase, which favored the enol has shifted to 









less polar C6D6 (Entry 2 in Table 2.19) as in the case of thiazole-based tautomers of 194-
196. It is stabilized only by 0.11 kcal mol-1 compared to the keto form. The calculated 
polarities of tautomers 197a and 197b in the gas phase are very close to each. Even 
though, the keto form is more exothermically solvated by 3.94 kcal mol-1 than the enol
form, the less exothermically solvated enol predominated over the keto form in C6D6 
because this smaller differential solvation favoring the keto form could not totally 






Figure 2.24 Energy differences between the tautomers of 197 in the gas phase (DFT) 
and in CDCl3 solution showing the relative solvation energies of these 






Figure 2.25 Energy differences between the tautomers of 197 in the gas phase (DFT) 
and in DMSO-d6 solution showing the relative solvation energies of these 
tautomers upon dissolving into DMSO-d6 
All three tautomeric forms 197a-197c were observed by NMR spectroscopy in the 
very polar DMSO-d6 (Entry 3 in Table 2.19) similar to equilibrating tautomers of thiazole 
derivatives, 194-196. The enaminone tautomer 197c was predicted to be the most polar 
tautomer. Therefore, it might be expected to predominate in polar DMSO-d6. However, 












then the enaminone 197c tautomers in DMSO-d6. The 4.22 kcal mol-1 lower stability (gas 
phase) of the enaminone was not totally overcomes by its greater exothermic solvation 
than the enol form. The keto and enaminone tautomers are 4.52 kcal mol-1 and 3.99 kcal 
mol-1, respectively, more exothermically solvated than the enol form (Figure 2.25). The 
hydrogen bonding of the enaminone tautomers to DMSO-d6 (See Figure 2.15on page 70)
contributes for the solvation of it and therefore, it was observed in addition to the enol 
and keto forms.  
Table 2.21 Calculated gas phase energies, energy differences and dipole moments of 
198a-198c using DFT and MP2 methodsa 
Ph Ph Ph 
H H H 
HO O O 
H 








(× 105 kcal mol-1) 








1.19 3.36 2.49 
4 
Energy 
(× 105 kcal mol-1) 
-4.9063628 -4.9063142 -4.9062944 
5 MP2c E 
(kcal mol-1) 




1.19 3.09 2.37 
a Calculations were performed at 298 K 
b 6-31++g-dp used as the basis set 




















The enol form 198a of the equilibrating benzoxazole derivative tautomers was 
predicted as the most stable, hence the most populated tautomeric form in the gas phase 
by both levels of theoretical calculations (Entries 1 and 4 in Table 2.21). The enol form 
198a is more stable than the keto 198b and enaminone 198c forms by 4.75 and 2.84 kcal 
mol-1, respectively, according to DFT calculations (Entry 2 in Table 2.21). Energies of
the keto tautomer calculated by the two methods are very close to each other. However, 
the stability order predicted by the DFT method for the keto and enaminone forms has 
reversed in MP2 method. The enol tautomer is more stable than the keto tautomer and 
enaminone tautomer by 4.86 and 6.84 kcal mol-1, respectively, as predicted by MP2 
method. The keto form 198b is the most polar and the enol form 198a is the least polar
among the three tautomers of 198 according to both DFT and MP2 calculations.
Table 2.22 Population ratios of 198a-198c in CDCl3, C6D6 and DMSO-d6 at 20 C from
1H NMR integrations 





















DFT = 1.19 DFT = 3.36 DFT = 2.49 
MP2 = 1.19 MP2 = 3.09 MP2 = 2.37 
1 CDCl3 4.8 1.04 1.06 1 -
2 C6D6 2.3 0 4.07 1 -













Table 2.23 Keq and G for the equilibrium between 198a and 198b in CDCl3, C6D6 




G = -RT lnKeq 
keto  kJ mol-1 kcal mol-1 
1 CDCl3 1.06 -0.14 -0.03 
2 C6D6 4.07 -3.42 -0.82 
3 DMSO-d6 0.54 1.50 0.36 
The enol tautomer 198a, which was the most stable tautomer in the gas phase, 
predominated over the keto form 198b in CDCl3 by a very small amount (Entry 1 in 
Table 2.22). The Keq is very close to one in CDCl3 and hence the G is very small (0.03 
kcal mol-1) between keto and enol tautomers (Entry 1 in Table 2.23). However, the keto 
form is more exothermically solvated (4.72 kcal mol-1) than the enol form based on the 
relative calculated energies by the DFT method in the gas phase and the relative energies 
obtained by the population ratios in CDCl3 by the NMR experiment (Figure 2.26).  
The equilibrium constant (Keq = 4.07) has shifted the equilibrium further towards 
the enol form 198a going from moderately polar CDCl3 to less polar C6D6 (Entry 2 in 
Table 2.23). However, the keto tautomer is more exothermically solvated species in C6D6 
(3.93 kcal mol-1). Even though, the keto form is more solvated, the enol, the least polar 




 Figure 2.26 Energy differences between the tautomers of 198 in the gas phase (DFT) 
and in CDCl3 solution showing the relative solvation energies of these 
tautomers upon dissolving them into CDCl3 
Only the enol 198a and the keto 198b tautomers were observed in the 1H NMR 
spectrum in DMSO-d6. This is in contrast to the results that were observed with the 
tautomers of thiazole derivatives 194-196 and oxazole derivative 197 where all three 
tautomers were observed. In DMSO-d6, the equilibrium constant (Keq = 0.54) favors the 
keto form 198b which corresponds to a G value of 0.36 kcal mol-1 (Entry 3 in Table 
2.23). This implies that the most polar keto tautomer has greatly stabilized by the 









1H NMR spectra in C6D6 of equilibrating tautomers 198a-198b are depicted in
Figures 2.28, 2.29 and 2.30, respectively. 
Figure 2.27 Energy differences between the tautomers of 198 in the gas phase (DFT) 
and in DMSO-d6 solution showing the relative solvation energies of these 











Figure 2.28 1H NMR spectrum (600 MHz, DMSO-d6 at 20 C) of the tautomers (Z)-2-
(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-(benzo[d]oxazol-2-yl)-







                                                                                                            
 
 







Figure 2.29 13C NMR spectrum (150 MHz, DMSO-d6 at 20 C) of the tautomers (Z)-2-
(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-(benzo[d]oxazol-2-yl)-











Figure 2.30 1H NMR spectrum (600 MHz, C6D6 at 20 C) of the tautomers (Z)-2- 
(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-(benzo[d]oxazol-2-yl)-











Table 2.24 Calculated gas phase energies, energy differences and dipole moments of 
199a-199c using DFT and MP2 methodsa 
Ph Ph Ph 
H H H 
HO O O 
H 








(× 105 kcal mol-1) 








3.55 2.96 2.31 
4 
Energy 
(× 105 kcal mol-1) 








3.05 2.65 2.25 
a Calculations were performed at 298 K 
b 6-31++g-dp used as the basis set 
c cc-pvtz used as the basis set 
The gas phase energies and the dipole moments of the equilibrating tautomers 
199, derived from benzothiazole, were also calculated. The enaminone form 199c was 
predicted as the most stable tautomer by DFT calculations (Entry 2 in Table 2.24). The 
keto form 199b was predicted as the most stable tautomer by MP2 calculations (Entry 5 
in Table 2.24). However, the energy difference between 199b and 199c is very small 
(0.18 kcal mol-1) as predicted by MP2 calculations compared to that predicted by DFT 
calculations (3.58 kcal mol-1). According to both calculation methods, the enol tautomer 
199a has the highest dipole moment and hence it is the most polar among three tautomers 

























Table 2.25 Population ratios of 199a-99c in CDCl3, C6D6 and DMSO-d6 at 20 C from 













DFT = 3.55 














DFT = 2.31 
MP2 = 2.25 
1 CDCl3 4.8 1.04 1.63 1 -
2 C6D6 46.7 3.96 5.49 1 -
3 DMSO- d6 2.3 0 - 1 7.17 
Table 2.26 Keq and G for the equilibrium between 199a and 199b in CDCl3 and C6D6 




G = -RTlnKeq 
keto  kJ mol-1 kcal mol-1 
1 CDCl3 1.63 -1.19 -0.28 
2 C6D6 5.49 -4.15 -0.99 
In CDCl3, the equilibrium constant (Keq = 1.63) favored the enol tautomer 199a
by a G value of -0.28 kcal mol-1 (Entry 1 in Table 2.26). This enol is the least stable 
tautomer in the gas phase (Entries 2 and 5 in Table 2.24). However, it is the most 
solvated tautomer in CDCl3 (12.35 kcal mol
-1). The solvation of the enol form 199a, 
which is the most polar in the gas phase, stabilizes it in CDCl3 relative to the keto form 
199b as illustrated in Figure 2.31. The calculated dipole moments predict that enaminone 
199c is the least polar and hence it could be expected as the major tautomer to be found 








2 in Table 2.26). This Keq has a G value of -0.99 kcal mol-1. This can also be explained 
by comparing energy differences of tautomers 199 in the gas phase using DFT method 
and in less-polar C6D6 from the NMR experiment. The enol tautomer 199a is 
exothermically stabilized by 13.06 kcal mol-1 than the keto tautomers 199b in C6D6. 
Figure 2.31 Energy differences between the tautomers of 199 in the gas phase (DFT) 
and in CDCl3 solution showing the relative solvation energies of these 






Figure 2.32 Energy differences between the tautomers of 199 in the gas phase (DFT) 
and in DMSO-d6 solution showing the relative solvation energies of these 
tautomers upon dissolving into DMSO-d6 
Interestingly, only the keto 199b and the enaminone 199c tautomers, the two most 
stable tautomers in the gas phase, were observed in DMOS-d6 (Entry 3 in Table 2.22). It 
is very interesting that the enol form 199a, which was predicted as the most polar 
tautomer in the gas phase was not observed in the very polar DMSO-d6. Even though, 
both enol and enaminone tautomers can form hydrogen bonding with DMSO-d6, the 
102 
hydrogen bonding of enaminone has contributed to the stronger exothermic solvation 
stabilization of it allowing it to be found in the tautomeric equilibrium (Figure 2.32). The 
keto tautomer 199b is still 2.43 kcal mol-1 more exothermically solvated than the 
enaminone form 199c but this amount of solvation leaves the enaminone slightly more 
stable in DMSO-d6. Therefore, 199c predominates.    
Figures 2.33 - 2.35 contain 1H and 13C NMR of the equilibrating tautomers 199b 












Figure 2.33 1H NMR spectrum (600 MHz, DMSO-d6 at 20 C) of the tautomers 2-
(benzo[d]thiazol-2-yl)-1-phenylethanone 199b and (E)-2-(benzo[d]thiazol-
















Figure 2.34 13C NMR spectrum (150 MHz, DMSO-d6 at 20 C) of the tautomers 2-
(benzo[d]thiazol-2-yl)-1-phenylethanone 199b and (E)-2-(benzo[d]thiazol-












Figure 2.35 1H NMR spectrum (600 MHz, C6D6 at 20 C) of the tautomers (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-yl)-




The base hydrolysis of the enol-esters 105, 184, 106, 107, 109 and 110 afforded 
the corresponding hydrolysis products, 2-heterocyclic-1-phenyl ethenols (heterocycles 
include thiazoles, oxazoles, benzothiazoles and benzoxazoles), 194-199 in good yield. All 
these hydrolysis products were in keto-enol tautomeric equilibria in CDCl3 at 20 C. This 
was further confirmed by variable temperature experiments at -50 C and 50 C. The 
energies and dipole moments of keto, enol and enaminone forms of the each tautomeric 







pvtz basis sets, respectively. The tautomeric ratios of the thiazole derivatives 194-196, 
oxazole derivative 197, benzoxazole derivative 198 and benzothiazole derivative 199 
were also determined by means of their 1H NMR in the more polar DMSO-d6 and less 
polar C6D6. The population ratios of the enol, keto and enaminone tautomers of 194-199 
were obtained using the corresponding 1H NMR spectra in CDCl3, DMSO-d6 and C6D6. 
The values obtained by 1H NMR were then compared with the gas phase energies 
obtained by computational studies. Tautomeric equilibria of 194-196 significantly varied 
in less polar C6D6 and very polar DMSO-d6 compared to that in CDCl3. The enaminone 
tautomer was observed in DMSO-d6 for the equilibrating tautomers of 194-197 and 199. 
The differential solvation stabilizations in each solvent could be the main factor, which 
governs the equilibrium to favor one tautomer over the other. Hydrogen bonding 
capability of the enol and enaminone forms with the negatively charged oxygen of the 
polar DMSO could be a contributor for the solvation of enol and enaminone tautomers in 
DMSO-d6. 
2.4 Experimental 
2.4.1 General Information 
Chemicals and solvents were purchased from commercial suppliers and used as 
received, except as follows. Acetonitrile and triethylamine were distilled from calcium 
hydride under nitrogen. All reactions were carried out under nitrogen. Silica gel with a 
particle size 230-400 mesh and a pore size 60 Ǻ, purchased from Sorbent Technologies, 
was used as the stationary phase for all flash chromatography analyses.
1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE III - 300 or 






MHz for carbon. The chemical shifts in spectra were reported in parts per million (ppm) 
on the delta (δ) scale relative to the internal standard, tetramethylsilylane for 1H (δ = 0 
ppm) and the center line of the deuterated solvent for 13C (CDCl3: δ = 77.0 ppm and 
DMSO-d6:  = 39.43 ppm) Splitting patterns are designed as “s, d, t, q, and m”, and these 
symbols indicate “singlet, doublet, triplet, quartet, and multiplet,” respectively. Coupling 
constants, J, were reported in Hertz (Hz). 
Melting points were recorded with a Mel-Temp apparatus and were uncorrected. 
IR spectra were recorded on a Nicolet 6700 FT-IR spectrometer.  
2.4.2 Preparation of enol-esters of thiazoles, oxazoles, benzoxazoles and 
benzothiazoles 
2.4.2.1  (Z)-1-Phenyl-2-(thiazol-2-yl)vinyl benzoate 105 
Triethylamine (1.83 g, 18.1 mmol, 3.6 eq.) was added to a stirred solution of 2-
methylthiazole 102 (0.496 g, 5 mmol, 1 eq.) in CH3CN (25 mL) at room temperature 
under nitrogen. Benzoyl chloride (2.13 g, 15 mmol, 3 eq.) in acetonitrile (20 mL) was 
added dropwise into this solution at room temperature under nitrogen. This solution was 
refluxed for 7 h. After cooling to room temperature, acetonitrile was removed by rotary 
evaporation. The residue was dissolved in dichloromethane (30 mL), washed with 
saturated aqueous NaHCO3 (2 × 30 mL) and dried over anhydrous sodium sulfate and 
filtered. After removal of dichloromethane by rotary evaporation, the crude product was 
purified by column chromatography (silica gel, ethyl acetate/hexane = 1:3) to give the 
title compound 105 (1.364 g, 88.8%). This general procedure was also used for the 
syntheses of compounds 106, 107, 109, 110 and 184 discussed in this section. 











1H NMR (300 MHz, CDCl3):  8.33 (d, J = 7.48 Hz, OCOC6H5 ortho, 2H), 7.82 
(d, J = 3.0 Hz, =NCH=CHS, 1H), 7.71 (t, J = 7.40 Hz, OCOC6H5 para, 1H), 7.63-7.55 
and 7.37-7.40 (m, OCOC6H5 meta, CH=C(C6H5)O ortho, meta and para, and 
N,S≥CCH= , 8H), 7.25 (d, J = 3.0 Hz, =NCH=CHS, 1H). 
13C NMR (150 MHz, CDCl3): 163.68 (OCOC6H5), 161.42 (N,S≥C), 150.18 
(CH=C(C6H5)O), 142.77 (=NCH=CHS), 134.13 (OCOC6H5 para), 133.85 
(OCOC6H5 ipso), 130.57 (OCOC6H5 ortho), 129.63 (CH=C(C6H5)O para), 128.89 
(OCOC6H5 meta), 128.85 (CH=C(C6H5)O meta), 128.82 (CH=C(C6H5)O ipso), 
124.96 (CH=C(C6H5)O ortho), 119.66 (=NCH=CHS), 112.08 (N,S≥CCH=).  
DEPT 135 NMR (150 MHz, CDCl3): 142.86, 134.23, 130.62, 129.73, 128.99, 
128.92, 125.06, 119.76, 112.18.
IR (neat, cm-1): 3116, 3069, 3032, 2981, 1732, 1642, 1599, 1448, 1235, 1175, 
1076, 1058, 1023, 762, 707, 692. 
2.4.2.2 (Z)-2-(4-methylthiazol-2-yl)-1-phenylvinyl benzoate 184 
The title compound 184 (3.95 g, 61.5%) was obtained by reacting 2,4-
dimethylthiazole 183 (2.29 g, 20 mmol, 1 eq.), triethylamine (7.29 g, 72 mmol, 3.6 eq.) 
and benzoyl chloride (8.54 g, 61 mmol, 3 eq.) using the general procedure for the 
synthesis and purification of 105. The eluent used for column chromatography over silica 
gel was ethyl acetate/hexane = 1:4.
Rf = 0.40 (ethyl acetate/hexane = 1:4); yellow solid; mp = 125-126 C. 
1H NMR (300 MHz, CDCl3):  8.33 (d, J = 7.19 Hz, OCOC6H5 ortho, 2H), 7.71 





   
 
 
CH=C(C6H5)O ortho, meta and para, 7H), 7.30 (s, =NC(CH3)=CHS, 1H), 6.80 (s, 
N,S≥CCH=, 1H), 2.43 (s, =NC(CH3)=CHS, 3H).  
13C NMR (75 MHz, CDCl3): 163.73 (OCOC6H5 or N,S≥C), 160.64 
(OCOC6H5 or N,S≥C), 152.69 (CH=C(C6H5)O or =NC(CH3)=CHS), 149.87 
(CH=C(C6H5)O or =NC(CH3)=CHS), 134.06 (OCOC6H5 para), 133.88 
(OCOC6H5 ipso), 130.50 (OCOC6H5 ortho), 129.52 (CH=C(C6H5)O para), 128.88 
(OCOC6H5 meta), 128.78 (CH=C(C6H5)O meta, 3C), 124.84 (CH=C(C6H5)O
ortho), 114.63 (=NC(CH3)=CHS), 111.95 (N,S≥CCH=), 16.90 (=NC(CH3)=CHS). 
The ipso carbon is overlapping with other peaks.  
DEPT 135 NMR (150 MHz, CDCl3): 134.15, 130.61, 129.62, 128.98, 128.87, 
124.94, 114.71, 112.05, 17.00. 
IR (neat, cm-1): 3107, 3073, 2971, 2929, 1731, 1635, 1599, 1510, 1448, 1421, 
1232, 1079, 1059, 1025, 1000, 968, 871, 765, 750, 692. 
HRMS (ESI, M+H): calcd for C19H15NO2S: 322.0900; found: 322.0880. 
2.4.2.3 (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylvinyl benzoate 106 
The title compound 106 (1.11 g, 66.1%) was obtained using 2,4,5-
trimethylthiazole 103 (0.636 g, 5 mmol, 1 eq.), triethylamine (1.84 g, 18 mmol, 3.6 eq.) 
and benzoyl chloride (2.13 g, 15 mmol, 3 eq.) by the general procedure used for the 
synthesis and purification of 105. Ethyl acetate/hexane = 1:3 was used as the eluent for 
column chromatography. 
Rf = 0.50 (ethyl acetate/hexane =1:3); yellow solid; mp = 156-158 C. 
1H NMR (300 MHz, CDCl3):  8.33 (d, J = 7.55 Hz, OCOC6H5 ortho, 2H), 7.72 










CH=C(C6H5)O ortho, meta and para, 7H), 7.23 (s, N,S≥CCH=, 1H), 2.31 (s, 
=NC(CH3)=C(CH3)S or =NC(CH3)=C(CH3)S, 3H), 2.28 (s, =NC(CH3)=C(CH3)S or 
=NC(CH3)=C(CH3)S, 3H). 
13C NMR (150 MHz, CDCl3): 163.84 (OCOC6H5 or N,S≥C), 156.69 
(OCOC6H5 or N,S≥C), 148.75 (CH=C(C6H5)O or =NC(CH3)=C(CH3)S), 148.38 
(CH=C(C6H5)O or =NC(CH3)=C(CH3)S), 134.03 (OCOC6H5 ipso), 134.01 
(OCOC6H5 para), 130.54 (OCOC6H5 ortho), 129.29 (CH=C(C6H5)O para), 129.00 
(OCOC6H5 ipso), 128.85 (OCOC6H5 meta or CH=C(C6H5)O meta), 128.79 
(OCOC6H5 meta or CH=C(C6H5)O meta), 127.80 (=NC(CH3)=C(CH3)S), 124.73 
(CH=C(C6H5)O ortho), 112.24 (N,S≥CCH=), 14.54 (=NC(CH3)=C(CH3)S or 
=NC(CH3)=C(CH3)S), 11.35 (=NC(CH3)=C(CH3)S or =NC(CH3)=C(CH3)S). 
DEPT 135 NMR (150 MHz, CDCl3): 134.09, 130.81, 129.37, 128.93, 128.87, 
124.81, 112.32, 14.62, 11.43. 
IR (neat, cm-1): 3066, 3045, 2951, 2915, 1741, 1655, 1537, 1450, 1432, 1227, 
1076, 1050, 1023, 885, 767, 694. 
2.4.2.4 (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylvinyl benzoate 107
The title compound 107 (1.26 g, 78.9%) was obtained using 2,4,5-
trimethyloxazole 104 (0.585 g, 5 mmol, 1 eq.), triethylamine (1.87 g, 18.5 mmol, 3.7 eq.) 
and benzoyl chloride (2.15 g, 15.1 mmol, 3 eq.). The general procedure used for both the 
synthesis and purification of 105 was followed. The crude product was purified by 
column chromatography using ethyl acetate/hexane = 1:4 over silica gel. 









1H NMR (300 MHz, CDCl3):  8.27 (d, J = 7.47 Hz, OCOC6H5 ortho, 2H), 
7.69-7.37 (m, OCOC6H5 meta and para, and CH=C(C6H5)O ortho, meta and para, 
8H), 6.83 (s, N,S≥CCH=, 1H), 2.01 (s, =NC(CH3)=C(CH3)O or =NC(CH3)=C(CH3)O, 
3H), 1.92 (s, =NC(CH3)=C(CH3)O or =NC(CH3)=C(CH3)O, 3H). 
13C NMR (150 MHz, CDCl3): 164.62 (OCOC6H5 or N,O≥C), 155.83 
(OCOC6H5 or N,O≥C), 149.71 (CH=C(C6H5)O or =NC(CH3)=C(CH3)O), 143.42 
(CH=C(C6H5)O or =NC(CH3)=C(CH3)O), 133.82 (OCOC6H5 ipso), 133.42 
(OCOC6H5 para), 132.00 (CH=C(C6H5)O ipso), 130.16 (OCOC6H5 ortho), 129.54 
(CH=C(C6H5)O para), 129.73 (=NC(CH3)=C(CH3)O), 128.69 (OCOC6H5 meta or 
CH=C(C6H5)O meta), 128.37 (OCOC6H5 meta or CH=C(C6H5)O meta), 124.86 
(CH=C(C6H5)O ortho), 103.10 (N,O≥CCH=), 10.92 (=NC(CH3)=C(CH3)O or 
(=NC(CH3)=C(CH3)O), 9.59 (=NC(CH3)=C(CH3)O or (=NC(CH3)=C(CH3)O).  
DEPT 135 NMR (150 MHz, CDCl3): 133.62, 130.35, 129.73, 128.88, 128.56, 
125.05, 103.29, 11.11, 9.78. 
IR (neat, cm-1): 3062, 2978, 2953, 2923, 2858, 1738, 1633, 1449, 1236, 1175, 
1082, 1064, 1024, 1000, 760, 705, 689. 
2.4.2.5 (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylvinyl benzoate 109 
The title compound 109 (2.94 g, 43%) was obtained by the reaction of 2-
methylbenzoxazole 108 (2.69 g, 20 mmol, 1 eq.), triethylamine (7.48 g, 74 mmol, 3.7 eq.) 
and benzoyl chloride (8.51 g, 60.5 mmol, 3 eq.). The general procedure used for the 
synthesis and purification of 105 was employed. The eluent used for column 
chromatography over silica gel was ethyl acetate/hexane = 1:5. 










1H NMR (300 MHz, CDCl3):  8.32 (d, J = 7.68 Hz, OCOC6H5 ortho, 2H), 
7.71-7.67, 7.60-7.54, 7.41-7.40 and 7.24-7.18 (m, OCOC6H5 meta and para, 
CH=C(C6H5)O ortho, meta and the four aromatic CHs on the benzoxazole ring, 11H), 
7.11 (d, J = 8.04 Hz, CH=C(C6H5)O para, 1H) 7.04 (s, CH=C(C6H5)O, 1H). 
13C NMR (150 MHz, CDCl3): 164.47 (OCOC6H5 or N,O≥C), 159.75 
(OCOC6H5 or N,O≥C), 154.09 (CH=C(C6H5)O or C next to O in the benzoxazole 
ring), 150.06 (CH=C(C6H5)O or C next to O on the benzoxazole ring), 141.57 (C next 
to N on the benzoxazole ring), 133.67 (OCOC6H5 para), 133.58 (OCOC6H5 ipso), 
130.45 (CH=C(C6H5)O para), 130.41 (OCOC6H5 ortho), 129.37 (CH=C(C6H5)O
ipso), 128.87 (OCOC6H5 meta or CH=C(C6H5)O meta), 128.56 (OCOC6H5 meta or 
(CH=C(C6H5)O meta), 125.48 (CH=C(C6H5)O ortho), 125.19, 124.39, 119.95 and 
110.12 (aromatic CHs on the benzoxazole ring), 103.22 (N,O≥CCH=). 
DEPT 135 NMR (150 MHz, CDCl3): 133.84, 130.61, 130.58, 129.04, 128.72, 
125.64, 125.36, 124.56, 120.11, 110.29. 103.38. 
IR (neat, cm-1): 3078, 1731, 1644, 1605, 1540, 1451, 1234, 1181, 1152, 1084, 
1067, 1027, 946, 848, 790, 746, 701, 687. 
2.4.2.6 (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylvinyl benzoate 110
The title compound 110 (1.89 g, 53%) was prepared from 2-methylbenzothiazole 
39 (1.51 g, 10 mmol, 1 eq.), triethylamine (3.71 g, 36.7 mmol, 3.7 eq.) and benzoyl 
chloride (4.26 g, 30 mmol, 3 eq.) by the general procedure used for the synthesis and 
purification of 105. Ethyl acetate/hexane = 1:6 was used as the eluent for column
chromatography over silica gel. 












1H NMR (600 MHz, CDCl3):  8.36 (d, J = 7.80 Hz, OCOC6H5 ortho, 2H), 7.97 
(d, J = 8.19 Hz, aromatic H in benzothiazole ring, 1H), 7.73 (dd, OCOC6H5 meta, 2H) 
7.65 (d, J = 7.65 Hz, CH=C(C6H5)O ortho, 2H), 7.60 (dd, CH=C(C6H5)O meta, 
2H), 7.45-7.39 (m, OCOC6H5 para, three aromatic CHs on the benzothiazole ring and 
CH=C(C6H5)O, 5H), 7.31 (t, J = 7.56 Hz, CH=C(C6H5)O para, 1H). 
13C NMR (150 MHz, CDCl3): 163.71 (OCOC6H5 or N,S≥C), 161.38 
(OCOC6H5 or N,S≥C), 152.57 (CH=C(C6H5)O or C next to S in the benzothiazole 
ring), 152.48 (CH=C(C6H5)O or C next to S in the benzothiazole ring), 135.05 (C next 
to N in the benzothiazole ring), 134.20 (OCOC6H5 para), 133.73 (OCOC6H5 ipso), 
130.63 (OCOC6H5 ortho), 130.05 (CH=C(C6H5)O para), 128.95 (OCOC6H5 meta or 
(CH=C(C6H5)O meta), 128.88 (OCOC6H5 meta or (CH=C(C6H5)O meta), 128.80 
(CH=C(C6H5)O ipso), 126.25 and 125.32 (aromatic CHs on the benzothiazole ring), 
125.21 (CH=C(C6H5)O ortho), 123.00 and 121.29 (aromatic CHs on the benzothiazole 
ring), 112.44 (N,S≥CCH=). 
DEPT 135 NMR (150 MHz, CDCl3): 134.32, 130.74, 130.17, 129.07, 129.00, 
126.37, 125.44, 124.33, 123.12, 121.41. 112.56. 
IR (neat, cm-1): 3061, 2981, 1739, 1641, 1596, 1452, 1445, 1432, 1227, 1209, 
1175, 1080, 1055, 1023, 1000, 850, 754, 656. 
2.4.3 Synthesis of the equilibrating tautomers of 2-(thiazole, oxazole, benzoxazole and 
benzothiazole)-1-phenylethenols 
2.4.3.1 (Z)-1-phenyl-2-(thiazol-2-yl)ethenol 194a and 1-phenyl-2-(thiazol-2-
yl)ethanone 194b 
(Z)-1-Phenyl-2-(thiazol-2-yl)vinyl benzoate 105 (2.144 g, 6.98 mmol, 1 eq.) was 










MeOH (10 mL), was added dropwise into this solution and stirred for 24 h at room
temperature. Then MeOH was removed by rotary evaporation. The residue was dissolved 
in water (30 mL), neutralized with 1M H2SO4 and extracted with dichloromethane (25 
mL × 2). The organic layer was further washed with water (30 mL), dried over anhydrous 
sodium sulfate and filtered. After removal of dichloromethane by rotary evaporation, the 
crude product was purified by column chromatography (silica gel, ethyl acetate/hexane = 
1:4) to isolate the titled compounds (1.273 g, 89.8%). 1H and 13C NMR in CDCl3 
confirmed that the isolated product consists of the equilibrating tautomers (Z)-1-phenyl-
2-(thiazol-2-yl)ethenol 194a and 1-phenyl-2-(thiazol-2-yl)ethanone 194b in a 1:2.0 ratio. 
Tautomers 194a and 194b (0.971 g, 97%) were isolated in another batch by 
reacting (Z)-1-phenyl-2-(thiazol-2-yl)vinyl benzoate 105 (1.509 g, 4.9 mmol) and KOH 
(0.554 g, 9.87 mmol, 2 eq.) in 30 mL of anhydrous MeOH. This general procedure was 
used for the hydrolysis of enol-esters 184, 106, 107, 109 and 110 to isolate corresponding 
equilibrating tautomers of 195-199, respectively.
Rf = 0.48 (ethyl acetate/hexane = 1:3); dark green oil.  
1H NMR (600 MHz, CDCl3):  (broadOH, 1H), 7.99 (d, J = 7.56 Hz, 
C6H5 ortho in 194b, 2H), 7.74 (d, J = 7.95 Hz, ortho in 194a, 2H), 7.70 (d, J = 3.25, 
=NCH=CHS in 194b, 1H), 7.61 (d, J = 3.32 Hz, =NCH=CHS in 194a, 1H), 7.53 (t, J
= 7.37 Hz, C6H5 meta in 194a, 2H), 7.42 (t, J = 7.70 Hz, C6H5 meta in 194b, 2H), 7.35-
7.31 (m, para in both 194a and 194b, 2H), 7.26 (d, J = 3.25 Hz, =NCH=CHS in 194b, 
1H), 7.00 (d, J = 3.32 Hz, =NCH=CHS in 194a, 1H), 6.28 (s, =CH in 194a, 1H), 4.69 
(s, CH2 in 194b, 2H). 
The areas of the peaks for 194a and 194b were considered separately since their 





of the vinyl proton (=CH) peak of the enol tautomer 194a at 6.28 ppm at one versus the 
rest of the resonances for 194a. The area of the methylene protons (CH2) of the keto 
tautomer 194b at 4.69 ppm was set at two versus the rest of the resonances for 194b. The 
integration values of each peak and coupling patterns were used when assigning proton 
signals for the each tautomer. To obtain the mole ratio between 194a and 194b in CDCl3, 
the integrated area of the CH2 at 4.69 ppm was set at two and then the =CH peak at 6.28 
ppm was integrated and found to have an area of 0.5 versus the integrated area of the 
methylene proton peak of the keto form. The enol =CH peak corresponds to one proton 
per molecule and the keto CH2 peak corresponds to two protons per molecule.  Therefore, 
to calculate the mole ratio between 194a and 194b, half of the keto CH2 integrated area 
(1.0) of 194b was divided by the enol =CH integrated area (0.5). This gave 1:2.0 ratio for 
194a:194b. 
13C NMR (150 MHz, CDCl3): 194.46 (CH2CO in 194b), 168.35 (=C(OH) in 
194a), 162.15 and 160.64 (N,S≥C in 194a and 194b), 142.10 and 140.11 
(>NCH=CHS in 194a and 194b), 135.71 and 134.60 (COC6H5, ipso in 194a and 
194b), 133.71 and 129.63 (COC6H5, para in 194a and 194b), 128.74 (COC6H5, ortho 
in 194b), 128.52 (COC6H5, meta in 194b), 128.34 (COC6H5, ortho in 194a), 125.42 
(COC6H5, meta in 194a), 120.04 and 114.39 (=NCH=CHS in 194a and 194b), 90.99 
(N,S≥CCH= in 194a), 42.65 (N,S≥CCH2 in 194b). 
DEPT 135 NMR (150 MHz, CDCl3): 142.24, 140.25, 133.85, 129.77, 128.88, 
128.66, 128.52, 125.56, 120.18, 114.53, 91.13, 42.78. 
IR (neat, cm-1): 3117, 3084, 3060, 1687, 1622, 1598, 1576, 1494, 1483, 1449, 











2.4.3.2 (Z)-2-(4-methylthiazol-2-yl)-1-phenylethenol 195a and 2-(4-methylthiazol-2-
yl)-1-phenylethanone 195b
Tautomers (Z)-2-(4-methylthiazol-2-yl)-1-phenylethenol 195a and 2-(4-
methylthiazol-2-yl)-1-phenylethanone 195b were synthesized by reacting (Z)-2-(4-
methylthiazol-2-yl)-1-phenylvinyl benzoate 184 (1.045 g, 3.25 mmol, 1 eq.) in 15 mL of 
anhydrous MeOH and KOH (0.365 g, 6.51  mmol) in 10 mL MeOH by the general 
procedure used for the synthesis and purification of hydrolyzed product 194. The eluent 
used for column chromatography over silica gel was ethyl acetate/hexane = 1:7. 
Tautomers 195a and 195b (0.473 g, 66.9%) was isolated. 1H and 13C NMR in CDCl3 
confirmed that the isolated product consists of equilibrating tautomers (Z)-2-(4-
methylthiazol-2-yl)-1-phenylethenol 195a and 2-(4-methylthiazol-2-yl)-1-phenylethanone 
195b in a 1:1.32 ratio. 
Rf = 0.42 (ethyl acetate/hexane = 1:7); yellow solid; mp = 96-97 C. 
1H NMR (300 MHz, CDCl3):  (broadOH, 1H), 7.98 (d, J = 7.23 Hz, C6H5 
ortho in 195b, 2H), 7.74-7.72 (d, J = 7.73 Hz, C6H5 ortho in 195a, 2H), 7.52 (t, J = 6.90 
Hz, C6H5 para in 195b, 1H), 7.42 (t, J = 7.79 Hz, C6H5 meta in 195b, 2H), 7.37-7.42 (m, 
C6H5 meta and para in 195a, 3H), 6.79 (d, J = 0.71 Hz, =NC(CH3)=CHS in 195b, 1H), 
6.53 (d, J = 0.74 Hz, =NC(CH3)=CHS in 195a, 1H), 6.21 (s, =CH in 195a, 1H), 4.63 (s, 
CH2 in 195b, 2H), 2.37 (s, J = 0.75 Hz, =NC(CH3)=CHS in 195b, 3H), 2.35 (d, J = 
0.78 Hz, =NC(CH3)=CHS in 195a, 3H). 
The areas of the peaks for 195a and 195b were considered separately since their 
mole ratio in the solution was not 1:1. All peaks were first integrated by setting the area 
of the vinyl proton (=CH) peak of the enol tautomer 195a at 6.21 ppm at one versus the 
rest of the resonances for 195a. The area of the methylene protons (CH2) of the keto 





integration values of each peak and coupling patterns were used when assigning proton 
signals for the each tautomer. To obtain the mole ratio between 195a and 195b in CDCl3, 
the integrated area of the CH2 at 4.63 ppm was set at two and then the =CH peak at 6.21 
ppm was integrated and found to have an area of 0.76 versus the integrated area of the 
methylene proton peak of the keto form. The enol =CH peak corresponds to one proton 
per molecule and the keto CH2 peak corresponds to two protons per molecule. Therefore, 
to calculate the mole ratio between 195a and 195b, half of the keto CH2 integrated area 
(1.0) of 195b was divided by the enol =CH integrated area (0.76). This gave 1:1.32 ratio 
for 195a:195b. 
13C NMR (75 MHz, CDCl3): 194.58 (CH2CO in 195b), 167.58 (=C(OH) in 
195a), 161.37 and 160.52 (N,S≥C in 195a and 195b), 152.02 and 150.11 
(=NC(CH3)=CHS in 195a and 195b), 135.61 and 134.67 (COC6H5, ipso in 195a and 
195b), 133.70 and 129.53 (COC6H5, para in 195a and 195b), 128.27 (COC6H5, ortho 
in 195b), 128.44 and 128.37 (COC6H5, meta in 195a and 195b), 125.30 (COC6H5, 
ortho in 195a), 114.56 (=NC(CH3)=CHS in 195b), 108.92 (=NC(CH3)=CHS in 
195a), 91.06 (N,S≥CCH= in 195a), 42.68 (N,S≥CCH2 in 195b), 16.95 
(=NC(CH3)=CHS in 195b), 16.68 (=NC(CH3)=CHS in 195b). 
DEPT 135 NMR (150 MHz, CDCl3): 133.74, 129.64, 128.83, 128.61, 128.48, 
125.49, 114.6, 108.98, 91.19, 42.86, 17.01, 16.75. 
IR (neat, cm-1): 3106, 3053, 2956, 2918, 1608, 1574, 1519, 1492, 1454, 1259, 













2.4.3.3 (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-dimethyl- 
thiazol-2-yl)-1-phenylethanone 196b
Tautomers (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-
dimethylthiazol-2-yl)-1-phenylethanone 196b were synthesized by reacting (Z)-2-(4,5-
dimethylthiazol-2-yl)-1-phenylvinyl benzoate 106 (0.502 g, 1.50 mmol, 1 eq.) in 10 mL
of anhydrous MeOH and KOH (0.168 g, 2.99  mmol, 2 eq.) in 10 mL MeOH by the 
general procedure used for the synthesis and purification of equilibrating tautomers of
194. The eluent used for column chromatography over silica gel was ethyl acetate/hexane 
= 1:7. Tautomers 196a and 196b (0.308 g, 84.8%) was isolated. 1H and 13C NMR in 
CDCl3 confirmed that the isolated product consists of equilibrating tautomers (Z)-2-(4-
methylthiazol-2-yl)-1-phenylethenol 196a and 2-(4-methylthiazol-2-yl)-1-phenylethanone 
196b in a 1:1.41 ratio. 
Rf = 0.44 (ethyl acetate/hexane = 1:6); yellow solid; mp = 80-81 C. 
1H NMR (300 MHz, CDCl3): 13.52 (broadOH, 1H), 8.04 (d, J = 7.66 Hz, C6H5 
ortho in 196b, 2H), 7.79 (d, J = 7.41 Hz, C6H5 ortho in 196a, 2H), 7.58 (t, J = 7.38 Hz, 
C6H5 para in 196b, 1H), 7.48 (t, J = 7.57 Hz, C6H5 meta in 196b, 2H), 7.41-7.35 (m, 
C6H5 meta and para in 196a, 3H), 6.19 (s, =CH in 196a, 1H), 4.61 (s, CH2 in 196b, 
2H), 2.32, 2.31 and 2.30 (s, =NC(CH3)=C(CH3)S and =NC(CH3)=C(CH3)S in both 
196a and 196b, 12H). 
The areas of the peaks for 196a and 196b were considered separately since their 
mole ratio in the solution was not 1:1. All peaks were first integrated by setting the area 
of the vinyl proton (=CH) peak of the enol tautomer 196a at 6.19 ppm at one versus the 
rest of the resonances for 196a. The area of the methylene protons (CH2) of the keto 
tautomer 196b at 4.61 ppm was set at two versus the rest of the resonances for 196b. The 






signals for the each tautomer. To obtain the mole ratio between 196a and 196b in CDCl3, 
the integrated area of the CH2 at 4.61 ppm was set at two and then the =CH peak at 6.19 
ppm was integrated and found to have an area of 0.71 versus the integrated area of the 
methylene proton peak of the keto form. The enol =CH peak corresponds to one proton 
per molecule and the keto CH2 peak corresponds to two protons per molecule.  Therefore, 
to calculate the mole ratio between 196a and 196b, half of the keto CH2 integrated area 
(1.0) of 196b was divided by the enol =CH integrated area (0.71). This gave 1:1.41 ratio 
for 196a:196b. 
13C NMR (75 MHz, CDCl3): 194.79 (CH2CO in 196b), 164.01 (=C(OH) in 
196a), 160.45 and 157.33 (N,S≥C in both 196a and 196b), 147.50 and 145.00 
(=NC(CH3)=C(CH3)S in both 196a and 196b), 135.86 and 135.10 (COC6H5, ipso in 
both 196a and 196b), 133.57 and 129.32 (COC6H5, para in both 196a and 196b), 
128.69 and 128.52 (COC6H5, ortho in both 196a and 196b), 128.33 (COC6H5, meta in 
196a or 196b), 127.27 (=NC(CH3)=C(CH3)S in 196a or 196b), 125.25 (COC6H5, 
meta in 196a or 196b), 121.56 (=NC(CH3)=C(CH3)S in 196a or 196b), 90.64 
(N,S≥CCH in 196a), 42.92 (N,S≥CCH2 in 196b), 14.52 (=NC(CH3)=C(CH3)S in 
196b), 14.24 (=NC(CH3)=C(CH3)S in 196a), 11.23 (=NC(CH3)=C(CH3)S in 196b),
11.14 (=NC(CH3)=C(CH3)S in 196a). 
DEPT 135 NMR (150 MHz, CDCl3): 133.68, 129.42, 128.80, 128.44, 125.35, 
90.75, 43.02, 14.63, 14.34, 11.34, 11.25.
IR (neat, cm-1): 3089, 3055, 3038, 2980, 2918, 1630, 1573, 1555, 1492, 1454, 







    
 
2.4.3.4 (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-dimethyl-
oxazol-2-yl)-1- phenylethanone 197b
Tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-
dimethyloxazol-2-yl)-1- phenylethanone 197b were synthesized by reacting (Z)-2-(4,5-
dimethyloxazol-2-yl)-1-phenylvinyl benzoate 107 (1.6 g, 5.1 mmol, 1 eq.) in 15 mL of 
anhydrous MeOH and KOH (0.578 g, 10.3  mmol, 2 eq.) in 10 mL MeOH by the general 
procedure used for the synthesis and purification of equilibrating tautomers of 194. The 
eluent used for column chromatography over silica gel was ethyl acetate/hexane = 1:7. 
Tautomers 197a and 197b (0.811 g, 73.8%) was isolated. 1H and 13C NMR in CDCl3 
confirmed that the isolated product consists of equilibrating tautomers (Z)-2-(4,5-
dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-dimethyloxazol-2-yl)-1- 
phenylethanone 197b in 1:3.57 ratio. 
Rf = 0.57 (ethyl acetate/hexane = 1:6); dark green oil.  
1H NMR (600 MHz, CDCl3): OH peak was not seen, 7.94 (d, J = 7.66 Hz, 
C6H5 ortho in 197b, 2H), 7.71 (d, J = 7.72, C6H5 ortho in 197a 2H), 7.51 (m, C6H5 meta
and para in 197a, and C6H5 meta in 197b, 5H), 7.32 (t, J = 7.56, para in 197b, 1H), 5.91 
(s, =CH in 197a, 0.40H), 4.37 (s, CH2 in 197b, 2H), 2.17 (s, =NC(CH3)=C(CH3)S
or =NC(CH3)=C(CH3)O in 197a, 3H), 2.14 (s, =NC(CH3)=C(CH3)O or 
=NC(CH3)=C(CH3)O in 197b, 3H), 2.03 =NC(CH3)=C(CH3)O or 
=NC(CH3)=C(CH3)O in 197a, 3H), 2.02 =NC(CH3)=C(CH3)O or 
=NC(CH3)=C(CH3)O in 197b, 3H). 
The areas of the peaks for 197a and 197b were considered separately since their 
mole ratio in the solution was not 1:1. All peaks were first integrated by setting the area 
of the vinyl proton (=CH) peak of the enol tautomer 197a at 5.91 ppm at one versus the 






tautomer 197b at 4.37 ppm was set at two versus the rest of the resonances for 197b. The 
integration values of each peak and coupling patterns were used when assigning proton 
signals for the each tautomer. To obtain the mole ratio between 197a and 197b in CDCl3, 
the integrated area of the CH2 at 4.37 ppm was set at two and then the =CH peak at 5.91 
ppm was integrated and found to have an area of 0.28 versus the integrated area of the 
methylene proton peak of the keto form. The enol =CH peak corresponds to one proton 
per molecule and the keto CH2 peak corresponds to two protons per molecule.  Therefore, 
to calculate the mole ratio between 197a and 197b, half of the keto CH2 integrated area 
(1.0) of 197b was divided by the enol =CH integrated area (0.28). This gave 1:3.57 ratio 
for 197a:197b. 
13C NMR (75 MHz, CDCl3): 193.28 (CH2CO in 197b), 161.23 (=C(OH) in 
197a), 160.92 (N,S≥C in 197a), 155.28 (N,S≥C in 197b), 143.98 
(=NC(CH3)=C(CH3)O in 197b), 140.21 (=NC(CH3)=C(CH3)O in 197a), 135.63 
(COC6H5, ipso in 197b), 134.42 (COC6H5, ipso in 197a), 133.49 (COC6H5, para in 
197b), 130.61 (COC6H5, para in 197a), 129.41 (=NC(CH3)=C(CH3)O in 197b), 
128.88 (=NC(CH3)=C(CH3)O in 197a), 128.57 (COC6H5, ortho in 197b), 128.36 
(COC6H5, meta in 197b), 128.22 (COC6H5, ortho in 197a), 125.08 (COC6H5, meta 
in 197a), 84.01 (N,O≥CCH= in 197a), 38.81 (N,O≥CCH2 in 197b), 10.88 
(=NC(CH3)=C(CH3)O in 197b), 10.73 (=NC(CH3)=C(CH3)O in 197a), 9.75 
(=NC(CH3)=C(CH3)O in 197b), 9.63 (=NC(CH3)=C(CH3)O in 197a). 
DEPT 135 NMR (150 MHz, CDCl3): 133.71, 129.62, 128.78, 128.58, 128.42, 
125.30, 84.23, 39.04, 11.05, 10.95, 9.97, 9.86. 
IR (neat, cm-1): 3059, 2980, 2953, 2924, 2882, 1693, 1633, 1598, 1578, 1532, 








2.4.3.5 (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-(benzo[d]oxazol-2-
yl)-1-phenylethanone 198b 
Tautomers (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-
(benzo[d]oxazol-2-yl)-1-phenylethanone 198b were synthesized by reacting (Z)-2-
(benzo[d]oxazol-2-yl)-1-phenylvinyl benzoate 109 (0.844 g, 2.47 mmol, 1 eq.) in 15 mL
of anhydrous MeOH and KOH (0.28 g, 5.2 mmol, 2.1 eq.) in 10 mL MeOH by the 
general procedure used for the synthesis and purification of equilibrating tautomers of
194. The eluent used for column chromatography over silica gel was ethyl acetate/hexane 
= 1:5. Tautomers 198a and 198b (0.541 g, 92.2%) was isolated. 1H and 13C NMR in 
CDCl3 confirmed that the isolated product consists of equilibrating tautomers (Z)-2-
(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-(benzo[d]oxazol-2-yl)-1-
phenylethanone 198b in a 1.06:1 ratio. 
Rf = 0.64 (ethyl acetate/hexane = 1:5); greenish white solid; mp = 87-89 C 
1H NMR (600 MHz, CDCl3): 12.62 (broadOH, 1H), 8.05 (d, J = 7.74 Hz, 
C6H5 ortho , 2H), 7.88 (dd, aromatic CH, 2H), 7.72 (dd, J = 4.21 Hz, aromatic CH, 1H), 
7.61 (dd, aromatic CH, 2H), 7.52-7.45 (m, aromatic CH, 7H), 7.34-7.31 (dd, J = 6.64 Hz, 
aromatic CH, 3H), 7.28 (t, J = 7.66 Hz, aromatic CH, 1H), 6.21 (s, =CH in 198a, 1H), 
4.64 (s, CH2 in 198b, 2H). 
The areas of the peaks for 198a and 198b were considered separately since their 
mole ratio in the solution was not 1:1. All peaks were first integrated by setting the area 
of the vinyl proton (=CH) peak of the enol tautomer 198a at 6.21 ppm at one versus the 
rest of the resonances for 198a. The area of the methylene protons (CH2) of the keto 
tautomer 198b at 4.64 ppm was set at two versus the rest of the resonances for 198b. The 
integration values of each peak and coupling patterns were used when assigning proton 






the integrated area of the CH2 at 4.64 ppm was set at two and then the =CH peak at 6.21 
ppm was integrated and found to have an area of 1.06 versus the integrated area of the 
methylene proton peak of the keto form. The enol =CH peak corresponds to one proton 
per molecule and the keto CH2 peak corresponds to two protons per molecule.  Therefore, 
to calculate the mole ratio between 198a and 198b, half of the keto CH2 integrated area 
(1.0) of 195b was used respect to the enol =CH integrated area (1.06). This gave 1.06:1 
ratio for 195a:195b. 
13C NMR (150 MHz, CDCl3): 192.38 (CH2CO in 198b), 166.19 (=C(OH) in 
198a), 165.68 (N,O≥C in 198b), 160.41 (N,O≥C in 198a), 151.24 (C next to O in 
benzoxazole rings of 198b), 148.69 (C next to O in benzoxazole rings of 198a), 141.26 
(C next to N in benzoxazole rings of 198b), 139.85 (C next to N in benzoxazole rings of 
198a), 135.66 (COC6H5, ipso in 198b), 134.03 (COC6H5, ipso in 198a), 133.71 
(COC6H5, para in 198b, 130.56 (COC6H5, meta in 198a), 128.85 (COC6H5, ortho in 
198b, 128.59 (COC6H5, meta in 198b, 128.53 (COC6H5, meta in 198a), 125.82 
(COC6H5, ortho in 198a), 124.98 (aromatic CH on the benzoxazole ring in 198b), 
124.61, 124.32 (aromatic CH on the benzoxazole ring in 198b), 124.08 (aromatic CH on 
the benzoxazole ring in 198a), 119.95 (aromatic CH on the benzoxazole ring in 198b), 
117.85 (aromatic CH on the benzoxazole ring in 198a), 110.61 (aromatic CH on the 
benzoxazole ring in 198b), 110.19 (aromatic CH on the benzoxazole ring in 198a), 83.66 
(N,O≥CCH= in 198a), 39.56 (N,O≥CCH2 in 198b). 
DEPT 135 NMR (150 MHz, CDCl3): 133.99, 130.64, 128.93, 128.67, 128.61, 
125.90, 125.07, 124.69, 124.16, 120.03, 117.93, 110.69, 110.27, 83.74, 39.64. 
IR (neat, cm-1): 3065, 3032, 3044, 2979, 1625, 1576, 1530, 1453, 1277, 1250, 













2.4.3.6 (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-
yl)-1-phenylethanone 199b
Tautomers (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-
(benzo[d]thiazol-2-yl)-1-phenylethanone 199b were synthesized by reacting (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylvinyl benzoate 110 (1.008 g, 2.82 mmol, 1 eq.) in 15 mL
of anhydrous MeOH and KOH (0.316 g, 5.63  mmol, 2 eq.) in 10 mL MeOH by the 
general procedure used for the synthesis and purification of equilibrating tautomers of
194b. The eluent used for column chromatography over silica gel was ethyl 
acetate/hexane = 1:5. Tautomers 199a and 199b (0.516 g, 72.8%) was isolated. 1H and 
13C NMR in CDCl3 confirmed that the isolated product consists of equilibrating 
tautomers 199a and 199b in a 1.63:1 ratio. 
Rf = 0.64 (ethyl acetate/hexane = 1:5); yellowish green solid; mp = 111-112 C. 
1H NMR (600 MHz, CDCl3): 13.91 (broadOH, 1H), 8.07 (d, J = 7.68 Hz, 
C6H5 ortho in 199b, 2H), 7.99 (d, J = 8.13 Hz, aromatic CH in the benzothiazole ring of 
199b, 1H), 7.85-7.87 (m, C6H5 ortho in 199a and aromatic CH in the benzothiazole ring 
of 199b, 3H), 7.80 (d, J = 8.10 Hz, aromatic CH in the benzothiazole ring of 199a, 1H), 
7.76 (d, J = 7.93 Hz, aromatic CH in the benzothiazole ring of 199a, 1H), 7.58 (dd, 
aromatic CH in benzothiazole ring in 199b, 1H), 7.48 (dd, C6H5 meta in 199b, 2H), 
7.41-7.46 (m, C6H5 meta in 199a and CH in the benzothiazole ring of 199a and 199b, 
5H), 7.36 (t, J = 7.53 Hz, C6H5 para in 199b, 1H), 7.27 (t, J = 7.53 Hz, C6H5 para in 
199a, 1H), 6.35 (s, =CH in 199a, 1H), 4.81 (s, CH2 in 199b, 2H). 
The areas of the peaks for 199a and 199b were considered separately since their 
mole ratio in the solution was not 1:1. All peaks were first integrated by setting the area 








rest of the resonances for 199a. The area of the methylene protons (CH2) of the keto 
tautomer 199b at 4.81 ppm was set at two versus the rest of the resonances for 199b. The 
integration values of each peak and coupling patterns were used when assigning proton 
signals for the each tautomer. To obtain the mole ratio between 199a and 199b in CDCl3, 
the integrated area of the CH2 at 4.81 ppm was set at two and then the =CH peak at 6.35 
ppm was integrated and found to have an area of 1.63 versus the integrated area of the 
methylene proton peak of the keto form. The enol =CH peak corresponds to one proton 
per molecule and the keto CH2 peak corresponds to two protons per molecule.  Therefore, 
to calculate the mole ratio between 199a and 199b, half of the keto CH2 integrated area 
(1.0) of 199b was used with respect to the enol =CH integrated area (1.63). This gave 
1:1.63 ratio for 199a:199b. 
13C NMR (150 MHz, CDCl3): 194.05 (CH2CO in 199b), 168.07 (N,S≥C in 
199b), 165.46 (N,S≥C in 199a), 163.44 (=C(OH) in 199a), 152.68 (C next to N in the 
benzothiazole rings in 199b), 150.38 (C next to N in the benzothiazole rings in 199a), 
135.88 and 135.78 (C next to S in the benzothiazole rings and COC6H5, ipso in 199b), 
134.74 (COC6H5, ipso in 199a), 133.82 (COC6H5, para 199b), 131.37 (C next to S in 
the benzothiazole rings of 199a), 130.28 (COC6H5, para 199a), 128.81 and 128.64 
(COC6H5, meta and ortho in 199b, 4C), 128.48 (COC6H5, meta in 199a, 2C), 126.46 
and 125.96 (aromatic CH in the benzothiazole ring of 199a and 199b, 2C), 125.89 
(COC6H5, ortho in 199a, 2C), 125.05, 124.11, 122.85, 121.51, 121.37 and 119.95 
(aromatic CH in the benzothiazole ring of 199a and 199b, 6C), 90.83 (N,S≥CCH= in 
199a), 43.81 (N,S≥CCH2 in 199b).
DEPT 135 NMR (150 MHz, CDCl3): 133.91, 130.38, 128.90, 128.73, 128.58, 
126.56, 126.06, 125.98, 125.15, 124.20, 122.95, 121.60, 121.46, 120.04, 90.92, 43.91.
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IR (neat, cm-1): 3057, 2922, 1610, 1596, 1573, 1494, 1473, 1436, 1378, 1264, 





    
 
CHAPTER III
REACTIONS OF THE TAUTOMERS OF 2-(THIAZOLE, OXAZOLE 
BENZOXAZOLE AND BENZOTHIAZOLE)-1-PHENYL  
ETHENOLS WITH ,-ALKYNYL ESTERS 
3.1 Introduction 
Thiazole, oxazole, benzoxazole and benzothiazole derivatives are important 
classes of heterocycles, found in many biologically active compounds including antiviral, 
antifungal, antibacterial, antiinflammatory and anticancer agents.60-63 A few such 
examples are summarized in Figure 3.1. 
2-(3-Amino-3-deoxy-b-D-xylofuranosyl)thiazole-4-carboxamide 201 is a novel 
tiazofurin analog which has a significant cytotoxicity against K562 cells. 201 was 
reported to be a 100-times more potent antitumor agent than tiazofurin.60a Thiazolyl-
1,3,4-oxadiazolines and 5-carboxiethyl-2-hydrazon-4-methyl-thiazoles as such 202a, 
202b, 202c and 203 were found to possess significantly more anti-inflammatory activity 
than commercially available Diclofenac.60e Pseudomonic acid A derivatives, as such 204, 
with substituted oxazole rings were reported as potent antibacterial agents.61 
127 
 
                  
         




Figure 3.1 Examples of biologically active thiazoles, oxazoles, benzoxazoles and 
benzothiazole derivatives60a,e,61,62a,b,63a
Polyhydroxylated 2-phenylbenzothiazole derivative 205a and 2-(4-acyamino- 
phenyl) benzothiazole derivative 205b have promising activity against breast cancer cells 
MCF-7 and MDA 468.62a,b 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-
[fluoro]ethoxy)benzoxazole 206 was reported as a novel PET agent for in vivo dense 
amyloid plaque detection in Alzheimer disease patients.63a Benzoxazole derivatives were 
also reported as novel 5-HT3 receptor partial agonists for irritable bowel syndrome 
treatments.63b This wide range of thiazole, oxazole, benzoxazole and benzothiazole 
128 
 




derivatives biological activities justify syntheses of novel heterocyclic compounds 
containing of these aromatic structures. 
Knolker et al reported making imidazo[1,2-a]pyridine-5-ones 207 and 208 as 
shown in Scheme 3.1. 2-Methylimidazole 97 was first reacted with benzoyl chloride to 
obtain enol-esters (benzyl vinyl esters) 99, and then hydrolyzed to give the tautomers of 
(Z)-2-(1H-imidazol-2-yl)-1-phenylethenol, 182a and 182b. 2-Phenacylimidazole was in 
keto-enol equilibrium in solution. These equilibrating tautomers were then reacted with 
dimethyl acetylenedicarboxylate (DMADC) or methyl propiolate to obtain 5,6-ring-fused 
heterocycle systems 207 and 208.37
We hypothesized that hydrolysis of enol-esters of thiazoles, oxazoles, 
benzoxazoles and benzothiazoles, followed by reactions of the resultant hydrolyzed 








3.2 Results and Discussion 
3.2.1 Reactions of the tautomers 194-199 with dimethyl acetaylenedicarboxylate  
Enol-esters 105, 184, 106, 107, 109 and 110 were synthesized (Scheme 3.2) and 
then hydrolyzed to obtain the corresponding six pairs of tautomers 194a,b-199a,b
(Scheme 3.3) as already described in Chapter II. The equilibrating tautomers were then 
reacted with dimethyl acetylenedicarboxylate (DMADC) in anhydrous methanol at either 
room temperature or refluxing temperature. These reactions produced a variety of new 
compounds (Scheme 3.4) including 213-216, 221 and 222 which are the fused 
heterocyclic analogs of 207 and 208. All products were characterized by 1H, 13C and 
DEPT 135 NMR, HR-MS and IR spectroscopy and melting points. Complete 
experimental details and characterizations of all these compounds are given in the 
experimental section. Scheme 3.4 compresses a large amount of information. Therefore, 
the individual reactions of each specific tautomeric pair, 194a,b-199a,b, with DMADC 
are shown in Tables 3.1-3.3 with the specific products produced and the isolated yields 








  Scheme 3.3 Hydrolysis of enol-esters 105, 184, 106, 107, 109 and 110 to
corresponding equilibrating tautomers of 2-(heterocyclic)-1-






































Table 3.1 Reactions of the tautomers of 194a,b and 195a,b with DMADC in 







N S N S 
194a 194b
Tautomers : DMADC 
(Molarities (M)) 
Products with 
Isolated Yieldsa (%) 
O CO2CH3 O CO2CH3 O 
H 
H3CO P Ph 
H H 





1 : 1.1 
(0.18 : 0.16) 
24 h, rt 
26 42 
1 : 1.49 
(0.18 : 0.26) 
24 h, reflux 
9 70 
1 : 2.5 
(0.18 : 0.44) 








N S N S 
195a 195b
CO2CH3 O 








1 : 2.49 
(0.18 : 0.44) 
24 h, reflux 
12 65 
1 : 1 
(0.08 : 0.08) 
24 h, reflux 
25 32 
a % Yields were calculated considering the sum of both tautomers as the limiting reagent. 
b 10% of the starting equilibrating tautomers were recovered at 194a:194b = 1 : 1.89 in 
CDCl3. 
c 0.135 g of solid was isolated and it was not identified. 
d Trace amounts of both (E)- and (Z)-dimethyl 2-methoxymaleate, 223 and 224 were 
isolated.
e 15% of the starting equilibrating tautomers were recovered at a 195a:195b = 1 : 1.25. 
The tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethenol 194a and 1-phenyl-2-(thiazol-






methyl 8-benzoyl-5-oxo-5H-thiazolo[3,2-a]pyridine-7-carboxylate 213, in moderate to 
good yields (42%-70%) under different reaction conditions (Entries 1-3 in Table 3.1). 
The open chain product, (E)-dimethyl 2-(2-oxo-2-phenyl-1-(thiazol-2-yl)ethylidene) 
succinate 209, was also isolated (9-26%) in addition to 213 in each case. The isolated
yield of 209 is higher when the reaction was carried out at the room temperature, but 213
was favored in refluxing MeOH (Entry 1 vs Entry 2 in Table 3.1). This reaction 
proceeded slowly when it was carried out at room temperature with 1.1 equivalents of 
DMADC. Product 213 was isolated in only 42% yield and 10% of the staring tautomer 
194 was recovered in a 194a:194b ratio of 1:1.89 ratio in CDCl3 (Entry 1 in Table 3.1). 
The best isolated yield (70%) of 213 was obtained when the reaction was carried out with 
approximately 1.5 equivalents of DMADC in refluxing MeOH for 24 h (Entry 2 in Table 
3.1). However, the yield of 213 decreased and another by-product was isolated with the 
increase of DMADC equivalents to 2.5 (Entry 3 vs Entry 2 in Table 3.1). This 
unidentified by-product was eluted as the last component of the product mixture and had 
a complicated 1H NMR spectrum. The 1H NMR spectra obtained after several 
recrystallization attempts did not show any simplification. Further analysis of this 
unidentified compound was not performed.  
The 5,6-ring-fused compound, methyl 8-benzoyl-3-methyl-5-oxo-5H-thiazolo 
[3,2-a]pyridine-7-carboxylate 214, was isolated in moderate yield (65%) along with a 
small amount (12%) of the open chain product, (E)-dimethyl 2-(1-(4-methylthiazol-2-yl)-2-
oxo-2-phenylethylidene)succinate 210, when 2.5 equivalents of DMADC was reacted in 
refluxing MeOH with the tautomers (Z)-2-(4-methylthiazol-2-yl)-1-phenylethenol 195a and 
2-(4-methylthiazol-2-yl)-1-phenylethanone 195b (Entry 4 in Table 3.1). Trace amounts of 







isolated in addition to 210 and 214. Formation of 223 and 224 by reacting DMADC with 
methanol has been reported.64 The use of a low concentration of tautomeric reagent 
195a,b and DMADC in MeOH contributed to forming 210 and 214 in low yields (Entry 5 
Table 3.1). In this case 15% of the unreacted starting tautomeric reagent 195a,b was 
isolated in a 195a:195b ratio of 1:1.25 in CDCl3. 
Table 3.2 (page 137) summarizes the results obtained for reactions of the 
tautomers of 196a,b and 197a,b with DMADC in anhydrous MeOH. The tautomers (Z)-
2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-dimethylthiazol-2-yl)-1-
phenylethanone 196b gave a 21% yield of the desired 5,6-ring-fused product, methyl 8-
benzoyl-2,3-dimethyl-5-oxo-5H-thiazolo[3,2-a]pyridine-7-carboxylate 215, when reacted 
with 1.5 equivalents of DMADC (Entry 1 in Table 3.2). )The open chain product, (E)-
dimethyl 2-(1-(4,5-dimethylthiazol-2-yl)-2-oxo-2-phenylethylidene)succinate 211, was 
also isolated in a moderate (46%) yield (Entry 1 in Table 3.2). The isolated yield of 215
(21%) is less than the isolated yields of analogous products 213 (70%) and 214 (65%) 
(Entry 1 in Table 3.2 vs Entries 2 and 4 in Table 3.1). The presence of two methyl 
substituents on the thiazole ring decreased the formation of the 5,6-ring-fused compound. 
Interestingly, the highly functionalized novel 5,7-ring-fused compound, (5S,6S,7Z,9Z)-
tetramethyl 9-benzoyl-2,3-dimethyl-5,6-dihydrothiazolo[3,2-a]azepine-5,6,7,8-tetracarb-
oxylate 217, was also isolated. This eluted as the last component in the product mixture. 
The yield of 217 increased from 7% to 23% by increasing the equivalents of DMADC 
from 1.5 to 2.49 (Entries 1 and 2 in Table 3.2). The analogous 5,7-ring-fused compounds 
were not isolated when the tautomeric reagents 194a,b or 195a,b, with no methyl group 
or a single methyl group on their respective thiazole rings, reacted with 1 to 2.5 




Only 4% the 5,6-ring-fused compound, methyl 8-benzoyl-2,3-dimethyl-5-oxo-
5H-oxazolo[3,2-a]pyridine-7-carboxylate 216, was isolated when the equilibrating 
tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-
dimethyloxazol-2-yl)-1-phenylethanone 197b were reacted with 2.5 equivalents of 
DMADC in refluxing MeOH (Entry 3 in Table 3.2). However, the open chain product, 
(Z)-dimethyl 2-(1-(4,5-dimethyloxazol-2-yl)-2-oxo-2-phenylethylidene)succinate 212, 
and the 5,7-ring-fused compound, (5S,6S,7Z,9Z)-tetramethyl 9-benzoyl-2,3-dimethyl-5,6-
dihydrooxazolo[3,2-a]azepine-5,6,7,8-tetracarboxylate 218, were isolated in 36% and 
47% yields, respectively. A trace (1%) of a new compound, tetramethyl 5-(4,5-
dimethyloxazol-2-yl)-6-phenylbenzene-1,2,3,4-tetracarboxylate 219, was isolated in 
addition to 212, 216 and 218. Product 216 was not seen when the reaction was carried out 
with only one equivalent of DMADC at room temperature (Entry 4 in Table 3.2). 
However, in this case only 212 (44%) and 218 (20%) were isolated along with 17% of 
the un-reacted starting tautomers 197a and 197b in a 1:2.73 ratio. The two methyl 
substituents on the oxazole ring could be the reason for isolating very low yield of the 
5,6-ring-fused compound analogous to the thiazole with two methyl substituents (Table 
3.2). Traces of (E)- and (Z)-dimethyl 2-methoxymaleate 223 and 224, respectively, were 








   
   
 
 
   
 
 
   
   














































































































































































































































































































































































































































































































































































































   





   








Isolated yields of the products obtained in reactions of DMADC in anhydrous 
MeOH with tautomers 198a,b and 199a,b derived from benzoxazole and benzothiazole 
derivatives are summarized in Table 3.3. 
Table 3.3 Reactions of the tautomers of 198a,b and 199a,b with DMADC in 
anhydrous MeOH at different reaction conditions 











N O N O 
198a 198b
O CO2CH3 O CO2CH3 O 
H 
H3CO Ph Ph 
H H 
N O O N O 
220 221
1 : 1.5 
(0.14 : 0.22) 
24 h, reflux 
2 93 
1 : 1.51 
(0.05 : 0.08) 








N S N S 
199a 199b
O CO2CH3 O CO2CH3 O 
H 
H3CO Ph Ph 
H H 
N S O N S 
225 222
1 : 2.49 
(0.18 : 0.44) 
24 h, reflux 
- 85 
1 : 1 
(0.08 : 0.08) 
24 h, rt 
- 65 
a % Yields were calculated considering the sum of both tautomers as the limiting reagent. 
b 41% of the starting tautomers was recovered at a 198a:198b = 1.11:1. 
c A trace amount of (E)- and (Z)-dimethyl 2-methoxymaleate, 223 and 224, were isolated.
d 22% of the starting tautomers were recovered at a 199a:199b = 1.62:1. 
The tautomers (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-
(benzo[d]oxazol-2-yl)-1-phenylethanone 198b afforded the 5,6-ring-fused heterocycle,




93% yield by reacting with 1.5 equivalents of  DMADC in refluxing MeOH (Entry 1 in 
Table 3.3). The yield of the 221 decreased from 93% to 11% while the yield of the open 
chain product, (Z)-dimethyl 2-(1-(benzo[d]oxazole-2-yl)-2-oxo-2-phenylethylidene) 
succinate 220, increased from 2% to 35% when a lower concentration of the tautomeric 
reagents (0.05M) and DMADC (0.08M) were used (Entry 2 vs Entry 1 in Table 3.3). 
Further, 41% of the starting tautomers 198 were recovered having a 198a:198b ratio of 
1.11:1. 
For a direct comparison with the benzoxazole tautomer 198a and 198b, their 
benzothiazole tautomeric analogs 199a and 199b were subjected to DMADC in refluxing 
methanol. Only the 5,6-ring-fused product, methyl 4-benzoyl-1-oxo-1H-
benzo[4,5]thiazolo[3,2-a]pyridine-3-carboxylate 222, was isolated (85%) by reacting (Z)-
2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-yl)-1-
phenylethanone 199b tautomers with 2.5 equivalents of DMADC (Entry 3 in Table 3.3). 
The open chain product, (E)-dimethyl 2-(1-(benzo[d]thiazol-2-yl)-2-oxo-2-phenyl 
ethylidene)succinate 225 is a likely precursor to 222. However, 225 was not observed 
even when reacting 199a,b at the room temperature with DMADC in low concentrations. 
It was interesting that 5,7-ring-fused compounds, analogous to 217 and 218 which 
formed when using 196a,b and 197a,b, were not observed when reacting either 198a,b or 
199a,b with DMADC. 
The presence of a single vinyl proton signal and one ester methoxy group signal 
in the 1H NMR spectra and three carbonyl carbon signals representing ketone, ester and 
amide functional groups in 13C NMR spectra were characteristic of the 5,6-ring-fused 
structures. IR spectra of 213-216, 221 and 222 show three distinct absorptions for 








structures were obtained for 213, 216 and 221 (Figures 3.2-3.4) to complete the definitive 
identification of these structures. The crystal structures were obtained with the help of Dr. 
William P. Henry. The crystal data collection, structure refinement parameters, bond 
lengths and bond angles for the crystal structure 213, 216 and 221 are given in 
Appendices A-C, respectively. The 1H, 13C and DEPT 135 NMR spectra of compounds 
215 and 221 are given in Figures 3.5-3.8, respectively. 










Figure 3.3 The crystal structure of methyl 8-benzoyl-2,3-dimethyl-5-oxo-5H-
oxazolo[3,2-a]pyridine-7-carboxylate 216 


















































CO2CH3 CO2CH3CO2CH3O OH O
(E) H HH 
H 
H3CO2C H3CO2C H3CO2C N S HN SN S 
227 209 226 
Isolated 
Scheme 3.5 Two possible tautomers of 209 
Not Isolated 
 
The presence of the methylene protons (CH2) signals in the 
1H NMR spectra 
(4.38-4.12 ppm) of the open chain products 209-212, and 220 (See Scheme 3.4 or Tables 
3.1, 3.2 and 3.3) excluded the two other possible tautomeric structures (such as 226 and 
227) (Scheme 3.5). The X-ray crystal structure of oxazole derivative 212 confirmed the 
(Z) geometrical isomer at the C=C bond in the open-chain (Figure 3.9). The crystal data 
collection, structure refinement parameters, bond lengths and bond angles for the crystal 
structure 212 is given in Appendix D. The 1H, 13C and DEPT 135 NMR spectra of 
compounds 212 and 220 are given in Figures 3.10-3.13, respectively. The Z geometrical 
isomer in 212 and 220, and their analogous E geometries in 209-211 and 225 are required 
for cyclization to the 5,6-ring-fused structures 216, 221, 213-215 and 222, respectively, 
to occur. If these double bonds had the opposite geometry, then cyclization at the 
nitrogen would only be possible for the carbonyl carbon of the ester group directly 












Figure 3.10 1H NMR spectrum (600 MHz, CDCl3) of (Z)-dimethyl 2-(1-
(benzo[d]oxazol-2-yl)-2-oxo-2-phenylethylidene)succinate 212































Figure 3.13 13C NMR (75 MHz, CDCl3) and DEPT 135 NMR spectra (150 MHz, 
CDCl3) of (Z)-dimethyl 2-(1-(benzo[d]oxazol-2-yl)-2-oxo-2-




Mechanisms for these conversions have not been systematically studied, but 
possible pathways are instructive to postulate and consider. Two possible reaction paths 
are depicted in Scheme 3.6 for the 5,6-ring-fused heterocycle’s formation. Formation of 













Enol 197a, or the corresponding enolate anion induced by the action of the 
oxazole nitrogen as a base, does a Michael type of nucleophilic attack on DMADC to 
give the allenic intermediate 228. The protonation of the central allene carbon of 228
forms 228a which can have either (E) or (Z) geometries at the C=C bond. The (Z)-isomer 
cannot give the observed 5,6-ring-fused compound. Therefore, if the (Z)-isomer is 
present, it isomerizes to the (E) geometry and rotates to give 228b, which now has the 
correct orientation for the 5,6-ring formation. Two possible pathways can lead to desired 
cyclocondensation starting from 228b. In path A, nucleophilic attack by nitrogen on the 
terminal ester carbonyl carbon of 228b gives the zwitterionic intermediate 228c which 
then gives oxazolium cation 228d by the loss of a methoxy group. Finally, 228d converts 
to the 5,6-ring-fused compound 216 via the loss of the acidic -proton of 228d. In 
alternative path B, 228b first tautomerizes to give 212 which was the isolated open-chain 
product mentioned in Table 3.2. The ester carbonyl of 212 is more electrophilic than the 
,-unsaturated ester carbonyl of 228b in Path A, but the ring nitrogen of 212 is less 
nucleophilic, because it is conjugated. The cyclocondensation of 212 via nitrogen 
nucleophilic attack gives 212a, followed by the loss of a methoxy group to give 212b and 
then the loss of the acidic proton gives 216. 
Isolations of the open-chain products 209-212 and 220 confirmed that the -
carbons of the starting tautomers can, in fact, give Michael type additions to DMADC. 
Are these isolated open-chain intermediate products the actual precursors for the 5,6-ring- 
fused compounds’ formation? To probe this question (Z)-dimethyl 2-(1-(benzo[d]oxazol-
2-yl)-2-oxo-2-phenylethylidene)succinate 220 was refluxed in anhydrous MeOH 
(Scheme 3.7). The reaction was monitored by TLC. Two spots corresponding to the 5,6-
ring-fused product 221 and un-reacted open-chain product 220, were observed on TLC 
153 
during the reaction. Only 221 was seen on TLC after refluxing for 15 h and 99% of 221 
was isolated after removing methanol, followed by extraction using water and 1,2-
dichloromethane. This result confirmed that the open chain products 209- 212 and 220 
meet the criteria as possible intermediates for the formation of the 5,6-ring-fused 
compounds, 213-216 and 221. 
 





The 1H NMR spectra of highly functionalized 5,7-ring fused compounds 217 and 
218 showed four ester methoxy groups versus the two methyl groups on the thiazole and 
oxazole rings, and two doublets (J = 5.2 and 4.9 Hz, respectively) in the downfield region 
each of which integrated as one proton. A single crystal of 218 was obtained by diffusion 
of hexane into a solution of 218 that was dissolved in acetone. The X-ray crystal structure 
was obtained with the help of Dr. W. P. Henry. The structure was found to be the 5,7-ring 
fused heterocycle 218 (Figure 3.14 (a)). The two ester groups on the two adjacent tertiary 
carbons are trans to each other (Figure 3.14 (b)). The coupling constant of 4.9 Hz agrees 
with the coupling constant value of vicinal proton coupling with a dihedral angle around 
50. The crystal structure showed that 218 was packed into the crystal in two slightly








     
(a) (b) 
Figure 3.14 (a) The crystal structure of (5S,6S,7Z,9Z)-tetramethyl 9-benzoyl-2,3-
dimethyl-5,6-dihydrooxazolo[3,2-a]azepine-5,6,7,8-tetracarboxylate 218;
(b) The orientation of hydrogens on C3 and C4 is illustrated.
structural differences included two slightly different H3-C3-C4-H4 dihedral angles 
(49.6) and H28-C28-C29-H29 (46.3). The crystal data collection, structure refinement 
parameters, bond lengths and bond angles for the crystal structure 218 are given in 
Appendix E. The 1H, 13C and DEPT 135 NMR spectra of compound 218 are given in 
Figures 3.15 and 3.16, respectively. The structures of 5,7-ring-fused compounds, 217 and 
218, indicate that two equivalents of DMADC have reacted with one equivalent of 
tautomers of 196a,b and 197a,b, respectively. The yield of 217 increased when more 
than two equivalent of DMADC was used (Entry 2 vs Entry 1 in Table 3.2 on page 137).  
Note: This crystal structure contains two individual molecules and the other molecule is 
shown in Appendix E. Solvent molecules (acetone) are not shown for clarity.  
A plausible mechanism is proposed in Scheme 3.8 for the 5,7-ring-fused 
formation taking 218 as the example. The proposed mechanism should be in accord and 
link up with the observations of the 5,6-ring-fused compound formation as well as the 






















Figure 3.16 13C NMR (75 MHz, CDCl3) and DEPT 135 NMR (150 MHz, CDCl3) 















The proposed reaction mechanism for the formation of the 5,7-ring fused 
compounds involves three consecutive Michael type additions. Enol 197a, or its enolate 
anion, perform a nucleophilic attack on the DMADC to form the allene intermediate 228.
This was also the first step in Scheme 3.6 (page 152). Then the protonation of the central 
carbon gives 228a (E and/or Z geometries) which isomerizes to the E geometry and 
rotates to give 228b. The removal of the acidic methylene proton of 228b via inter- or 
intramolecular base catalysis forms the zwitterionic intermediate 228e. Alternatively, 
tautomerization of 228b to 212, catalyzed by inter- or intramolecular base catalysis, 
followed by deprotonation of 212 also leads to 228e. All these steps to 228b and 212
were also proposed in Scheme 3.6 and are common to the paths to the open-chain, 5,6- 
and 5,7-ring-fused products. However, if 228e gives the second Michael type addition to 
another DMADC to give 228f in competition to the cyclization of 212 to a 5,6-ring 
fusion, a route to 5,7-ring-fused products becomes possible. Proton transfer from 228f to 
228g, followed by the keto-enol tautomerization forms 228h. Now 228h can undergo 
intramolecular cyclization via a third Michael type addition to give 228i. Then 
protonation followed by the keto-enol tautomerization gives the observed 5,7-ring-fused 
compound 218. The postulated pathways in Schemes 3.6 and 3.8 provide a general 
picture of how the observed products may form. 
Product 219 was not discussed. Its structure (See Entry 3 in Table 3.2 on page 
137) was assigned based on the 1H, 13C, DEPT 135 NMR and IR spectral data. Its 1H 
NMR spectrum had four ester methoxy signals and five phenyl hydrogens versus two 
methyl groups on the oxazole ring. Its 13C spectrum had four ester carbonyl carbon 
signals. However, there was no aromatic ketone carbonyl carbon signal present as in 212, 









four ester carbonyl groups. The 1H, 13C and DEPT 135 NMR spectra are given in Figures 
3.17 and 3.18, respectively. A postulated mechanism for the formation of 219 is depicted 
in Scheme 3.9 (page 162). This suggested mechanism is identical to that in Scheme 3.8 
up to structure 228h, again emphasizing the general framework postulated. 
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Scheme 3.9 A possible mechanism for 219 formation
Two consecutive Michael type additions with two equivalents of DMADC form
the intermediate 228h as previously shown in Scheme 3.8. Removal of the acidic proton 
in 228h places negative charge density on the carbon alpha to the terminal ester function 








unsaturated phenyl ketone carbonyl carbon to give 228l upon protonation. The loss of 
H2O from 228l gives 219.
We envisioned that the reactions of the isolated open chain products, such as 209, 
with a base might facilitate the cyclocondensation as depicted in Scheme 3.10. These 
isolated open chain products are known intermediates for 5,6-ring-fused compounds’ 
formation (see pages 133, 137 and 138). To test this hypothesis, the isolated 
intermediates 209, 211, 212 and 220 were refluxed in THF in the presence of the strong 
base, NaH which will convert these intermediates to their enolate anions, quantitatively. 
This ring closure of 209 to 213 occurred in 76% yield within 7 h. Results are summarized 
in Table 3.4 for each of these reactions. 














































Table 3.4 Synthesis of 5,6-ring-fused heterocycles 213, 215, 216 and 221 starting from
corresponding intermediate products 209, 211, 212 and 220  using NaH 


























































a Isolated yields are calculated assuming 100% conversion of the intermediate product to 
the corresponding 5,6-ring-fused compound.
b 39% of 212 was recovered. 





Intermediates 209, 211 and 220 were converted to the corresponding 5,6-ring-
fused compounds 213, 215 and 221, respectively, when those were reacted for 7-8 hours 
with NaH in refluxing THF (Entries1, 2 and 5 in Table 3.4). No other products were 
observed by TLC. Isolated yields reported for 213, 215 and 221 were obtained after work 
up which included column chromatography purification. Compound 212 was only 
partially converted to 216 even after refluxing for 24 h in THF (Entry 3 in Table 3.4). 
Only 40% of 216 was isolated along with 39% of the unreacted starting intermediate 212. 
Performing the reaction at higher temperature in refluxing 1,4-dioxane (BP 101 C) 
rather than THF (BP 66 C) did not give satisfactory results (Entry 4 in Table 3.4). Only 
7% of 216 was isolated along with 32% unreacted intermediate 212 after 24 h. Increasing 
the temperature may have destroyed the starting material and/or the 5,6-ring-fused 216
that was forming, causing the very low yield of 216. Neither 212 nor 216 was refluxed in 
1,4-dioxane without NaH present in order to test their thermal stability in this solvent.       
Our next target was to increase the yields of 5,6-ring-fused compounds 215 and 
216, and 5,7-ring fused compounds 217 and 218. The idea tested was to add a stronger 
base (NaOCH3) at the start of the reaction with the tautomeric starting materials. This 
might enhance the rate of both (1) the initial Michael addition to DMADC and (2) the 
cyclization step analogous to the conversion of 209 to 213 in Scheme 3.10. Tautomeric 
pairs 196a,b and 197a,b were independently treated with 2.5 DMADC equivalents in 
MeOH in the presence of 0.32 and 0.28 equivalent NaOMe, respectively (Scheme 3.11). 
After refluxing for 24 h the corresponding 5,6-ring-fused compounds 215 (from 196a,b) 
and 216 (from 197a,b), along with 230 and 219 were isolated. The 5,7-ring-fused 
compounds 217 or 218 were not detected by TLC. Isolated products and their % yields 






Scheme 3.11 Reactions of the tautomers 196a,b and 197a,b with DMADC in the 






   















   































HO O 0.32 eq. 




















HO O 0.28 eq. 












H3C  CH3 
219
17 
a Reactions were carried out in refluxing anhydrous MeOH with 2.5 equivalents of 
DMADC.
b Yields were calculated considering the starting tautomers as the limiting reagent.
c Trace amounts of (E)- and (Z)-dimethyl 2-methoxymaleate, 223 and 224, were isolated. 
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We speculated that reaction of intermediate product 212 with DMADC in the 
presence of a base may raise the yield of 5,7-ring-fused compound 218. Therefore, 212
was treated with 1.1 equivalents of DMADC in the presence of small amount of NaOMe 
for 24 h in refluxing methanol (Scheme 3.12). However, 218 was never detected on TLC 
and 5,6-ring-fused compound 216  (65%) and 219 (4%) were isolated along with the un-
reacted 212 (18%) after the work up. This absence of 5,7-ring-fused product 218 is 
consistent with the results summarized in Scheme 3.11 and Table 3.5 where NaOMe was 
used to try to increase the yield of the 5,7-ring-fused product 218 starting from tautomers 
197a,b and 2.5 equivalents of DMADC. 
This observation led us to postulate that methoxide could reopen 218 to its open 
chain enolate anion 228k which could then reclose via an aldol condensation to 219. To 








temperature (Scheme 3.13). The reaction solution was monitored by TLC which showed 
that 218 disappeared. The spot for 218 was not detected on TLC after only 15 min. A 
new spot appeared and it was identified as 219. Compound 219 was isolated in 37%. This 
showed that if 218 had formed from 212 (Scheme 3.12) or from 197 (Table 3.5) with 
methoxide present it could have been converted on to 219. 
Scheme 3.13 Reaction of 218 with NaOMe 
A possible mechanism for the 219 formation from 218 in the presence of NaOMe 
is illustrated in Scheme 3.14. The acidic proton is removed by methoxide and this opens 
the seven-membered ring. This ring-opening gives enolate anion 228k which is an 
intermediate in the proposed mechanism for the 219 formation (See Scheme 3.9). 
Nucleophilic aldol attack by this anion on to unsaturated phenyl carbonyl carbon gives 








Scheme 3.14 A possible mechanism for the 219 formation by reacting 218 with NaOMe 
in methanol 
3.2.2 Attempted reactions of the tautomers 194a,b, 197a,b and 199a,b with methyl 
propiolate 
Methyl propiolate was used as an analog ,-alkynyl ester to DMADC in an 
effort to extend the successful syntheses of the 5,6-ring-fused compounds 213-216, 221
and 222 from tautomeric pairs 194a,b-199a,b achieved with DMADC. Methyl propiolate 
is a weaker electrophile than DMADC. The tautomers 194a,b, 197a,b and 199a,b were 
reacted with methyl propiolate in MeOH. (Scheme 3.15). However, the expected 5,6-







Scheme 3.15 Attempted reactions of the tautomers 194a,b, 197a,b and 199a,b with 
methyl propiolate 
The crude product mixture obtained by reacting the thiazole-based tautomers 
194a,b with 1.5 equivalents of methyl propiolate for 24 h in MeOH at reflux showed the 
spot for unreacted 194a,b and two new spots on TLC. These two new spots were very 
close to each other (Rf = 0.65, 0.62; ethyl acetate:hexane = 3:2). The unreacted starting 
tautomers 194a,b were recovered in 14% yield as the first fraction by the column
chromatography. The fraction corresponding to the two close spots was then collected. 
This fraction gave a yellow solid (0.21 g) which had a very complex 1H and 13C NMR 
spectra (See Figures 3.24 and 3.25 on pages 211 and 212, respectively) and these 
products were never identified. These two compounds could not be separated by column 
chromatography by changing the eluting solvent’s polarity using different ethyl 
acetate/hexane or acetone/hexane ratios. Furthermore, crystallization by diffusing hexane 
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into a solution of this unidentified solid dissolved in chloroform gave a solid, which had 
the same 1H NMR spectrum that was seen before crystallization. The melting point of 
this solid was very broad (178 C-190 C). Further, purification or analysis of this solid 
was not attempted. 
The oxazole-based tautomers 197a,b (0.444 g) were also reacted with 1.5 
equivalents of methyl propiolate in refluxing MeOH for 24 h (Scheme 3.16). Three spots 
were seen by TLC. First, the starting tautomers 197a,b were recovered and isolated in
66% yield by column chromatography. Then a new compound 234, corresponding to the 
second TLC spot, was isolated in only 4% yield. A more polar component corresponding 
to the third TLC spot (intense yellow solid; 0.026 g) was collected. This fraction was not 
identified. Its 1H NMR spectrum is given in Figure 3.26 in the experimental section on 
page 213 of this chapter. This reaction was repeated by refluxing 197a,b (0.37 g) in 
MeOH for 27 h and 41% of 197a,b, 6% of 234 and 0.058 g of the same intense yellow 









Scheme 3.16 Reactions of the tautomers 197a,b with methyl propiolate in refluxing 
MeOH 
Either the oxazole ring’s nitrogen atom or the sp2-carbon adjacent to the enol 
could potentially attack the -carbon of methyl propiolate to give 234 or 235, 














Figure 3.19 1H NMR spectrum (600 MHz, CDCl3) of (E)-methyl 3-(4,5-dimethyl-2-(2-
oxo-2-phenylethylidene)oxazol-3(2H)-yl)acrylate 234 
Only 234 was confirmed as a product. The 1H NMR spectrum of 234 has one 
ester methoxy group and three vinyl protons versus five phenyl protons and six methyl 
protons. Two of the vinyl protons are doublets with a coupling constant of 15 Hz. This
value is consistent with vicinal trans vinyl proton coupling. Having nine carbon signals in 
the DEPT 135 NMR spectrum helped to exclude the other possible structure 235, since 
only eight signals should be seen in the DEPT 135 NMR spectrum if the structure was 
235. Figures 3.19 and 3.20 show the 1H, 13C and DEPT 135 NMR spectra of 234, 









Figure 3.20 13C and DEPT 135 NMR spectra (150 MHz, CDCl3) of (E)-methyl 3-(4,5-
dimethyl-2-(2-oxo-2-phenylethylidene)oxazol-3(2H)-yl)acrylate 234 
 
Two possible reaction paths are illustrated in Scheme 3.18 for the formation of 






attack on methyl propiolate to give the two intermediates 236a or 236b, respectively. In 
path A, the central allene carbon of 236a protonates to give 234. In path B, N-attack 
forms the zwitterionic intermediate 236b. Then, protonation of the central allene carbon 
of 236b forms the cation 236c, which gives product 234 via loss of the acidic -proton. 
The geometry of the exocyclic double bond is not known. The NOESY 2D NMR 
technique or X-ray crystal structure could elucidate the exact assignment of the -carbon 
geometry, but this was not undertaken.      
Scheme 3.18 Proposed routes for the formation of 234 from either 197a or 197b
Tautomers 197a,b were also reacted with just 1 eq. (vs 1.5 eq.) of methyl 
propiolate in MeOH at room temperature (vs refluxing) in an attempts to see if the open-
chain product 235 or 237 could be formed (Scheme 3.19). If 237 was formed, it could be 
converted to the 5,6-ring-fused compound 232 by reacting with a base. However, neither 






39% of the starting tautomers 197a,b. Compound 238 was isolated in 13% yield when 
this reaction was performed for the first time at room temperature for 24 h. 
Scheme 3.19 Reactions of the tautomers 197a,b with methyl propiolate in MeOH at 
room temperature 
The 1H and 13C NMR spectra of 238 are depicted in Figures 3.21 and 3.22, 
respectively. Its 1H and 13C NMR spectra illustrate that 238 has 13 hydrogens and 13 
carbons, which is exactly the same numbers of hydrogens and carbons in either 197a or 
197b. There are no carbons in 238 from methyl propiolate. The crystal structure was 
obtained (Dr. Henry) to further identify this product (Figure 3.23). The crystal data 
collection, structure refinement parameters, bond lengths and bond angles for the crystal 
structure 238 are given in Appendix F. The crystal structure of 238 contains two 
independent molecules, which are enantiomers. The crystal structure of 237 contains 
13Hs, 13Cs, 1N and 3Os atoms. Thus, this compound contains one extra oxygen that has 
come from a source besides the starting tautomers 197a,b. This reaction was repeated by 










it was suspected that the oxygen came from water. However, only 11% of 238 was 
isolated.
















Figure 3.23 The crystal structure of 2-acetyl-2-methyl-6-phenyl-2,3-dihydro-1,3-
oxazin-4-one 238. This crystal structure contains two independent 
molecules, which are enantiomers  
 
The benzothiazole-based tautomers 199a,b (0.202 g) were also reacted with 1.5 
equivalents of methyl propiolate in refluxing MeOH for 23 h. Two new spots were 
detected on TLC below the spot for unreacted 199a,b. The unreacted tautomers 199a,b
were recovered in 59% yield by the column chromatography as the first fraction. Two 
fractions were then collected (fractions 2 and 3) corresponding to the two new spots 
observed on TLC. Fraction 2 (Rf = 0.44; ethyl acetate/hexane = 1:3) and fraction 3 (Rf = 
0.29; ethyl acetate/hexane = 1:3) gave only 0.03 g for each. These two fractions were 
never identified. The 1H NMR spectra of fraction 2 and fraction 3 are illustrated in 










Reactions of the tautomeric pairs 194a,b-199a,b afforded a variety of compounds 
when those were reacted with DMADC at room temperature or at reflux. Thiazole- and 
oxazole-based tautomers, 194a,b-197a,b, formed the corresponding 5,6-ring-fused 
compounds 213-216 and the open-chain intermediates 209-212. The tautomers with two 
methyl substituents on the thiazole or oxazole ring, 196a,b and 197a,b, afforded novel 
5,7-ring-fused compounds 217 and 218, respectively, in addition to the corresponding 
open-chain compounds 211 and 212, and 5,6-ring-fused compounds 215 and 216. The 
benzoxazole-based tautomers 198a,b also gave the open-chain product 220 and the 
expected 5,6-ring-fused product 221 while the analogous benzothiazole-based tautomers 
199a,b afforded only the 5,6-ring-fused product 222. Product yields depend on the 
heteroatoms and substituents on the ring, and different reaction conditions used such as 
concentration and temperature. The open-chain products 213, 215, 216 and 220 were 
converted to the corresponding 5,6-ring-fused compounds by treating with the strong 
base NaH in THF. 
The attempted 5,6-ring-fused compounds synthesized from reactions of 
tautomeric pairs 194a,b, 196a,b or 199a,b with methyl propiolate were unsuccessful. The 
tautomers 196a,b gave two new compounds 234 and 238 in refluxing MeOH and at room
temperature in MeOH, respectively. Unreacted starting tautomers were recovered in each 
case. Several fractions were collected from the reactions of the tautomers 194a,b and 
199a,b with methyl propiolate. These fractions had complex 1H NMR spectra and further 
analysis were not performed to identify them. The NMR spectra of unidentified fractions 









Methyl propiolate is a weaker electrophile than DMADC and the reaction 
conditions used herein were not appropriate for the syntheses of fused-ring systems. 
Therefore, future efforts in this research area would involve optimization of reaction 
conditions that are suitable for the syntheses of fused-ring systems using methyl 
propiolate. Furthermore, this work could be extended to ,-unsaturated esters as such 
methyl acrylate to explore the possibility of synthesizing new fused-ring heterocycles.
3.4 Experimental 
3.4.1 General information 
Tautomers of 2-(heterocyclic)-1-phenylethenols used in this chapter were 
synthesized as described in Chapter II. Dimethyl acetylenedicarboxylate (DMADC), 
methyl propiolate and anhydrous methanol were purchased from Sigma Aldrich and used 
as received. The description of NMR, IR and melting point instrumentation used can be 
found in Chapter II. A Bruker AXS Smart 1000 diffractometer, upgraded with an APEX 
II detector and software which incorporates SHELX components,65 was employed for 
crystal structure determinations which were performed at -173 C. All reactions were 
carried out under nitrogen. 
3.4.2 Reaction of the tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethanol 194a and 1-
phenyl-2-(thiazol-2-yl)ethanone 194b with dimethyl acetylenedicarboxylate 
(DMADC)
MADC (0.63 g, 4.4 mmol, 2.5 eq.) in 5 mL of anhydrous MeOH was added 
dropwise to a stirred solution of the tautomers, (Z)-1-phenyl-2-(thiazol-2-yl)ethanol 194a
and 1-phenyl-2-(thiazol-2-yl)ethanone 194b, (0.357 g, 1.76 mmol, 1 eq.) in 5 mL of 




the tautomers are 0.44 M and 0.18 M, respectively. This solution was refluxed for 24 h 
under nitrogen and then MeOH was removed by rotary evaporation. The residue was 
dissolved in dichloromethane (40 mL), washed with water (2 × 40 mL) and dried over 
anhydrous sodium sulfate. After removal of dichloromethane by rotary evaporation, the 
crude product was purified by column chromatography (silica gel, ethyl acetate/hexane = 
1:3  3:1) and isolated. The open chain intermediate product 209 (0.079 g, 13%) eluted 
first followed by the 5,6-ring-fused product 213 (0.278 g, 50.5%). 0.135 g of orange color 
solid was isolated which is not identified. This general procedure was also used for the 
syntheses of compounds 209–222. 
3.4.2.1 Synthesis of compounds 209 and 213 under other reaction conditions
Compounds 209 (0.054 g, 8.8%) and 213 (0.584 g, 69.8%) were prepared by 
combining solutions of DAMDC (0.378 g, 2.63 mmol, 1.49 eq.) in 5 mL anhydrous 
MeOH, and the tautomers 194a and 194b (0.357 g, 1.76 mmol, 1 eq.) in 5 mL of 
anhydrous MeOH and then following the general procedure mentioned above. The 
molarities of DMADC and the tautomers are 0.26 M and 0.18 M, respectively.   
DAMDC (0.77 g, 5.36 mmol, 1.1 eq.) in 10 mL of anhydrous MeOH was added 
dropwise to a solution of the tautomers 194a and 194b (0.99 g, 4.87 mmol, 1 eq.) in 
20 mL of anhydrous MeOH at room temperature under nitrogen. The molarities of 
DMADC and the tautomers are 0.18 M and 0.16 M, respectively. After stirring for 24 h at 
room temperature, 209 (0.426 g, 25.8%) and 213 (0.639 g, 41.9%) were isolated along 
with 10% of the starting tautomers at a 194a:194b ratio of 1:1.89. The products were 











3.4.2.2 (E)-Dimethyl 2-(2-oxo-2-phenyl-1-(thiazol-2-yl)ethylidene)succinate 209
Rf = 0.42 (ethyl acetate/hexane = 1:2); yellow solid; mp = 130-131 °C.  
1H NMR (600 MHz, CDCl3): 8.08d, J = 7.73 Hz, C6H5 ortho, 2H), 7.96 d, J = 
2.64 Hz, =NCHCHS, 1H), 7.55 (t, J = 7.26 Hz, C6H5 para, 1H), 7.45 (m, C6H5 meta 
and =NCHCHS, 3H), 4.12 (s, CH2CO2CH3, 2H), 3.79 (s, C(CO2CH3), 3H), 3.57 
(s, CH2CO2CH3, 3H). 
13C NMR (150 MHz, CDCl3):  194.59 COC6H5), 171.01 (CH2CO2CH3),
 166.17 (=C(CO2CH3)), 160.50 (N,S≥C), 144.62 (=NCH=CHS), 143.84 
(CH2C(CO2CH3)=), 135.55 (COC6H5, ipso), 133.55 (COC6H5, para), 128.97 
(COC6H5), ortho), 128.80 (COC6H5, meta), 127.17 (=C(COC6H5)), 122.73 
(=NCH=CHS), 52.54 (CH2CO2CH3), 52.54 (C(CO2CH3)), 35.11 (CH2CO2CH3).
DEPT 135 NMR (150 MHz, CDCl3): 144.72, 133.65, 129.06, 128.90, 122.83, 5 
2.63, 52.31, 35.20. 
IR (neat, cm-1): 3134, 3112, 3096, 3040, 3001, 2951, 2843, 1733, 1712, 1679, 
1663, 1612, 1448, 1256, 1198, 1176, 1113, 1102. 
HRMS (ESI, [M+H]+): calcd for C17H16NO5S: 346.0749; found: 346.0740. 
3.4.2.3 Methyl 8-benzoyl-5-oxo-5H-thiazolo[3,2-a]pyridine-7-carboxylate 213
Rf = 0.42 (ethyl acetate/hexane = 1:1); yellow solid; mp = 145-146 °C. 
1H NMR (600 MHz, CDCl3): 8.36d, J = 4.27 Hz, >NCH=CHS, 1H), 7.59 d, J 
= 7.95 Hz, C6H5 ortho, 2H), 7.53 (t, J = 7.28 Hz, C6H5 para, 1H), 7.46 (m, C6H5 meta,
2H),  7.31 d, J = 4.27 Hz, >NCH=CHS, 1H), 6.67 (s,CH=C(CO2CH3), 1H), 3.18 (s, CO2CH3, 
3H). 
13C NMR (150 MHz, CDCl3): 191.20COC6H5), 166.43 (CO2CH3), 15 





139.37 (COC6H5, ipso), 131.86 (COC6H5, 
para), 128.54 (COC6H5, ortho), 127.85 (COC6H5, meta), 124.14 (>NCH=CHS), 117. 
00 (NCOCH=), 109.81 (>NCH=CHS, 108.09 (=C(COC6H5)), 52.39 (CO2CH3). 
DEPT 135 NMR (150 MHz, CDCl3): 131.95, 128.62, 127.93, 124.22, 117.85, 
109.90, 52.48. 
IR (neat, cm-1): 3158, 3125, 3091, 3062, 3030, 3008, 2953, 1725, 1681, 1663, 
1619, 1595, 1472, 1439, 1409, 1331, 1252, 1159, 1096, 1077. 
HRMS (ESI, [M+H]+): calcd for C16H12NO4S: 314.0487; found: 314.0455. 
Single crystals were grown for X-ray crystallography by the vapor diffusion 
method. Hexane was diffused into a solution of compound 213 dissolved in chloroform. 
The crystal structure of 213 is given on Figure 3.2 on page 140. 
3.4.3 Reaction of the tautomers (Z)-2-(4-methylthiazol-2-yl)-1-phenylethenol 195a
and 2-(4-methylthiazol-2-yl)-1-phenylethanone 195b with dimethyl 
acetylenedicarboxylate (DMADC) 
The open chain intermediate product 210 and the 5,6-ring-fused product 214 were 
synthesized by reacting DMADC (0.638 g, 4.44 mmol, 2.49 eq.) in 5 mL of anhydrous 
MeOH with the tautomers, (Z)-2-(4-methylthiazol-2-yl)-1-phenylethenol 195a and 2-(4-
methylthiazol-2-yl)-1-phenylethanone 195b, (0.386 g, 1.78 mmol) in 5 mL MeOH by the 
general procedure used for the synthesis and purification of 209 and 213. The molarities 
of DMADC and tautomers are 0.44 M and 0.18 M, respectively. The eluent used for 
column chromatography over silica gel was ethyl acetate/hexane = 1:1. The compound 









3.4.3.1 Syntheses of compounds 210 and 214 under other reaction conditions
DAMDC (0.233 g, 1.62 mmol, 1 eq.) in 10 mL of anhydrous MeOH was added 
dropwise to a solution of the tautomers 195a and 195b (0.352 g, 1.62 mmol, 1 eq.) in 
10 mL of anhydrous MeOH at room temperature under nitrogen. The molarities of 
DMADC and tautomers are 0.08 M and 0.08 M, respectively. After stirring for 24 h at 
room temperature, 210 (0.147 g, 25.2%) and 214 (0.169 g, 31.9%) were isolated along 
with 15% of the starting tautomers at a 195a:195b ratio of 1:1.25. The products were 
worked up by the general procedure. 
3.4.3.2 (E)-Dimethyl 2-(1-(4-methylthiazol-2-yl)-2-oxo-2-phenylethylidene)succinate 
210
Rf = 0.47 (ethyl acetate/hexane = 1:2); yellow solid; mp = 114-115 °C. 
1H NMR (600 MHz, CDCl3): 8.07d, J = 6.74 Hz, C6H5 ortho, 2H), 7.54 (t, J = 
6.39Hz, C6H5 para, 1H), 7.45 (dd, C6H5 meta, 2H), 7.26 (s,  =NC(CH3)CHS, 1H), 
4.12 (s, CH2CO2CH3, 2H), 3.80 (s, C(CO2CH3), 3H), 3.57 (s, CH2CO2CH3, 3H), 
2.47 (s, =NC(CH3)CHS ,  3H). 
13C NMR (150 MHz, CDCl3): 194.52COC6H5), 171.19 (CH2CO2CH3), 
166.23 (=C(CO2CH3)), 159.22 (N,S≥C or =C(COC6H5)), 155.04 (N,S≥C or 
=C(COC6H5)), 143.81 (=C(CO2CH3)), 135.54 (COC6H5, ipso), 133.42 (COC6H5, 
para), 128.86 (COC6H5, ortho), 128.69 (COC6H5, meta), 126.30 (=NC(CH3)CHS), 
117.87 (=NC(CH3)CHS), 52.42 (=C(CO2CH3)), 51.98 (CH2CO2CH3), 35.15 
(CH2CO2CH3), 17.02 (=N(CH3)CCHS). 










IR (neat, cm-1): 3100, 2997, 2949, 2933, 1733, 1711, 1679, 1604, 1505, 1446, 
1257, 1231, 1198, 1172. 
HRMS (ESI, [M+H]+): calcd for C18H18NO5S: 360.0906; found: 360.0908. 
3.4.3.3 Methyl 8-benzoyl-3-methyl-5-oxo-5H-thiazolo[3,2-a]pyridine-7-carboxylate 
214 
Rf = 0.53 (ethyl acetate/hexane = 1:1); yellow solid; mp = 203-204 °C.  
1H NMR (600 MHz, CDCl3): 7.57d, J = 7.14 Hz, C6H5 ortho, 2H), 7.51 (t, J = 
7.38 Hz, C6H5 para, 1H), 7.44 (dd, C6H5 meta, 2H), 6.74 (s, >NC(CH3)CHS, 1H), 6.53 
(s, CH=CCO2CH3, 1H), 3.16 (s, CO2CH3, 3H), 2.92 (s, >NC(CH3)CHS, 3H). 
13C NMR (150 MHz, CDCl3): 190.97COC6H5), 166.35 (CO2CH3), 16 
1.18 (NCOCH= or N,SC=), 157.55 (NCOCH= or N,SC=), 142.18 (=CCO2CH3), 
139.56 (NC(CH3)CHSrCOC6H5 ipso), 138.93 (NC(CH3)CHSrCOC6H5 
ipso), 131.64 (COC6H5, para), 128.42 (COC6H5, ortho), 127.78 
(COC6H5, meta), 112.36 (NCOCH=), 111.34 (>NC(CH3)CHS), 107.46 
(=C(COC6H5)), 52.26 (CO2CH3), 18.25 (>NC(CH3)CHS).
DEPT 135 NMR (150 MHz, CDCl3): 131.77, 128.55, 127.91, 112.50, 111.48, 
52.40, 18.40. 
IR (neat, cm-1): 3128, 3066, 2981, 2951, 1723, 1667, 1625, 1594, 1475, 1435, 
1406, 1304, 1255, 1144, 1126. 











3.4.4 Reaction of the tautomers (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 
196a and 2-(4,5-dimethylthiazol-2-yl)-1-phenylethanone 196b with dimethyl 
acetylenedicarboxylate (DMADC) 
The open chain intermediate product 211, the 5,6-ring-fused product 215 and the
5,7-ring-fused product 217 were synthesized by reacting DMADC (0.638 g, 4.44 mmol, 
2.49 eq.) in 5 mL of anhydrous MeOH with the tautomers, (Z)-2-(4,5-dimethylthiazol-2-
yl)-1-phenylethenol 196a and 2-(4,5-dimethylthiazol-2-yl)-1-phenylethanone 196b, 
(0.337 g, 1.46 mmol) in 5 mL MeOH by the general procedure used for the synthesis and 
purification of 209 and 213. The molarities of DMADC and tautomers are 0.44 M and 
0.15 M, respectively. The eluent used for column chromatography over silica gel was 
silica gel, 1:2 3:1 ethyl acetate: hexane. The compound 211, (0.175 g, 32.3%), eluted 
first followed by the compound 215 (0.08 g, 16%) and compound 217 (0.173 g, 23.1%). 
Trace amount of (E) and (Z)-dimethyl 2-methoxymaleate 223 and 224 were also isolated 
as by products. 
3.4.4.1 Synthesis of compounds 211, 215 and 217 under other reaction conditions 
The open chain intermediate 211 (0.249 g, 45.8%), the 5,6-ring-fused compound 
215, (0.102 g, 20.5%) and the 5,7-ring-fused compound 217 (0.05 g, 7%) were prepared 
by combining solutions of DAMDC (0.313 g, 2.18 mmol, 1.5 eq.) in 5 mL anhydrous 
MeOH, and the tautomers 196a and 196b (0.336 g, 1.45 mmol, 1 eq.) in 5 mL of 
anhydrous MeOH and then the general procedure mentioned above was followed. The 
molarities of DMADC and tautomers are 0.22 M and 0.15 M, respectively. 
3.4.4.2  (E)-Dimethyl 2-(1-(4,5-dimethylthiazol-2-yl)-2-oxo-2-phenylethylidene) 
succinate 211












1H NMR (300 MHz, CDCl3): d, J = 7.50 Hz, C6H5 ortho, 2H), 7.55 (t, J = 
7.21 Hz, C6H5 para, 1H), 7.45 (dd, C6H5 meta, 2H), 4.12 (s, CH2CO2CH3, 2H), 3.79 (s, 
=C(CO2CH3), 3H), 3.55 (s, CH2CO2CH3, 3H), 2.33 (s, =NC(CH3)=C(CH3)S, 3H), 
2.30 (s, =NC(CH3)=C(CH3)S, 3H). 
13C NMR (75 MHz, CDCl3): COC6H5), 171.33 (CH2CO2CH3),
166.34 (=C(CO2CH3)), 154.98 (N,S≥C or =NC(CH3)=C(CH3)S), 151.20 (N,S≥C or 
=NC(CH3)=C(CH3)S), 144.00 (=C(COC6H5)) 135.61 (=C(CO2CH3) or 
COC6H5 ipso), 133.32 (=C(CO2CH3) or COC6H5 ipso), 131.79 (COC6H5, para), 
128.83 (COC6H5, ortho), 128.66 (COC6H5, meta), 129.95 (NC(CH3)=C(CH3)S), 
52.35 (=C(CO2CH3)), 51.94 (CH2CO2CH3), 35.10 (CH2CO2CH3), 14.70 
(=NC(CH3)=C(CH3)S), 11.17 (=NC(CH3)=C(CH3)S). 
DEPT 135 NMR (150 MHz, CDCl3): 133.47, 128.96, 128.81, 52.49, 52.08, 
35.23, 14.84, 11.37 
IR (neat, cm-1): 3060, 3023, 2997, 2981, 2951, 2925, 2847, 1736, 1714, 1672, 
1628, 1294, 1254, 1491, 1407, 1205, 1170, 1121, 939, 785, 729, 689. 
HRMS (ESI, [M+H]+): calcd for C19H20NO5S: 374.1062; found: 374.1074. 
3.4.4.3 Methyl 8-benzoyl-2,3-dimethyl-5-oxo-5H-thiazolo[3,2-a]pyridine-7-
carboxylate 215
Rf = 0.58 (ethyl acetate/hexane = 1:1); yellow solid; mp = 172-174 °C.  
1H NMR (600 MHz, CDCl3): d, J = 7.84 Hz, C6H5 ortho, 2H), 7.51 (t, J = 
7.02 Hz, C6H5 para, 1H), 7.44 (dd, C6H5 meta, 2H), 6.53 (s, CH=C(CO2CH3), 1H), 









13C NMR (150 MHz, CDCl3): COC6H5), 166.55 (CO2CH3), 16 
1.06 (NCOCH=) or N,SC=), 155.57 (NCOCH=) or N,SC=), 141.50 (=C(CO2CH3)), 
139.73 (COC6H5, ipso), 133.24 (NC(CH3)=C(CH3)S), 131.61 (COC6H5, para), 
128.44 (COC6H5, ortho), 127.85 (COC6H5, meta), 122.59 (NC(CH3)=C(CH3)S, 
111.68 (NCOCH=), 107.19 (C(COC6H5)), 52.25 (CO2CH3), 15.11 
(C(CH3)=C(CH3)S, 11.61 (NC(CH3)=C(CH3)S. 
DEPT 135 NMR (150 MHz, CDCl3):  131.71, 128.53, 127.94, 111.77, 52.34, 
15.21, 11.71. 
IR (neat, cm-1): 3081, 3030, 2970, 2981, 2951, 2936, 1733, 1683, 1608, 1598, 
1539, 1480, 1443, 1413, 1323, 1310, 1280, 1249, 1174, 1123, 981, 947, 847, 780, 694. 
HRMS (ESI, [M+H]+): calcd for C18H16NO4S: 342.0800; found: 342.0773. 
3.4.4.4 (5S,6S,7Z,9Z)-Tetramethyl 9-benzoyl-2,3-dimethyl-5,6-dihydrothiazolo[3,2-
a]azepin-5,6, 7,8-tetracarboxylate 217 
Rf = 0.45 (ethyl acetate/hexane = 3:1); yellowish orange solid; mp = 216-218 °C.  
1H NMR (600 MHz, CDCl3): d, J = 7.16 Hz, C6H5 ortho, 2H), 7.38 (t, J = 
7.34 Hz, C6H5 para, 1H), 7.31 (dd, C6H5 meta, 2H), 5.76 (d, J = 5.2 Hz, 
>NCH(CO2CH3), 1H), 4.98 (d, J = 5.2 Hz, CH(CO2CH3)C(CO2CH3)=, 1H), 3.71 (s, 
CH(CO2CH3)C(CO2CH3)=, 3H), 3.68 (s, =C(CO2CH3)C(COC6H5)=, 3H), 3.67 (s, 
CH(CO2CH3)C(CO2CH3)=, 3H) 3.03 (s, >NCH(CO2CH3), 3H), 2.24, 2.21 (s, 
>NC(CH3)=C(CH3)S, 6H). 
13C NMR (150 MHz, CDCl3): COC6H5), 169.06, 167.73, 167.70, 
167.08 (four CO2CH3), 160.25 (N,SC=), 142.15 (=C(CO2CH3)C(COC6H5)= or 
COC6H5 ipso), 140.86 (=C(CO2CH3)C(COC6H5)= or COC6H5 ipso), 132.81 







(COC6H5, meta), 119.90 (CH(CO2CH3)C(CO2CH3)=), 116.90 
(>NC(CH3)=C(CH3)S), 97.59 (C(COC6H5)), 64.12 (>NCHCO2CH3), 53.16, 53.07, 
52.35, 51.93, (four CO2CH3), 46.32 (CH(CO2CH3)C(CO2CH3)=), 12.51 and 11.43 
(>NC(CH3)=C(CH3)S, 2C). 
DEPT 135 NMR (150 MHz, CDCl3):  130.52, 129.41, 127.60, 64.19, 53.23, 
53.15, 52.43, 52.00, 46.39, 12.58, 11.50. 
IR (neat, cm-1): 1996, 2949, 2840, 1738, 1709, 1549, 1449, 1333, 1348, 1213, 
1137, 997, 786, 740, 700, 662. 
HRMS (ESI, [M+H]+): calcd for C25H26NO9S: 516.1328; found: 516.1286. 
3.4.4.5 (E)-Dimethyl 2-methoxymaleate 22364 
Brown oil 
1H NMR (600 MHz, CDCl3): 5.21 (s, =CH(CO2CH3), 1H), 3.89, 3.75 (s, two 
CO2CH3, 6H), 3.71 (s, OCH3, 3H).
13C NMR (600 MHz, CDCl3): 166.38, 164.08 (two CO2CH3), 162.59 
(=C(CO2CH3)OCH3), 93.26 (=CH(CO2CH3)), 57.08 , 53.04 (two CO2CH3) , 51.78 
OCH3). 
3.4.4.6 (Z)-Dimethyl 2-methoxymaleate 22464 
Brown oil 
1H NMR (600 MHz, CDCl3): 5.21 (s, =CH(CO2CH3), 1H), 3.89, 3.75 (s, two 
CO2CH3, 6H), 3.71 (s, OCH3, 3H).
13C NMR (600 MHz, CDCl3): 166.38, 164.08 (two CO2CH3), 162.59 















3.4.5 Reaction of the tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a
and 2-(4,5-dimethyloxazol-2-yl)-1-phenylethanone 197b with dimethyl 
acetylenedicarboxylate (DMADC) 
The open chain intermediate product 212, the 5,6-ring-fused product 216 and the
5,7-ring-fused product 218 were synthesized by reacting DMADC (0.601 g, 4.19 mmol, 
2.51 eq.) in 5 mL of anhydrous MeOH and the tautomers, (Z)-2-(4,5-dimethyloxazol-2-
yl)-1-phenylethenol 197a and 2-(4,5-dimethyloxazol-2-yl)-1-phenylethanone 197b, 
(0.360 g, 1.67 mmol, 1 eq.) in 5 mL MeOH by the general procedure used for the 
synthesis and purification of 209 and 213. The molarities of DMADC and the tautomers 
are 0.42 M and 0.17 M, respectively. The eluent used for column chromatography over 
silica gel was 1:2 4:1 ethyl acetate: hexane. The intermediate product 212 (0.212 g, 
35.5%), eluted first followed by 219 (0.011 g, 1.3%), 5,6-ring-fused compound 216
(0.023 g, 4.3%) and 5,7 ring-fused compound 218 (0.392 g, 47%). Trace amount of (E) 
and (Z)-dimethyl 2-methoxymaleate 223 and 224 were also isolated.
3.4.5.1 Synthesis of compounds 212 and 218 under other reaction conditions
The open chain intermediate product 212 (0.206 g, 44.2%) and 5,7-ring-fused 
product 218 (0.166 g, 19.8%) were prepared by stirring the tautomers 197a and 197b
(0.363 g, 1.68 mmol, 1 eq.) and DAMDC (0.242 g, 1.68 mmol, 1 eq.) in 10 mL of 
anhydrous MeOH at room temperature for 24 h. The starting tautomers (16.5%) were 
recovered at a 197a:197b  ratio of 1 : 2.73. The molarities of both DMADC and 
tautomers are 0.17 M. The 5,6-ring-fused compound was not detected on TLC.  
3.4.5.2 (Z)-Dimethyl 2-(1-(4,5-dimethyloxazol-2-yl)-2-oxo-2-phenylethylidene) 
succinate 212









1H NMR (600 MHz, CDCl3): d, J = 7.92 Hz, C6H5 ortho, 2H), 7.55 (t, J = 
7.30 Hz, C6H5 para, 1H), 7.46 (dd, C6H5 meta, 2H), 4.22 (s, CH2CO2CH3, 2H), 3.78 (s, 
=C(CO2CH3), 3H), 3.55 (s, CH2CO2CH3, 3H), 2.16 (s, =NC(CH3)=C(CH3)O, 3H), 
2.07 (s, =NC(CH3)=C(CH3)O, 3H). 
13C NMR (150 MHz, CDCl3):  192.63 COC6H5), 171.13 (CH2CO2CH3), 
166.14 (=C(CO2CH3)), 154.61 (N,O≥C), 145.93 (=C(COC6H5)), 138.17 
(=C(CO2CH3) or COC6H5 ipso or =NC(CH3)=C(CH3)O), 136.16 (=C(CO2CH3) or 
COC6H5 ipso or =NC(CH3)=C(CH3)O), 134.06 (=C(CO2CH3) or COC6H5, ipso or 
=NC(CH3)=C(CH3)O), 133.22 (COC6H5, para), 128.77 (COC6H5, ortho), 128.65 
(COC6H5, meta), 126.95 (NC(CH3)=C(CH3)O), 52.44 (=C(CO2CH3)), 52.09 
(CH2CO2CH3), 34.94 (CH2CO2CH3), 11.19 (=NC(CH3)=C(CH3)O), 10.05 
(=NC(CH3)=C(CH3)O). 
DEPT 135 NMR (150 MHz, CDCl3): 133.30, 128.86, 128.74, 52.52, 52.17, 
35.02, 11.28, 10.14. 
IR (neat, cm-1): 3084, 3066, 3029, 2959, 2935, 2850, 1736, 1708, 1601, 1434, 
1361, 1335, 1279, 1248, 1216, 1195, 1174, 1120, 942, 968, 896, 866. 
HRMS (ESI, [M+H]+): calcd for C19H20NO6: 358.1291; found: 358.1261. 
Single crystals were grown for X-ray crystallography by the vapor diffusion 
method. Hexane was diffused into a solution of compound 212 dissolved in chloroform. 
The crystal structure of 212 is given on Figure 3.9 on page 147. 
3.4.5.3 Methyl 8-benzoyl-2,3-dimethyl-5-oxo-5H-oxazolo[3,2-a]pyridine-7-
carboxylate 216








1H NMR (600 MHz, CDCl3): d, J = 8.42 Hz, C6H5 ortho, 2H), 7.50 (t, J = 
7.38 Hz, C6H5 para, 1H), 7.44 (dd, C6H5 meta, 2H), 6.54 (s, CH=C(CO2CH3), 1H), 
3.16 (s, CO2CH3, 3H), 2.83, 2.35 (d, J = Hz, >OC(CH3)=C(CH3)N<, 6H). 
13C NMR (150 MHz, CDCl3): COC6H5), 166.08 (CO2CH3), 158.48 
(>NCOCH= or (N,C=), 153.22 (>NCOCH= or (N,C=), 142.76 (=C(CO2CH3)), 
142.10 (>NC(CH3)=C(CH3)O), 138.43 (COC6H5, ipso), 132.84 (COC6H5, para), 
128.69 (COC6H5, ortho), 128.45 (COC6H5, meta), 119.38 (>NC(CH3)=C(CH3)O), 
109.85 (>NCOCH=), 97.77 (=C(COC6H5)), 52.62 (CO2CH3), 9.95, 9.79 
(>NC(CH3)=C(CH3)O). 
DEPT 135 NMR (150 MHz, CDCl3):  132.91, 128.76, 128.52, 109.92, 52.68, 
10.00, 9.85. 
IR (neat, cm-1): 3079, 2993, 2973, 2950, 2933, 1733, 1706, 1663, 1640, 1444, 
1428, 1270, 1154, 971. 
HRMS (ESI, [M+H]+): calcd for C18H16NO5: 326.1028; found: 326.0998. 
Single crystals were obtained for X-ray crystallography by the vapor diffusion 
method. Hexane was diffused into a solution of compound 216 dissolved in chloroform. 
The crystal structure of 216 is given in Figure 3.3 on page 141. 
3.4.5.4 (5S,6S,7Z,9Z)-Tetramethyl 9-benzoyl-2,3-dimethyl-5,6-dihydrooxazolo[3,2-
a]azepine-5, 6, 7,8-tetracarboxylate 218 
Rf = 0.35 (ethyl acetate/hexane = 4:1); intense yellow solid; mp = decompose at 
170 °C. 
1H NMR (600 MHz, CDCl3): d, J = 7.58 Hz, C6H5 ortho, 2H), 7.39 (t, J = 
7.25 Hz, C6H5 para, 1H), 7.31 (dd, C6H5 meta, 2H), 5.42 (d, J = 4.9 Hz, 






CH(CO2CH3)C(CO2CH3)=, 3H), 3.73 (s, =C(CO2CH3)C(COC6H5)=, 3H), 3.69 (s, 
CH(CO2CH3)C(CO2CH3)=, 3H) 3.65 (s, >NCH(CO2CH3), 3H), 2.05, 1.83 (s, 
>NC(CH3)=C(CH3)O, 6H). 
13C NMR (75 MHz, CDCl3): COC6H5), 170.38, 168.76, 167.08, 
166.58 (four CO2CH3), 158.96 (N,SC=), 144.31 (=C(CO2CH3)C(COC6H5)= or 
COC6H5 ipso), 141.85 (=C(CO2CH3)C(COC6H5)= or COC6H5 ipso), 138.12 
(CH(CO2CH3)C(CO2CH3)= or (>NC(CH3)=C(CH3)O), 130.69 (COC6H5, para), 
128.40 (COC6H5, ortho), 127.71 (COC6H5, meta), 121.44 
(CH(CO2CH3)C(CO2CH3)= or (>NC(CH3)=C(CH3)O), 110.70 
(>NC(CH3)=C(CH3)O), 89.79 (C(COC6H5)), 60.29 (>NCHCO2CH3), 53.28, 53.16, 
52.32, 52.25, (four CO2CH3), 44.93 (CH(CO2CH3)C(CO2CH3)=), 9.59, 7.59 
(>NC(CH3)=C(CH3)O, 2C). 
DEPT 135 NMR (150 MHz, CDCl3):  130.75, 128.49, 127.78, 60.40, 53.31, 
53.21, 52.36, 52.30, 45.06, 9.64, 7.65. 
IR (neat, cm-1): 2997, 2991, 2980, 2930, 1729, 1683, 1657, 1570, 1515, 1430, 
1232, 1227, 1225, 1170, 1120, 1097, 1000, 855, 768, 716, 695. 
HRMS (ESI, [M+H]+): calcd for C25H26NO10: 500.1557; found: 500.1530. 
Single crystals were grown for X-ray crystallography by the vapor diffusion 
method. Hexane was diffused into a solution of compound 218 dissolved in acetone. The 
X-ray crystal structure of 218 is given in Figure 3.14 on page 155. 
3.4.5.5 Tetramethyl 5-(4,5-dimethyloxazol-2-yl)-6-phenylbenzene-1,2,3,4-tetra carbo- 
xylate 219 











1H NMR (600 MHz, CDCl3): m, C6H5 para and meta, 3H), 7.06 (d, J = 
7.19 Hz, C6H5 ortho, 1H), 3.90, 3.88, 3.76, 3.50 (s, four CO2CH3, 12H), 1.99, 1.92 (s, 
>NC(CH3)=C(CH3)O, 6H). 
13C NMR (150 MHz, CDCl3): 166.42, 165.85, 165.82 (four CO2CH3), 
154.26 (N,C=), 144.52, 142.90, 136.44, 135.98, 135.27, 131.75, 131.48, 130.99, 
129.89 (aromatic, 7C and >NC(CH3)=C(CH3)O, 2C), 53.24, 53.20, 52.88, 52.51 (four 
CO2CH3), 11.08, 9.57 (>NC(CH3)=C(CH3)O). 
DEPT 135 NMR (150 MHz, CDCl3):  128.47, 128.03, 127.88, 53.30, 53.26, 
52.57, 11.14, 9.63. 
IR (neat, cm-1): 3023, 3018, 3001, 2981, 2956, 2928, 1735, 1438, 1335, 1209, 
1187, 1176, 1153, 1094, 924, 857, 824, 715. 
HRMS (ESI, [M+H]+): calcd for C25H24NO9: 482.1451; found: 482.1435. 
3.4.6 Reaction of the tautomers (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a
and 2-(benzo[d]oxazol-2-yl)-1-phenylethanone 198b with dimethyl 
acetylenedicarboxylate (DMADC) 
The open chain intermediate product 220 and the 5,6-ring-fused product 
221, were synthesized by reacting DMADC (0.308 g, 2.15 mmol, 1.5 eq.) in 5 mL of 
anhydrous MeOH with the tautomers (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a
and 2-(benzo[d]oxazol-2-yl)-1-phenylethanone 198b (0.339 g, 1.43 mmol, 1 eq.) in 5 mL
MeOH by the general procedure used for the synthesis and purification of 209 and 213. 
The molarities of DMADC and tautomers are 0.22 M and 0.14 M, respectively. The 
eluent used for column chromatography over silica gel was ethyl acetate: hexane = 1:3. 










3.4.6.1 Syntheses of compounds 220 and 221 under other reaction conditions
(Z)-Dimethyl 2-(1-(benzo[d]oxazol-2-yl)-2-oxo-2-phenylethylidene)succinate 220
0.172 g, 35.3%) and methyl 4-benzoyl-1-oxo-1H-benzo[4,5]oxazolo[3,2-a]pyridine-3-
carboxylate 221 (0.049 g, 11%) were prepared by combining solutions of DAMDC 
(0.279 g, 1.94 mmol, 1.51 eq.) in 10 mL of  anhydrous MeOH, and the tautomers 198a
and 198b (0.305 g, 1.28 mmol, 1 eq.) in 15 mL of anhydrous MeOH and then following 
the general procedure mentioned above. The molarities of DMADC and tautomers are 
0.08 M and 0.05 M, respectively. The starting tautomers (40.6%) were recovered in a 
198a:198b ratio of 1.11:1. 
3.4.6.2 (Z)-Dimethyl 2-(1-(benzo[d]oxazol-2-yl)-2-oxo-2-phenylethylidene)succinate 
220 
Rf = 0.48 (ethyl acetate/hexane = 1:2); yellow solid; mp = 130-132 °C. 
1H NMR (300 MHz, CDCl3): d, J = 8.53 Hz, C6H5 ortho, 2H), 7.77-7.73 
(m, aromatic H), 7.57 (t, J = 7.93 Hz, C6H5 para, 1H), 7.50-7.47 (m, aromatic H), 7.37-
7.33 (m, aromatic H), 4.38 (s, CH2CO2CH3, 2H), 3.81 (s, =C(CO2CH3), 3H), 3.61 (s, 
CH2CO2CH3, 3H). 
13C NMR (75 MHz, CDCl3): 192.12COC6H5), 170.72 (CH2CO2CH3), 
165.75(=C(CO2CH3))158.21(N,O≥C)150.05(=NC≥CO)141.13(=C(COC6H5))1 
38.43(=C(CO2CH3) or =NC≥CO),135.96(COC6H5, ipso)133.64 (COC6H5, 
para)132.39 =C(CO2CH3) or =NC≥CO), 128.93 (COC6H5, ortho), 128.90 
(COC6H5, meta), 126.92, 125.25, 121.12, 111.10 (aromatic C) 52.86 (=C(CO2CH3)), 
52.47 (CH2CO2CH3), 35.45 (CH2CO2CH3). 
DEPT 135 NMR (150 MHz, CDCl3):  133.64, 128.97, 128.92, 126.93, 125.28, 








IR (neat, cm-1): 3086, 3067, 2981, 2952, 2923, 2849, 1743, 1720, 1694, 1596, 
1534, 1449, 1434, 1296, 1243, 1209, 1181, 1001, 944, 753, 725, 692.
HRMS (ESI, [M+H]+): calcd for C21H18NO6: 380.1134; found: 380.1115. 
3.4.6.3 Methyl 4-benzoyl-1-oxo-1H-benzo[4,5]oxazolo[3,2-a]pyridine-3-carboxylate 
221
Rf = 0.48 (ethyl acetate/hexane = 1:1); pale yellow solid; mp = 193-195 °C. 
1H NMR (600 MHz, CDCl3): d, J = 7.49 Hz, C6H5 ortho, 2H), 7.85 (d, J = 
7.74 Hz, aromatic, 1H), 7.61 (t, J = 7.31 Hz, C6H5 para, 1H), 7.50-7.44 (m, aromatic, 
5H), 6.89 (s, CH=C(CO2CH3), 1H). 3.61 (s, CH=C(CO2CH3), 3H). 
13C NMR (150 MHz, CDCl3): 189.40COC6H5), 165.57 (CO2CH3 or 
>NCOCH= or N,C=), 158.07 (CO2CH3 or >NCOCH= or N,C=), 152.87 
(>NCOCH=), 147.03 (=C(CO2CH3) or (>NC≥CO), 143.08(=C(CO2CH3) or 
(>NC≥CO), 137.96 (COC6H5, ipso), 133.34 (COC6H5, para), 128.99 (COC6H5, 
ortho), 128.69 (COC6H5, meta), 127.72 (aromatic CH) , 126.44 (>NC≥CO), 125.56 
117.37, 112.76 (aromatic CH), 110.96 (>NCOCH=), 98.16 (=C(COC6H5)), 52.94 
(CO2CH3). 
DEPT 135 NMR (150 MHz, CDCl3):  133.40, 129.04, 128.75, 127.78, 125.62, 
117.42, 112.82, 111.02, 52.99. 
IR (neat, cm-1): 3081, 3040, 3006, 2952, 1739, 1687, 1648, 1634, 1599, 1516, 
1441, 1418, 1297, 1250, 1164, 1050, 1000, 850, 790, 782, 757, 623. 
HRMS (ESI, [M+H]+): calcd for C20H14NO5: 348.0872; found: 348.0829. 
Single crystals of 221 were obtained for X-ray crystallography by the vapor 
diffusion method. Hexane was diffused into a solution of compound 221 dissolved in 










3.4.7 Reaction of the tautomers (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a
and 2-(benzo[d]thiazol-2-yl)-1-phenylethanone 199b with dimethyl 
acetylenedicarboxylate (DMADC) 
The 5,6-ring-fused product 222 was synthesized by reacting DMADC (0.226 g, 
1.57 mmol,  1.5 eq.) in 5 mL of anhydrous MeOH and the tautomers, (Z)-2-
(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-yl)-1-
phenylethanone 199b, (0.261g, 1.03 mmol, 1 eq.) in 15 mL MeOH by the general 
procedure used for the synthesis and purification of 209 and 213. The molarities of
tautomers : DMADC = 0.05 : 0.08. The eluent used for column chromatography over 
silica gel was ethyl acetate: hexane = 1:2. The compound 222 (0.317 g, 84.8%) was 
isolated as the only product. 
3.4.7.1 Synthesis of compound 222 under other reaction conditions 
DAMDC (0.141 g, 0.98 mmol, 1 eq.) in 5 mL of anhydrous MeOH was added 
dropwise to a solution of the tautomers 199a and 199b (0.261g, 1.03 mmol, 1 eq.), 
(0.247 g, 0.98 mmol) in 15 mL of anhydrous MeOH at room temperature under nitrogen. 
The molarities of both DMADC and tautomers are 0.05 M. After 24 h stirring at room 
temperature, the 5,6-ring-fused product 222 (0.230 g, 64.7%) was isolated along with 
21.8% starting tautomers at 199a:199b = 1.62:1. The products were worked up by the 
general procedure. 
3.4.7.2 Methyl 4-benzoyl-1-oxo-1H-benzo[4,5]thiazolo[3,2-a]pyridine-3-carboxylate 
222 
Rf = 0.43 (ethyl acetate/hexane = 1:2); intense yellow solid; mp = 234-236 °C. 
1H NMR (600 MHz, CDCl3): d, J = 8.14 Hz, C6H5 ortho, 2H), 7.81 (d, J = 






7.47 (dd, C6H5 meta, 2H), 6.83 (s, CH=C(CO2CH3), 1H), 3.23 (s, CH=C(CO2CH3), 
3H). 
13C NMR (150 MHz, CDCl3): 191.72COC6H5), 166.09 (CO2CH3), 161.13 
(>NCOCH=), 154.90 (N,SC=, 141.70 (=C(CO2CH3)), 139.25 (>NC≥CS) or 
COC6H5, ipso), 137.20 (>NC≥CS) or COC6H5, ipso), 132.12 (COC6H5, para), 
128.61 (COC6H5, ortho), 128.35 (>NC≥CS), 127.98 (COC6H5, meta), 127.48 127.06, 
121.66, 120.34 (aromatic CH), 113.92 (>NCOCH=), 108.16 (=C(COC6H5)), 52.46 
(CO2CH3). 
DEPT 135 NMR (150 MHz, CDCl3):  132.19, 128.68, 128.05, 127.54, 127.13, 
121.41, 120.41, 113.98, 52.53. 
IR (neat, cm-1): 3126, 3094, 3068, 3013, 2981, 2952, 1719, 1672, 1621, 1559, 
1492, 1434, 1409, 1289, 1264, 1244, 1196, 1120, 1066, 996, 945, 858, 805, 762, 679, 
620. 
HRMS (ESI, [M+H]+): calcd for C20H14NO4S: 364.0644; found: 364.0600. 
3.4.8 Conversion of the (Z)-dimethyl 2-(1-(benzo[d]oxazol-2-yl)-2-oxo-2-phenyl 
ethylidene) succinate 220 to methyl 4-benzoyl-1-oxo-1H-benzo[4,5]oxazolo[3,2-
a]pyridine-3-carboxylate 221
The open chain product 220 (0.20 g, 0.53 mmol) was dissolved in anhydrous 
MeOH (3 mL) and refluxed. The reaction was monitored by TLC. The spot for 220 was 
not observed after 15 h. MeOH was removed by rotary evaporation and residue was 
dissolved in dichloromethane (10 mL) and washed with water (2 × 10 mL) . Organic 
layer was dried with anhydrous sodium sulfate. Sodium sulphate was filtered and 











(0.182 g) yield. The 1H, 13C, DEPT 135 NMR, HR-MS and IR spectroscopy data, and 
melting point of 221 are given on page 197. 
3.4.9 Synthesis of methyl 8-benzoyl-5-oxo-5H-thiazolo[3,2-a]pyridine-7-carboxylate
213 from  (E)-dimethyl 2-(2-oxo-2-phenyl-1-(thiazol-2-yl) ethylidene)succinate 
209 using NaH
The open chain intermediate 209 (0.301 g, 0.84 mmol) in 10 mL THF was added 
to a suspension of NaH (in 60% mineral oil) (0.051, 1.28 mmol, 1.5 eq.) in 10 mL THF at 
room temperature under nitrogen. Hydrogen bubbles were evolved. The unreacted 209
was not observed on the TLC after refluxing for 7 h. Then THF was removed by rotary 
evaporation. The residue was dissolved in 30 mL dichloromethane, washed with water (2 
× 20 mL) and dried over anhydrous sodium sulfate. After removal of dichloromethane by 
rotary evaporation, the crude product was purified by column chromatography (silica gel, 
ethyl acetate/hexane = 1:1). The 5,6-ring-fused product 213 (0.086 g, 76%) was isolated. 
This general procedure was also used for the syntheses of compounds 215, 216 and 221 
from 211, 213 and 220, respectively, discussed in this section. The 1H, 13C, DEPT 135 
NMR, HR-MS and IR spectroscopy data, and melting point of 213 are given on page 184. 
3.4.10 Synthesis of methyl 8-benzoyl-2,3-dimethyl-5-oxo-5H-thiazolo[3,2-a]pyridine-
7-carboxylate 215 from (Z)-dimethyl 2-(1-(4,5-dimethylthiazol-2-yl)-2-oxo-2-
phenylethylidene)succinate 211 using NaH 
The 5,6-ring-fused product 215 (0.064 g, 61%) was synthesized by refluxing the 
open chain intermediate product 211 (0.114 g, 0.31 mmol, 1 eq.) and NaH (0.02 g, 0.5 
mmol, 1.6 eq.) in 20 mL THF for 8 h. The unreacted 211 was not observed on the TLC. 
The product was purified by the general procedure used in synthesizing 215 from 211. 










1H, 13C, DEPT 135 NMR and IR spectroscopy data and melting point of 215 are given on 
page 189. 
3.4.11 Synthesis of methyl 8-benzoyl-2,3-dimethyl-5-oxo-5H-oxazolo[3,2-a] pyridine-
7-carboxylate 216 from (Z)-dimethyl 2-(1-(4,5-dimethylthiazol-2-yl)-2-oxo-2-
phenylethylidene)succinate 212 using NaH 
The 5,6-ring-fused product 216 (0.073 g, 40%) was synthesized by refluxing the 
open chain intermediate product 212  (0.203 g, 0.57 mmol) and NaH (0.034 g, 0.85 
mmol, 1.5 eq.) in 20 mL THF for 24 h. The products were purified by the general 
procedure used in synthesizing 213 from 209. The eluent used for column 
chromatography over silica gel was 1:1 ethyl acetate: hexane. 38.6% of 212 was 
recovered. 
The 5,6-ring-fused product 212 (0.013 g, 7%) was synthesized by refluxing the 
open chain intermediate product 216  (0.208 g, 0.58 mmol) and NaH (0.035 g, 0.88 
mmol, 1.5 eq.) in 20 mL 1,4-dioxane for 24 h. The products were purified by the general 
procedure used in synthesizing 213 from 209. The eluent used for column 
chromatography over silica gel was 1:1 ethyl acetate: hexane. 31.6% of 212 was 
recovered. Reaction solution became very dark brown while refluxing. A dark brown spot 
was seen on the base line on the TLC. 1H, 13C, DEPT 135 NMR, HR-MS and IR 
spectroscopy data and melting point of 216 are given on page 193. 
3.4.12 Synthesis of methyl 4-benzoyl-1-oxo-1H-benzo[4,5]oxazolo[3,2-a]pyridine-3-
carboxylate 221 from (Z)-dimethyl 2-(1-(benzo[d]oxazol-2-yl)-2-oxo-2-
phenylethylidene)succinate 220
The 5,6-ring-fused product 221 (0.088 g, 79%) was synthesized by refluxing the 
open chain intermediate product 220 (0.121 g, 0.32 mmol) and NaH (0.02 g, 0.5 mmol, 








refluxing for 8 h. The products were purified by the general procedure used in 
synthesizing 209 from 213. The eluent used for column chromatography over silica gel 
was 1:1 ethyl acetate: hexane. 1H, 13C, DEPT 135 NMR and IR spectroscopy data and 
melting point of 221 are given on page 197. 
3.4.13 Reaction of the tautomers (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 
196a and 2-(4,5-dimethylthiazol-2-yl)-1-phenylethanone 196b with dimethyl 
acetylenedicarboxylate (DMADC) in the presence of NaOMe in MeOH 
DMADC (0.523 g, 3.64 mmol, 2.5 eq.) in 5 mL of anhydrous MeOH was added 
dropwise to a solution of the tautomers 196a and 196b (0.337 g, 1.46 mmol) in 5 mL of 
anhydrous MeOH at room temperature under nitrogen. Then, 25 wt% NaOMe in MeOH 
(0.1 ml, 0.5 mmol, 0.32 eq.) was added. This solution was refluxed for 24 h under 
nitrogen and then MeOH was removed by rotary evaporation. The residue was dissolved 
in 40 mL dichloromethane, washed with water (2 × 40 mL) and dried over anhydrous 
sodium sulfate. After removal of dichloromethane by rotary evaporation, the crude 
product was purified by column chromatography (silica gel, ethyl acetate/hexane = 1:2) 
and isolated. The the 5,6-ring-fused product 215 (0.221 g, 44.4%) eluted first followed by 
230 (0.067 g, 9.2%). A mixture (0.069 g) of (E)-dimethyl 2-methoxymaleate 223 and (Z)-
dimethyl 2-methoxymaleate 224 was also isolated. The 5,7-ring-fused product 217 was 
not detected on TLC. 1H, 13C, DEPT 135 NMR, HR-MS and IR spectroscopy data and 
melting point of 215 is given on page 189. 
3.4.13.1 Tetramethyl 5-(4,5-dimethylthiazol-2-yl)-6-phenylbenzene-1,2,3,4-
tetracarboxylate 230 









1H NMR (600 MHz, CDCl3): m, C6H5 para and meta, 3H), 7.11 (d, 
J = 7.68 Hz, C6H5 ortho, 2H), 3.89, 3.87, 3.72, 3.47 (s, four CO2CH3, 12H), 2.26, 2.20 
(s, >NC(CH3)=C(CH3)S, 6H). 
13C NMR (150 MHz, CDCl3): 166.81, 166.08, 165.78 (four CO2CH3), 
156.93 (N,SC=), 148.01, 141.68, 135.96, 135.81, 135.28, 134.94, 131.41, 130.18, 
130.99 (aromatic, 7C and >NC(CH3)=C(CH3)S, 2C), 129.50 (C6H5, ortho), 128.55 
(C6H5, para), 128. 14 (C6H5, meta), 53.15, 53.10, 52.49, 52.40 (four CO2CH3), 14.41, 
11.18 (>NC(CH3)=C(CH3)S).
DEPT 135 NMR (150 MHz, CDCl3):  129.63, 128.67, 128.26, 53.27, 52.22, 
52.61, 52.52, 14.54, 11.31. 
IR (neat, cm-1): 3081, 3030, 2981, 2951, 2936, 1733, 1683, 1608, 1598, 1539, 
1480, 1443, 1310, 1413, 1323, 1280, 1249, 947, 789, 747, 726, 694. 
HRMS (ESI, [M+H]+): calcd for C25H24NO8S: 498.1223; found: 498.1182. 
3.4.14 Reaction of the tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a
and 2-(4,5-dimethyloxazol-2-yl)-1-phenylethanone 197b with dimethyl 
acetylenedicarboxylate (DMADC) in the presence of NaOMe in MeOH 
The 5,6-ring-fused product 216 and the substituted biphenyl derivative 219
were synthesized by reacting DMADC (0.599 g, 4.17 mmol, 2.5 eq.), tautomers 197a and 
197b (0.359 g, 1.67 mmol), and NaOMe (0.1 ml, 0.5 mmol, 0.28 eq.) in 10 mL MeOH. 
Products were purified by the procedure used for the synthesis and purification of 215 
and 230. The eluent used for column chromatography over silica gel was 1:1 ethyl 
acetate: hexane. The compound 230 (0.286 g, 36.1%) eluted first followed by compound 









DEPT 135 NMR, HR-MS and IR spectroscopy data and melting point of 216 and 219 are 
given on pages 193 and 195. 
3.4.15 Reaction of (Z)-dimethyl 2-(1-(4,5-dimethylthiazol-2-yl)-2-oxo-2-phenyl 
ethylidene)succinate 212 with DMADC using NaOMe as the base 
DMADC (0.112 g, 0.78 mmol, 1.1 eq.) in 2 mL of anhydrous MeOH was added 
dropwise to a solution of 212 (0.255 g, 0.71 mmol) in 3 mL of anhydrous MeOH at room
temperature under nitrogen. Then, 25 wt% NaOMe in MeOH (1.5 L, 0.01 eq.) was 
added. This solution was refluxed for 24 h under nitrogen and then MeOH was removed 
by rotary evaporation. The residue was dissolved in 40 mL dichloromethane, washed 
with water (2 × 40 mL) and dried over anhydrous sodium sulfate. After removal of 
dichloromethane by rotary evaporation, the crude product was purified by column 
chromatography (silica gel, ethyl acetate/hexane = 1:2) and isolated. The 5,7-ring-fused 
product 218 was not detected on TLC. Instead the 5,6-ring-fused product 216 (0.15 g, 
65%) and 219 (0.012 g, 3.6%) was isolated. Further, 18% of the starting ring open 
intermediate 212 was recovered. 1H, 13C, DEPT 135 NMR and IR spectroscopic data and 
melting point of 216 and 219 are given on pages 193 and 195. 
3.4.16 Reaction of (5S,6S,7Z,9Z)-tetramethyl 9-benzoyl-2,3-dimethyl-5,6-dihydro 
oxazolo[3,2-a]azepine-5, 6, 7,8-tetracarboxylate 218 with NaOMe in MeOH 
NaOMe in MeOH (0.09 ml, 0.4 mmol, 0.9 eq.) was added to 218 (0.2 g, 0.4 
mmol) in MeOH at room temperature. The intense yellow color of the 218 in MeOH 
changed to dark brown color. The solution was analyzed by TLC after stirring for 15 
minutes at room temperature. The spot for the starting 5,7-ring-fused compound 218
disappeared while a new spot appeared on TLC plate. The new spot was identified as 






were purified by the procedure used for the synthesis and purification of 215 and 230. 
The eluent used for column chromatography over silica gel was 1:1 ethyl acetate: hexane. 
Compound 219 (0.072 g, 37.1%) was isolated. 1H, 13C, DEPT 135 NMR and IR 
spectroscopic data and melting point of 219 are given on pages 195. 
3.4.17 Reaction of (Z)-1-phenyl-2-(thiazol-2-yl)ethenol 194a and 1-phenyl-2-(thiazol-
2-yl)ethanone 194b with methyl propiolate in refluxing MeOH 
Methyl propiolate (0.691 g, 8.14 mmol, 1.5 eq.) in 10 mL of anhydrous MeOH 
was added dropwise to a stirred solution of the tautomers 194a,b (1.1 g, 5.4 mmol, 1 eq.) 
in 15 mL of anhydrous MeOH at room temperature under nitrogen. The molarities of
methyl propiolate and the starting tautomers are 0.33 M and 0.22 M, respectively. This 
solution was refluxed for 24 h under nitrogen and then MeOH was removed by rotary 
evaporation. The residue was dissolved in dichloromethane (40 mL), washed with water 
(2 × 40 mL) and dried over anhydrous sodium sulfate. Two very close spots were 
detected on the TLC (Rf = 0.65, 0.62; ethyl acetate:hexane = 3:2) in addition to the spot 
for unreacted 194a,b. After removal of dichloromethane by rotary evaporation, the crude 
product was purified by column chromatography (silica gel, ethyl acetate/hexane = 1:4 
1:2) and isolated. The starting tautomers 194a,b were recovered in 14% yield as the first 
fraction. The compounds corresponding to the two very close spots seen on TLC were 
collected as a single fraction (yellow solid; 0.21 g) This fraction had a complex 1H NMR 
spectra. The compounds representing the two TLC spots could not be separated by 
column chromatography by changing the eluting solvent’s polarity using different ethyl 
acetate/hexane or acetone/hexane ratios. Further purification of this fraction was 
attempted by crystallization which was carried out by diffusion of hexane vapor into a 





and this had a very broad melting point range from 178 C-190 C. The 1H NMR spectra 
of this solid is exactly the same as that of the solid before recrystallization. The 1H, 13C 
and DEPT 135 NMR spectra of this unidentified solid are given in Figures 3.24 and 3.25, 
respectively. This general purification procedure was used in the other reactions 
discussed below. 
3.4.18 Reaction of (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-
dimethyloxazol-2-yl)-1-phenylethanone 197b with methyl propiolate in 
refluxing MeOH 
Methyl propiolate (0.264 g, 3.11 mmol, 1.51 eq.) in 5 mL of anhydrous MeOH 
was added dropwise to a stirred solution of the tautomers 197a and 197b (0.444 g, 
2.06 mmol, 1 eq.) in 10 mL of anhydrous MeOH at room temperature under nitrogen. 
The molarities of methyl propiolate and tautomers are 0.21 M and 0.14 M, respectively. 
This solution was refluxed for 24 h under nitrogen and then MeOH was removed by 
rotary evaporation. Two new spots were detected on TLC in addition to the spot for 
unreacted 197a,b (ethyl acetate:hexane = 1:2). The above-mentioned general procedure 
was used for the purification and isolation of products. The crude product was purified by 
column chromatography using ethyl acetate/hexane = 1:3 and then 1:1 over silica gel. 
The unreacted starting tautomers 197a,b (0.291, 65.5%) were collected first in a 
197a:197b ratio of 1:3.03 in CDCl3. Next, compound 234 (0.022 g, 4.3%) was isolated. 
A more polar high-intense yellow solid (0.026 g) corresponding to the third spot was also 
isolated. The Rf of this last fraction is 0.29 (ethyl acetate:hexane = 1:2). Figure 3.26 
shows its 1H NMR spectrum.
This reaction was repeated with 197a,b (0.37 g, 1.7 mmol, 1 eq.), methyl 









unreacted starting tautomers 197a,b (0.15 g, 40.5%), 234 (0.03 g, 5.8%) and the same 
intense yellow solid (0.058 g) described in the above reaction were isolated.  
3.4.18.1 (E)-Methyl 3-(4,5-dimethyl-2-(2-oxo-2-phenylethylidene)oxazol-3(2H)-
yl)acrylate 234 
Rf = 0.40 (ethyl acetate/hexane = 1:2); yellow solid, mp = 150-152°C. 
1H NMR (600 MHz, CDCl3): 8.09 (d, J = 14.95 Hz, >NCH=, 1H), 7.46 (m, 
C6H5, 5H), 6.70 (s, =CH(COPh), 1H), 5.32 (d, J = 14.95 Hz, =CH(CO2CH3), 1H), 3.75 
(s, =CH(CO2CH3), 3H), 2.03 and 1.72 (s, =NC(CH3)=C(CH3)O, 6H). 
13C NMR (150 MHz, CDCl3):  203.52 (COC6H5), 168.84 (=CH(CO2CH3), 
167.46 (N,C=), 162.13 (COC6H5 ipso), 134.10 (>NCH=), 131.51 (COC6H5 para), 
129.44 (COC6H5 ortho), 129.39 (=NC(CH3)=C(CH3)O), 127.24 (COC6H5, meta), 
120.34 (=CH(CO2CH3), 99.73 (=CH(COPh)), 75.44 (=NC(CH3)=C(CH3)O), 51.57 
(=CH(CO2CH3), 23.39 (=NC(CH3)=C(CH3)O), 18.21 (=NC(CH3)=C(CH3)O).
DEPT 135 NMR (150 MHz, CDCl3): 134.16, 131.53, 129.49, 127.29, 120.44, 
99.85, 51.58, 23.41, 18.25 
IR (neat, cm-1): 3084, 3001, 2951, 2850, 1699, 1635, 1597, 1573, 1450, 1351, 
1326, 1289, 1239, 1222, 1152, 1123, 1064, 978, 924, 861, 834, 763, 680. 
HRMS (ESI, [M+2H]+): calcd for C17H19NO4: 301.1314; found: 301.1407. 
3.4.19 Reaction of (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-
dimethyloxazol-2-yl)-1-phenylethanone 197b with methyl propiolate in MeOH 
at room temperature 
Methyl propiolate (0.097 g, 1.1 mmol, 1 eq.) in 10 mL of anhydrous MeOH was 
added dropwise to a stirred solution of the tautomers 197a and 197b (0.24 g, 1.1 mmol, 1 







methyl propiolate and 194a,b were both 0.05 M. Then this solution was stirred for 18 h 
under nitrogen. MeOH was removed by rotary evaporation. The general work up 
procedure mentioned above was then employed. The crude product was purified by 
column chromatography using ethyl acetate/hexane = 1:3 then 2:1 over silica gel. 
The title compound 238 (0.042 g, 16%) was isolated along with the un-reacted starting 
tautomers 197a,b (0.096 g, 38.9%) in a 197a:197b ratio of 1:2.86. 
Reaction of 197a,b (0.269 g, 1.25 mmol, 1 eq.) with methyl propiolate (0.109 g, 
1.28 mmol, 1 eq.) in 20 mL MeOH at room temperature for 24 h afforded 238 in 13% 
(0.036 g) yield. 
A control reaction was carried out in the presence of water without methyl 
propiolate to see if 238 would form from 197a,b in the presence of water. Water (10 mL) 
was added to tautomers 197a,b (0.282 g, 1.31 mmol) in methanol (10 mL). Then solution 
was refluxed for 24 h at about 80 C. The crude product mixture was purified according 
to the general procedure used for purification and isolation of products 209 and 213. 
Compound 238 (0.032 g, 11%) was isolated showing that methyl propiolate was not 
involved in its formation.  
3.4.19.1 2-Acetyl-2-methyl-6-phenyl-2,3-dihydro-1,3-oxazin-4-one 238
Rf = 0.45 (ethyl acetate/hexane = 1:2); pale yellow solid, mp = 142-144 °C. 
1H NMR (300 MHz, CDCl3): 8.37 (s, >NH, 1H), 7.78 (d, J = 7.37 Hz, C6H5 
ortho), 7.54-7.44 (m, C6H5 meta and para, 3H), 5.83 (s, =CH, 1H), 2.33 (s, COCH3, 
3H), 1.79 (s, >CCH3, 3H). 
13C NMR (75 MHz, CDCl3):  205.48 (COCH3), 165.55 (CONH or 








ipso), 128.76 (C6H5 meta), 126.56 (C6H5 ortho), 96.55 (=CH), 91.09 (>CCH3), 
24.80 (COCH3), 22.09 (>CCH3). 
IR (neat, cm-1): 3168, 3055, 2895, 1727, 1652, 1451, 1394, 1197, 1108, 1053, 
1021, 952, 900, 825, 769, 684, 664. 
HRMS (ESI, [M+H]+): calcd for C13H14NO3: 232.0974; found: 232.0992. 
Single crystals were grown for X-ray crystallography by the vapor diffusion 
method. Hexane was diffused into a solution of compound 238 dissolved in chloroform. 
The crystal structure of 238 is given in Figure 3.23 on page 191. 
3.4.20 Reaction of (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-
(benzo[d]thiazol-2-yl)-1-phenylethanone 199b with methyl propiolate in 
refluxing MeOH 
A solution of the tautomers 199a,b (0.202 g, 0.80 mmol, 1 eq.) and methyl 
propiolate (0.102 g, 1.20 mmol, 1.5 eq.) in 10 mL of anhydrous MeOH was refluxed for 
23 h. The molarities of the tautomers 199a,b and methyl propiolate are 0.08 M and 0.12 
M, respectively. Two new spots were seen on TLC in addition to the spot for 199a,b after 
23 h. Then the general work up procedure mentioned on page 206 was followed. The 
crude product was purified by column chromatography using ethyl acetate/hexane = 1:3 
over silica gel. The starting tautomers 199a,b (fraction 1) were recovered in 58.9% 
(0.119 g) yield. Fraction 2 (Rf = 0.44; ethyl acetate/hexane = 1:3) and fraction 3 (Rf = 
0.29; ethyl acetate/hexane = 1:3) were separated and each fraction weighted 0.03 g each. 
These two fractions were unidentified. The 1H NMR spectra of these two fractions are 







         
         
         
 
3.4.21 NMR spectra of unidentified fractions collected from column separation  
3.4.21.1 Reaction of the tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethenol 194a and 1-
phenyl-2-(thiazol-2-yl)ethanone 194b with methyl propiolate 










Figure 3.25 13C and DEPT 135 NMR spectra (150 MHz, CDCl3) of two inseparable 









3.4.21.2 Reaction of the tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 
197a and 2-(4,5-dimethyloxazol-2-yl)-1- phenylethanone 197b with methyl 
propiolate 













3.4.21.3 Reaction of the tautomers (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 
199aand 2-(benzo[d]thiazol-2-yl)-1-phenylethanone 199b with methyl 
propiolate 
Figure 3.27 1H NMR spectrum (600 MHz, CDCl3) of the fraction 2 (Rf = 0.44; ethyl 
acetate;hexane = 1:3) 
Figure 3.28 1H NMR spectrum (600 MHz, CDCl3) of the fraction 3 (Rf = 0.29; ethyl 







REACTIONS OF THE TAUTOMERS OF 2-(THIAZOLE, OXAZOLE,
BENZOXAZOLE AND BENZOTHIAZOLE)-1-PHENYL




1,3-Diacid chlorides and N-chlorocarbonyl isocyanate are useful dielectrophiles 
which can be used for the syntheses of fused-ring systems. Syntheses of highly 
functionalized fused-ring heterocycles using 1,3-diacid chlorides and N-chlorocarbonyl 
isocyanate in the presence of Et3N was reported by our group.
4,6,50 For example, Zhou et 
al synthesized 5,6-ring-fused heterocycles starting from 2-alkyloxazolines and 2-
alkylthiazoline using 1,3-diacid chlorides and N-chlorocarbonyl (see Scheme 1.30 in 
Chapter I) in the presence of Et3N.
4 Syntheses of tricyclic (5,6,6-ring-fused) heterocycles 
by the reaction 2-methylimidazoline with a variety of 1,3-diacid chlorides in the presence 
of Et 503N were reported by Ye and co-workers (Scheme 1.31 in Chapter I).  Further, 
aromatic heterocycles as such 2-alkylimidazole and 2-methylbenzimidazole were 
reported to form variety of products, including fused-ring heterocycles, when reacted 
with 1,3-diacid chlorides in the presence of Et 6 3N (Scheme 1.32 in Chapter I). Reactions 
of 2-methyl-2-oxazoline, 2-methyl-2-thiazoline, 2-methyl-2-imidazoline, 2-
methylimidazole and 2-methylbenzimidazole with diacid chlorides and N-chlorocarbonyl 
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isocyanate proceed via the corresponding CKA intermediates, as described in the Chapter 
I. For example, reactions of 2-ethyl-2-thiazoline 239 with 1,3-diacid chlorides and N-
chlorocarbonyl isocyanate proceed via nucleophilic CKA intermediates 240, 241 and 
244, respectively, as shown in Scheme 4.1.4 
Scheme 4.1 Cyclization reactions of 2-ethyl-2-thiazolines 239 with 1,3-diacid 
chlorides and N-chlorocarbonyl isocyanate4 
The cyclization reactions were attempted on the aromatic heterocycles, 2,4,5-
trimethylthiazole and 2,4,5-trimethyloxazole, using 2,2-dimethylmalonyl dichloride and 
2,2-diethylmalonyl dichloride, or on 2-methylbenzimidazole and 1,2-dimethylimidazole 
employing diethylmalonyl dichloride in refluxing acetonitrile in the presence of Et3N 





  Scheme 4.2 Unsuccessful fused-ring heterocycles syntheses4b,40
 
Thiazole, oxazole, benzoxazole and benzothiazole derivatives are found in many 
biologically active compounds, as described in Chapter III.60-63 Therefore, it is worth 
developing synthetic routes to highly functionalized fused-ring systems, which contain 
thiazole, oxazole, benzoxazole and benzothiazole rings.  
Reactions of the five tautomeric pairs 194a,b and 196a,b-199a,b, with 2,2-
disubstituted-1,3-diacid chlorides and N-chlorocarbonyl isocyanate dielectrophiles in the 
presence of a base could form such 5,6-ring-fused compounds as 251-257 and 258-262 
shown in Schemes 4.3 and 4.4, respectively. The syntheses of each of these highly 






Scheme 4.3 Syntheses of 5,6-fused-ring heterocycles which were attempted in this 





   
   
   
   
   
  
 






Ph Ph O O 
H
H OHO O H HN Ph 
Cl N C ON X N X O N X ? 
Et3N 
THF, reflux R R R R R R 
194a,196a and 197a 194b,196b and 197b 258 - 260 
194a,b: X = S; R = H 258: X = S; R = H
196a,b: X = S; R = Me 259: X = S; R = Me
197a,b: X = O; R = Me 260: X = O; R= Me 
Ph O OPh O 
HH 
HN PhHO O H Cl N C O 
Et3N ON X N X N X ? 
THF/CH3CN, reflux 
261: X = O198a and 199a 198b and 199b 
262: X = S
198a and 198b: X = O 
199a and 199b: X = S 
Scheme 4.4 Syntheses of 5,6-fused-ring heterocycles which were attempted in this 






4.2 Results and Discussion 
4.2.1 Reactions of the tautomeric pairs, 194a,b and 196a,b-199a,b, with2,2-
disubstituted-1,3-diacid chlorides 
Enol-esters 105, 106, 107, 109 and 110 (Schemes 2.2 and 2.3 in Chapter II) were 
synthesized and then hydrolyzed to obtain the equilibrating tautomeric pairs 194a,b and 
196a,b-199a,b (Schemes 2.5 and 2.6 in Chapter II) as already described in the 
experimental section of Chapter II. The tautomeric pairs were then reacted with 2,2-
disubstituted-1,3-diacid chlorides in dry CH3N in the presence of Et3N. These reactions 
produced new compounds including the 5,6-ring-fused compounds 251, 252 and 254-






























198a and 199a 198b and 199b 256: X = S 257: X = O 
198a and 198b: X = O 
199a and 199b: X = S Ph O O Ph 
H H 
O O 
H3C  CH3 
N S N S 
266 
Scheme 4.5 Isolated products by reacting tautomeric pairs, 194a,b and 196a,b-199a,b 




are summarized in Tables 4.1-4.3. Complete experimental details and the 1H, 13C and 
DEPT 135 NMR, IR and HR-MS spectral and melting point data of compounds 251, 252, 






The tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethenol 194a and 1-phenyl-2-(thiazol-
2-yl)ethanone 194b were reacted with the three dielectrophiles 2,2-dimethylmalonyl 
dichloride, 2,2-diethylmalonyl dichloride and cyclobutane-1,1-dicarbonyl dichloride in 
the presence of Et3N in refluxing CH3CN (These are summarized in Scheme 4.5 and 
Entries 1-6 in Table 4.1). Reaction of 194a,b with 1.5 equivalents of 2,2-
dimethylmalonyl dichloride and 3.5 equivalents of Et3N for 5 h at reflux (Entry 1 in 
Table 4.1) afforded the desired 5,6-ring-fused heterocycle, 8-benzoyl-6,6-dimethyl-6H-
thiazolo[3,2-a]pyridine-5,7-dione 251, but in only 35% yield. Interestingly, the vinyl 
benzoate ester, (Z)-1-phenyl-2-(thiazol-2-yl)vinyl benzoate 105, was also isolated in 18% 
yield (Entry 1 in Table 4.1). Vinyl ester 105 is the original starting material for the 
synthesis of the tautomers 194a,b via its base hydrolysis in MeOH (See Scheme 2.5 in 
Chapter I). This vinyl ester 105 must be formed by the self-reaction of 194a,b because it 
is the only source of the benzoyl function. Further, 15% of the unreacted starting 
tautomer 194a,b was also isolated (Entry 1 in Table 4.1). All isolated products account 
for 86% of the starting tautomers. The yield of 251 increased from 35% to 65% using 
1.7 equivalents of 2,2-dimethylmalonyl dichloride and increasing the reaction time from
5 h to 7 h (Entry 2 in Table 4.1). Still 10% of 105 was isolated. Thus, 85% of the 









   
   
   




   
   




















































































































































































































































































































































   
   
   




   
   
   
  
 
   
   








   
   
   




   
   
  
 
   
   

























































































































































































































































































































































































































































































What caused the conversion of 194a,b to 105? A control reaction was carried out 
to investigate this question. A solution of 194a,b in the presence of 3.5 equivalents of 
Et3N was refluxed without adding 2,2-dimethylmalonyl dichloride and this reaction was 
monitored by TLC. A spot for 105 was not observed even after refluxing for 12 h (Entry 
3 in Table 4.1). However, the spot for 105 appeared on TLC after refluxing the same
reaction solution for 8 h in the presence of 1.5 equivalents of 2,2-dimethylmalonyl 
dichloride (Entry 3 in Table 4.1). Compound 251 (19%) and 105 (16%) were isolated. 
Triethylammonium chloride (Et3NH
+Cl-) might have catalyzed the formation of 105. 
Refluxing tautomers 194a,b with Et3NH+Cl- in CH3CN would be a good way to test this 
possibility, but this was not done. 
The 5,6-ring-fused compound, 8-benzoyl-6,6-diethyl-6H-thiazolo[3,2-a]pyridine-
5,7-dione 252, was isolated in 52% yield along with 10% of the starting tautomers when 
the tautomers 194a,b were reacted with 1.2 equivalents of 2,2-diethylmalonyl dichloride 
and 3.3 equivalents of Et3N for 5 h in refluxing CH3CN (Entry 4 in Table 4.1). This 
accounts for 62% of the starting tautomers.  
Reaction of 194a,b with 1.5 equivalents of cyclobutane-1,1-dicarbonyl dichloride 
and 3.6 equivalents of Et3N in refluxing CH3CN for 5 h gave a new 5,6,6-tri-ring-fused 
compound, 10-benzoyl-7,8-dihydropyrano[2,3-d]thiazolo[3,2-a]pyridin-5(6H)-one 263 
(Entries 5 and 6 in Table 4.1). The expected 5,6-ring-fused compound 253 was not 
isolated. This reaction was first carried out by adding 1.5 equivalents of cyclobutane-1,1-
dicarbonyl dichloride to a solution of 194a,b and 3.6 equivalents of Et3N in CH3CN for 
15 min at room temperature and then refluxing for 5 h. Only 13% of 263 was isolated 
(Entry 5 in Table 4.1). Three other fractions also eluted before 263 in an order of fraction 




three unidentified fractions are given at the end of the experimental part of this chapter 
(Figures 4.19, 4.20 and 4.21, respectively). However, 263 was isolated in 34% yield 
when the reaction was repeated, but the inverse addition was performed. A solution of 
194a,b and 3.4 equivalents of Et3N in CH3CN was added to a solution of 1.5 equivalents 
of cyclobutane-1,1-dicarbonyl dichloride in CH3CN over 20 min at room temperature, 
followed by refluxing for 5 h (Entry 6 in Table 4.1). Starting tautomer 194a,b was not 
observed on TLCs of product mixtures. Two other fractions were collected before 263
(fraction 1: 0.102 g and fraction 2: 0.207 g). The 1H NMR spectra of these two 
unidentified fractions are shown in Figures 4.22 and 4.23. All of these unidentified 










       
   
   










   
   





   
   





















































































































































































































































































        
   
   
   










   
   





   
   


























































































































































































































































































































































































































































































The results obtained for the reactions of the tautomeric pairs 196a,b and 197a,b
with 2,2-dimethylmalonyl dichloride in the presence of Et3N in CH3CN are summarized 
in Table 4.2 (Entries 1-4). The tautomers 196a,b are the thiazole-based tautomers with 
two methyl substituents at the C4 and C5 positions. 2,2-Dimethylmalonyl dichloride (1.5 
equivalents) in CH3CN was added into a solution of 196a,b and 3.6 equivalents Et3N in
CH3CN at room temperature over a 20 min period and then refluxed for 6 h (Entry 1 in 
Table 4.2). The starting tautomer 196a,b was not seen by TLC. Three new spots were 
detected and these were isolated by column chromatography. Fraction 1 (0.099 g; Entry 
1 in Table 4.2) was isolated first and it was not identified. Its 1H NMR is given in Figure 
4.24. Next, the 5,6-ring-fused compound, 8-benzoyl-2,3,6,6-tetramethyl-6H-thiazolo[3,2-
a]pyridine-5,7-dione 254, was isolated in only 34% yield (Entry 1 in Table 4.2). A bis-
vinyl ester, bis((Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylvinyl) 2,2-dimethylmalonate
264, was also isolated in 10% yield as the third fraction (Entry 1 in Table 4.2). The two 
isolated products 254 and 264 account for only 54 % of the starting tautomers 196a,b. 
The inverse addition of 196a,b and 3.5 equivalents of Et3N to 1.5 equivalents of 
1,2-dimethylmalonyl dichloride in CH3CN over 20 min period at room temperature was 
carried out to minimize the formation of the bis-vinyl ester 264 and to try to increase the 
yield of 254 (Entry 2 in Table 4.2). Three spots were observed by TLC. Fractions 
corresponding to only 254 and 264 have been isolated. Product 254 formed in an 
increased yield, but the isolated yield was only 49% when this reaction was carried out in 
refluxing CH3CN for 6 h after following the inverse addition. Only 5% of 264 was 
isolated. These two products have again used up only 54% of 196a,b. 
The N,O tautomers 197a,b were reacted with 1.4 equivalents of 2,2-










(Entry 3 in Table 4.2). In this reaction, the diacid chloride was added over 20 min at room
temperature to a solution of 197a,b and Et3N. There were several TLC spots which are 
very close. No starting tautomer 197a,b was observed by TLC. Only three fractions from
the column chromatography have been collected. First, the 5,6-ring-fused compound, 8-
benzoyl-2,3,6,6-tetramethyl-6H-oxazolo[3,2-a]pyridine-5,7-dione 255, was isolated, but 
in only 27% yield (Entry 3 in Table 4.2). The bis-vinyl ester, bis(Z)-2-(4,5-
dimethyloxazol-2-yl)-1-phenylvinyl) 2,2-dimethyl-malonate 265, was then isolated in 
18% yield (Entry 3 in Table 4.2) as a sticky oil (fraction 2). This compound was only 
characterized by its 1H NMR spectrum. The 1H NMR spectrum of 265 is given in Figure 
4.18 in the experimental part in this chapter on page 275. The 1H NMR spectrum of 265
is very similar to that of N,S bis-vinyl ester 264 (Figure 4.6). Further characterizations of 
265 (13C NMR and IR spectra) were not performed since the sample was destroyed when 
the round bottom flask fell into the water bath of the rotary evaporator while trying to 
remove solvent after another column chromatography purification. The third fraction was 
isolated in 0.08 g (Entry 3 in Table 4.2). The isolated yields of products 255 and 265
account for 63% of the starting tautomers 197a,b. 
This reaction was repeated using the inverse addition (over 30 min at room 
temperature) order of reagents. The tautomers 197a,b were reacted with 3.5 equivalents 
of Et3N and 1.4 equivalents of 2,2-dimethylmalonyl dichloride for 7 h in refluxing 
CH3CN. The spot corresponding to 197a,b was not observed. Several very close spots 
were detected by the TLC, but only three other fractions have been collected by column 
chromatography in addition to the fraction corresponding to 255. Fraction 1 (0.089 g) and 
fraction 2 (0.045 g) in order of elution were isolated. Fraction 3 corresponded to 255. The 





4.2). Fraction 4 (0.056 g) was collected last. The 1H NMR spectra of fractions 1, 2 and 4 
are given in Figures 4.26-4.28 and these were unidentified. None of these 1H NMR 
spectra (Figures 4.26-4.28) of the unidentified fractions were similar to the 1H NMR 












   
   
   
   
   
 
 
   
   




   
   
   
   
  
 
    
   
   
   





















































































































































































































































































































   
   
   
   
   
   
 
   
   
   
   
   
 
    
   
   
   
    
   
   










































































































































































































































































































































































































































                           
  
 
Reactions of tautomers of 2-(heterocycles)-1-phenylethenols with 1,3-diacid 
chlorides were further extended to benzoxazole and benzothiazole derived tautomers 
198a,b and 199a,b, respectively. First, 1.5 equivalents of 2,2-dimethylmalonyl dichloride 
was added dropwise into a solution of the tautomers 198a,b  and 3.6 equivalents of Et3N 
in CH3CN, and then refluxed for 9 h (Entry 1 in Table 4.3). TLC of the product mixture 
had several spots. Fractions corresponding to all these spots were not isolated. The first 
isolated fraction (0.076 g) was an unidentified brown oil and its 1H NMR spectrum is 
given in Figure 4.29. The 5,6-ring-fused compound 256 was isolated in only 31% yield 
(Entry 1 in Table 4.3) after performing column separation.  
This reaction was performed by the inverse addition of 198a,b and 3.6 equivalents 
of Et3N into 1.5 equivalents of 2,2-dimethylmalonyl dichloride in CH3CN (over 30 min at 
room temperature), followed by reflux for 9 h (Entry 2 in Table 4.3). Tautomers 198a,b
were not seen by TLC. The major TLC spot was identified as 256 and it was isolated by 
column separation in 35% yield. Any other fractions have not been isolated. This reaction 
was repeated using 2 equivalents of 2,2-dimethylmalonyl dichloride and 3.5 equivalents 
of Et3N (Entry 3 in Table 4.3). A solution of 198a,b and Et3N was added to a solution of 
diacid chloride in CH3CN and refluxed for 9 h. The first fraction isolated was the brown 
oil (0.034 g) mentioned above (1H NMR in Figure 4.29). A 42% yield of 256 was 
isolated after column separation.                                                                                              
The benzothiazole-based tautomer 199a,b formed both the 5,6-ring-fused 
compound, 4-benzoyl-2,2-dimethyl-1H-benzo[4,5]thiazolo[3,2-a]pyridine-1,3(2H)-dione 
257, and the bis-vinyl ester, bis((Z)-2-(benzo[d]thiazol-2-yl)-1-phenylvinyl) 2,2-
dimethylmalonate 266, when refluxed with 2,2-dimethylmalonyl dichloride and Et3N 





in only 7% yield after refluxing the reaction solution for 8 h (Entry 4 in Table 4.3). In this 
reaction, 1.5 equivalents of 2,2-dimethylmalonyl dichloride was added dropwise to a 
solution of the tautomers 199a,b and 3.6 equivalents of Et3N. Two more fractions 
(fraction 1: 0.061 g and fraction 2: 0.049 g) were collected before 257 and 266 eluted, 
and their 1H NMR spectra are given in Figures 4.30 and 4.31. These were not identified. 
Products 257 and 266 account for 58% of 199a,b. 
The yield of 257 increased from 44% to 62% using an 8 h reflux after performing 
an inverse addition by adding a solution of the tautomers 199a,b and 3.5 equivalents of 
Et3N into a solution of 1.5 equivalents of 2,2-dimethylmalonyl dichloride (Entry 5 in 
Table 4.3). A very pale spot was seen on TLC corresponding to 266, which was not 
isolated. The starting tautomer was not detected by TLC and other fraction corresponding 
to any other spots have not been isolated. 
1,3-Diacid chlorides are hygroscopic and hydrolyze to the corresponding 
carboxylic acids if exposed to moisture. These diacids would wash out of reaction 
mixtures during the aqueous work up. Solvents and glassware were dried prior to use.  
The structures of 5,6-ring-fused compounds 251, 252 and 254-257 were identified 
by their 1H, 13C and DEPT 135 NMR, and IR spectra, HR-MS and melting points. The 
presence of three carbonyl carbon signals representing the two ,-unsaturated ketones 
and the amide carbonyl groups in the 13C NMR spectra are characteristic of these 5,6-
ring-fused structures. The X-ray crystal structure of 255 is depicted in Figure 4.1. Single 
crystals of 255 were obtained by slow evaporation of hexane in to a solution of 255
dissolved in chloroform. Its crystal structure was obtained with the help of Dr. William P. 
Henry and further confirms the spectral identification of its structure. The crystal data 








structure 255 is given in Appendix G. The 1H, 13C and DEPT 135 NMR spectra of 254
and 257 are given in Figures 4.2-4.5, respectively. 










  254 


















































































Plausible mechanisms for the formation of the 5,6-ring-fused compounds 251, 
252 and 254-257 are given in Schemes 4.6, 4.7 and 4.8, taking 254 as an example. The 
deprotonation of the enolic proton of the enol tautomer 196a or a proton on the -carbon 
of keto tautomer 196b by triethylamine generates the ambident nucleophile 267. In 267
the electron density is delocalized over the -carbon (267a), ring nitrogen (267b) and 
oxygen (267c) (Scheme 4.6). Therefore, either the -carbon of 267a or the ring-nitrogen 
of 267b can initially react with 1,3-diacid chloride in the process of the formation of 254
as depicted in Schemes 4.7 and 4.8. No mechanistic studies were performed to verify any 
of these proposed pathways. 
The formation of 5,6-ring-fused heterocycles 251, 252 and 254-257 follow an 
initial nucleophilic attack and a cyclization reaction sequence. The initial nucleophilic 
attack by the -carbon of 267a to the 1,3-diacid chloride carbonyl carbon forms the 
intermediate 268 which gives the intermediate 268a by the loss of chloride (Scheme 4.7). 
The acidic hydrogen on the -carbon of 268a is removed by Et3N to generate the CKA 
intermediate 268b. This introduces a negative charge on the ring nitrogen. Then, the ring 
nitrogen of 268b does the intramolecular nucleophilic attack on the terminal carbonyl 
carbon on the side chain to form 268c. Finally, the desired product 254 forms by the loss 





O OPh Ph O Cl 
Cl Cl H3C 
H 
CH3 
H3CO H3C CH3 O CH3 Ph H 
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PhH3C Ph H3CH3C Ph 
OOO N S N S N SClCl 
254 268c 268b 
Scheme 4.7 A postulated mechanism for the formation of 254 by the initial 
nucleophilic attack by the -carbon, followed by cyclocondensation by the 





In the other pathway illustrated in Scheme 4.8, the ring nitrogen of resonance 
hybrid 267b first does the nucleophilic attack on the carbonyl carbon of the 1,3-diacid 
chloride. The resultant intermediate 269 gives the CKA intermediate 269a via the 
chloride loss. The -carbon of the 269a is nucleophilic due to the electron donation from
both heteroatoms on the ring. This -carbon now does the intramolecular nucleophilic 
attack on the terminal carbonyl carbon on the side chain. This cyclocondensation 
generates the zwitterion 269b. Then the loss of chloride forms the thiazolium ion 269c
which then forms the 5,6-ring-fused compound 254 by the deprotonation of the acidic 




PhPhPh Ph O O
Et3NH HHH H H OO O O C Cl ClH .. 
H3C CH3Et3N N SN S N S N S 
267b 196b 267 196a 
O O O OO Cl O 
H3C H3CCl Cl 
H3C 
H3C 
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269c 254 
Scheme 4.8 A postulated mechanism for the formation of 254 by the initial 
nucleophilic attack by the nitrogen, followed by cyclocondensation by the 
intramolecular nucleophilic attack from the -carbon 
 
 The 1H, 13C and DEPT 135 NMR spectra of the bis-vinyl ester compounds 264
and 266 (See Entries 1 and 4 in Table 4.2 and 4.3, respectively) are shown in Figures 4.6-
4.9. The presence of vinyl proton signals (7.0 ppm and 7.17 ppm) in the 1H NMR 
spectrum, and vinyl carbon signals (111.42 ppm and 111.26 ppm) and ester carbonyl 
carbon signals (169.58 ppm and 169.52 ppm) in the 13C NMR spectra are characteristic of 
these products. These structures were further confirmed by two phase-up peaks, 
corresponding to =CH groups, at 111.49 ppm and 111.31 ppm in the DEPT 135 NMR 









Figure 4.6 1H NMR spectrum (600 MHz, CDCl3) of bis((Z)-2-(4,5-dimethylthiazol-2-
yl)-1-phenylvinyl) 2,2-dimethylmalonate 264
 
illustrated in Figure 4.18 in on page 275. A likely mechanism for the formation of the bis-
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267c 196a 196b 267 
Ph O PhO O Ph O Cl 
H 
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H3C  CH3 H3C  CH3N S N S N S N S 
270b 264 
Scheme 4.9 Mechanism for the formation of the dimerized product 264
 
 
Oxygen is the third nucleophilic center of the ambident nucleophilic intermediate 
267 (Scheme 4.6). The initial nucleophilic attack by the oxygen of 267c on the carbonyl 
carbon of the 1,3-diacid chloride forms 270. The loss of chloride from 270 generates 
270a. This reacts with another equivalent of the 267c to give 270b. Then the loss of 
chloride from 270b forms the isolated bis-vinyl ester 264. The addition of the 196a,b and 
Et3N in CH3CN to a solution of 1,3-diacid chloride in CH3CN reduces the bis-vinyl ester 
yield versus adding the 1,3-diacid chloride to a solution of  the tautomers and Et3N in 






270a can react with the second equivalent of 267c due to the low concentration of 
tautomers in the reaction solution. This allows more time for intramolecular cyclization 
to give 254 as illustrated in Schemes 4.7 and 4.8.   
The three mechanisms illustrated in Schemes 4.7-4.9 show the variety of reactions 
that can compete when tautomeric pairs 194a,b and 196a,b-199a,b are subjected to 1,3-
diacid chlorides. These reactions can lead to a wide variety of products due to the 
presence of several nucleophilic centers. 
The 1H, 13C and DEPT 135 NMR spectra of the 5,6,6-tri-fused ring product 263
from the cyclobutane ring expansion (Entries 5 and 6 in Table 4.1) product 263 are 
illustrated in Figures 4.10 and 4.11. The presence of only one carbonyl carbon signal at 
190.52 ppm and two carbon signals in the alkene carbon region (104.05 and 99.89 ppm) 
in the 13C spectrum excluded the structure of expected 5,6-ring-fused product 8'-benzoyl- 
spiro[cyclobutane-1,6'-thiazolo[3,2-a]pyridine]-5',7'-dione 253 (Scheme 4.3). Single 
crystals of 263 were obtained by slow diffusion of hexane into a solution of 263 in 
chloroform. The X-ray crystal structure of 263 (Figure 4.12) was obtained with the help 
of Dr. William P. Henry. The crystal data collection, structure refinement parameters, 
bond lengths and bond angles for the crystal structure 263 is given in Appendix I. This 
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Figure 4.12 The crystal structure of 10-benzoyl-7,8-dihydropyrano[2,3-d]thiazolo[3,2-
a]pyridin-5(6H)-one 263 
Product 263 is likely formed by the ring-opening of the cyclobutane of 253 by 
chloride that is present as triethylammonium chloride in the reaction solution. This is 
depicted in Scheme 4.10. Nucleophilic chloride opening of the four-membered ring of 
253 gives 271.The displacement of chloride in 271 by SN2 attack by the negatively 
charged oxygen gives 263. Formation of a similar product by reaction of 2-







4.2.2 Reactions of the tautomeric pairs, 194a,b and 196a,b-199a,b, with N-
chlorocarbonyl isocyanate 
N-Chlorocarbonyl isocyanate was also employed as a dielectrophile in order to 
determine if possible to synthesize the 5,6-ring-fused compounds 258-262 depicted in 
Scheme 4.4 near the beginning of this chapter. The five products 258-262 were 
successfully synthesized by reactions of each of the five tautomeric pairs, 194a,b and 
196a,b-199a,b, with 1.4 equivalents of N-chlorocarbonyl isocyanate and 2.5 equivalents 
of Et3N in refluxing THF. Products 258-262 were isolated in moderate to good yields and 





























Table 4.4 Reactions of the tautomers 194a,b and 196a,b-199a,b with N-
chlorocarbonyl isocyanate in refluxing THFa 
Entry Tautomer Reagent 
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a  Mole ratio of tautomers:Et3N:N-chlorocarbonyl isocyanate = 1:2.5:1.4.
b % Yields were calculated considering the sum of both tautomers as the limiting reagent. 
The tautomers 194a,b formed, 8-benzoyl-6H-thiazolo[3,2-f]pyrimidine-5,7-dione 
258, in 83% when reacted with 1.4 equivalents of N-chlorocarbonyl isocyanate and 2.5 
equivalents of Et3N for 5 h in refluxing THF (Entry 1 in Table 4.4). 8-Benzoyl-2,3-
dimethyl-6H-thiazolo[3,2-f]pyrimidine-5,7-dione 259, was isolated in 71% yield by 
refluxing the tautomeric pair 196a,b with 1.4 equivalents of N-chlorocarbonyl isocyanate 
and 2.5 equivalents of Et3N for 5 h in THF (Entry 2 in Table 4.4). The reaction of 197a,b
tautomeric pair with 1.4 equivalents of N-chlorocarbonyl isocyanate and 2.5 equivalents 
of Et3N in refluxing THF for 5 h also afforded the desired 5,6-ring-fused compound, 8-
benzoyl-2,3-dimethyl-6H-oxazolo[3,2-f]pyrimidine-5,7-dione 260, in 73% yield (Entry 3 






tautomers 199a,b were also behaved similarly to the thiazole- and oxazole-derived 
tautomers 194a,b, 196a,b and 197a,b when refluxed for 5 h in THF with 1.4 equivalents 
of N-chlorocarbonyl isocyanate and 2.5 equivalents of Et3N (Entries 4 and 5 in Table 
4.4). Tautomers 198a,b and 199a,b afforded 4-benzoyl-1H-benzo[4,5]oxazolo[3,2-
c]pyrimidine-1,3(2H)-dione 261 (65%) and 4-benzoyl-1H-benzo[4,5]thiazolo[3,2-
c]pyrimidine-1,3(2H)-dione 262 (88%), respectively, under these conditions. In these 
reactions, the starting tautomeric pairs 194a,b and 196a,b-199a,b were not detected by 
TLC after each reaction. 
A single crystal of 260 was obtained by vapor diffusion method. Hexane was 
slowly diffused into a chloroform solution of 260. Dr. William P. Henry helped to obtain 
the crystal structure. This structure is shown is Figure 4.13. The disorded solvent 
molecule present in the crystal structure was squeezed using squeeze option in Platon 
software.67 This removed 93 Å3 volume and 28 electrons from the unit cell. The crystal 
data collection, structure refinement parameters, bond lengths and bond angles for the 








Figure 4.13 The crystal structure of 8-benzoyl-2,3-dimethyl-6H-oxazolo[3,2-f] 
pyrimidine-5,7-dione 260 
Pyrimidinedione products 258-262 are highly functionalized compounds, 
combining an ,-unsaturated phenyl ketone, an ,-unsaturated amide and an urea type 
carbonyl functions. Products were characterized by their 1H, 13C and DEPT 135 NMR, 
and IR spectroscopy, HR-MS and melting points. 1H, 13C and DEPT 135 NMR of 260 
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A plausible mechanism for the formation of 259 (representative of 258-262) is 
depicted in Scheme 4.11. The deprotonation of tautomers 196a,b generates the ambident 
nucleophile 267 as previously mentioned in Scheme 4.6. Either the -carbon or the ring 
nitrogen nucleophilically attack on the carbonyl carbon of N-chlorocarbonyl isocyanate in 
the first step. Both nucleophilic centers will react to give the 5,6-ring-fused product 259. 
In the mechanism shown in Scheme 4.11, it is proposed that nucleophilic attack by the -
carbon occurs first. The nucleophilic attack of the -carbon of 267a on the acid chloride 
function, followed by chloride loss gives 272a. The intermediate 272b is formed upon 
removal of the acidic hydrogen on the -carbon. The negatively charge nitrogen on CKA 
272b does an intramolecular nucleophilic attack on the remaining carbonyl carbon. 
Cyclocondensation of 272b followed by proton transfer of 272c give 259. No 







Scheme 4.11 A plausible mechanism for the formation of 259 from the reaction of the 
tautomers 196a,b with N-chlorocarbonyl isocyanate. 
4.3 Conclusions 
Reactions of the tautomers 194a,b and 196a,b-199a,b with 2,2-dimethylmalonyl 
dichloride in the presence of Et3N in CH3CN at reflux afforded the desired 5,6-ring-fused 
compounds 251 and 254-257. The reaction of 194a,b with 2,2-diethylmalonyl dichloride 
also formed the 5,6-ring-fused compound 252 as expected. However, the reaction of 
cyclobutane-1,1-dicarbonyl dichloride with 194a,b formed the 5,6,6-tri-ring- fused 








carbon of 253, instead of the expected 5,6-ring-fused compound 253. The three bis-vinyl-
ester products 264-266 were also formed when the tautomers 196a,b, 197a,b and 199a,b
were reacted with 2,2-dimethylmalonyl dichloride. The isolated yields of products were 
low to moderate. This results from the formation of a variety of by-products due to the 
reactions of ambident nucleophilic tautomeric intermediate with the 1,3-diacid chlorides.
The tautomers 194a,b and 196a,b-199a,b were reacted with N-chlorocarbonyl 
isocyanate in the presence of Et3N in refluxing THF as expected. The 5,6-ring-fused 
products 258-262 were isolated in moderate to good yield. 
Reactions of tautomeric pairs, 194a,b and 196a,b-199a,b, with dielectrophiles 
provided a good route for the synthesis of highly-functionalized fused-ring heterocycles. 
Therefore, reactions of these tautomers with other dielectrophiles as such malonyl 
dichloride, pthaloyl dichloride and N-chlorosulfonyl isocyanate are worth exploring in 
the future.
4.4 Experimental 
4.4.1 General information 
The five pairs of tautomeric reagents 194a,b, 196a,b-199a,b used in this chapter 
were synthesized according to the procedures described in Chapter II. 2,2-
Dimethylmalonyl dichloride and 2,2-diethylmalonyl dichloride were purchased from 
TLC America and N-chlorocarbonyl isocyanate was purchased from Sigma Aldrich, and 
used as received. Cyclobutane-1,1-dicarbonyl dichloride was synthesized by treating 
cyclobutane-1,1-dicarboxylic acid (Matrix Scientific Co.) with thionyl chloride. 
Acetonitrile (CH3CN) and triethylamine were distilled from calcium hydride under 







Tetrahydrofuran (THF) was distilled from Na metal/benzophenone ketyl. The dried 
CH3CN and THF were freshly distilled prior to use. The round bottom flasks were baked 
in the oven and tried under nitrogen prior to use. Instruments and techniques used for 
NMR and IR spectroscopic methods, X-ray crystallography, and melting point 
determination are the same as those described in the experimental parts in Chapters II and 
III. Yields were calculated based on the sum of both tautomers as the limiting reagent.
4.4.2 Reaction of the tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethanol 194a and 1-
phenyl-2-(thiazol-2-yl)ethanone 194b with 2,2-dimethylmalonyl dichloride 
2,2-Dimethylmalonyl dichloride (0.53 g, mmol, 1.5 eq.) in CH3CN (15 mL) was 
added dropwise over a period of 10 min to a stirred solution of the tautomers 194a,b
(0.414 g, 2.04 mmol, 1 eq.) and triethylamine (0.726 g, 7.17 mmol, 3.5 eq.) in CH3CN 
(30 mL) at room temperature under nitrogen. This solution was refluxed (82 C) for 5 h 
under nitrogen and then CH3CN was removed by rotary evaporation. The residue was 
dissolved in dichloromethane (30 mL), washed with 10% aqueous sodium bicarbonate 
(30 mL), followed by water (2 × 30 mL) and dried over anhydrous sodium sulfate. 
Sodium sulfate was removed by filtration. After removal of dichloromethane by rotary 
evaporation, the crude product was purified by column chromatography over silica gel 
(ethyl acetate/hexane = 1:2). 194a,b eluted first followed by 105 and then compound 251. 
The un-reacted starting tautomers 194a,b (0.065 g, 15%), the vinyl benzoate ester 105 
(0.056 g, 18%; mp = 105-106 C) and the 5,6-ring-fused compound 251 (0.216 g, 
35.4%) were isolated. 
This general purification procedure was applied for the syntheses of compounds 





   
This reaction was repeated as follows. The tautomer 194a,b (0.582 g, 2.86 mmol, 
1 eq.) and Et3N (1.01 g, 9.98 mmol, 3.49 eq.) were dissolved in CH3CN (30 mL). Then 
2,2-dimethylmalonyl dichloride (0.779 g, 4.8 mmol, 1.68 eq.) in CH3CN (15 mL) was 
added dropwise over a period of 20 min to the stirred solution of 194a,b and Et3N and 
refluxed for 7 h. The general procedure mentioned above was followed for the 
purification and isolation of products. 10% (0.045 g) of 105 and 65% (0.56 g) of 251 
were isolated. 
A control reaction was carried out in the absence of 2,2-dimethylmalonyl 
dichloride to see whether the 2,2-dimethylmalonyl dichloride is a necessary reagent for 
the formation of 105 in refluxing CH3CN. A solution of the tautomers 194a,b (0.205 g, 
1.01 mmol, 1 eq.) and Et3N (0.357 g, 3.5 mmol, 3.5 eq.) in CH3CN (35 mL) was 
refluxed. The spot for 105 did not appear on the TLC even after refluxing for 12 h. The 
reaction solution was cooled to room temperature, 2,2-dimethylmalonyl dichloride (0.265 
g, 1.54 mmol, 1.54 eq.) was added dropwise and then the reaction solution was refluxed 
for another 8 h. The vinyl ester 105 (0.023 g, 16%) and the 5,6-ring-fused compound 251 
(0.056 g, 19%) were isolated after following the above mentioned general procedure for 
purification and isolation. 
4.4.2.1 8-Benzoyl-6,6-dimethyl-6H-thiazolo[3,2-a]pyridine-5,7-dione 251
Rf = 0.53 (ethyl acetate/hexane = 2:3); yellow solid; mp = 213-214 °C.  
1H NMR (600 MHz, CDCl3): (d, J = 4.60 Hz, =NCHCHS, 1H), 7.50 (d, 
J = 7.65 Hz C6H5 ortho, 2H), 7.46 (t, J = 7.39 Hz, C6H5 para, 1H), 7.39 (dd, C6H5 meta, 








   
 
13C NMR (600 MHz, CDCl3): COC6H5), 189.64 (C(CH3)2CO),
172.70 (>NCO), 167.77 (N,S>C=), 139.96 (COC6H5, ipso), 130.83 (>NCH=CHS), 
127.68 (COC6H5, ortho and para, 3C), 122.82 (COC6H5, meta), 112.99 
(>NCH=CHS), 106.63 (=C(COC6H5)), 53.76 (C(CH3)2), 23.82 (C(CH3)2). 
DEPT 135 NMR (150 MHz, CDCl3): 130.88, 127.73, 122.88, 113.04, 23.87.
IR (neat, cm-1): 3155, 3110, 3095, 2974, 2927, 1741, 1637, 1593, 1568, 1523, 
1475, 1386, 1331, 1158, 1096, 914, 874, 803, 768, 734, 710, 676. 
HRMS (ESI, [M+H]+): calcd for C16H14NO3S: 300.0694; found: 300.0692. 
4.4.3 Reaction of the tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethanol 194a and 1-
phenyl-2-(thiazol-2-yl)ethanone 194b with 2,2-diethylmalonyl dichloride 
2,2-Diethylmalonyl dichloride (0.531 g, 2.75 mmol, 1.2 eq.) in CH3CN (10 mL) 
was added dropwise over a period of 20 min to a stirred solution of the tautomers 194a,b
(0.479 g, 2.36 mmol, 1 eq.) and Et3N (0.815 g, 9.51 mmol, 3.3 eq.) in CH3CN (25 mL). 
This solution was refluxed for 5 h. The general procedure mentioned above was used for 
the purification and isolation of products. The title compound 252 was isolated in 52.1% 
(0.402 g) along with the starting tautomers 194a,b in 9.8% (0.047 g) yield. 
4.4.3.1 8-Benzoyl-6,6-diethyl-6H-thiazolo[3,2-a]pyridine-5,7-dione 252 
Rf = 0.67 (ethyl acetate/hexane = 2:3); yellow solid; mp = 185-186 °C.  
1H NMR (600 MHz, CDCl3): (d, J = 4.59 Hz, =NCHCHS, 1H), 7.51 (d, 
J = 7.64 Hz C6H5 ortho, 2H), 7.47 (t, J = 7.32 Hz, C6H5 para, 1H), 7.40 (dd, C6H5 meta, 
1H), 6.77 d, J = 4.59 Hz, =NCHCHS, 1H), 2.13 (qt, Jgem = 15.0 Hz, Jvis = 7.42 Hz, 
CH2CH3, 2H), 2.01 (qt, Jgem = 15.0 Hz, Jvis = 7.42 Hz, CH2CH3, 2H), 0.87 (t, J = 7.42 








13C NMR (600 MHz, CDCl3): COC6H5), 188.93 (C(CH3)2CO),
172.16 (>NCO), 168.61 (N,S>C=), 140.21 (COC6H5, ipso), 130.80 (COC6H5, para), 
127.76 (COC6H5, ortho), 127.63 (COC6H5, meta), 122.53 (>NCH=CHS), 113.03 
(>NCH=CHS), 109.06 (=C(COC6H5)), 32.37 (CH2CH3, 2H), 9.54 (CH2CH3, 
2H). 
DEPT 135 NMR (150 MHz, CDCl3): 130.85, 127.81, 127.69, 122.58, 113.09, 
32.43, 9.60. 
IR (neat, cm-1): 3161, 3124, 3061, 2962, 2935, 2876, 1729, 1681, 1633, 1601, 
1475, 1385, 1331, 1204, 1163, 927, 876, 841, 821, 796, 699, 676. 
HRMS (ESI, [M+H]+): calcd for C18H18NO3S: 328.1007; found: 328.0992. 
4.4.4 Reaction of the tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethanol 194a and 1-
phenyl-2-(thiazol-2-yl)ethanone 194b with cyclobutane-1,1-dicarbonyl 
dichloride 
Cyclobutane-1,1-dicarbonyl dichloride (0.631 g, 3.49 mmol, 1.5 eq.) in CH3CN 
(10 mL) was added dropwise over a period of 15 min at room temperature to a stirred 
solution of the tautomers 194a,b (0.465 g, 2.29 mmol, 1 eq.) and Et3N (0.83 g, 8.2 mmol, 
3.6 eq.) in CH3CN (25 mL). This solution was refluxed 5 h. The general procedure 
mentioned above for the purification and isolation of product 251 was followed. The spot 
corresponding to the staring tautomers 194a,b was not observed on TLC of the products 
mixture. The title compound 263 was isolated in 13% (0.093 g). Ethyl acetate:hexane = 
1:1 used as the eluent for the column chromatography over silica. Three other liquid 
fractions were collected through column in addition to the fraction that corresponds to 





product. Fraction 1 (0.217 g) eluted first followed by fraction 2 (0.066 g), and then 
fraction 3 (0.353 g). The 1H NMR spectra of these three fractions were not clear enough 
to analyze and identify the structures. These 1H NMR spectra are given in Figures 4.19-
4.21. 
This reaction was repeated employing an inverse addition by adding a solution of 
the tautomers 194a,b (0.423 g, 2.08 mmol, 1 eq.) and Et3N (0.71 g, 7.02 mmol, 3.4 eq.) 
in CH3CN (25 mL) to a solution of cyclobutane-1,1-dicarbonyl dichloride (0.57 g, 3.15 
mmol, 1.5 eq.) in CH3CN (10 mL) dropwise over a period of 20 min at room temperature. 
Then this solution was refluxed for 5 h. There was no TLC spot detected for the starting 
tautomers 194a,b on the TLC. After following the general work up procedure 263 was 
isolated in 34.1% yield. Two other liquid fractions were also isolated which eluted before 
the product (Eluting solvent was ethyl acetate/hexane = 1:1). The fraction 1 (0.102 g) 
isolated first, followed by fraction 2 (0.207 g). The 1H NMR spectra of fractions 1 and 2 
are appeared in Figure 4.22 and 4.23. 
4.4.4.1 10-Benzoyl-7,8-dihydropyrano[2,3-d]thiazolo[3,2-a]pyridin-5(6H)-one 263
Rf = 0.50 (ethyl acetate/hexane = 3:1); white crystalline solid; mp = 226-227 °C.  
1H NMR (600 MHz, CDCl3): 8.24 (d, J = 4.48 Hz, >NCH=CHS, 1H),  7.57 (d, 
J = 7.69 Hz C6H5 ortho, 2H), 7.46 (t, J = 7.29 Hz, C6H5 para, 1H), 7.40 (dd, C6H5 
meta, 2H), 7.04 (d, J = 4.48 Hz, >NCH=CHS, 1H), 3.94 (t, J = 5.13 Hz, 
OCH2CH2CH2C=, 2H), 2.68 (t, J = 6.46 Hz, OCH2CH2CH2C=, 2H), 1.95 (tt, 
OCH2CH2CH2C=, 2H).  
13C NMR (150 MHz, CDCl3): 190.52(COC6H5), 161.37 (NCO), 159.08 





127.90 (COC6H5, ortho), 127.38 (COC6H5, meta), 123.51 (>NCH=CHS), 114.00 
(>NCH=CHS) 104.05 (>NCOC=), 99.89 (=C(COC6H5)), 66.61 (OCH2CH2CH2C=), 
20.69 (OCH2CH2CH2C=), 19.67 (OCH2CH2CH2C=). 
DEPT 135 NMR (150 MHz, CDCl3): 130.74, 128.02, 127.49, 123.62, 114.11, 
66.72, 20.80, 19.28. 
IR (neat, cm-1): 3149, 3089, 3066, 2979, 2937, 2904, 1645, 1597, 1530, 1489, 
1333, 1308, 1266, 1183, 1158, 1058, 961, 905, 848, 733, 697. 
HRMS (ESI, [M+H]+): calcd for C17H14NO3S: 312.0694; found: 312.0677. 
Single crystals of 263 were grown for X-ray crystallography by the vapor 
diffusion method. Hexane was diffused into a solution of compound 263 dissolved in 
chloroform. The crystal structure of 263 is given in Figure 4.12 on page 251. 
4.4.5 Reaction of the tautomers (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 
196a and 2-(4,5-dimethylthiazol-2-yl)-1-phenylethanone 196b with 2,2-
dimethylmalonyl dichloride 
2-Dimethylmalonyl dichloride (0.53 g, 3.1 mmol, 1.53 eq.) in CH3CN (10 mL) 
was added dropwise over a period of 20 min to a stirred solution of the tautomers 196a,b
(0.465g, 2.01 mmol, 1 eq.) and Et3N (0.721 g, 7.13 mmol, 3.55 eq.) in CH3CN (25 mL). 
This solution was refluxed for 6 h. There was no spot on TLC corresponding to the 
starting material. Three spots with Rf values 0.64, 0.50 and 0.35 (ethyl acetate:hexane = 
1:2) were detected. The general procedure mentioned above in synthesis of 251 was 
employed for the purification and isolation of products. Ethyl acetate:hexane 1:2 was 
used as the eluting solvent for the column chromatography. The first fraction (Rf = 0.64; 






   
given in Figure 4.23. Product 254 (0.221 g, 33.5%) eluted next, followed by bis-vinyl 
ester 265 (0.058 g, 10%). 
An inverse addition was performed by adding a solution of the tautomers 196a,b
(0.463 g, 2.0 mmol, 1 eq.) and Et3N (0.712 g, 7.04 mmol,  3.52 eq.) in CH3CN (25 mL) 
to a solution of 2,2-dimethylmalonyl dichloride (0.523 g, 3.03 mmol, 1.51 eq.) in CH3CN 
(10 mL) dropwise over a period of 20 min. This solution was refluxed for 6 h. Three 
spots were observed (Rf = 0.67, 0.52, 0.36; ethyl acetate:hexane = 1:2) on TLC and no 
spot was seen for 196a,b. Compound 254 (0.322 g, 49.2%) was isolated using ethyl 
acetate:hexane 1:2 as the eluting solvent for the column chromatography after the general 
work up procedure. The bis-vinyl ester 264 was also isolated in 4.9% (0.016 g) yield. The 
fraction corresponding to Rf = 0.67 has not been collected. 
4.4.5.1 8-Benzoyl-2,3,6,6-tetramethyl-6H-thiazolo[3,2-a]pyridine-5,7-dione 254 
Rf = 0.50 (ethyl acetate/hexane = 1:2); yellow crystalline solid; mp = 173-174 °C.  
1H NMR (600 MHz, CDCl3): 7.46 (d, J = 7.43 Hz, C6H5 ortho, 2H), 7.42 (t, J 
= 7.36 Hz, C6H5 para, 1H), 7.36 (dd, C6H5 meta, 2H), 2.44 (s, >NC(CH3)=C(CH3)S
or >NC(CH3)=C(CH3)S, 3H), 2.17 (s, >NC(CH3)=C(CH3)S or >NC(CH3)=C(CH3)S, 
3H), 1.53 (s, C(CH3)2, 6H). 
13C NMR (150 MHz, CDCl3): 190.81(COC6H5), 188.79 
(NCOC(CH3)2CO), 174.50 (NCO), 168.24 (N,S>C=), 140.48 (COC6H5, ipso), 
130.89 (>NC(CH3)=C(CH3)S), 130.21 (COC6H5, para), 127.39 (COC6H5, ortho), 
127.35 (COC6H5, meta), 118.80 (>NC(CH3)=C(CH3)S), 105.52 (=C(COC6H5)), 
54.70 (C(CH3)2C), 23.31 (C(CH3)2C), 13.93 (>NC(CH3)=C(CH3)S or 






DPET 135 NMR (150 MHz, CDCl3):  130.47, 127.65, 127.62, 23.57, 14.20, 
10.95. 
IR (neat, cm-1): 3062, 3022, 2986, 2940, 1741, 1688, 1649, 1589, 1564, 1453, 
1386, 1372, 1356, 1220, 1184, 1082, 983, 910, 922, 842, 802, 768, 735, 708, 634. 
HRMS (ESI, [M+H]+): calcd for C18H18NO3S: 328.1007; found: 328.0988. 
4.4.5.2 Bis((Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylvinyl) 2,2-dimethylmalonate 264 
35 (ethyl acetate/hexane = 1:2); pale yellow solid; mp = 170-172°C.  
1H NMR (600 MHz, CDCl3): .54 (d, J = 7.41 Hz, C6H5 ortho, 4H), 7.26-7.23 
(m, C6H5 meta and para, 6H), 7.00 (s, CH=C(C6H5)O), 2.34 (s, 
>NC(CH3)=C(CH3)S, 6H), 2.32 (s, >NC(CH3)=C(CH3)S, 6H), 1.99 (s, C(CH3)2, 
6H). 
13C NMR (150 MHz, CDCl3): CO2C(C6H5)=, 156.12 (N,S>C=), 
148.97 (=C(C6H5)O or >NC(CH3)=C(CH3)S), 148.32 (CH=C(C6H5)O or 
>NC(CH3)=C(CH3)S), 134.11 (COC6H5, ipso), 129.26 (COC6H5, para), 128.62 
(COC6H5, ortho), 127.73 (>NC(CH3)=C(CH3)S), 125.23 (COC6H5, meta), 111.42 
(CH=C(C6H5)O), 51.16 (C(CH3)2), 23.63 (C(CH3)2),14.61 
(>NC(CH3)=C(CH3)S or >NC(CH3)=C(CH3)S), 11.29 (>NC(CH3)=C(CH3)S or 
>NC(CH3)=C(CH3)S). 
DEPT 135 NMR (150 MHz, CDCl3):  129.32, 128.69, 125.30, 111.49, 23.70, 
14.68, 11.37. 
IR (neat, cm-1): 3057, 2981, 2951, 2922, 2858, 1768, 1745, 1632, 1536, 1248, 
1129, 1082, 1021, 760, 690. 








4.4.6 Reaction of the tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 196a 
and 2-(4,5-dimethyloxazol-2-yl)-1-phenylethanone 196b with dimethyl 
acetylenedicarboxylate (DMADC) 
2,2-Dimethylmalonyl dichloride (0.301 g, 1.74 mmol, 1.38 eq.) in CH3CN (10 
mL) was added dropwise over a period of 20 min to a stirred solution of the tautomers 
197a,b (0.272, 1.26 mmol, 1 eq.) and Et3N (0.432 g, 4.27 mmol, 3.39 eq.) in CH3CN (25 
mL). This solution was refluxed for 7 h. The spot corresponding to the starting tautomers 
197a,b was not detected by TLC. About five to six spots were observed on the TLC 
analysis of the reaction products. The general procedure mentioned above was employed 
for the purification and isolation of products. The separation of each of them was not 
easy. Ethyl acetate:hexane 1:2 was used as the eluting solvent for the column
chromatography. Fractions corresponding to all spots were not isolated. Only three 
fractions have been collected. The 5,6-ring-fused compound 255 was isolated in 27% 
yield (0.106 g) as the first fraction. The isolated fraction 2 was a brown sticky oil. This 
compound was identified as the bis-vinyl ester 265 (0.059g, 18%) based on the 1H NMR 
spectrum. Its 1H NMR is given in Figure 4.18. Unfortunately, compound lost while trying 
to do further purification before taking the 13C NMR or IR spectra (the round bottom
flask dropped in to the water bath while trying to do rotary evaporation). The 1H NMR 
spectrum of fraction 3 (0.08 g), which eluted last was unidentified and its 1H NMR 
spectrum is given Figure 4.25. 
An inverse addition version of this reaction was also performed by adding 
solution of the tautomers 197a,b (0.47g, 2.2 mmol, 1 eq.) and Et3N (0.781 g, 7.72 mmol, 
3.51 eq.) in CH3CN (30 mL) to a solution of 2,2-dimethylmalonyl dichloride (0.541 g, 
3.14 mmol, 1.43 eq.) in CH3CN (20 mL) dropwise over a period of 30 min. This solution 





in the previous case. Some of these spots were very close. Therefore, separate fractions 
were not collected corresponding to all these spots. Ethyl acetate:hexane 1:3 and then 1:1 
were used as the eluting solvent for the column chromatography. Only four fractions 
were collected. Fraction 1 (0.089 g) followed by fraction 2 (0.045 g) were collected as the 
first two fractions. Their 1H NMR spectra are given in Figures 4.26 and 4.27, 
respectively. Compound 255 (0.237 g, 35%) was isolated as the third fraction (fraction 
3). Fraction 4 (0.056 g) was collected as the last fraction and it was also unidentified. The 
1H NMR spectra of fraction 4 is given in Figure 4.28. The 1H NMR spectra of the 
isolated unidentified fractions 1,2 and 4 do not match up with the spectrum corresponding 
to bis-vinyl ester 265 in Figure 4.18. 
4.4.6.1 8-Benzoyl-2,3-dimethyl-6H-oxazolo[3,2-a]pyrimidine-5,7-dione 255 
Rf = 0.36 (ethyl acetate/hexane = 1:1); yellow crystalline solid; mp = 176-178 °C.  
1H NMR (600 MHz, CDCl3): .70 (d, J = 7.7 Hz, C6H5 ortho, 2H), 7.50 (t, J = 
7.21 Hz, C6H5 para, 1H), 7.40 (dd, C6H5 meta, 2H), 2.39 (s, >NC(CH3)=C(CH3)O, 
3H), 2.18 (s, >NC(CH3)=C(CH3)O, 3H), 1.54 (s, C(CH3)2, 6H). 
13C NMR (150 MHz, CDCl3): COC6H5), 190.79 
(NCOC(CH3)2CO), 173.04 (NCO), 164.25 (N,S>C=), 140.88 (COC6H5, ipso), 
139.29 (>NC(CH3)=C(CH3)O), 132.19 (COC6H5, para), 128.68 (COC6H5, ortho), 
127.97 (COC6H5, meta), 117.54 (>NC(CH3)=C(CH3)O), 95.93 (=C(COC6H5)), 53.63 
(C(CH3)2), 24.34 (C(CH3)2), 9.69 (>NC(CH3)=C(CH3)O or 
>NC(CH3)=C(CH3)O), 9.49 (>NC(CH3)=C(CH3)O or >NC(CH3)=C(CH3)O). 







IR (neat, cm-1): 3053, 2997, 2960, 1739, 1715, 1652, 1599, 1586, 1415, 1258, 
1186, 1014, 986, 914, 821, 803, 770, 749, 712, 691, 651. 
HRMS (ESI, [M+H]+): calcd for C18H18NO4: 312.1236; found: 312.1219. 
Single crystals of 255 were obtained for X-ray crystallography by the vapor 
diffusion method. Hexane was diffused into a solution of compound 255 dissolved in 
chloroform. The crystal structure of 255 is given in Figure 4.1 on page 235. 
4.4.6.2 Bis((Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylvinyl) 2,2-dimethylmalonate 265 
Rf = 0.49 (ethyl acetate/hexane = 1:1); brown sticky oil.  
1H NMR (600 MHz, CDCl3): .58 (d, J = 7.60 Hz, C6H5 ortho, 4H), 7.28-7.23 
(m, C6H5 meta and para, 6H), 6.74 (s, CH=C(C6H5)O, 2H), 2.21 (s, 







Figure 4.18 1H NMR spectrum (600 MHz, CDCl3) of bis((Z)-2-(4,5-dimethyloxazol-2-
yl)-1-phenylvinyl) 2,2-dimethylmalonate 265 
  4.4.7 Reaction of the tautomers (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a
and 2-(benzo[d]oxazol-2-yl)-1-phenylethanone 198b with 2,2-dimethylmalonyl 
dichloride 
2,2-Dimethylmalonyl dichloride (0.373 g, 2.16 mmol, 1.54 eq.) in CH3CN (10 
mL) was added dropwise over a period of 20 min to a stirred solution of the tautomers 
198a,b (0.332 g, 1.40 mmol, 1 eq.) and Et3N (0.509 g, 5.03 mmol, 3.59 eq.) in CH3CN 
(25 mL). This solution was refluxed for 9 h. There was no spot on the TLC analysis 
corresponding to the starting material. The general procedure mentioned in the procedure 
for the synthesis of 251 was employed for the purification and isolation of products. The 
TLC of the product mixture had several spots that were very close. Isolation of fractions 
corresponding to all these spots was not attempted. Ethyl acetate:hexane 1:3 was used as 






0.076 g) was unidentified and its 1H NMR spectrum is given in Figure 4.29. The next 
fraction collected, corresponding to the major spot, was 256. This was isolated in 31.3% 
yield (0.146 g). 
Next, an inverse addition reaction was carried out. A solution of the tautomers 
198a,b (0.476 g, 2.01 mmol, 1 eq.) and Et3N (0.722 g, 7.14 mmol, 3.55 eq.) in CH3CN 
(30 mL) was added dropwise to a solution of 2,2-dimethylmalonyl dichloride (0.526 g, 
3.05 mmol, 1.52 eq.) in CH3CN (15 mL) over a period of 30 min. This solution was then  
refluxed for 9 h. The major spot on the TLC analysis of this product mixture 
corresponded to 256. Compound 256 (0.244 g, 35.4%) was isolated using ethyl 
acetate:hexane 1:3 as the eluting solvent for the column chromatography after completing 
the general work up procedure. Several other spots, which were not very well separated, 
were seen on TLC. Their further separations were not attempted.  
This reaction was repeated by the inverse addition of 198a,b (0.211 g, 0.89 mmol, 
1 eq.) and Et3N (0.316 g, 3.12 mmol, 3.55 eq.) to a solution of 2,2-dimethylmalonyl 
dichloride (0.307 g, 1.78 mmol,  2 eq.), followed by refluxing for 9 h. The general work 
up procedure was followed. The 1H NMR of the first fraction isolated (brown oil; 0.034 
g) from this reaction is same as that of the first fraction mentioned above corresponding 
to the brown oil (Figure 4.29). The 5,6-ring-fused compound 256 was isolated in 41.7% 
yield (0.124 g) after column separation.  
4.4.7.1 4-Benzoyl-2,2-dimethyl-1H-benzo[4,5]oxazolo[3,2-a]pyridine-1,3(2H)-dione 
256








1H NMR (600 MHz, CDCl3):  (d, J = 7.94 Hz, aromatic, 1H), 7.80 (d, J = 
7.79 Hz, C6H5 ortho, 2H), 7.56 (t, J = 7.36 Hz, C6H5 para, 1H), (dd, C6H5 meta, 2H), 
7.39-7.34 (m, aromatic H, 3H), 1.64 (s, C(CH3)2, 6H). 
13C NMR (150 MHz, CDCl3): COC6H5), 190.07 (NCOC(CH3)2CO), 
172.16 (NCO), 163.38 (N,O>C=), 146.88 (>NC≥CO or COC6H5, ipso), 138.38 
(>NC≥CO  or COC6H5, ipso), 132.98 (COC6H5, para), 128.98 (COC6H5, ortho), 
128.29 (COC6H5, meta), 126.66 (aromatic C), 126.10 (aromatic C), 125.90 
(>NC≥CO), 115.41 (aromatic C), 111.10 (aromatic C), 97.12 (=C(COC6H5)), 53.51 
(C(CH3)2), 24.42 (C(CH3)2).
DEPT 135 (150 MHz, CDCl3): 133.01, 129.02, 128.33, 126.14, 115.42, 111.15, 
24.46. 
IR (neat, cm-1): 3110, 3095, 3060, 3027, 3001, 2933, 1730, 1644, 1569, 1467, 
1396, 1352, 1307, 1213, 1159, 11245, 1008, 965, 910, 827, 761, 743, 708, 693, 654, 607. 
HRMS (ESI, [M+H]+): calcd for C20H16NO4: 334.1079; found: 334.1054. 
4.4.8 Reaction of the tautomers (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a 
and 2-(benzo[d]thiazol-2-yl)-1-phenylethanone 199b with 2,2-dimethylmalonyl 
dichloride 
2,2-Dimethylmalonyl dichloride (0.293 g, 1.77 mmol, 1.49 eq.) in CH3CN (10 mL) 
was added dropwise over a period of 20 min to a stirred solution of the tautomers 199a,b
(0.302 g, 1.19 mmol, 1 eq.) and Et3N (0.429 g, 4.24 mmol, 3.56 eq.) in CH3CN (25 mL). 
This solution was refluxed for 8 h. The spot for 199a,b was not observed on TLC. The 
general purification procedure mentioned in the synthesis of 251 was employed for the 
purification and isolation of products. Ethyl acetate:hexane 1:3 was used as the eluting 










followed by compound 266 (0.026 g, 7.3%). In addition to fractions corresponding to 257
and 266, two more fractions have been collected, which had complex 1H NMR spectra 
(Figures 4.30 and 4.31). These two fractions were collected before 257 and 266, in the 
order of fraction 1 (0.061 g) and fraction 2 (0.049 g).    
An inverse addition reaction was also performed by adding a solution of the 
tautomers 199a,b (0.507 g, 2.00 mmol, 1 eq.) and Et3N (0.715 g, 7.07 mmol, 3.54 eq.) in 
CH3CN (30 mL) to a solution of 2,2-dimethylmalonyl dichloride (0.524 g, 3.04 mmol, 
1.52 eq.) in CH3CN (15 mL) dropwise over a period of 30 min. This solution was 
refluxed for 8 h and the general work up procedure was followed. The eluting solvent 
used for the column chromatography was ethyl acetate:hexane 1:3. Compound 257 was 
isolated in 62.1% yield (0.435 g). There were several other spots including a very pale 
spot for compound 266, but these were not isolated. 
4.4.8.1 4-Benzoyl-2,2-dimethyl-1H-benzo[4,5]thiazolo[3,2-a]pyridine-1,3(2H)-dione 
257 
Rf = 0.51 (ethyl acetate/hexane = 1:3); white cotton like solid; mp = 238-239 °C.  
1H NMR (600 MHz, CDCl3):  (d, J = 8.34 Hz, aromatic H, 1H), 7.68 (d, J = 
7.65 Hz, aromatic H, 1H), 7.52-7.39 (m, C6H5 ortho, para, meta and aromatic H, 7H), 
1.64 (s, C(CH3)2, 6H). 
13C NMR (150 MHz, CDCl3): COC6H5), 190.16 
(NCOC(CH3)2CO), 174.44 (NCO), 168.27 (N,S>C=), 139.96 (>NC≥CS or
COC6H5 ipso), 136.09 (>NC≥CS  or COC6H5 ipso), 131.12 (COC6H5 para), 128.06 
(aromatic C), 127.78 (COC6H5, ortho), 127.67 (COC6H5 meta), 127.14 (>NC≥CS),
126.80 (aromatic C), 122.02 (aromatic C), 118.02 (aromatic C), 107.58 (=C(COC6H5)), 





   
 
DEPT 135 (150 MHz, CDCl3): 131.20, 128.14, 127.86, 127.75, 126.88, 122.10, 
118.10, 23.88. 
IR (neat, cm-1): 3126, 3080, 3028, 3000, 2947, 1732, 1657, 1609, 1471, 1385, 
1356, 1212, 1121, 936, 910, 760, 736, 700, 593. 
HRMS (ESI, [M+H]+): calcd for C20H16NO3S: 350.0851; found: 350.0819. 
4.4.8.2 Bis((Z)-2-(benzo[d]thiazol-2-yl)-1-phenylvinyl) 2,2-dimethylmalonate 266 
Rf = 0.54 (ethyl acetate/hexane = 1:1); off white solid; mp = 139-141 °C.  
1H NMR (600 MHz, CDCl3): 03 (d, J = 8.09 Hz, aromatic, 2H), 7.82 (d, J = 
7.91 Hz, aromatic, 2H), 7.63 (d, J = 6.94 Hz, C6H5 ortho, 4H), 7.48 (t, J = 7.56 Hz C6H5 
para, 2H), 7.37 (t, J = 7.51 Hz, aromatic, 2H), 7.28-7.25 (m, C6H5 meta and aromatic H, 
6H), 7.17 (s, =CH, 2H), 2.14 (s, C(CH3)2, 6H). 
13C NMR (150 MHz, CDCl3): 169.52CO2C(C6H5)=), 160.72 (N,S>C=), 
153.18 (=C(C6H5)O or >NC≥CS), 151.84 (CH=C(C6H5)O or >NC≥CS), 134.97 
(>NC≥CS or COC6H5 ipso), 133.71 (>NC≥CS or COC6H5 ipso), 130.07 (COC6H5, 
para), 128.76 (COC6H5, ortho), 126.44 (aromatic C), 125.68 (COC6H5, meta), 125.47 
(aromatic C), 123.09 (aromatic C), 121.42 (aromatic C), 111.26 (CH=C(C6H5)O), 
51.44 (C(CH3)2), 23.80 (C(CH3)2).
DEPT 135 NMR (150 MHz, CDCl3): 130.13, 128.82, 126.50, 125.74, 125.52, 
123.14, 121.47, 111.31, 23.85. 
IR (neat, cm-1): 3059, 2993, 2942, 1760, 1739, 1577, 1253, 1209, 1073, 755, 727, 
689. 






    
 
4.4.9 4Reaction of the tautomers (Z)-1-phenyl-2-(thiazol-2-yl)ethanol 194a and 1-
phenyl-2-(thiazol-2-yl)ethanone 194b with N-chlorocarbonyl dichloride 
N-Chlorocarbonyl isocyanate (0.335 g, 3.18 mmol, 1.4 eq.) in THF (15 mL) was 
added dropwise to a stirred solution of the tautomers, (Z)-1-phenyl-2-(thiazol-2-
yl)ethanol 194a and 1-phenyl-2-(thiazol-2-yl)ethanone 194b, (0.461 g, 2.26 mmol, 1 eq.) 
and triethylamine (0.574 g, 5.67 mmol, 2.51 eq.) in THF (20 mL) at room temperature 
under nitrogen. This solution was refluxed (66 C) for 5 h under nitrogen and then THF 
was removed by rotary evaporation. The residue was dissolved in dichloromethane 
(50 mL), washed with 10% aqueous sodium bicarbonate (30 mL), followed by water (2 × 
30 mL) and dried over anhydrous sodium sulfate. Sodium sulfate was then removed by 
filtration. After removal of dichloromethane by rotary evaporation, the crude product was 
purified by column chromatography over silica gel (ethyl acetate/hexane = 3:1) to give 8-
benzoyl-6H-thiazolo[3,2-f]pyrimidine-5,7-dione 258 (0.512 g, 83%). This general 
procedure was also used for the syntheses of compounds 259–262 discussed in this 
section. 
4.4.9.1 8-Benzoyl-6H-thiazolo[3,2-f]pyrimidine-5,7-dione 258
Rf = 0.30 (ethyl acetate/hexane = 1:1); yellow solid; mp = decomposed at 270 °C.  
1H NMR (300 MHz, DMSO): 11.77 (broad, NH, 1H), 8.03 (d, J = 3.96 Hz, 
=NCHCHS, 1H), 7.54-7.36 (m, C6H5 ortho, C6H5 para, C6H5 meta and 
=NCHCHS, 6H). 
13C NMR (600 MHz, DMSO): COC6H5), 163.81 (>NCONHCO), 
159.67 (>NCONHCO or N,S>C=), 145.95 (>NCONH or N,S>C=), 139.98 (COC6H5, 
ipso), 130.40 (COC6H5, para), 127.95 (COC6H5, ortho), 127.21 (COC6H5, meta),







DEPT 135 NMR (150 MHz, DMSO): 130.97, 128.51, 127.78, 124.15, 114.87.
IR (neat, cm-1): 3230, 3166, 3106, 1724, 1668, 1580, 1574, 1505, 1404, 1336, 
1225, 1178, 1093, 938, 868, 801, 776, 758, 654. 
HRMS (ESI, [M]+): calcd for C13H8N2O3S: 272.0256; found: 272.0451. 
4.4.10 Reaction of the tautomers (Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a
and 2-(4,5-dimethylthiazol-2-yl)-1-phenylethanone 196b withN-chlorocarbonyl 
dichloride 
The title compound 259 (0.283 g, 71.4%) was synthesized using the tautomers, 
(Z)-2-(4,5-dimethylthiazol-2-yl)-1-phenylethenol 196a and 2-(4,5-dimethylthiazol-2-yl)-
1-phenylethanone 196b (0.307 g, 1.33 mmol, 1 eq.), triethylamine (0.336 g, 3.32 mmol, 
2.5 eq.), and N-chlorocarbonyl isocyanate (0.202 g, 1.92 mmol, 1.44 eq.) in THF (25 
mL). The general procedure used for the synthesis and purification of 258 was employed. 
The eluent used for the column chromatography over silica gel was ethyl acetate/hexane 
= 2:1. 
4.4.10.1 8-Benzoyl-2,3-dimethyl-6H-thiazolo[3,2-f]pyrimidine-5,7-dione 259 
Rf = 0.36 (ethyl acetate/hexane = 1:1); pale white solid; mp = 240-241 °C.  
1H NMR (600 MHz, DMSO): s, NH, 1H). 1H), 7.49 (d, J = 7.25 Hz, 
C6H5 ortho, 1H), 7.46 (t, J = 7.28 Hz, C6H5 para, 1H), 7.47 (dd, C6H5 meta, 1H), 2.51 
(>NC(CH3)=C(CH3)S, 3H), 2.23 (>NC(CH3)=C(CH3)S, 3H). 
13C NMR (600 MHz, DMSO): COC6H5), 163.85 (>NCONHCO), 
158.97 (>NCONHCO or N,S>C=), 147.20 (>NCONHCO or N,S>C=), 140.26 
(COC6H5, ipso), 131.27 (>NC(CH3)=C(CH3)S), 130.27 (COC6H5, para), 127.89 






(=C(COC6H5)), 14.19 (>NC(CH3)=C(CH3)S or >NC(CH3)=C(CH3)S), 10.57 
(>NC(CH3)=C(CH3)S or >NC(CH3)=C(CH3)S). 
DEPT 135 NMR (150 MHz, DMSO): 130.83, 128.45, 127.75, 14.76, 11.13. 
IR (neat, cm-1): 3194, 3117, 3063, 2999, 2936, 2864, 2827, 1752, 1650, 1601, 
1575, 1489, 1444, 1418, 1324, 1214, 1152, 1062, 993, 931, 747, 695, 685, 624. 
HRMS (ESI, [M+H]+): calcd for C15H13N2O3S: 301.0647.; found: 301.0651. 
4.4.11 Reaction of the tautomers (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a
and 2-(4,5-dimethyloxazol-2-yl)-1-phenylethanone 197b  withN-chlorocarbonyl 
dichloride 
The title compound 261 (0.329 g, 72.8%) was synthesized by the reaction of the 
tautomers, (Z)-2-(4,5-dimethyloxazol-2-yl)-1-phenylethenol 197a and 2-(4,5-
dimethyloxazol-2-yl)-1-phenylethanone 197b (0.342 g, 1.59 mmol, 1 eq.), and 
triethylamine (0.409 g, 4.04 mmol, 2.54 eq.) in THF (15 mL) with N-chlorocarbonyl 
isocyanate (0.236 g, 2.24 mmol, 1.41 eq.) in THF (10 mL). The general procedure used 
for the synthesis and purification of 258 was followed. Ethyl acetate/hexane = 4:1 was 
used as the eluent for the column chromatography over silica gel. No any other spots 
detected on the TLC of the crude product mixture except the spot for 260. 
4.4.11.1 8-Benzoyl-2,3-dimethyl-6H-oxazolo[3,2-f]pyrimidine-5,7-dione 260
Rf = 0.37 (ethyl acetate/hexane = 3:1); pale white solid; mp = 222-224 °C.  
1H NMR (600 MHz, DMSO): s, NH, 1H), 7.69 (d, J = 8.08 Hz, C6H5 
ortho, 1H), 7.54 (t, J = 7.37 Hz, C6H5 para, 1H), 7.42 (dd, C6H5 meta, 1H), 2.35 (s, 






13C NMR (600 MHz, DMSO): COC6H5), 161.11 (>NCONHCO), 
160.26 (>NCONHCO or N,O>C=), 145.20 (>NCONHCO or N,O>C=), 140.62 
(COC6H5, ipso), 139.22 (>NC(CH3)=C(CH3)O), 131.87 (COC6H5, para), 128.59 
(COC6H5, ortho), 127.76 (COC6H5, meta), 117.39 (>NC(CH3)=C(CH3)O), 90.97 
(=C(COC6H5)), 9.01 (>NC(CH3)=C(CH3)O or >NC(CH3)=C(CH3)O), 8.98 
(>NC(CH3)=C(CH3)O or >NC(CH3)=C(CH3)O).
IR (neat, cm-1): 3101, 2980, 2816, 1750, 1703, 1636, 1600, 1576, 1468, 1425, 
1350, 1321, 1287, 1249, 1173, 1107, 1045, 1002, 930, 866, 747, 694, 668. 
HRMS (ESI, [M+H]+): calcd for C15H13N2O4: 285.0875; found: 285.0830 
Single crystals of 260 were obtained for X-ray crystallography by the vapor 
diffusion method. Hexane was diffused into a solution of compound 260 dissolved in 
acetone. The crystal structure is given in Figure 4.13 on page 256. The X-ray crystal 
structure contained a disorded solvent molecule. Therefore, the squeeze command in the 
Platon software66 was used to squeeze the crystal structure of 260.ref The volume that was 
squeezed is 93 Å3, which removed 23 electrons.  
4.4.12 Reaction of the tautomers (Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a
and 2-(benzo[d]oxazol-2-yl)-1-phenylethanone 198b with N-chlorocarbonyl 
dichloride 
The title compound 261 (0.225 g, 64.7%) was prepared by reacting the tautomers, 
(Z)-2-(benzo[d]oxazol-2-yl)-1-phenylethenol 198a and 2-(benzo[d]oxazol-2-yl)-1-
phenylethanone 198b, (0.2az98 g, 1.26 mmol, 1 eq.) and triethylamine (0.32 g,  3.16 
mmol, 2.51 eq.) in THF (15 mL) with N-chlorocarbonyl isocyanate (0.187 g, 1.77 mmol, 





of 258. The eluent used for column chromatography over silica gel was ethyl 
acetate/hexane = 1:1.  
4.4.12.1 4-Benzoyl-1H-benzo[4,5]oxazolo[3,2-c]pyrimidine-1,3(2H)-dione 261
Rf = 0.40 (ethyl acetate/hexane = 1:1); white solid; mp = decomposed at 286 °C.  
1H NMR (600 MHz, DMSO): s, NH). 1H), 8.03 (d, J= 7.30 Hz, 
aromatic CH in benzoxazole ring, 1H), 7.87 (d, J= 7.39 Hz, COC6H5 ortho, 2H), 7.65 (d, 
J= 7.72 Hz, aromatic CH in benzoxazole ring, 1H, 1H ), 7.61 (t, COC6H5 para, 1H), 
7.5-7.41 (m, COC6H5 meta and two aromatic CH in benzoxazole ring, 1H, 4H). 
13C NMR (600 MHz, DMSO): COC6H5), 161.60 (>NCONHCO), 
159.89 (>NCONHCO or N,O>C=), 146.69 (>NCONHCOor N,O>C=), 145.23 (C next 
to O in the benzoxazole ring), 138.33 (COC6H5, ipso), 132.72 (COC6H5, para), 128.93 
(COC6H5, ortho), 128.11 (COC6H5, meta), 125.98 (aromatic CH in benzoxazole ring), 
125.90 (C next to N in the benzothiazole ring), 125.64 (aromatic CH in benzoxazole 
ring), 114.15 (aromatic CH in benzoxazole ring), 111.00 (aromatic CH in benzoxazole 
ring), 92.23 (=C(COC6H5)). 
DEPT 135 (150 MHz, DMSO): 133.32, 129.52, 128.71, 126.57, 126.24, 114.74, 
111.60. 
IR (neat, cm-1): 3194, 3113, 3075, 1722, 1662, 1634, 1602, 1470, 1434, 1297, 
1279, 1164, 1106, 1088, 959, 856, 755, 744, 698, 673. 










4.4.13 Reaction of the tautomers (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a
and 2-(benzo[d]thiazol-2-yl)-1-phenylethanone 199b with N-chlorocarbonyl 
dichloride 
The title compound 262 (0.361 g, 88.3%) was synthesized by the reaction the 
tautomers, (Z)-2-(benzo[d]thiazol-2-yl)-1-phenylethenol 199a and 2-(benzo[d]thiazol-2-
yl)-1-phenylethanone 199b (0.321 g, 1.27 mmol, 1 eq.) and triethylamine (0.322 g, 3.18 
mmol, 2.5 eq.) in THF (15 mL) with N-chlorocarbonyl isocyanate (0.188 g, 1.78 mmol, 
1.4 eq.) in THF (10 mL) by the general procedure used for the synthesis and purification 
of 258. The eluent used for column chromatography over silica gel was ethyl 
acetate/hexane = 4:1.  
4.4.13.1 4-Benzoyl-1H-benzo[4,5]thiazolo[3,2-c]pyrimidine-1,3(2H)-dione 262
Rf = 0.37 (ethyl acetate/hexane = 3:1); white solid; mp = decomposed at 321 °C. 
1H NMR (600 MHz, DMSO): 11.67 (broad s, NH, 1H), d, J = 8.41 Hz, 
C6H5 para or aromatic CH in benzothiazole ring, 1H), 8.05 (d, J = 7.80 Hz, C6H5 para 
or aromatic CH in benzothiazole ring, 1H), 7.59 (m, C6H5 ortho and aromatic CH in 
benzothiazole ring, 3H), 7.52 (m, aromatic CH in benzothiazole ring, 2H), 7.42 (dd, 
C6H5 meta, 2H). 
13C NMR (150 MHz, DMSO): 190.96COC6H5), 164.30 (>NCONHCO), 
159.26 (>NCONHCOor N,S>C=), 147.61 (>NCONHCOor N,S>C=), 139.81 (C next 
to N in the benzothiazole ring or COC6H5, ipso), 135.90 (C next to N in the 
benzothiazole ring or COC6H5, ipso), 130.87 (COC6H5, para),128.02 (COC6H5, 
ortho), 127.58 (aromatic CH on benzothiazole ring), 127.37 (COC6H5, meta), 126.84 (C 
next to S in the benzothiazole ring), 126.30 (aromatic CH on benzothiazole ring), 122.89 











DEPT 135 (150 MHz, DMSO): 131.38, 128.60, 128.08, 127.91, 126.78, 123.42, 
117.88. 
IR (neat, cm-1): 3462, 3181, 3114, 3083, 3068, 3013, 2823, 1744, 1716, 1652, 
1601, 1490 1410, 1320, 1023, 960, 930, 866, 750, 700, 680, 642. 
HRMS (ESI, [M+H]+): calcd for C17H11N2O3S: : 323.0490; found: 323.0451 
4.4.14 1H NMR spectra of unidentified fractions collected from column 
chromatography 
4.4.14.1 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl dichloride: 
Addition of diacid chloride to a solution of the tautomers and Et3N in CH3CN 
Figure 4.19 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl 








             
 
Figure 4.20 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl 
dichloride (Fraction 2; Entry 5 in Table 4.1) 
Figure 4.21 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl 










            
 
4.4.14.2 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl dichloride: 
Addition of the tautomers 194a,b and Et3N to a solution of the diacid chloride 
in CH3CN 
Figure 4.22 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl 
dichloride (Fraction 1; Entry 6 in Table 4.1) 
Figure 4.23 Reaction of the tautomers 194a,b with cyclobutane-1,1-dicarbonyl 











                  
 
4.4.14.3 Reaction of the tautomers 196a,b with 2,2-dimethylmalonyl dichloride: 
Addition of diacid chloride to a solution of the tautomers and Et3N in CH3CN 
Figure 4.24 Reaction of the tautomers 196a,b with 2,2-dimethylmalonyl dichloride 
(Fraction 1; Entry 1 in Table 4.2) 
4.4.14.4 Reaction of the tautomers 197a,b with 2,2-dimethylmalonyl dichloride: 
Addition of diacid chloride to a solution of the tautomers and Et3N in CH3CN 
Figure 4.25 Reaction of the tautomers 197a,b with 2,2-dimethylmalonyl dichloride 










      
 
4.4.14.5 Reaction of the tautomers 197a,b with 2,2-dimethylmalonyl dichloride: 
Addition of a solution of the tautomers and Et3N in CH3CN into a diacid 
chloride in CH3CN 
Figure 4.26 Reaction of the tautomers 197a,b with 2,2-dimethylmalonyl dichloride 
(Fraction 1; Entry 4 in Table 4.2)  
Figure 4.27 Reaction of the tautomers 197a,b with 2,2-dimethylmalonyl dichloride 









            
 
Figure 4.28 Reaction of the tautomers 197a,b with 2,2-dimethylmalonyl dichloride 
(Fraction 4; Entry 4 in Table 4.2)  
4.4.14.6 Reaction of the tautomers 198a,b with 2,2-dimethylmalonyl dichloride: 
Addition of diacid chloride to a solution of the tautomers and Et3N in CH3CN 
and inverse addition 
Figure 4.29 Reaction of the tautomers 198a,b with 2,2-dimethylmalonyl dichloride 










                     
 
4.4.14.7 Reaction of the tautomers 199a,b with 2,2-dimethylmalonyl dichloride: 
Addition of diacid chloride to a solution of the tautomers and Et3N in CH3CN 
Figure 4.30 Reaction of the tautomers 199a,b with 2,2-dimethylmalonyl dichloride 
(Fraction 1; Entry 4 in Table 4.3) 
Figure 4.31 Reaction of the tautomers 199a,b with 2,2-dimethylmalonyl dichloride 
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TRIFULOROACETYLATIONS OF IN-SITU GENERATED  
N-METHYL N,O/S-CYCLIC KETENE ACETALS 
5.1 Introduction 
Reactions of 2-methyl-2-oxazoline, 2-methyl-2-oxazine, 2-methyl-2-thiazoline 
and 2,4,4-trimethyl-2-oxazoline with mono-electrophiles including aliphatic and aromatic 
acid chlorides, aryl isocyanates, and aryl isothiocyanate were explored and reported by 
Pittman’s group (Schemes 1.6, 1.16, 1.26 in Chapter I).7,21a,36 These reactions proceed via 
the corresponding cyclic ketene-N,X-acetal (X = O, S) intermediates. CKAs are 
extremely nucleophilic, simultaneously combining the reactivity of enamines, vinyl 
ethers or vinyl thioethers (Scheme 5.1) as described in Chapter I.  
An example of CKA nucleophilicity is the benzoylation of the five-membered 
rings, 2,4,4-trimethyl-2-oxazoline 68 and 2-methyl-2-oxazoline 69 to afford the ring-
retained bis-N,C-benzoylated product 74 and the ring-opened N,C,O-trisbenzoylated 
product 76, respectively (Scheme 5.2).36 Compounds 74 and 76 both go on to produce the 
ambident nucleophilic CKAs 75 and 77, respectively, upon debenzoylation by KOH in 
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Scheme 5.2 Benzoylation reactions of 2,4,4-trimethyl-2-oxazoline 68, 2-methyl-2-




MeOH (Scheme 5.2).36 The six-membered ring 2-methyl-2-oxazine 70 behaved similarly 
to its five-membered ring analog 69, forming the N,C,O-trisbenzoylated compound 78 
(Scheme 5.2).36 Benzoylation of 2-methyl-2-thiazoline 28 afforded the ring-retained bis-
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Scheme 5.3 Benzoylation reactions of N-methylated cyclic ketene-N,X-acetals (X= O, 




The benzoylations of five membered-ring N-methylated cyclic ketene-N,X-acetals 
(X = O, S) 65 and 33 formed -C-benzoylated CKAs 67 and 274, respectively (Scheme 
5.3).21a,4b These products are the N-methylated analog of 71  and the N-methylated S-
analog of 73, respectively. CKAs 67 and 274 were synthesized starting from the 
corresponding iodide salts 138 and 30, respectively, by deprotonation with NaH in THF 
to give 65 and 33, which were isolated prior to their benzoylation to 67 and 274, 
respectively. 
Trifluoroacetylations of 2,4,4-trimethyl-2-oxazoline 68, 2-methyl-2-oxazoline 69, 
2-methyl-2-oxazine 70 and 2-methyl-2-thiazoline 28 were also carried out in our 
laboratory.58,68 Trifluoroacetic anhydride is a stronger mono-electrophile than benzoyl 
chloride. Trifluoroacetylations of 68, 69 and 28 in the presence of Et3N in refluxing THF 
afforded the β-monotrifluoroacetylated products 275, 277 and 280, respectively, instead 










Scheme 5.4 Trifluoroacetylations of 2,4,4-trimethyl-2-oxazoline 68, 2-methyl-2-
oxazoline 69, 2-methyl-2-oxazine 70 and 2-methyl-2-thiazoline 2855,67 
The ring-opened N,C,O-tristrifluoroacetylated compounds 279 and 284 were also 
not formed when 69 and 70 reacted with trifluoroacetic anhydride (Scheme 5.4). The
trifluoroacetylation of the six-membered ring 2-methyl-2-oxazine 70 formed the β,β-bis-







(Scheme 5.4).55,67 Therefore, trifluoroacetylations are not following the pathway which 
he benzoyl chloride electrophile proceeded by (See Scheme 5.2). 
Trifluoroacetylated products 275, 277, 280 and 282 constitute strong push-pull 
alkene systems due to the presence of the strong electron withdrawing trifluoroacetate 
function in one end of the alkene and two electron-donating heteroatoms (N and 
O/S) in the other end of the alkene. 
The reactivities of 2,4,4-trimethyl-2-oxazoline 68, 2-methyl-2-oxazoline 69, 2-
methyl-2-oxazine 70 and 2-methyl-2-thiazoline 28 with benzoyl chloride and 
trifluoroacetic anhydride differ from each other. It would be of interest to find out how 
would in situ-generated N-methyl cyclic ketene-N,X-acetals (X = O, S) of 68, 69, 70 and 
30 react with trifluoroacetic anhydride in the presence of a base. Would in situ-generated 
N-methyl cyclic ketene-N,X-acetals (X = O, S) 65, 119, 141 and 33 give -mono-
substituted products, ,-disubstituted products, ring opened-products or rearranged 
products when subjected to this strong electrophile (Scheme 5.5)? Therefore, 
trifluoacetylations of in situ-generated N-methyl cyclic ketene-N,X-acetals (X = O, S) 65, 
119, 141 and 33 were explored using the trifluoroacetic anhydride as the electrophile in 
the presence of Et3N in refluxing THF in this research work. 
Scheme 5.5 Attempted trifluoroacetylation reactions of in situ-generated cyclic ketene-





5.2 Results and Discussion 
2,3,4,4-Tetramethyl-2-oxazolinium iodide 138, 2,3-dimethyl-2-oxazolinium 
iodide 139, 2,3-dimethyloxazinium iodide 140 and 2,3-dimethyl-2-thiazolinium iodide 30 
were synthesized by reactions of 2,4,4-trimethyl-2-oxazoline 68, 2-methyl-2-oxazoline 
69, 2-methyl-2-oxazine 70 and 2 -methyl-thiazoline 28 with MeI, respectively, according 
to previously reported methods.68,69 The isolated iodide salts 138, 139, 140 and 30 were 
refluxed with trifluoroacetic anhydride in the presence of Et3N in THF. A summary of 
these reactions and the structures of products are given in Table 5.1. The β,β-
bistrifluoroacetylation products 285, 286, 288 and 290, the rearrangement product 287 
and β-monotrifluoroacetylation product 289 were isolated. Complete experimental details 
including melting points, the 1H, 13C and DEPT 135 NMR, and IR spectral data of 285-










































Table 5.1 Trifluoroacetylations of in situ-generated cyclic ketene-N,X-acetals (X = O, 
S) 65, 119, 141 and 33a 









































HF3C 289 10 
5d I 30
33 N S 
O O 
N S 
F3C CF3 290 60 
N S 
a All reactions were carried out in refluxing THF for 5 h. 
b % Yields were calculated based on the theoretical yields considering the iodide salts as 
the limiting reagent.
c Reactant molar ratio in each reaction was iodide salt: (CF3CO)2O:Et3N = 1:2.3:2.5. 
d Reactant molar ratio in reaction was iodide salt:(CF3CO)2O:Et3N = 1:2.5-2.6:4. 
Note: A brown oil was isolated in each reaction in a small amount. This fraction was 
common for all entries. Its NMR spectra are given in the end of the experimental part of 
this chapter. Reaction of (CF3CO)2O and Et3N in refluxing THF also formed this brown 
oil, indicating that this simply a byproduct from the excess (CF3CO)2O present in the 
reaction. It has nothing to do with the consumption of the iodide salts or their 








3,4,4-Trimethyl-2-methylene-oxazolidine 65, generated in situ from the iodide 
salt 138, afforded the β,β-bistrifluoroacetyled product, 1,1,1,5,5,5-hexafluoro-3-(3,4,4-
trimethyloxazolidin-2-ylidene)pentane-2,4-dione 285, in 70% yield when reacted with 
2.3 equivalents of (CF3CO)2O and 2.5 equivalents of Et3N in refluxing THF for 5 h 
(Entry 1 in Table 5.1). The isolated yield was increased to 88% when 4 equivalents of 
Et3N and 2.5 equivalents of (CF3CO)2O were reacted with 138 (Entry 2 in Table 5.1). 
3-Methyl-2-methylene-oxazolidine 119, generated in situ from 139, behaved 
differently than 65 under the same reaction conditions. A -lactam, 1-methyl-3-(2,2,2-
trifluoro-1,1-dihydroxy-ethyl)-pyrrolidin-2-one 287 (23%), was also isolated in addition 
to the β,β-bistrifluoroacetylated product, 1,1,1,5,5,5-hexafluoro-3-(3-methyloxazolidin-2-
ylidene)pentane-2,4-dione 286 (24%), (Entry 3 in Table 5.1). The overall low yield based 
on 119 occurred because 287 was water soluble and acidic. The work up of these 
reactions involved an aqueous sodium bicarbonate washing step that caused major losses 
of 287. The formation of the hydrated ketone 287 was not anticipated. Iodide-catalyzed 
rearrangement of 286 was expected to produce the far less water-soluble ketone rather 
than its hydrated form.  
The six-membered ring, 3-methyl-2-methylene-1,3-oxazinane 141, exclusively 
gave the ,-bistrifluoroacetylated product, 1,1,1,5,5,5-hexafluoro-3-(3-methyl-1,3-
oxazinan-2-ylidene)pentane-2,4-dione 288, in 76% yield (Entry 4 vs Entry 3 in Table 
5.1), in contrast to its five-membered ring analog 119, where the analogous product 286
rearranged to 287. 
Trifluoroacetylation of 3-methyl-2-methylene-thiazolidine 33 gave both -
monotrifluoroacetylated product, (E)-1,1,1-trifluoro-3-(3-methylthiazolidin-2-ylidene) 
propan-2-one 289, and its ,-bistrifluoroacetylated product, 1,1,1,5,5,5-hexafluoro-3-(3-
300 
 




methylthiazolidin-2-ylidene)pentane-2,4-dione 290, in 10% and 60% yields, respectively,
after 5 h in THF (Entry 5 in Table 5.1).  
A brown oil fraction (Rf = 0.51; ethyl acetate/hexane = 1:2) was collected as the 
first fraction in small amount in all five reactions. Its 1H, 13C, DEPT 135 NMR spectra 
are given in the experimental section (Figures 5.9 and 5.10). A control reaction 
performed with only (CF3CO)2O and Et3N in refluxing THF also gave this oil. This result 
further confirmed that the formation of this oily by-product was not affected by the 
presence of iodide salts. 
Reactions of the N-methylated iodide salts 138, 139, 140 and 30 (Entries 1-5 in 
Table 5.1) with (CF3CO)2O and Et3N, are similar to reported reactions of (CF3CO)2O 
with the N-methylated iodide salt of 2-methylbenzothiazole, in the presence of pyridine.70 
The trifluoroacetylations of  138, 139, 140 and 30 involve in situ generation of cyclic 
ketene-N,X-acetals (X= O, S) 65, 119, 141 and 33, respectively, by Et3N. A plausible 
mechanism for the formation of the β,β-bistrifluoroacetylated products 285, 286, 288 and 
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Scheme 5.6 A plausible mechanism for the formation of 286 
The nucleophilic -carbon of in situ-generated CKA 119 first attacks the carbonyl 
carbon of the trifluoroacetic anhydride forming the zwitterionic intermediate 291. The 
loss of trifluoroacetate group, which is a good leaving group, gives oxazolinium cation 
292. The subsequent removal of the acidic -hydrogen of 292 forms the -
monotrifluoroacetylated intermediate 293. Intermediate 293 further reacts with the 
second equivalent of (CF3CO)2O via nucleophilic attack by the -carbon, followed by the 
loss of trifluoroacetate to give 294. The resultant oxazolinium cation 294 forms the ,-
bistrifluoroacetylated product 286 upon loss of the acidic hydrogen on the -carbon. 
The formation of β,β-bistrifluoroacetylation products finds analogy in our 
previous work on β,β-bis(N-arylamido) cyclic ketene-N,O-acetals syntheses (Scheme 
1.26 in Chapter I).7 The reaction of 33 with (CF3CO)2O (Entry 3 in Table 5.1) gave the 
β-mono-trifluoroacetylated product 289 in addition to the ,-bistrifluoroacetylated 
product 290. In contrast to this behavior, no monotrifluoroacetylated product was 
















Figure 5.1 Bisected or non-planar 3D drawing of polarized 286
containing 289 is less nucleophilic than its mono-C-trifluoroacetylated oxygen analog, 
which is due to the lower electron donating ability of sulfur versus oxygen. Replacement 
of oxygen with sulfur slows further trifluoroacetylation of 289 to 290. 
Only one 13C NMR resonance was observed corresponding to the two CF3 groups 
and one 13C resonance for the two carbonyl carbons for all β,β-bistrifluoroacetylated 
roducts 285, 286, 288 and 290. This indicates that the exocyclic C=C bonds of products 
285, 286, 288 and 290 are highly polarized and have significantly reduced double bond 
character, allowing either fast rotation or  bisected structure libration at the exocyclic 
C=C bond. This is illustrated for 286 in Figure 5.1. 1H and 13C NMR spectra of 286 are 
















Figure 5.3 13C NMR spectrum (150 MHz, CDCl3) of 1,1,1,5,5,5-hexafluoro-3-(3-
methyl-oxazolidin-2-ylidene)-pentane-2,4-dione 286 
The X-ray crystal structure of 286 (Figure 5.4 (a)) was obtained by Dr. William P. 
Henry. Single crystals were grown by vapor diffusion method by evaporating hexane into 
a solution of 286 in chloroform. The crystal data collection, structure refinement 
parameters, bond lengths and bond angles for the crystal structure 286 are given in 
Appendix J. The elongation of exocyclic C=C bond (1.443(2) Å) and a 51.5(2) (N1-C6-
C3-C4) out-of-plane twist in 286 (Figure 5.4 (b)) confirmed its reduced bond order, and a 
large degree of charge separation. This double bond twist results from its reduced bond 






 Figure 5.4 (a) The crystal structure of 1,1,1,5,5,5-hexafluoro-3-(3-methyl-oxazolidin-
2-ylidene)-pentane-2,4-dione 286; (b) Torsional angle N1-C6-C3-C4 of 
286. Only C3-C6 bond and atoms attached are shown. CCDC: 864636 
 
   
stable zwitterionic nature. In solution, the geometry may not be exactly the same (twist 
angle could be larger, for example). The low double bond character would allow fast 
libration if the twist energy minimum is not a 90 angle. This fast libration would 
equilibrate the CF3 and carbonyl carbons. The syntheses of twisted push-pull alkenes 
from N,N-dimethyl cyclic ketene-N,N-acetals were earlier reported by our group.45 
The structure of the -lactam 287 was confirmed by obtaining the crystal structure 
(Figure 5.5) with the help of Dr. William P. Henry. A single crystal was obtained by slow 
evaporation of hexane in to a solution of 287 in acetone. Lactam 287 has an 
intramolecular OH to oxygen hydrogen-bonding between H1 and O3 (1.99 Å) (Figure 
5.5) and intermolecular OH to oxygen hydrogen-bonding between H8 and O3 (1.879 Å) 










Figure 5.6 Intermolecular OH to oxygen hydrogen bonding between two molecules of   
287
 
structure refinement parameters, bond lengths and bond angles for the crystal structure 
287 are given in Appendix K. 
Figure 5.5 The crystal structure of 1-methyl-3-(2,2,2-trifluoro-1,1-dihydroxy-ethyl)-
pyrrolidin-2-one 287. CCDC: 864637 
The formation of the lactam 287 finds analogy in the earlier iodide-catalyzed 
rearrangement of β,β-bis(N-arylamido) cyclic ketene-N,O-acetals reported by Song et al 
(Scheme 1.26 in Chapter I).7 A plausible mechanism for the formation of 287 is proposed 
in Scheme 5.7. The β,β-bistrifluoroacetylation product 286 undergoes a nucleophilic 









   
 
 
Scheme 5.7 Two possible routes for the formation of the lactam 287 from β,β-
bistrifluoroacetylated products 286 or β-monotrifluoroacetylated products 
293
two methyl groups at C4 of compound 285 sterically retard attack by iodide at C5.7 The 
ambident nucleophile 295 undergoes an intramolecular SN2 attack at C5 forming the 
lactam 296. Subsequent detrifluoroacetylation of 296 by water during the aqueous 
workup gives 287 via 297-299a,b. A COCF3 moiety of 296 is more susceptible to attack 
by water compared to that of the -monotrifluoroacetylation intermediate 293. This is 
due to the lack of conjugation with an exocyclic C=C in 296 as is present in 293. 
Therefore, the hydrated keto product 287 is ultimately formed. However, a rearrangement 
from 293 to 287, via 300 and 299b, cannot be completely ruled out. 
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Is the β,β-bistrifluoroacetylated product 286 a precursor for the lactam 287
formation? To prove that this is possible, the β,β-bistrifluoroacetylated product 286 was 
reacted with tetrabutylammonium iodide in refluxing THF for 20 h. Only 287 was 
isolated (in 37% yield) confirming our hypothesis (Scheme 5.8). All 286 was actually
converted to 287 but a lot of water soluble 287 was lost in the aqueous bicarbonate work 
up. The β,β-bistrifluoroacetylated product 286 was completely converted to 287 based on 
TLC analysis. However, 287 is acidic and water-soluble. The removal of 287 during 
aqueous sodium bicarbonate washing led to the low isolated yield. The isolation of 286
(24%) and 287 (23%) (Entry 2 in Table 5.1) from the trifluoroacetylation of 119 in low 
yields is due to this rearrangement reaction. The trifluoroacetylation of 119 forms the β,β-
bistrifluoroacetylated product 286, which rearranges in the presence of iodide to 287. 
After 5 h only 286 and 287 were seen, but 286 progressively is converted to 287 at longer 
times. The 287 is formed as the only product from 119 at long reaction times, but isolated 
yields are low due to serious losses during an aqueous bicarbonate wash used in work up.   
The 1H, 13C and DEPT 135 NMR spectra of 287 in CDCl3 are given in Figures 5.7 
and 5.8. These spectra show two sets of peaks. The 1H NMR spectrum of 287 shows 16-











state. The 1H NMR spectrum of 287 has three distinct hydroxyl peaks (12.08 ppm, 8.15 
ppm and 4.07 ppm) which correspond to the intramolecular and intermolecular hydrogen 





Figure 5.7 1H NMR spectrum (600 MHz, CDCl3) of 1-methyl-3-(2,2,2-trifluoro-1,1-











Figure 5.8 13C and DEPT 135 NMR spectra (150 MHz, CDCl3) of 1-methyl-3-(2,2,2-








   
 
5.3 Conclusions 
Significant ring size and substituent effects were observed in trifluoroacetylations 
of in situ-generated cyclic ketene acetals 65, 119, 141 and 33. The five-membered ring N-
methylated cyclic ketene-N,O-acetals 3,4,4-trimethyl-2-methylene-oxazolidine 65 and the 
six-membered ring 3-methyl-2-methylene-1,3-oxazinane 141 exclusively formed the β,β-
bistrifluoroacetylated products 285 and 288, respectively. However, the five-membered 
ring 3-methyl-2-methylene-oxazolidine 119 afforded the -lactam 287 in addition to the 
β,β-bistrifluoroacetylated product 286. This lactam 287 is formed by an iodide-catalyzed 
rearrangement of its β,β-bistrifluoroacetylated derivative 286. In situ-generated 3-methyl-
2-methylene-thiazolidine 33 gave both β-mono- and β,β-bistrifluoroacetylation products, 
289 and 290, respectively, and no lactam, in contrast to its N,O-analog 3-methyl-2-
methyleneoxazolidine 119. These results clearly show that the reactivities of in situ-
generated cyclic ketene-N,X-acetals (X = O, S) 65, 119, 141 and 33 towards 
trifluoroacetic anhydride also depend on the ring-size, the heteroatom and the substituents 
similar to that found in benzoylation and trifluoroacetylations of 2,4,4-trimethyl-2-
oxazoline 68, 2-methyl-2-oxazoline 69, 2-methyl-2-oxazine 70 and 2-methyl-2-thiazoline 
28. 
5.4 Experimental
5.4.1 General information 
2,4,4-Trimethyl-2-oxazoline 68, 2-methyl-2-oxazoline 69 and 2-methyl-2-
thiazoline 28 and trifluoroacetic anhydride were used as received. 2-Methyl-2-oxazine 70 
was synthesized according to a literature procedure.68,69 Triethylamine was distilled from 








Tetrahydrofuran (THF) was distilled from Na metal/benzophenone ketyl and distilled 
prior to use. The round bottom flasks were baked in the oven and tried under the nitrogen 
prior to use. Instruments and techniques used for NMR and IR spectroscopic methods, X-
ray crystallography, and melting point determination are the same as those described in 
the experimental part in Chapter II.   
5.4.2 Preparation of N-methyl iodide salts 138, 139, 140 and 30 
5.4.2.1 2,3,4,4-Tetramethyl-2-oxazolinium iodide 138 
2,4,4-Trimethyl-2-oxazoline 68 (11.78 g, 103.1 mmol, 1 eq.) was placed in a 100 
mL flask, followed by dried THF (13.1 mL) and CH3I (19.84 g, 138.4 mmol, 1.34 eq.) 
The flask was wrapped with aluminum foil and the mixture was stirred for 15 h at room
temperature. White crystals of product 138 formed and were filtered, washed with dried 
THF and vacuum-dried. 18.90 g (74.1 mmol) of 138 was obtained, yield 71.9%. Melting 
point, and 1H and 13C NMR spectroscopy data are available in ref. 69. 
5.4.2.2 2,3-Dimethyloxazolinium iodide 139 
2-Methyl-2-oxazoline 69 (7.55 g, 86.9 mmol, 1 eq.) was placed in a 250 mL flask, 
followed by dried THF (47.1 mL) and CH3I (16.44 g, 114.7 mmol, 1.32 eq.). The flask 
was surrounded with aluminum foil to keep out light and the mixture was stirred for 48 h 
at room temperature. White crystals of product 139 precipitated and were filtered, washed 
with dried THF and vacuum-dried. 16.38 g (72.1 mmol) of 139 was obtained, yield 
83.0%. mp = 156 -158 C 1H NMR (600 MHz, CDCl3):  5.11 (t, J = 9.9 Hz, OCH2, 









5.4.2.3 2,3-Dimethyloxazinium iodide 140
2-Methyl-2-oxazine 70 (8.11 g, 80.7 mmol, 1 eq.) was placed in a 100 ml flask, 
followed by dried THF (40 mL) and CH3I (15. 14 g, 106.66 mmol, 1.32 eq). The flask 
was wrapped with aluminum foil and the mixture was stirred for 24 h at room
temperature. White crystals of product 140 were generated. This solid was filtered, 
washed with dried THF and vacuum dried. 17.73 g (73.5 mmol) of 140 was obtained, 
yield 91.2%. mp 136-138 C. 1H NMR (300 MHz, CDCl3):  4.78 (t, J = 5.5 Hz, 
OCH2, 2H), 3.87 (t, J = 5.9 Hz, >NCH2, 2H), 3.50 (s, >NCH3, 3H), 2.61 (s, 
>NC(CH3)O, 3H), 2.49 (tt, J = 5.8 Hz, CH2CH2CH2, 2H). 
5.4.2.4 2,3-Dimethylthiazolinium iodide 30
2-Methyl-2-thiazoline 28 (16.57g, 162.1 mmol, 1 eq.) was placed in a 250 mL
flask, followed by dried THF (75.6 mL) and CH3I (23.26 g, 162.2 mmol, 1 eq.). The flask 
was covered with aluminum foil and the mixture was stirred for 18 h at room
temperature. White crystals of product 30 formed. These crystals were filtered, washed 
with dried THF and vacuum dried. 20.57 g (84.6 mmol) of 30 was obtained, yield 52.2%. 
Melting point, 1H and 13C NMR spectroscopy data, and IR spectroscopy data are 
available in ref. 68. 
5.4.3 Trifluoroacetylations of 2,3,4,4-tetramethyl-2-oxazolinium iodide 138
2,3,4,4-Tetramethyl-2-oxazolinium iodide 138 (1.64 g, 6.43 mmol, 1 eq.) was 
placed in a 100 mL flask, followed by dried THF (35 mL) and triethylamine (2.61 g, 
25.79 mmol, 4 eq.). (CF3CO)2O (3.45 g, 16.26 mmol, 2.5 eq.) in dried THF (15 mL) was 
added dropwise at ice bath temperature under nitrogen. The resulting suspension was 






residue was dissolved in dichloromethane (30 mL) and washed with saturated NaHCO3 
(30 mL). The organic layer was washed further with water (2 × 40 mL), dried over 
anhydrous Na2SO4 and filtered. After removing dichloromethane by rotary evaporation, 
the crude product was purified by flash column chromatography over silica gel, using 
mixed ethyl acetate/hexanes = 3:1 as the eluting solvent. The title compound 285 (1.81 g) 
was isolated in 88.2% yield. 
Product 285 was isolated in 70% (0.70 g) yield when 138 (0.801 g, 3.14 mmol, 1 
eq.) was reacted with (CF3CO)2O (1.519 g, 7.23 mmol, 2.3 eq.) in the presence of Et3N 
(0.81 g, 8 mmol, 2.5 eq.) according to the general procedure mentioned above.  
5.4.3.1 1,1,1,5,5,5-Hexafluoro-3-(3,4,4-trimethyloxazolidin-2-ylidene) pentane-2,4-
dione 285
Rf = 0.55 (ethyl acetate/hexane = 3:1); yellow solid; mp = 118-119 °C.  
1H NMR (600 MHz, CDCl3):  4.42 (s, OCH2, 2H), 2.95 (s, >NCH3, 3H), 1.53 
(s, >NC(CH3)2, 6H). 
13C NMR (150 MHz, CDCl3):  175.12 (q, J = 35.04 Hz, COCF3), 173.11 
(N,O>C=), 116.89 (q, J = 290.50 Hz, CF3), 88.11 (=C(COCF3)2), 78.97 (OCH2), 
65.44 (>NC(CH3)2), 30.19 (>NCH3), 23.69 (>NC(CH3)2). Only one signal was observed 
for the two CF3 groups in 
13C NMR. This is also the case for the two C=O carbons. The 
exocyclic C=C bond has a low order of -bonding (low double bond order) and it is 
highly polarized due to the presence of two electron withdrawing COCF3 groups and 
strong electron donation from the nitrogen and oxygen atoms of the five-membered ring. 
Fast rotation about the exocyclic C=C bond or fast libration at the central bond of an out-








IR (neat, cm-1): 3032, 2993, 2947, 1681, 1623, 1578, 1431, 1415, 1391, 1158, 
1182, 1134, 968, 928, 855, 781, 730, 723, 696, 670. 
This general procedure was used for the synthesis and purification of compounds 
286-290. In addition to isolated products 285-290, another less polar brown oily fraction 
(Rf = 0.51; ethyl acetate/hexane = 1:2) was also isolated in each reaction. The 
1H, 13C and 
DEPT 135 spectra of this by-product are given in end of the experimental part of this 
chapter. This oily by-product forms by the reaction of Et3N with (CF3CO)2O in THF. 
This was confirmed by separately reacting only Et3N and (CF3CO)2O in THF at reflux. 
5.4.4 Trifluoroacetylations of 2,3-dimethyloxazolinium iodide 139
Compounds 286 and 287 were obtained by reacting 2,3-dimethyloxazolinium
iodide 139 (1.54 g, 6.78 mmol, 1 eq.) with trifluoroacetic anhydride (3.60 g, 17 mmol, 
2.5 eq.) and triethylamine (2.74 g, 27.1 mmol, 4.0 eq.) in 50 mL THF. The procedure for 
both synthesis and purification was performed in the same way as that for 285. Ethyl 
acetate:hexane = 3:1 was used as the eluent for the column chromatography over silica 
gel. Compound 287 (0.302 g, 22.9%) eluted first followed by 286 (0.471 g, 23.9%). TLC, 
1H and 13C NMR and column chromatography showed the only product produced from
the reaction of 139 with trifluoroacetic anhydride was 286. After 286 was formed, it 
began to rearrange to 287 in competition with its formation. Thus, after 5 h, 23.9% of 286
was observed after 139 was completely consumed. Long reaction times allow for the 
complete conversion of 286 to 287. However, using the work up procedure described for 
285, involved replacing the THF with CH2Cl2 and then performing an aqueous 









which employ water or water/bicarbonate wash steps give low isolated yields, due to loss 
of 287 into the water layer.
5.4.4.1 1,1,1,5,5,5-Hexafluoro-3-(3-methyloxazolidin-2-ylidene)pentane-2,4-dione 
286
Rf = 0.35 (ethyl acetate/hexane = 3:1); white solid; mp = 104-105 °C.  
1H NMR (600 MHz, CDCl3):  4.73 (t, J = 9.18 MHz, CH2O, 2H), 4.13 (t, J = 
9.18 MHz, >NCH2, 2H), 3.10 (s, >NCH3, 3H).  
13C NMR (150 MHz, CDCl3):  175.99 (q, J = 35.19 Hz, COCF3), 173.74 
(N,O>C=), 116.68 (q, J = 289.55 Hz, CF3), 87.61 (=C(COCF3)2), 67.49 (OCH2), 
51.95 (>NCH2), 36.51 (>NCH3). Only one peak was observed for the two CF3 groups of 
compound 286, and one peak for the two C=O carbons, in 13C NMR. This can be 
explained by the same bisected type of structure and fast libration argument as stated for 
compound 285. 
IR (neat, cm-1): 3007, 2971, 1675, 1626, 1603, 1422, 1395, 1281, 1167, 1131, 
1000, 948, 889, 782, 747, 729, 671. 
The crystal structure of 286 is shown in Figure 5.4 on page 306. Single crystals 
were grown by diffusing hexane vapor into a solution of 286 dissolved in chloroform.  
The isolated compound 1-methyl-3-(2,2,2-trifluoro-1,1-dihydroxy-ethyl)-
pyrrolidin-2-one 287 turned out to be a mixture of 287 and (Z)-1-methyl-3-(2,2,2-
trifluoro-1-hydroxyethylidene)pyrrolidin-2-one 299a, as indicated by its 1H and 13C NMR 
spectra. The molar ratio of 287 to 299a was 5:1 (based on the integrations of the two N-
CH3 groups in its 








5.4.4.2 1-Methyl-3-(2,2,2-trifluoro-1,1-dihydroxy-ethyl)-pyrrolidin-2-one 287 and
(Z)-1-methyl-3-(2,2,2-trifluoro-1-hydroxyethylidene)pyrrolidin-2-one 299a 
Rf = 0.52 (ethyl acetate/hexane = 1:1); white crystalline solid; mp = 76-78 °C.  
1H NMR (600 MHz, CDCl3):  12.08 (OH in 299a), 8.15 (intramolecular 
hydrogen-bonded OH in 287), 4.07 (OH in 287), 3.49 (t, J = 7.02 Hz, 
N(CH3)CH2CH2 in 299a, 2H), 3.37 (p, J = 8.50 Hz, N(CH3)CH2CH2 in 287, 2H), 
2.94 (s, >NCH3 in 299a, 3H), 2.91 (s, >NCH3 in 287, 3H), 2.86 (m, COCHCH2 in 287
and N(CH3)CH2CH2 in 299a, 3H), 2.31 (p, J = 10.53 Hz, N(CH3)CH2CH2 in 287, 
1H), 2.19 (broad m, N(CH3)CH2CH2 in 287, 1H). 
13C NMR (150 MHz, CDCl3):  174.14 (N(CH3)COC in 287), 171.97 
(N(CH3)COC in 299a), 147.36 (q, J = 37.00 Hz, =C(OH)CF3 in 299a), 122.39 (q, J = 
286.64 Hz, CF3 in 287), 119.63 (q, J = 274.52 Hz, CF3 in 299a), 105.43 (q, J = 2.37 
Hz, CH2C=C(OH)CF3), 93.54 (q, J = 32.34 Hz, =C(OH)2CF3 in 287), 47.68 
(N(CH3)CH2CH2 in 299a), 47.65 (N(CH3)CH2CH2 in 287), 42.91 (COCHCH2 in 
287), 29.73 (>NCH3 in 299a), 29.51 (>NCH3 in 299a), 20.29 (J = 1.35 Hz, 
N(CH3)CH2CH2 in 287), 20.03 (J = 1.93 Hz, N(CH3)CH2CH2 in 299a). 
DEPT 135 NMR (150 MHz, CDCl3):  47.76, 47.73, 42.99, 29.81, 29.60, 20.38, 
20.10. 
IR (neat, cm-1): broad peak 3500-3000, 3006, 2971, 2947, 2894, 1652, 1500, 
1472, 1417, 1313, 1291, 1268, 1231, 1155, 1109, 1070, 1021, 997, 896, 827, 773, 736, 
684, 637. 
HRMS (ESI, [M299a+Na]
+): calcd for C7H8F3NO2Na: 218.0405; found: 218.0362. 
HRMS (ESI, [M287+Na+CH3-H]








Single crystals of 287 (which contained no 299a) were grown by the vapor 
diffusion method. Hexane was diffused into a chloroform solution of 287 and 299a. The 
crystal structure of 287 is depicted in Figure 5.5 on page 307. 
5.4.5 Trifluoroacetylations of 2,3-dimethyloxazinium iodide 140 
The title compound 288 was obtained by reacting 2,3-dimethyloxazinium iodide 
140 (1.30 g, 5.39 mmol, 1 eq.) with trifluoroacetic anhydride (2.88 g, 13.6 mmol, 2.52 
eq.) and triethylamine (2.20 g, 21.74 mmol, 4.03 eq.) in THF. The procedure for the 
synthesis and purification of 285 was employed. Ethyl acetate/hexane = 5:1 was used as 
the eluent for the flash column chromatography over silica gel. Compound 288 (1.26 g, 
76.4%) was isolated. 
5.4.5.1 1,1,1,5,5,5-Hexafluoro-3-(3-methyl-1,3-oxazinan-2-ylidene) pentane-2,4-
dione 288
Rf = 0.62 (ethyl acetate/hexane = 6:1); white solid; mp = 91-92°C. 
1H NMR (600 MHz, CDCl3):  4.46 (t, J = 5.18 Hz, OCH2, 2H), 3.70 (t, J = 
6.52 Hz, >NCH2, 2H), 3.20 (s, >NCH3, 3H), 2.31 (tt, CH2CH2CH2, 2H). 
13C NMR (150 MHz, CDCl3):  174.39 (q, J = 34.25 Hz, COCF3), 172.30 
(N,O>C=), 117.03 (q, J = 290.57 Hz, CF3), 93.66 (=C(COCF3)), 67.46 (OCH2), 
48.05 (>NCH2), 42.18 (>NCH3), 20.58 (CH2CH2CH2). Only one peak was observed 
for the two CF3 groups of compound 288, and one peak for the two C=O carbons, in its 
13C NMR. The bisected type structure and fast libration around the central bond cause 
two COCF3 functions to be equal as explained for compound 285. 








5.4.6 Trifluoroacetylations of 2,3-dimethylthiazolinium iodide 30
The title compounds 289 and 290 were prepared by reacting 2,3-
dimethylthiazolinium iodide 30 (1.45 g, 5.96 mmol, 1 eq.) with trifluoroacetic anhydride 
(3.25 g, 15.32 mmol, 2.57 eq.) and triethylamine (2.41 g, 23.82 mmol, 4.0 eq.) in THF. 
The procedure for the preparation and purification of 285 was applied. Two fractions 
were isolated by column chromatography over silica gel using ethyl acetate:hexane in 3:1 
volume ratio. One fraction contained both -monotrifluoroacetylated compound (0.752 g) 
289 and ,-bistrifluoroacetyled compound 290 in 1:5 molar ratio (based on 1H NMR 
peak area for the CH3 group of 289 versus that of 289). Slow diffusion of hexane vapor 
into a solution of the mixture of 289 and 290 in chloroform crystallized 289. The other 
fraction (0.463 g) contained only ,-bistrifluoroacetylated compound 290. Yields of 289
(0.13 g) and 290 (1.09 g) are 10% and 59.6% respectively.  
5.4.6.1 (E)-1,1,1-Trifluoro-3-(3-methylthiazolidin-2-ylidene)propan-2-one 289 
Rf = 0.61 (ethyl acetate/hexane = 5:1); white solid; mp = 108-109°C.  
1H NMR (600 MHz, CDCl3):  5.58 (=CH(COCF3)), 3.82 (t, J = 7.93 MHz, 
>NCH2, 2H), 3.18 (t, J = 7.93 MHz, CH2S, 2H), 3.08 (s, >NCH3, 3H). 
13C NMR (150 MHz, CDCl3):  174.03 (q, J = 32.42 Hz, COCF3), 171.26 
(N,O>C=), 117.70 (q, J = 289.99 Hz, CF3), 83.31 (=CH(COCF3)), 56.10 (>NCH2), 
35.26 (>NCH3), 27.16 (SCH2). 
IR (neat, cm-1): 3118, 3010, 2929, 2873, 2802, 1616, 1548, 1440, 1411, 1337, 
1274, 1261, 1165, 1107, 946, 865, 758, 728, 708, 686. 










Rf = 0.54 (ethyl acetate/hexane = 5:1); white solid; mp = 99-101 °C.  
1H NMR (600 MHz, CDCl3):  4.28 (t, J = 8.55 MHz, >NCH2, 2H), 3.40 (t, J = 
8.55 MHz, CH2S, 2H), 3.08 (s, >NCH3, 3H). 
13C NMR (150 MHz, CDCl3):  183.66 (N,S>C=), 174.38 (q, J = 34.57 Hz, 
COCF3), 116.82 (q, J = 290.74 Hz, CF3), 93.35 (=C(COCF3)2), 60.01 (>NCH2), 
39.57 (>NCH3), 27.39 (SCH2). Only one peak was observed for the two CF3 groups of 
compound 290, and one peak for the two C=O carbons, in its 13C NMR. This can be 
explained by the bisected type of structure and fast libration at the central bond of 290 as 
stated for compound 285. 
IR (neat, cm-1): 3118, 2954, 2918, 2872, 2849, 2802, 1616, 1545, 1441, 1410, 
1336, 1273, 1261, 1165, 1105, 1009, 945, 863,757, 727, 708, 685. 
5.4.7 Bu4NI catalyzed rearrangement of 1,1,1,5,5,5-hexafluoro-3-(3-methyl-   
oxazolidin-2-ylidene)pentane-2,4-dione 286 to 1-methyl-3-(2,2,2-trifluoro-1,1-
dihydroxy-ethyl)-pyrrolidin-2-one 287
1,1,1,5,5,5-Hexafluoro-3-(3-methyloxazolidin-2-ylidene)pentane-2,4-dione 286 
(0.85 g, 2.9 mmol, 1 eq.) and Bu4NI (0.11 g, 0.30 mmol, 0.1 eq.) in THF (15 mL) was 
refluxed for 20 h. During this period all of 286 in the reaction was consumed and the only 
product observed (by TLC) was lactam 287. This reaction appears to go quantitatively. 
However, serious losses of 287 were encountered during the work up and isolation. The 
general procedure used for the purification of 285 was employed. This work up employed 
an aqueous bicarbonate wash step. Compound 287 is both water soluble and acidic. 







smaller isolated yields of 287. The eluent used for the column chromatography over silica 
gel was ethyl acetate/hexane = 1:1. Lactam 287 (0.213 g, 36.6%) was isolated. 
5.4.8 Unidentified oily fraction 
A brown oil (Rf = 0.51; ethyl acetate/hexane = 1:2) was isolated in all five 
reactions. This eluted as the first fraction. Its 1H, 13C and DEPT 135 NMR spectra are 
given in Figures 5.9-5.10. According to these NMR spectra, this unknown oil contains at 
least one trifluoro acetate group. Since this oil was isolated in each of the five reactions, 
iodide salts 138, 139, 140 or 30 or their corresponding CKAs 65, 119, 141 or 33 were not 
involved in its formation. A control reaction was run with (CF3CO)2O (1.524 g, 7.2 
mmol, 1 eq.) and Et3N (1.16 g, 1.6 eq.) in refluxing THF (5 mL) for 5 h. The spot for this 
oil was observed on the TLC. Part of the reaction mixture was worked up according to 
the general procedure and the oil was isolated. Its 1H NMR spectrum matched up with 
that of the isolated oil from each reaction. This confirmed that iodide salts does not 




        
                                                 
 
 
Figure 5.9 1H NMR spectrum (600 MHz, CDCl3) of unidentified brown oil from the 









Figure 5.10 13C and DEPT 135 NMR spectra (150 MHz, CDCl3) of unidentified brown 
oil from the reaction of 139 with trifluoroacetic anhydride in the presence 
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ATTEMPTED SYNTHESES OF HIGHLY FUNCTIONALIZED POLYMERS FROM 
PLANT-DERIVED 5-(HYDROXYMETHYL)FURFURAL
6.1 Introduction and Research Goals 
Petroleum-based resources widely used in energy and material production are 
rapidly diminishing due to enormous consumption. Scientists are looking for alternative 
sources which can replace petroleum resources. Renewable biomass resources are now 
becoming a promising alternative which can produce a wide variety of important 
chemicals for not only energy production but also pharmaceuticals, polymers or fine 
chemical syntheses. Furan derivatives obtained from biomass feedstocks by thermolysis 
can serve as substituents for petrochemicals. 5-(Hydroxymethyl)furfural (HMF) is one of 
the key furan-based building blocks that can be obtained from abundant carbohydrates 
and cellulose (Scheme 6.1).1-3 Monosaccharides such as fructose and glucose or 
disaccharides such as sucrose or polysaccharides such as cellulose and starch have been 


























(Wood, Sugar cane, Sugar Beet, Wheat, Corn Stover)
Fructose, Glucose, Sucrose, Cellulose, Starch











HFM can be transformed into various other furan derivatives that are important in 
chemical industries.1-3 A few of such furan derivatives are portrayed in Scheme 6.2. 2,5-
furandicarboxaldehyde 302, 2,5-furandicarboxylic acid 303 and 5-hydroxymethyl-2-
furancarboxylic acid 304 are derived from oxidation of HMF 301. 2,5-
Furandicarboxaldehyde 302 is a precursor for diamine and Schiff base synthesis.15 2,5-
furandicarboxylic acid 303 is an alternative for terephthalic acid and isophthalic acid, 






                       
 
  
    
   
   
   
   
   
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





   
   
   
   
   
 
   
   
   
 
   
   
   
   
   
   
   
   
   
   
   


































































































































































   
 
 
The hydrogenation of HMF 301 forms 2,5-bis(hydroxymethyl)furan 305, 2,5-bis 
(hydroxymethyl)tetrahydrofuran 306 and 5-(hydroxymethyl)tetrahydrofuran-2-
carbaldehyde 307. Both unsaturated and saturated furan dialcohols, 305 and 306 can be 
used as monomers in polymer synthesis. Hence, the combination of diacid 303 with diols 
305 and 306 can leads to biomass-derived polyesters. 
Methodology development for the synthesis of HMF 301 is a very active field. 
Lots of research is being attempted to produce this industrially useful chemical on a large 
scale and in a cost effective manner. Fructose and glucose are the two major feedstocks 
that are used in HMF production.4-13 This process involves a triple dehydration (Scheme 
6.3).3-5 Furthermore, synthesis of HMF from the fructose portion of sucrose was also 
reported.11,13,14 Fructose dehydration in water under acidic conditions unfortunately leads 
to many byproducts due to fragmentation, condensation and/or rehydration of HMF and 
intermediates formed during this process.10 Levulinic acid is one of the major by 
products. Most of the HMF syntheses mainly focus on efficient conversion of the 
biomass feedstocks to HMF. However, production of HMF in a large industrial scale has 
not been achieved and remains a challenge. Organic solvents, ionic liquids and 
supercritical solvents have been also used in attempted of HMF syntheses.3,11 A wide 
variety of mineral acids, organic acids, salts and ion-exchange resins have also been 




  Scheme 6.3 HMF synthesis from the triple dehydration of fructose and glucose3-5
 
 
As mentioned above, 2,5-furandicarboxylic acid 303, 2,5-bis(hydroxy 
methyl)furan 305 and bis(hydroxymethyl)tetrahydrofuran 306 are potential monomers in 
polymer syntheses. Our research objective was to synthesize functionalized polymers 
starting from plant-derived HMF using a combination of Grubbs’s catalyzed ring-opening 
metathesis polymerization (ROMP) and polycondensation steps. Schemes 6.4 and 6.5 
illustrate the proposed synthetic approach that could furnish highly functionalized cross-
linked polymers via combination of both ROMP and polycondensation methods.  
Our first goal was to synthesize HFM 301 from, fructose, sucrose or glucose and 
then convert HMF into 2,5-bis(hydroxymethyl)furan (2,5-BHMF) 305 by reduction of the 
aldehyde function of HMF. Then our plan was to synthesize several Diels-Alder adducts 
from diol 305, as such 312, 313 (Scheme 6.4), 316 and 317 (Scheme 6.5). Diels-Alder 
adducts of 305 each contain a 7-oxanorbornene-type of strained double bond. Thus, they 
may have the ability to serve as monomers for ROMP. All four monomers are diols, so 
they may be viable monomers for polycondensation reactions. If monomers 312, 313, 
316 and 317 undergo ROMP they would form polymers I (Path A in Scheme 6.4) and 
polymer IV (Path A in Scheme 6.5). These polymers could be then subsequently cross-
linked to highly functionalized three-dimensional resins: polymers III (Scheme 6.4) and 
VI (Scheme 6.5) via polycondensation reactions with either diacids, or diacid chlorides. 






By switching the polymerization sequence to polycondensation of 312, 313, 316
or 317 followed by ROMP (Path B in Schemes 6.4 and 6.5), functionalized cross-linked 
polymers III (Scheme 6.4) and VI (Scheme 6.5) might be obtained. Again, the use of 
diacid and diacid chlorides could be replaced with diisocyanates to obtain polyurethane
type polymers. 
This synthetic platform offers an enormous variety of functional group density in 
a myriad of polymers and resins. Consider polymer I (Scheme 6.4). This contains a high 
unsaturation density, ether, primary alcohol and imide functions in the same polymer. 
When R = H, for every ten carbon atoms, this polymer has five oxygens (one ether, two 
primary alcohols, two imide carbonyls). Polyester II features two ester functions, two 
imide carbonyls, an imide nitrogen, and a strained double bond for every repeating unit. 
Overall, the opportunity exists to tailor solubilities from water to a wide variety of 
organic solvents. A variety of adhesive bonding possibilities to surfaces exists and 



































































































































































































































          
 
          
 











   
 
 

































































































































































































       
 
            
 


























































































































































































































































 Scheme 6.6 ROMP of norbornene 318 and 7-oxa-norbornene 319 
 





ROMP is a versatile polymerization technique that can be used in polymerization 
of strained ring structures as such cyclobutene, cyclopentene, cyclooctene, norbornene 
and 7-oxanorbornene (Scheme 6.6).19-24 This is a living-polymer type of chain-growth 
polymerization technique in which the ring strain is released. It can generate high 
molecular weight linear polymers of narrow molecular weight distributions. 
Grubbs ruthenium-based, functional group tolerant catalysts are now widely used 
19-26 in ROMP of bicyclic monomers as such norbornene 318 and 7-oxanorbornene 319. 
Ruthenium-based catalysts 320-322 (Scheme 6.7) represent three useful Grubbs catalysts 
in ROMP. Grubbs catalysts have several advantages over other catalysts used in ROMP. 
Especially, these catalysts have a higher tolerance to functional groups containing loan 
pairs of electrons than titanium, tungsten or molybdenum-based metal catalysts.19,22,25,26 
Further, Grubbs catalysts are less air and moisture sensitive than molybdenum-based  
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Scheme 6.7 Grubbs 1st generation catalyst 320 and 2nd generation catalyst 321 and 3rd




The Grubbs 1st generation catalyst, bis(tricyclohexylphosphine)benzylidine 
ruthenium(IV) chloride 320 is a better catalyst for ROMP and possesses improved 
initiation efficiencies compared to other 1st generation catalysts.19,20,25 Grubbs 2nd 
generation catalyst, (1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro 
(phenylmethylene)(tricyclohexylphosphine) ruthenium 321 has also shown excellent 
ROMP activities.19,26 This 2nd generation catalyst 321 is prepared by replacing one of the 
PCy3 groups in the 1
st generation catalyst with N-heterocyclic carbene (NHC) ligand. 
However, this catalyst leads to polymers with uncontrollable molecular weights and high 
polydispersity indices (PDI) due to slow initiation and high propagation rates. The new
3rd generation Grubbs’ catalyst, (1,3-dimesityl-2-imidazolidinylidene]dichloro(phenyl- 
methylene)bis(3-bromopyridine) ruthenium(II) 322 is one of the promising Grubbs 
catalysts which provides high molecular weight polymers with narrow PDIs.19,22,25,26 This 
catalyst contains strongly ligating NHC and two weakly coordinating pyridine ligands. 







320-322 were used to try to catalyze ROMP reactions in this work due to their high 
efficiency and functional group tolerance reported in the literature.    
6.2 Results and Discussions 
Our first target was to synthesize a large amount of 5-(hydroxymethyl)furfural 
(HMF) 301 for use in polymer synthesis. A convenient methodology that can be used 
readily in the laboratory was sought. There are many research papers which discuss the 
conversion of fructose, sucrose or glucose into HMF using different solvents and 
catalysts.1-14,16-18 However, in most of the cases, isolation of HMF from the reaction 
solution is not convenient to follow or not explored. In 1944, Haworth et al reported the 
conversion of the fructose portion of sucrose into HMF by treating sucrose with 0.25% 
oxalic acid in an aqueous medium (Scheme 6.8).11 They claimed that a maximum yield of 
20 g of HMF was isolated from 100 g of sucrose after optimizing the reaction conditions. 
This was about a 54% yield based on the fructose amount present in sucrose.  
Scheme 6.8 Synthesis of HMF from sucrose in an acidic aqueous medium11 
The method published by Haworth et al was chosen to make HMF in a large scale 
using a one-gallon autoclave reactor, after several small-scale syntheses.11 About 56 g of 
HMF was isolated as a brown oil from 700 g of sucrose after extracting the aqueous 









amount present in sucrose. The one-gallon reactor used had a limitation. It did not have a 
proper cooling system. The temperature could not be adjusted and this resulted in over 
dehydration when the reaction was kept too long at about 145-135 C during cooling to 
125 C. It took several hours to cool down to the room temperature. Char had formed on 
the wall, on the bottom and on the stirrer of the reactor. This char had to be removed by 
filtration prior to follow the work up and the extraction with ethyl acetate.
Another method to synthesize HMF from fructose was also attempted. This 
approach was reported by Zhang et al in 2007 and involved ionic liquids as the solvent 
and CrCl2 as a catalyst (Scheme 6.9).
12 However, they never reported the isolation of 
HMF from the ionic liquid medium. We e-mailed Dr. Zhang to get more information 
about separation of HMF from the ionic liquid. However, he has replied mentioning that 
he could not disclose more information since a project was underway on the separation of 
HMF from the ionic liquid. Ethyl acetate was used as the extracting solvent to remove 
HMF from the ionic liquid/catalyst solution. About 2.2 g of HMF (brown oil) was 
isolated when 4 g of fructose was used. This was approximately 80% based on the 
fructose used. However, this method was not used for large-scale HMF synthesis because 
of the expense of using this ionic liquid to make HMF on a 50-100 g scale. 
Scheme 6.9 Synthesis of HMF from fructose using CrCl2 as the catalyst and the ionic 
liquid ([EMIM]Cl) as the solvent12
341 
 






Isolated HMF (brown oil) was used without further purification for the synthesis 
of 2,5-bis(hydroxymethyl)furan (2,5-BHMF) 305 (Scheme 6.10).19 Reduction of the 
aldehyde function of HMF using NaBH4 afforded the 2,5-BHMF 305 in 56% yield. 
Required monomers 312, 313, 316 and 317 were then synthesized by Diels-Alder 
reactions of 2,5-BHMF 305 with N-phenylmaleimide 310, maleimide 311, diethyl 
acetylenedicarboxylate (DEADC) 314 and dimethyl acetylenedicarboxylate (DMADC) 
315, respectively. Results from these four types of Diels-Alder reactions are summarized 
in Tables 6.1 and 6.2. Monomers 312, 313, 316 and 317 were synthesized applying the 
procedures reported in synthesis of Diels-Alder adducts that are similar to these 
monomers with slight modifications.28-32
Diels-Alder reaction of 2,5-BHMF 305 with N-phenylmaleimide 310 in refluxing
CH3CN for 10 h afforded pure exo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-
3a,4,7,7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312b (6%) and a mixture of 
both endo 312a and exo 312b adducts (46%) in a ratio of 3.6:1 (endo:exo) (Entry 1 in 
Table 6.1). The total isolated yield was 52%. In contrast to using refluxing CH3CN, only 
the endo adduct 312a was isolated in 76% yield when this reaction was carried out at 








A mixture of endo- and exo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-3a,4,7,7a-
tetrahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione, 313a and 313b (endo:exo = 7.6:1), 
respectively, was isolated in 73% yield when 2,5-BHMF 305 was reacted with maleimide 
311 in refluxing CH3CN for 15 h. Only endo adduct 313a was formed (68%) when this 
reaction was performed at room temperature for 24 h in diethyl ether. Thus, the use of 
room temperature and the less polar diethyl ether favored the endo product in the Diels-
Alder reaction of both 310 and 311 with 2,5-BHMF 305. 
The Diels-Alder reaction between 2,5-BHMF 305 and DEADC 314 in refluxing 
1,4-dioxane for 8 h afforded diethyl 1,4-bis(hydroxymethyl)-7-oxa-bicyclo[2.2.1]hepta-
2,5-diene-2,3-dicarboxylate 316 in 72% yield (Entry 1 in Table 6.2). Dimethyl 1,4-
bis(hydroxymethyl)-7-oxa-bicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate 317 was also 
synthesized in 50% yield by the reaction 305 with DMADC 315 for 5 h in 1,4-dioxane at 
reflux (Entry 2 in Table 6.2). 
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conditions Isolated yieldsa (%) 
  
OH OH O O O 
H O 
H NPh   H 
NPh O H 
OH Ph O OH O N  O  312a  312b
CH3CN   - 6 
1b 
 310 Reflux 10 h 
 52 
 
Et2O 2 76 -
rt 24 h 
 
  
OH OH O O O 
H O 
  H NH H 
NH O H H 
OH O N O OH O    313b313a 
   311
3c 
CH3CN  73 
Reflux 15 h 
 
 
Et2O 4 68 -
rt 24 h 
 
 a Yields were calculated considering 2,5-BHMF as the limiting reagent.
 b 6% of exo and 46% of both endo and exo in a 3.6:1 (endo:exo) ratio was isolated.
c Only a mixture of endo and exo in a ratio of 7.6:1 (endo:exo) was isolated. 
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 a Yields were calculated considering 2,5-BHMF as the limiting reagent.
Next, several ROMP reactions were tried (Schemes 6.11-6.13). First, ROMP of 
the exo adduct 312b was attempted using Grubbs’ 1st generation catalyst 320 
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Monomer 312b was not completely soluble in 1,2-dichloroethane and undissolved 312b
was seen even after heating overnight. Thus, the true monomer/catalyst ratio in solution 
was less than 100:1. The reaction was quenched by adding ethyl vinyl ether and 
undissolved 312b was recovered in 68% yield. The reaction solution was poured into 
both methanol and n-pentane to precipitate if any polymer has formed. However, no 
polymer precipitation occurred. Filtrate was not further analyzed for unreacted starting 
material.  
ROMP of endo 312a was attempted next using dry N,N-dimethylformamide 
(DMF) as the solvent (Scheme 6.12). Monomer 312a was completely soluble in DMF. 
The endo adduct 312a, obtained exclusively at room temperature in diethyl ether (Entry 2 
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Scheme 6.12 Three attempted ROMPs of 312a with Grubbs’ catalysts 320-322 in DMF 




ROMP of 312a was carried out first with Grubbs’ 1st generation catalyst 320 for 1 
day in DMF at 60 C. The reaction was terminated by adding excess ethyl vinyl ether. 
Then the reaction solution was added to a large excess of n-pentane to precipitate any 
polymer generated. However, a precipitate that formed was identified as the starting 
monomer 312a by TLC and confirmed by its 1H NMR. It was recovered in 71% yield. No 
polymer was found. Then this reaction was attempted with Grubbs’ 2nd generation 
catalyst 321 under the same reaction conditions used with Grubb’s 1st generation catalyst. 
The starting monomer 312a again precipitated when the reaction was poured into n-
pentane after quenching with ethyl vinyl ether. Monomer 312a was recovered in 66% 
yield and no polymer was obtained. Clearly, neither catalyst 320 nor 321 was able to 
ROMP 312a. In these two attempted polymerization reactions, the monomer to catalyst 
ratio was 100:1. 
Materia Inc. and the material science section of Sigma-Aldrich were contacted to 
get information about Grubbs’ catalysts suitable for ROMP of monomers as such 312, 
313, 316 and 317 when catalysts 320 and 321 did not work. Grubbs’ catalyst 322, 
recommended by Sigma-Aldrich was chosen. However, the attempted ROMP of 312a




   
 



















60 oC, 1 day 
CO2C2H5 
CO2C2H5 
C2H5O2C  CO2C2H5 
Scheme 6.13 Attempted ROMP of 316 with Grubbs’ 3rd generation catalyst 322 
reaction was carried out at 60 C with a 100:1 monomer:catalyst ratio in DMF for 3 
days. Solids precipitated after quenching the reactions with ethyl vinyl ether, followed 
adding into n-pentane in both reactions of 312a and 313a. These solids were the starting 
monomers 312a (59%) and 313a (63%). 
The attempted ROMP of monomer 316 with more active catalyst 322 in 1,2-
dichloroethane was unsuccessful (Scheme 6.13). Monomer 316 was soluble in 1,2-
dichloroethane. The spot for the starting monomer 316 along with another spot on the 
base line was observed by TLC after heating at 60 C for one day. 
Grubbs’ catalysts 320-322 have been used in ROMP of norbornene 318 and 7-
oxanorbornene 319 type monomers (See Scheme 6.6).19-24 Monomers which contain free 
hydroxy functions have been polymerized using Grubbs’ catalysts and afforded high 
molecular weight polymers.23,33,34 However, our attempted polymerizations of monomers 
312 and 316 with these catalysts were unsuccessful (Schemes 6.11-6.13).  
Monomers 312, 313, 316 and 317 that were synthesized for ROMP (Tables 6.1 
and 6.2), contain quaternary carbon centers at either end of the double bond to be 
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(Scheme 6.6). Further, 312, 313, 316 and 317 contain two free hydroxymethyl groups 
which are close to the double bond. These each hydroxy group might have a high 
frequency factor of encountering Ru (Figure 6.1) and with two of them this factor will be 
grater. Thus, there may be a tendency to chelate with the Ru metal center and deactivate 
the catalyst. The combination of the steric effect and the presence of two free hydroxy 
groups close to the double bonds might retard  ROMP of monomers 312a and 313a in 












Figure 6.1 Chelation of free hydroxy group of the monomer 312 with Ru catalyst  
Exo-3a,4,7,7a-tetrahydro-4-(hydroxymethyl)-2-phenyl-4,7-epoxy-1H-isoindole-1, 
3(2H)-dione 328 (76%) (Scheme 6.14) and exo-1-methyl-4-phenyl-10-oxa-4-
azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione 330 (81%) (Scheme 6.15) were also 
synthesized by reacting furfural alcohol 327 and 2-methylfuran 329, respectively, with N-
phenylmaleimide in refluxing CH3CN. These two reactions afforded only the 
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Monomer 328 contains only one CH2OH group close to the double bond and only 
one of the two carbons adjacent to the double bond is quaternary. This reduces the steric 
congestion close to the double bond compared to monomers 312, 313, 316 and 317 each 
of which contain two CH2OH groups and two adjacent quaternary carbons. Monomer 330
does not contain any hydroxymethyl group near the double bond. Further, like 328, the 
double bond in 330 is less sterically hindered than monomers 312, 313, 316 317 and 317. 
ROMP of 328 and 330 has never been reported according to my literature search. 
Therefore, their ROMP was also attempted. 
ROMP of 328 using Grubbs’ 3rd generation catalyst 322 (monomer:catalyst = 
100:1) was attempted (Scheme 6.16). This reaction was carried out in DMF at 60 C for 3 
days. DMF was used because 328 was not adequately soluble in 1,2-dichloroethane. The 
solid formed after quenching the reaction and precipitating into n-pentane was only 






Scheme 6.16 Attempted ROMP of 328 with Grubbs’ 3rd generation catalyst 322
In contrast to all the other monomers (312a, 312b, 313a, 316, and 328), ROMPs 
of 330 using all three catalysts 320-322 were successful. These reactions were carried out 
in 1,2-dichloroethane at 60 C for 1 day. Molecular weights (Mn, Mw and Mz) obtained by 
the gel permeation chromatography (GPC) via direct comparison with polystyrene 
standards are summarized in Table 6.3. A monomer:catalyst ratio of 100:1 was used in 
each reaction (Entries 1-3 in Table 6.3). The molecular weight of the polymer obtained 
by Grubbs’ 1st generation catalyst 320 (Entry 1 in Table 6.3) was lower than that obtained 
with Grubbs’ 2nd and 3rd generation catalysts 321 and 322 (Entries 2 and 3 in Table 6.3). 
There was not a huge difference in the molecular weights of the polymer 331 obtained by 
Grubbs’ 2nd and 3rd generation catalysts 321 and 322 (Entries 2 and 3 in Table 6.3). 
Yields of the polymer 332 in each reaction were also moderate (61%-72%).  
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 Table 6.3 ROMP of exo monomer 330a 
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O OGrubbs' catalysts n 
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a Reactions were carried out in 1,2-dichloroethane at 60 C for 1 day.
b Yields were calculated based on the weights of the monomer used. 
c Mn, Mw and Mz values are obtained by gel permeation chromatography by direct 
comparison with polystyrene standards. 
d Degree of polymerization (DP) was defined as Mw/molecular weight of the repeating  















Figure 6.2 Monomer 333 which contain two methyl groups at each bridgehead   
Successful polymerization of 330 and inability to polymerize 328 suggest that the 
free hydroxyl groups present near the double bond might have been a major contributor 
to inhibition of ROMP. The presence of two hydroxymethyl groups close to the double 
bond in monomers 312, 313, 316 and 317 might have made this inhibition more serious 
and it could be made worse by the two quaternary carbons adjacent to the double bond. It 
would be interesting to study ROMP of the dimethyl analog 333 (Figure 6.2) of 330. 
With a methyl at each bridgehead but no hydroxy groups in chelating distance of the 
ruthenium, the issue of having two quaternary carbons adjacent to the double bond could 
be evaluated. Would steric hindrance in 333 prevent its ROMP when using the same
three catalysts?  
Condensation polymerizations were then tried. Polycondensations of monomer 
312a were attempted with either succinic acid or terephthalic acid under reaction 
conditions borrowed from peptide syntheses. Dicyclohexaylcarbodiimide (DCC) or 1,3-
diisopropylcarbodiimide (DIPTS) were used as activating agents and 4-
(dimethylamino)pyridine (DMAP) or 4-(dimethylamino)pyridinium 4-toluenesulfonate 
(DPTS) were used as catalysts. Results are summarized in Tables 6.4 and 6.5. 
Polycondensation reactions of aliphatic or aromatic dialcohols and diacids using 
combinations of DCC or DIPC with either DMAP or DPTS have previously been 
reported.36-39 Thus, a reported literature procedure was applied for the polycondensation 
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of 312a with both succinic acid and terephthalic acid.36 All six polycondensation 
reactions (Entries 1-3 in Tables 6.4 and 6.5) were carried out at room temperature in 


































































































































































































































































































































































































































The polycondensation of endo diol 312a with succinic acid using DCC (1.3 eq.) 
and DMAP (0.5 eq.) afforded the polyester 334 in 77% yield (Entry 1 in Table 6.4). The 
molecular weights obtained by GPC were low (Mn = 2568 and Mw = 3989) and the PDI 
was somewhat broad (PDI = 1.55). The degree of polymerization (DP) was only 10. The 
polymer 334 was isolated in 83% yield when DCC (1.5 eq.) was used with DPTS (0.5 
eq.) in the polycondensation of 312a and succinic acid (Entry 2 in Table 6.4). However, 
the molecular weights were very low (Mn = 882 and Mw = 1156). The PDI = 1.31 and DP 
was only 3. The combination of DIPC (1.5 eq.) with DPTS (0.5 eq.) in the 
polycondensation of 312a with succinic acid gave the polyester 334 with Mn = 2635, Mw 
= 3575 and PDI = 1.36. (Entry 3 in Table 6.4). The isolated yield of the polymer was 
85%. The degree of polymerization was 9. 
The polycondensation of endo diol 312a with terephthalic acid was also 
performed at room temperature in dichloromethane overnight (Entries 1-3 in Table 6.5). 
The molecular weights of the polyester 335 were in the range of 10000-12000 when DCC 
(1.5 eq.) was used with either DMAP (0.5 eq.) or DPTS (0.5 eq.) and isolated yields were 
61% and 69%, respectively (Entries 1 and 2 in Table 6.5). The PDIs were also small. 
When DIPC (1.5 eq.) was used with DPTS (0.5 eq.) in the polycondensation of 312a with 
terephthalic acid a lower molecular weight (Mn = 2434 and Mw = 3500) polyester 335 was
isolated in 74% yield (Entry 3 in Table 6.5). The PDI and DP of this polymer was 1.44 
and 8, respectively. Further optimizations of these polycondensation reaction conditions 

















































































































































































































































































































































































Scheme 6.17 Polycondensation of 316 with succinic acid
 
 
The polycondensation of bicyclic monomer 316 and succinic acid was also
attempted and DIPC (1.5 eq.) with DPTS (0.5 eq.) were used to promote this process 
(Scheme 6.17). This reaction was also carried out at room temperature overnight in 
dichloromethane. The polymer 336 was isolated in 58% yield (Mn = 9701, Mw = 9730, 
PDI = 1.00 and DP = 51). 
Finally, one cross-linking reaction of the synthesized polyester 334 was attempted 
via ROMP (Scheme 6.18). This was done knowing that monomers 312a,b, 313a and 316 
could not be “ROMPED”. However, monomers 312a,b, 313a and 316 have two hydroxyl 
groups in chelating distance of a coordinated Ru during ROMP. However, in polymer 
334 these hydroxyls are now ester groups with the carbonyl oxygen seven atoms removed 
from a coordinated Ru. ROMP of 334 (Mn = 882 and the Mw = 1156) was carried out 
using Grubbs’ 3rd generation catalyst 322 (monomer:catalyst = 100:1) in 1,2-dichloethane 
at 60 C for one day. A polymer was isolated by quenching the reaction with ethyl vinyl 
ether, followed by adding this solution into n-pentane and precipitating a product in only 
7% yield. This polymer 337 was analyzed by GPC which gave Mn = 10302, Mw = 10964 
and PDI = 1.07. This was the original polyester 334 which had been cross-linked by 
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Scheme 6.18 Cross-linking polyester 334 (Mn = 882 and Mw = 1156) using Grubbs’ 3rd








The reported molecular weights in this chapter (Mn, Mw and Mz) were obtained 
using a GPC instrument that coupled with only a refractive index detector. The molecular 
weights are obtained by direct comparison of retention volumes of polymers with that of 
polystyrene standards by means of a calibration curve (log of M.W. of standards vs 
retention volume).40 In GPC polymer molecules are separated based on their 
hydrodynamic radii.40 These radii control diffusion into pores of the gel. The polystyrene 
standards have different structures than the analyzed polymers. Thus, polymers of the 
same hydrodynamic radii (which control the elution volumes) will not have the same
molecular weights. Therefore, the molecular weights of the polymers that were obtained 
by the GPC are not exact. This problem can be overcome by using the universal 
calibration method.40 The hydrodynamic volume (Vh) is directly proportional to the 
intrinsic viscosity ().40 Therefore, by constructing a new calibration curve (log M.W. × 
 vs retention volume), the universal calibration curve can be obtained.40 The intrinsic
viscosity of the polymer samples can be directly measured by using a differential 
viscometer detector, but this was not available at MSU. Further, viscosity measurements 
can also be carried out using an Ubbelohde viscometer40 is sufficient sample sizes are





molecular weight polymers. Therefore, this method is also not very practical. Hence, 
universal calibration was not attempted.  
6.3 Conclusions 
In conclusion, attempted ring-opening polymerization of monomers 312a, 312b 
and 316 using Grubbs’ catalysts 320-322 under different reaction conditions were 
unsuccessful. The unreacted starting monomers were recovered in these attempted 
ROMPs. The presence of two free hydroxyl groups close to the double bond in position 
to coordinate to the ruthenium metal during ROMP could be the main reason for the 
unsuccessful polymerization of these monomers.  
There are many future research opportunities remaining in this research field. 
Attempts should focuse on finding suitable catalysts that can effectively ROMP 
monomers as such 312, 313, 316 and 317. Ruthenium catalysts are reported as more 
functional group tolerant than molybdenum and tungsten metathesis catalysts. New 
molybdenum-based catalysts have been synthesized for metathesis reactions.41 These new 
molybdenum metathesis catalysts could be tried in the ROMP of these types of 
monomers.  
Protecting the free hydroxy groups of these monomers with either methoxy or 
acetate groups should be done and then ROMP reactions should be explored. This will 
help to find out whether the presence of free hydroxy groups, which are close to the 
double bonds, is the reason for the ROMP failures observed here.  
Attempted polycondensation reactions of endo adduct 312a with either succinic 
acid or terephthalic acid were successful. However, the molecular weights of the 











have made these esterifications difficult, leading to the low observed molecular weights. 
The reaction conditions should be further optimized for the polycondensation reactions. 
Diacid chlorides to speed polyesterification and less sterically effect diisocyanates to 
generate polyurethanes can also be used with these dialcohol monomers.  
6.4 Experimental 
6.4.1 General information 
Fructose, oxalic acid dihydrate, lead acetate, calcium carbonate (CaCO3), 
dicyclohexaylcarbodiimide (DCC), chromium(II) chloride (CrCl2) and sodium
borohydride (NaBH4) were purchased from Alfa Aesar. Normal sugar (sucrose) was 
bought from the Wal-Mart and was directly used. Grubbs 1st generation catalyst,
bis(tricyclohexylphosphine)benzylidine ruthenium(IV) chloride 318, and the 2nd 
generation catalysts, (1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro 
(phenylmethylene)(tricyclohexylphosphine) ruthenium 319 and the 3rd generation 
catalyst, (1,3-dimesityl-2-imidazolidinylidene]dichloro(phenylmethylene)bis(3-bromo 
pyridine) ruthenium(II) 320, were purchased from Sigma Aldrich. Dimethyl 
acetylenedicarboxylate (DMADC), diethyl acetylenedicarboxylate (DEADC), N-
phenylmaleimide, maleimide, succinic acid, terephthalic acid, 4-(dimethylamino)pyridine 
(DMAP), p-toluenesulfonic acid (PTSA) and 1,3-diisopropylcarbodiimide (DIPC) were 
also purchased from Sigma Aldrich and used as received. 1-Ethyl-3-methylimidazolium
chloride ([EMIM]Cl) and 4-(dimethylamino)pyridinium 4-toluenesulfonate (DPTS) were 
synthesized according to the literature procedures. Ethyl vinyl ether, anhydrous methanol 




and acetonitrile were dried over calcium hydride, and distilled. N N,N-
dimethylformamide (DMF) was dried over MaSO4 and distilled prior to use. 
Melting points were recorded with a Mel-Temp apparatus and were uncorrected. 
The FT-IR spectra were recorded neat on a Thermo 18 Nicolet 6700 FT-IR spectrometer. 
1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE III -300 or -600 
spectrometer operating at 300 MHz and 600 MHz for proton, and 75 MHz and 150 MHz 
for carbon. The chemical shifts in spectra were reported in parts per million (ppm) on the 
delta (δ) scale relative to the internal standard, tetramethylsilane for 1H (δ = 0 ppm) and 
the center line of the deuterated solvents at 77.0 ppm and 39.43 ppm for CDCl3 and 
DMSO-d6, respectively. Splitting patterns are designed as “s, d, t, q, and m”; these 
symbols indicate “singlet, doublet, triplet, quartet, and multiplet,” respectively. Coupling 
constants, J, were reported in Hertz (Hz). Gel permeation chromatography (GPC) was 
performed using a Waters GPC instrument equipped with a Waters 717 plus autosampler, 
a Waters 1515 isocratic HPLC pump, a column heater, Waters Styragel HR 5E and 4E  
columns, and a guard column. A Waters 2414 refractive index detector was employed. 
This system was operated at 0.3 mL/min flow rate at 30 °C using Optima tetrahydrofuran 
as eluting solvent. GPC was calibrated using polystyrene standards. Hence, the molecular 
weights given from GPC are based on a direct comparison of elution volumes with 








6.4.2 Synthesis of 5-(hydroxymethyl)furfural (HMF), 301
6.4.2.1 From the fructose portion of sucrose11
Sucrose (700 g) and dihydrated oxalic acid  (4.9 g) were dissolved in water (2.1 
L) in a one-gallon stainless steel autoclave. The temperature of the autoclave was 
gradually increased to 145 C while the contents were stirring at about 400 RPM. The 
pressure of the autoclave was about 60 PSIG at 145 C. The solution was heated at
145 C for 30 min while stirring at 400 RPM. Then the temperature of the system was 
brought down to 125 C from 145 C and the solution was heated for 2 h and 15 min at 
this temperature while stirring at 400 RPM. The pressure of the autoclave was about 40 
PSIG at 125 C. Then the solution was cooled to room temperature while the reactor
vessel sitting in the autoclave. Since this autoclave did not have a cooling system it took 
several hours to cool down to the room temperature. The solution was stirred while it was 
cooling down to room temperature. The vessel was removed from the autoclave. Char 
had formed on the wall and the bottom of the reactor vessel. The resultant brown solution 
was filtered to remove char and neutralized with adding CaCO3. CaCO3 was filtered and 
the filtrate was extracted with ethyl acetate. Ethyl acetate was dried over anhydrous 
MgSO4 and filtered. HMF 301 (56 g) was obtained as a brown oil after removing ethyl 
acetate by rotary evaporation. This is approximately 21.7% of the theoretical yield 
calculated on the amount of fructose present in sucrose. The difficulty of quickly 
adjusting the temperature to 125 C in this large reactor resulted in over dehydration at 
145 C, lowering the yield. This crude HMF was used for the synthesis of 2,5-BHMF 305 









6.4.2.2 From fructose using CrCl2 as the catalyst and ionic liquid ([EMIM]Cl) as the 
solvent12 
The ionic liquid, [EMIM]Cl, (40 mg) and CrCl2 (6 mol % based on the moles of 
fructose) were added to a the reactor vessel (250 mL). The autoclave was heated to 
150 C and stirred for 20 min. Then the reactor was cooled to room temperature and 
fructose (4 g) was added and heated at 80 C for 3 h. Water (160 mL) was added to the 
reaction solution and the resulting solution stirred at room temperature for another 10 
min. Then HMF was extracted using ethyl acetate, dried using anhydrous MgSO4 and 
filtered. HMF was isolated as a brown liquid in 79.8% yield (2.21 g) after removing ethyl 
acetate by rotary evaporation.   
6.4.2.3 5-(Hydroxymethyl)furfural (HMF), 30142 
Brown liquid 
1H (300 MHz, DMSO-d6):  9.55 (s, CHO, 1H), 7.50 (d, J = 3.52 Hz, 
C(CHO)=CH, 1H), 6.61 (d, J = 3.52 Hz, C(CH2OH)=CH, 1H), 5.62 (broad, 
CH2OH, 1H), 4.52 (s, CH2OH, 2H). 
IR (neat, cm-1): 3372, 3120, 2931, 1658, 1582, 1519, 1396, 1368, 1337, 1278, 
1188, 1070, 1017, 987, 965, 806, 764. 
6.4.3 Synthesis of 2,5-bis(hydroxymethyl)furan (2,5-BHMF), 30527 
2,5-BHMF was prepared according to a modified literature procedure.27 HMF (20 
g, 157 mmol, 1 eq.) was dissolved in anhydrous MeOH (200 mL) in a 500 mL round 
bottom flask. This solution was cooled and maintained at 4 C using an ice water bath. 
NaBH4 (12.1 g, 320 mmol, 2 eq.) was added slowly while stirring the solution. This 
solution was stirred for another 2 h at room temperature. Then the MeOH was removed, 







was extracted with ethyl acetate (30 mL × 5). Then the organic layer was dried using 
anhydrous MgSO4 and filtered. Ethyl acetate was removed by rotary evaporation. Ethyl 
acetate/hexane = 1:3 was used as the eluting solvent over silica gel for column
chromatography. 2,5-BHMF 305 was isolated in 56% yield (11.4 g). 
6.4.3.1 2,5-bis(Hydroxymethyl)furan (2,5-BHMF), 305
White crystals; mp = 73-74 C (Lit. 74-75 C)27
1H (300 MHz, DMSO-d6):  6.24 (s, C(CH2OH)=CH, 2H), 5.25 (t, J = 5.25 Hz, 
CH2OH, 2H), 4.40 (d, J = 5.25 Hz, CH2OH, 4H). 
IR (neat, cm-1): 3312, 3229, 3129, 2943, 2877, 1562, 1452, 1429, 1398, 1243, 
1197, 1182, 1022, 999, 968, 9212, 810, 756, 727, 684. 
6.4.4 Diels-Alder reaction of 2,5-BHMF 305 and N-phenylmaleimide 310 
2,5-BHMF 305 (5.29 g, 41.3 mmol, 1 eq.) and N-phenylmaleimide 310 (8.85 g, 
49.6 mmol, 1.2 eq.) in dried CH3CN (50 mL) were refluxed for 15 h. The reaction 
solution was cooled to room temperature. A white solid precipitated. This solid was 
filtered, washed with CH3CN and dried in vacuo. This precipitate was identified as the 
exo adduct (0.81 g, 6.5%), 312b (149-150 C). Then the filtrate was concentrated by 
removing CH3CN. Diethyl ether was added to the residue. A solid precipitated. It was 
filtered and washed with diethyl ether. The resultant solid was a mixture of both endo 
312a and exo 312b isomers (5.7 g, 45.8%; mp = 116-146 C; 312a:312b = 3.6:1). This 
ratio was calculated from the integrations of endo and exo hydrogens of each isomer in 
the 1H NMR spectrum of the mixture. The total yield of both the pure exo and the mixture 











A solution of 2,5-BHMF 305 (2.0 g, 15.6 mmol, 1 eq.) and N-phenylmaleimide 
310  (3.36 g, 18.8 mmol, 1.21 eq.) in diethyl ether (30 mL) was stirred at room
temperature for 24 h. A white solid precipitated during this period. This solid was 
filtered, washed with diethyl ether and dried in vacuo. Only the endo adduct 312a was 
isolated in 75.8% yield (3.58 g) as a white solid. Diethyl ether solution was not 
concentrated to recover more product. 
6.4.4.1 Endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-3a,4,7,7a-tetra-hydro-1H-
4,7-epoxy isoindole-1,3(2H)-dione 312a 
Rf = 0.59 (acetone:hexane = 3:2); mp = 128-129 C. 
1H (600 MHz, DMSO-d6):  7.46 (dd, C6H5 meta, 2H), 7.40 (t, J = 7.16 Hz, C6H5 
para, 1H), 7.12 (d, J = 7.56 Hz, C6H5 ortho, 2H), 6.50 (s, CH=CH, 2H), 5.24 (t, 3JCH-
OH = 5.4 Hz, CH2OH, 2H), 4.07 (dd, Jgem = 12.5 Hz and 3JCH-OH = 5.4 Hz, CH2OH, 
2H), 3.77 (dd, Jgem = 12.5 Hz and 3JCH-OH = 5.4 Hz, CH2OH, 2H), 3.67 (s, exo 2H). 
13C (150 MHz, DMSO-d6):  174.47 (CONPh), 136.06 (CH=CH), 131.94 
(C6H5 ipso), 128.84 (C6H5 meta), 128.36 (C6H5 para), 126.86 (C6H5 ortho), 92.51 
(CO(CH2OH)), 59.63 (CH2OH), 47.21 (CH(CO)). 
IR (neat, cm-1): 3234, 3078, 3008, 2938, 2939, 2863, 2845, 1777, 1699, 1595, 
1496, 1458, 1443, 1374, 1304, 1168, 1043, 1028, 992, 940, 870, 853, 758, 723, 717, 692. 
6.4.4.2 Exo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-3a,4,7,7a-tetra-hydro-1H-
4,7-epoxyiso- indole-1,3(2H)-dione 312b 
Rf = 0.57 (acetone:hexane = 3:2); mp = 149-150 C 
1H (300 MHz, DMSO-d6):  7.49 (dd, C6H5 meta, 2H), 7.42 (t, J = 7.17 Hz, C6H5 









OH = 5.0 Hz, CH2OH, 2H), 4.07 (dd, Jgem = 12.5 Hz and 3JCH-OH = 5.0 Hz, CH2OH, 
2H), 3.77 (dd, Jgem = 12.5 Hz and 3JCH-OH  = 5.0 Hz, CH2OH, 2H), 3.16 (s, endo  2H).
13C (150 MHz, DMSO-d6):  173.90 (CONPh), 138.20 (CH=CH), 132.08 
(C6H5 ipso), 128.90 (C6H5 meta), 128.32 (C6H5 para), 126.79 (C6H5 ortho), 91.66 
(CO(CH2OH)), 59.06 (CH2OH), 50.69 (CH(CO)). 
IR (neat, cm-1): 3465, 3377, 3090, 2964, 2934, 2915, 2860, 1775, 1698, 1594, 
1494, 1454, 1387, 1330, 1280, 1249, 1198, 1165, 1093, 1056, 1002, 924, 901, 858, 735, 
687. 
HRMS (ESI, [M+Na]+): calcd for C16H15NO5Na: 324.0848; found: 324.0848. 
6.4.5 Diels-Alder reaction of 2,5-BHMF 305 and maleimide 311
2,5-BHMF 305 (1.0 g, 7.8 mmol, 1 eq.) and maleimide 311 (0.91 g, 9.4 mmol, 1.2 
eq.) in dried CH3CN (20 mL) were reacted at reflux for 15 h. A white solid precipitated 
when the reaction solution was cooled to room temperature. CH3CN was removed and 
diethyl ether was added to the residue. The solid formed was filtered and washed with
diethyl ether. The product was isolated in 72.7% (1.28 g) as a white crystalline solid 
which was a mixture of both endo 313a and exo 313b isomers (mp = 148-153 C) in a 
ratio of 7.6 (endo):1 (exo). This ratio was calculated using the integration ratios between 
the endo and exo hydrogens of each isomer in the 1H NMR spectrum of the mixture. 
2,5-BHMF 305 (2.02 g, 15.6 mmol, 1 eq.) and maleimide 311 (1.82 g, 18.6 
mmol, 1.2 eq.) in diethyl ether (30 mL) were stirred at room temperature for 24 h. A 
white solid precipitated. This solid was filtered and wash with diethyl ether and dried in 










Rf = 0.50 (acetone:hexane = 5:2); mp = 150-151 C. 
1H (600 MHz, DMSO-d6):  10.85 (>NH, 1H), 6.38 (s, CH=CH, 2H), 5.14 (t, 
3JCH-OH = 5.4 Hz, CH2OH, 2H), 3.96 (dd, Jgem = 12.8 Hz and 3JCH-OH = 5.4 Hz, 
CH2OH, 2H), 3.84 (dd, Jgem = 12.8 Hz and 3JCH-OH = 5.4 Hz, CH2OH, 2H), 3.44 (s, exo
2H). 
13C (150 MHz, DMSO-d6):  176.83 (CONH), 135.92 (CH=CH), 92.02 
(CO(CH2OH)), 59.73 (CH2OH), 48.69 (CH(CO)). 
IR (neat, cm-1): 3444, 3318, 3078, 1773, 1699, 1466, 1413, 1384, 1350, 1281, 
1251, 1237, 1174, 1072, 1042, 988, 867, 679, 660. 
6.4.5.2 Exo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-3a,4,7,7a-tetrahydro-1H-4,7-
epoxyisoindole-1,3(2H)-dione 313b
Exo adduct 313b was not isolated in the pure form, and this came from the endo 
and exo mixture. Chemical shift values for exo isomer 313b were assigned comparing the 
1H and 13C spectra of endo and exo mixture with those of endo isomer 313a. 
1H (600 MHz, DMSO-d6):  10.85 (>NH, 1H), 6.48 (s, CH=CH, 2H), 4.94 
(broad, CH2OH, 2H), 3.80 (broad d, Jgem = 11.06 Hz and 3JCH-OH = peaks are not 
resolved well, CH2OH, 2H), 3.71 (broad d, Jgem = 11.06 Hz and 3JCH-OH = peaks are 
not resolved well, CH2OH, 2H), 2.94 (s, endo 2H). 
13C (150 MHz, DMSO-d6):  176.21 (CONH), 138.04 (CH=CH), 91.36 
(CO(CH2OH)), 59.06 (CH2OH), 51.76 (CH(CO)). 










6.4.6 Diels-Alder reaction of 2,5-BHMF 305 and DEADC 314
2,5-BHMF 305 (1.1 g, 7.8 mmol, 1 eq.) and DEADC 314 (1.67 g, 9.8 mmol, 1.3 
eq.) in anhydrous 1,4-dioxane (15 mL) were refluxed for 8 h. Dioxane was removed and 
the residue was dissolved in dichloromethane and washed with water. The organic layer 
was dried with anhydrous MgSO4 and filtered. The filtrate was concentrated and 
separated by the column chromatography using 6:1 ethyl acetate/hexane over silica gel 
afforded 316 in 72.1% (1.68 g) yield. 
6.4.6.1 Diethyl 1,4-bis(hydroxymethyl)-7-oxa-bicyclo[2.2.1]hepta-2,5-diene-2,3-
dicarboxylate 316
Rf = 0.49 (ethyl acetate:hexane = 6:1); brown oil 
1H (600 MHz, DMSO-d6):  7.09 (s, CH=CH, 2H), 5.15 (t, 3JCH-OH = 5.47 Hz, 
CH2OH, 2H), 4.15 (m, CO2CH2CH3, 4H), 4.07 (dd, Jgem = 12.5 Hz and 3JCH-OH = 5.67 
Hz, CH2OH, 2H), 4.00 (dd, Jgem = 12.5 Hz and 3JCH-OH = 5.18 Hz, CH2OH, 2H), 1.20 
(t, J = 7.10 Hz, CO2CH2CH3, 6H). 
13C (150 MHz, DMSO-d6): 163.38 (COCH2CH3), 152.67 (=CCOC2H5), 144.47 
(CH=CH), 96.99 (CO(CH2OH)), 60.69 (CH2OH), 58.11 (OCH2CH3), 13.80 
(OCH2CH3). 
IR (neat, cm-1): 3447, 2983, 2939, 2907, 2875, 1707, 1701, 1632. 1446, 1369, 
1306, 1242, 1095, 1022, 854, 793, 715. 
HRMS (ESI, [M+Na]+): calcd for C14H18NO7Na: 321.0950; found: 321.0958. 
6.4.7 Diels-Alder reaction of 2,5-BHMF 305 and DMADC 315 
A solution of 2,5-BHMF 305 (4.1 g, 32 mmol, 1 eq.) and DMADC 315 (6.84 g, 
48.1 mmol, 1.5 eq.) in anhydrous 1,4-dioxane (25 mL) was refluxed for 5 h. Dioxane was 













   
Dichloromethane layer was dried over MgSO4. MgSO4 was filtered and dichloromethane 
was removed by rotary evaporation. Column chromatography using 3:1 ethyl 




1H (300 MHz, acetone-d6):  6.98 (s, CH=CH, 2H), 4.07 (q, J = 13.32 Hz, 
CH2OH, 4H), 3.62 (t, CO2CH3, 6H). 
IR(neat, cm-1): 3428, 2980, 2935, 1711, 1700, 1639, 1450, 1310, 1240, 1090, 790. 
6.4.8 Diels-Alder reaction of furfural alcohol 327 and N-phenylmaleimide 310 
Furfural alcohol 327 (1.13 g, 11.5 mmol, 1 eq.) was added into a solution of N-
phenylmaleimide 310 (2.21 g, 12.4 mmol, 1.1 eq.) in CH3CN (20 mL). This solution was 
refluxed for 15 h under N2. The reaction solution was cooled to room temperature. White 
crystals formed. CH3CN was removed by rotary evaporation and diethyl ether was added 
into the residue. A white solid formed was filtered, rinsed thoroughly with diethyl ether 
and dried in vacuum. The exo-adduct of 328 was isolated in 76.3% yield (2.38 g). 
6.4.8.1 Exo-3a,4,7,7a-tetrahydro-4-(hydroxymethyl)-2-phenyl-4,7-epoxy-1H-
isoindole-1,3(2H)-dione 328
Rf = 0.73 (acetone/hexane = 5:2); mp = 156-157 C (lit. 156 C)29
1Hexo (300 MHz, DMSO-d6):  7.52-7.39 (m, C6H5 meta and para, 2H), 7.20 (d, J
= 8.50 Hz, C6H5 ortho, 2H), 6.58 (s, CH=CH, 2H), 5.20 (s, OCH(C=), 2H), 5.07 (t, 








1H), 3.79 (dd, Jgem = 12.5 Hz and 3JCH-OH  = 6.1 Hz, CH2OH, 1H), 3.21 (d, J = 6.5 Hz, e 
CH(CO)C(CH2OH), 1H), 3.03 (d, J = 6.5 Hz, CH(CO)CH, 1H). 
IR (neat, cm-1): 3498, 3014, 2956, 2915, 2872, 1772, 1695, 1594, 1497, 1391, 
1283, 1209, 1075, 1041, 997, 976, 880, 845, 762, 716, 687, 648. 
6.4.9 Diels-Alder reaction of 2-methylfuran 329 and N-phenylmaleimide 310 
2-Methylfuran 329 (2.27 g, 27.7 mmol, 1.3 eq.) was added into N-phenyl-
maleimide (3.84 g, 21.7 mmol, 1 eq.) in CH3CN (20 mL). This solution was refluxed for 
15 h. The reaction solution was concentrated by removing CH3CN. Diethyl ether was 
added into the residue. A white solid formed. This  solid was filtered, rinsed thoroughly 
with diethyl ether and dried in vacuum. The exo-adduct of 330 was isolated in 80.7% 
(4.47 g). 
6.4.9.1 Exo-1-methyl-4-phenyl-10-oxa-4-azatricyclo[5.2.1.0 2,6]dec-8-ene-3,5-dione 
330 
Rf = 0.66 (ethyl acetate/hexane = 1:1); mp = 140-141 C (lit. 144-146 C)35
1H NMR (300 MHz, DMSO-d6): 7.53-7.42 (m, meta and para C6H5, 3H), 7,21 (d, 
J = 8.10 Hz, ortho C6H5, 2H), 6.60 (d, J = 5.39 Hz, CH=CHCOH, 1H), 6.45 (d, J = 
5.56 Hz, CH=CHCO(CH3), 1H), 5.14 (s, CH=CHCOH, 1H), 3.21 (d, J = 6.44 Hz, 
CH(CO)CH, 1H), 2.93 (d, J = 6.44 Hz, CH(CO)C(CH3), 1H), 1.63 (s, 
CH(CO)C(CH3), 3H). 
IR (neat, cm-1): 3087, 2995, 2936, 1772, 1700, 1494, 1389, 1199, 1159, 1097, 











6.4.10 Attempted ROMP of exo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-
3a,4,7,7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312b with Grubbs’ 
1st generation catalyst 320 in (CH2Cl)2 
Exo monomer, 312b (210 mg, 0.70 mmol, 100 eq.), was added into a 1,2-
dichloroethane (1 mL) and stirred for 10 min. Grubbs 1st generation catalyst 320 (5.8 mg, 
7.05 mol, 1 eq.) in 1,2-dichloroethane (1 mL) was added into the suspension of 312b 
solution. This solution was heated overnight at 60 C. The undissolved solid of the 
starting diol 312b was observed. Excess ethyl vinyl ether was added into the solution to
terminate the reaction and the solid was filtered off and dried in vacuum. Unreacted 312b 
was recovered in 68.1% (143 mg). The filtrate (2.5 mL) was added into methanol (50 
mL) and no precipitation of a polymer occurred. Then methanol was removed and residue 
was redissolved in 1,2-dichloroethane (2 mL). This solution was added into n-pentane (50 
mL). A precipitate was not observed. Further analysis of the filtrate was not carried out.
6.4.11 Attempted ROMP of endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-
3a,4,7,7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312a with Grubbs’ 
1st generation catalyst 320 in DMF 
Endo monomer, 312a (122 mg, 0.40 mmol, 100 eq.), was dissolved in dry DMF 
(1 mL). Grubbs 1st generation catalyst 320 (3.3 mg, 4.0 mol, 1 eq.) in DMF (1 mL) was 
added into this solution. The concentration of the monomer was 0.2 M. This solution was 
heated at 60 C for 1 day. Excess ethyl vinyl ether was added into the solution to 
terminate the reaction. This solution (3 mL) was poured into a vigorously stirring n-
pentane (100 mL). A precipitate formed. This precipitate was identified as the monomer 
312a by TLC and confirmed by the 1H NMR. Any other spot was not observed on the 
TLC other than a spot on the baseline. The weight of the recovered monomer 312a was 








6.4.12 Attempted ROMP of endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-
3a,4,7,7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312a with Grubbs’ 
2nd generation catalyst 321 in DMF 
Grubbs 2nd generation catalyst 321 (3.4 mg, 4 mol, 1 eq.) in DMF (1 mL) was 
added into a solution of endo monomer 312a (120 mg, 0.40 mmol, 100 eq.) in DMF (1 
mL). This solution was heated at 60 C for one day. The monomer concentration was 0.2 
M. There was no viscosity observed. The reaction was quenched with an excess ethyl 
vinyl ether and poured into n-pentane (100 mL). A white material was precipitated which 
was monomer 312a. This was isolated in 79 mg (65.8%).  
6.4.13 Attempted ROMP of endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-
3a,4,7,7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312a with Grubbs’ 
3rd generation catalyst 322 in DMF 
Endo monomer 312a (118 mg, 0.39 mmol, 1 eq.) was dissolved in DMF (1 mL). 
The monomer 312a was completely soluble in DMF. Grubb’s 3rd generation catalyst 322
(3.5 mg, 3.96 mol, 98 eq.) dissolved in DMF (1 mL) was added in to this solution under 
N2. The concentration of the monomer was 0.2 M. The reaction solution was heated for 3 
days at 60 C and quenched with adding an excess ethyl vinyl ether. DMF was removed 
by vacuum. The resultant black color residue was dissolved in THF (4 mL) and added 
into vigorously stirring n-pentane (100 mL). A white material formed. This was identified 
as the monomer 312a. Monomer 312a (58.5%, 691 mg) was recovered. 
6.4.14 Attempted ROMP of endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-3a,4,7,7a-
tetrahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 313a with Grubbs’ 3rd 
generation catalyst 322 in DMF 
Grubbs 3rd generation catalyst 322 (3.5 mg, 3.96 mol, 1 eq.) in DMF (1 mL) was 
added into a solution of endo monomer 313a (91 mg, 0.4 mmol, 100 eq.) in DMF (1 mL) 








The concentration of the monomer was 0.2 M. The reaction was terminated by adding an 
excess ethyl vinyl ether and poured into n-pentane (100 mL). The solid that precipitated 
was the monomer 313a. This was isolated in mg 63% yield (57 g).  
6.4.15 Attempted ROMP of diethyl 1,4-bis(hydroxymethyl)-7-oxa-bicyclo[2.2.1] hepta-
2,5-diene-2,3-dicarboxylate 316 with Grubbs’ 3rd generation catalyst 322 in 
DMF 
Monomer 316 (295 mg, 0.98 mmol, 52 eq.) was dissolved in 1,2-dichloroethane 
(1 mL). Grubbs’ 3rd generation catalyst 322 (16.5 mg, 18.7 mol, 1 eq.) dissolved in 1,2-
dichloroethane (1 mL) was then added to the solution of 316. The monomer 
concentration was 0.49 M. The reaction solution was stirred at 60 C for 1 day and 
terminated by adding an excess ethyl vinyl ether. The starting material’s spot was 
observed by TLC of this solution and another spot was observed on the base line. A few 
drops were added into methanol (10 mL), and those were completely soluble in methanol. 
Then the rest of the reaction solution (2 mL) was added into n-pentane (100 mL). A 
dark brown oily drops were observed on the bottom. This oily material was identified as 
the monomer 316 by TLC. 
6.4.16 Attempted ROMP of exo-3a,4,7,7a-tetrahydro-4-(hydroxymethyl)-2-phenyl-4,7-
epoxy-1H-isoindole-1,3(2H)-dione 328 with Grubbs’ 3rd generation catalyst 322
in DMF 
Grubbs 3rd generation catalyst 322 (6.6 mg, 0.75 mol, 1 eq.) in DMF (1 mL) was 
added into a solution of endo monomer 326 (202 mg, 0.74 mmol, 100 eq.) in DMF (1 
mL) under N2. The monomer concentration was 0.37 M. This solution was heated at 
60 C for 3 days under N2 and quenched with an excess ethyl vinyl ether. This solution 







precipitated. This material was filtered and dried in vacuum. It was identified as the 
monomer 326 by TLC. The monomer 326 was isolated in 130 mg (64.4%). 
6.4.17 ROMP of exo-1-methyl-4-phenyl-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-ene-
3,5-dione 330 in (CH2Cl)2 
6.4.17.1 Using Grubbs 1st generation catalyst 320 
Grubbs 1st generation catalyst 320 (4.91 mg, 5.95 mol, 1 eq.) in 1,2-
dichloromethane (1 mL) was added into the monomer 330 (150 mg, 0.59 mmol, 101 eq.) 
in 1,2-dichloromethane (1 mL). The monomer concentration was 0.3 M. The reaction 
solution was heated at 60 C for one day under N2. The reaction was terminated by 
adding ethyl vinyl ether and poured into a vigorously stirred MeOH (100 mL). A white 
color solid was precipitated. The polymer was collected and purified by redissolving in 
1,2-dichloromethane and precipitating into methanol. The isolated yield of the polymer 
was 61.3% (92 mg). GPC results Mn = 7491, Mw = 9365, Mz = 11436 and PDI = 1.25; by 
direct comparison with polystyrene standards. 
1H NMR (300 MHz, CDCl3): 7.40-7.20 (m, C6H5, 5H), 6.12-6.02 (broad m, 
CH=CH, 2H), 4.86 (CH(O), 1H), 3.55-3.49 (broad m, 2H), 1.42 (CH3, 3H). 
IR (neat, cm-1): 3066, 2976, 2934, 2873, 1779, 1708, 1597, 1497, 1290, 1178, 
968, 743, 690. 
6.4.17.2 Using Grubbs 2nd generation catalyst 321
Monomer 330 (100 mg, 0.39 mmol, 98 eq.) was dissolved in 1,2-dichloroethane 
(1 mL) and Grubbs’ 2nd generation catalyst 321 (3.4 mg, 4 mol, 1 eq.) in 1,2-
dichloroethane (1 mL) was added. The concentration of the monomer was 0.2 M. This 







terminate the reaction. A polymer was precipitated into methanol (100 mL) and collected 
by suction filtration. The resultant polymer was dissolved in 1,2-dichloroethane and 
precipitate into methanol. The polymer was filtered and dried in vacuum to give 325 in 
68% yield (68 mg). GPC results; Mn = 13293, Mw = 21481, Mz = 30462 and PDI = 1.62. 
6.4.17.3 Using Grubbs 3rd generation catalyst 322
Grubbs 3rd generation catalyst 322 (5.3 mg, 6 mol, 1 eq.) in 1,2-dichloroethane 
(1 mL) was added into a solution of 330 (152 mg, 0.6 mmol, 100 eq.) in 1,2-
dichloroethane (1 mL). The monomer concentration was 0.3 M. The reaction solution 
was stirred at 60 C. After 1 day, excess ethyl vinyl ether was added to quench the 
reaction. A polymer was precipitated into methanol (100 mL) and collected by suction 
filtration. The Polymer was redissolved in 1,2-dichloroethane and precipitated into 
methanol to purify. The polymer was collected to give 72.4% yield (110 mg). GPC 
results; Mn = 13604, Mw = 19689, Mz = 26478 and PDI = 1.45. 
6.4.18 Polycondensation of endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-
3a,4,7,7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312a with succinic 
acid
6.4.18.1 Using DMAP and DCC
Diol 312a (0.10 g, 0.33 mmol, 1 eq.) was added into a stirred solution of succinic 
acid (0.04 g, 0.34 mmol, 1 eq.) and DMAP (0.021 g, 0.17 mmol,  0.5 eq.) in 
dichloromethane (10 mL). The was stirred for a few min. Then DCC (0.091 g, 0.43 
mmol, 1.3 eq.) was added into this and stirred at room temperature overnight. N,N-
Dicyclohexylurea precipitate was removed by filtration. Dichloromethane was removed 








filtered off, dissolved in chloroform (4 mL) and reprecipitated into methanol (75 mL). 
Polymer was filtered and dried in vacuum. Yield 77% (0.098 g). GPC results: Mn = 2568, 
Mw = 3989, Mz = 5420 and PDI = 1.55; by direct comparison with polystyrene standards.   
1H NMR (600 MHz, CDCl3): 7.38 (m, C2H5 meta and para, 3H), 7.09 (broad t, 
C2H5 ortho, 2H), 6.51 (s, CH=CH, 2H), 4.88 (d, CH2O, J = 12.3 Hz, 2H), 4.62 
(broad, CH2O, 2H), 3.68 (s, exo, 2H), 2.76 (COCH2CH2CO, 4H). 
IR (neat, cm-1): 3534, 3080, 2955, 1736, 1705, 1497, 1379, 1177, 1148, 1028, 
999, 895, 760, 729, 694. 
6.4.18.2 Using DPTS and DCC 
Succinic acid (0.392 g, 3.32 mmol, 1 eq.) and DPTS (0.488 g, 1.66 mmol, 0.5 eq.) 
were mixed in dichloromethane (25 mL). Diol 312a (1.01 g, 3.32 mmol, 1 eq.) was added 
into this solution. DCC (1.038 g, 4.98 mmol, 1.5 eq.) was then added into this and stirred 
at room temperature overnight. N,N-Dicyclohexylurea was filtered off. Methanol (10 mL) 
was added into the residue, after evaporation of dichloromethane. The polymer 
precipitated and it was filtered. This polymer was redissolved in chloroform (5 mL) and 
precipitated into methanol (80 mL) again. The precipitated polymer was filtered and 
vacuum dried. Yield 83.3% (1.06 g). GPC results: Mn = 882, Mw = 1156, Mz = 1564 and 
PDI = 1.31; by direct comparison with polystyrene standards. 
6.4.18.3 Using DPTS and DIPC 
Diol 312a (1.01 g, 3.32 mmol, 1 eq.) was added into a stirred solution of succinic 
acid (0.393 g, 3.33 mmol, 1 eq.) and DPTS (0.491 g, 1.67 mmol, 0.5 eq.) in 
dichloromethane (15 mL), and stirred for a few min. Then DIPC (0.636 g, 4.99 mmol, 1.5 







Diisopropylurea was removed by filtration. Methanol was added into the residue, after 
evaporation of dichloromethane. A white color polymer precipitated out. The polymer 
was filtered off, redissolved in chloroform and reprecipitated into methanol. Precipitated 
polymer was filtered and dried in vacuo. Yield 84.9% (1.08 g). GPC results: Mn = 2635, 
Mw = 3575, Mz = 4558 and PDI = 1.36; by direct comparison with polystyrene standards. 
6.4.19 Polycondensation of endo-(3a,4,7,7a)-4,7-bis(hydroxymethyl)-2-phenyl-3a,4,7, 
7a-tetra-hydro-1H-4,7-epoxyisoindole-1,3(2H)-dione 312a with terephthalic acid
6.4.19.1 Using DMAP and DCC
Terephthalic acid (0.075 g, 0.45 mmol, 1 eq.) and DMAP (0.028 g, 0.23 mmol, 
0.5 eq.) were dissolved in dichloromethane (10 mL). Diol 312a (0.135 g, 0.45 mmol, 1 
eq.) was added into this solution and the solution was stirred for few min. Then DCC 
(0.142 g, 0.68 mmol, 1.5 eq.) was added and stirred at room temperature overnight. N,N-
Dicyclohexylurea was removed by filtration. Dichloromethane was removed and 
methanol (10 mL) was added into the residue. A polymer was precipitated. The polymer 
was purified by redissolving in chloroform (5 mL), followed by reprecipitating into 
methanol (80 mL). Precipitated polymer was filtered and vacuum dried. Yield 61.3 % 
(0.119 g). GPC results: Mn = 11537, Mw = 12082, Mz = 12784 and PDI = 1.05; by direct 
comparison with polystyrene standards. 
1H NMR (600 MHz, CDCl3): 8.03 (m, C2H5 in the terephthalic acid, 4H), 7.48 
(m, C2H5, 3H), 7.13 (broad s, C2H5 ortho, 2H), 6.66 (s, CH=CH, 2H), 5.12 (broad s, 
CH2O, 2H), 4.93 (broad s, CH2O, 2H), 3.80 (s, exo 2H). 
IR (neat, cm-1): 3540 (broad), 3079, 2961, 1708, 1705, 1407, 1379, 1264, 1180, 










6.4.19.2 Using DPTS and DCC 
Diol 312a (0.157 g, 0.52 mmol, 1 eq.) was added into a stirred solution of 
terephthalic acid (0.087 g, 0.52 mmol, 1 eq.) and DPTS (0.077 g, 0.26 mmol,  0.5 eq.) in 
dichloromethane (10 mL). This solution was stirred for a few min. Then DCC (0.163 g, 
0.78 mmol, 1.5 eq.) was added and stirred at room temperature overnight. N,N-
Dicyclohexylurea precipitate was removed by filtration. Methanol (10 mL) was added 
into the residue, after evaporation of dichloromethane. The resultant polymer was 
filtered, dissolved in chloroform (5 mL) and reprecipitated into methanol (80 mL). The 
polymer was filtered and dried in vacuo. Yield 68.7% (0.154 g). GPC results: Mn = 
10247, Mw = 10370, Mz = 10509 and PDI = 1.01; by direct comparison with polystyrene 
standards.  
6.4.19.3 Using DPTS and DIPC 
Diol 312a (0.501 g, 1.66 mmol, 1 eq.), terephthalic acid (0.276 g, 1.66 mmol, 1 
eq.), DPTS (0.244 g, 0.83 mmol, 0.5 eq.) and DIPC (0.318 g, 2.49 mmol, 1.5 eq.) in 
dichloromethane (15 mL) were stirred at room temperature overnight. N,N-
Diisopropylurea was filtered off. Dichloromethane was removed by evaporation and 
methanol (10 mL) was added into the residue. The precipitated polymer was filtered off,
redissolved in chloroform (5 mL) and reprecipitated into methanol (80 mL). Resultant
Polymer was filtered and vacuum dried. Yield 74% (0.53 g). GPC results: Mn = 2434, Mw 
= 3500, Mz = 4676 and PDI = 1.44; by direct comparison with polystyrene standards. 
6.4.20 Polycondensation of 1,4-bis(hydroxymethyl)-7-oxa-bicyclo[2.2.1]hepta-2,5-
diene-2,3-dicarboxylate 316 with succinic acid
Succinic acid (0.065 g, 0.55 mmol, 1 eq.) and DPTS (0.081 g, 0.28 mmol, 0.51 







bicyclo [2.2.1]hepta-2,5-diene-2,3-dicarboxylate 316 (0.165 g, 0.55, 1 eq.) dissolved in 
dichloromethane (3 mL) was then added, followed by DIPC (0.106 g, 0.83 mmol, 1.51 
eq.). This solution was stirred overnight at room temperature. N,N-Diisopropylurea was 
removed by  filtration. Dichloromethane was evaporated and methanol (10 mL) was 
added into the residue. Residue was soluble in methanol and there were no precipitation 
of a polymer. Then methanol was evaporated. The resultant residue was redissolved in 
chloroform (5 mL) and slowly added into a stirred solution of n-pentane (100 mL). The 
solution became milky. A brown colored viscous material stuck to the bottom of the 
flask. The solution was decanted, the sticky material was dissolved in chloroform and 
transferred into a round bottom flask. Chloroform was removed by rotary evaporation 
and vacuum dried (57.9 %; 0.121 g). This material was analyzed by GPC without further 
purification. GPC results: Mn = 9701, Mw = 9730, Mz = 9761 and PDI = 1.00; by direct 
comparison with polystyrene standards. 
1H NMR (300 MHz, CDCl3): 7.38 (m, C2H5 meta and para, 3H), 7.09 (broad t, 
C2H5 ortho, 2H), 6.51 (s, CH=CH, 2H), 4.83 (broad, CH2O, 4H), 4.25 (broad, 
OCH3, 4H), 2.66 (broad s, COCH2CH2CO, 4H), 1.31 (broad m, CH3, 4H). 
IR (neat, cm-1): 2968, 2934, 1736, 1709, 1645, 1601, 1445, 1369, 1245, 1267, 
1150, 996, 805. 
6.4.21 ROMP of polyester using Grubbs’ 3rd generation catalyst 322
Polyester 334 (251 mg, 0.66 mmol, 100 eq.), which having Mn = 1156 and Mw = 
882, was dissolved in 1,2-dichloroethane (2 mL). Grubbs’ 3rd generation catalyst 322 (5.8 
mg, 6.56 mol, 1 eq.) in 1,2-dichloroethane (1 mL) was added under N2 into the 




was added. Solution (3 mL) was added into vigorously stirring n-pentane solution (100 
mL). A brown color solid precipitated. Precipitate was collected and dried in vacuum. A 
brown color solid (17.1 mg, 6.8%) was isolated. GPC results: Mn  = 10302, Mw = 10964, 


























1. Rosatella, A. A.; Simeonov, S. P.; Frade, R. F. M. Afonso, C. A. M. Green Chem.
2011, 13, 754. 
2. Moreau, C.; Belgacem, M. N. Gandini, A. Tpoics in Catalysis, 2004, 27, 11. 
3. Zakrzewska, M. E.; Bogel-Lukasik, E.; Bogel-Lukasik, R. Chem. Rev. 2011, 111, 
397, and references there in. 
4. Hu, S.; Zhang, Z.; Song, J.; Zhou, X.; Han, B. Green Chem. 2009, 11, 1746. 
5. Chheda, J. N.; Roman-Leshkov, Y.; Dumesic, J. A. Green Chem. 2007, 9, 342. 
6. Chan, J. Y. G.; Zhang, Y. ChemSusChem 2009, 2, 731. 
7. Qi, X.; Watanabe, M.; Aida, T. M.; Smith, R. L., Jr. ChemSusChem. 2009, 2, 944. 
8. Hu, S.; Zhang, Z.; Zhou, Y.; Han, B.; Fan, H.; Li, W.; Song, J.; Xie, Y. Green 
Chem. 2008, 10, 1280. 
9. Tong, X.; Li, Y. ChemSusChem 2010, 3, 350. 
10. Roman-Leshkov, Y.; Chheda, J. N. Dumesic. Science, 2006, 312, 1933. 
11. Haworth, W. N.; Jones, W. G. M. J. Chem. Soc. 1944, 667. 
12. Zhao, H.; Holladay, J. E.; Brown, H.; Zhang, Z. C. Science. 2007, 316, 1597. 
13. Binder, J. B.; Raines, R. T. J. Am. Chem. Soc. 2009, 131, 1979. 
14. Vanoye, L.; Fanselow, M.; Holbrey, J. D.; Atkins, M. P.; Seddona, K. S. Green 
Chem. 2009, 11, 390. 
15. Gandini, A.; Belgacem, M. N. Prog. Poly. Sci. 1997, 22, 1203. 
16. Roman-Leshkov, Y.; Barrett, C. J.; Liu, Z. Y.; Dumesic, J. A. Nature. 2007, 447, 
982. 
17. Seri, K.; Inoue, Y.; Ishida, H. Bull. Chem. Soc. Jpn. 2001, 74, 1145. 
18. Asghari, F. S.; Yoshida, H.; Ind. Eng. Chem. Res. 2006, 45, 2163. 
19. Bielawski, C. W.; Grubbs, R. H. Prog. Polym. Sci. 2007, 32, 1, and references 
therein



















    
  
  
21. Sinner, F.; Buchmeiser, M. R. Macromolecules. 2000, 33, 5777. 
22. Choi, T.; Grubbs, R. H. Angew. Chem. Int. Ed. 2003, 42, 1743. 
23. Lee, B. S.; Mahajan, S.; Clapham, B.; Janda, K. D. J. Org. Chem. 2004, 69, 3319. 
24. Delaude, L.; Demonceau, A.; Noels, A. F. Macromolecules, 1999, 32, 2091. 
25. Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18. 
26. Schrodi, Y.; Pederson, R. AldrichimicaACTA. 2007, 40, 45. 
27. Cottier, L.; Descotes, G.; Soro, Y. Synth. Commun. 2003, 33, 4285. 
28. Ravikumar, V. T.; Kumar, R. K.; Olsen, P.; Moore, M. N. Carty., R. L. Andrade, 
M. Groman, D.; Zhu, X.; Cedillo, I.; Wang, Z.; Mendez, L.; Scozzari, A. N.; 
Aguirre, G.; somanathan, R.; Bernees, S. Organic process Rearch & 
Development. 2008, 12, 399. 
29. Jegat, C.; Mignard, N. Polymer Bulletin. 2008, 60, 799. 
30. Lu, Z.; Weber, R. Twieg, R. J. Tetrahedron Lett. 2006, 47, 7213. 
31. Wong, H. N. C.; Xing, Y. D.; Zhou, Y. F.; Gong, Q. Q.; Zhang, C. Synth. 
Commun. 1984, 9, 787. 
32. Andreu, C.; Villarroya, J.; Garcia-Ganstaldi, A.; Medio-Simon, M.; Tetrahedron: 
Asymmetry, 1998, 9, 3105. 
33. Bielawski, C. W. Grubbs, R. H. Macromolecules. 2001, 34, 8838. 
34. Ren, L.; Zhang, J.; Bai, X.; Hardy, C. G.; Shimizu, K. D.; Tang, C. Chem. Sci., 
2012, 3, 580. 
35. a) Jarosz, S.; Mach, M.; Szewczyk, K.; Skóra, S.; Ciunik, C. Eur. J. Org. Chem.
2001, 2001, 2955. b) Gousse, C.; Gandini, A.; Hodge, P. Macromolecules. 1998, 
31, 314. 
36. Vanhaecht, B.; Teerenstar, M. N. Suwier, D. R. Koning, C. E. J. Moacromol. Sci.
Part A. 2000, 36, 633. 
37. Hawker, C. J.; Frechet, J. M. J. J. Am. Chem. Soc., 1992, 114, 8405.
38. Hawker, C. J.; Frechet, J. M. J. J. Chem. Soc. Perkin Trans, 1, 1992, 2459.









40. Young, R. J.; Lovell, P. A. Characterization: Introduction to polymers; Chapman 
& Hall; London, 1991; pp 138-236. 
41. Yu, M.; Wang, C.; Kyle, A. F.; Jakubec, P.; Dixon, D. J. Schrock, R. R.; 
Hoveyda, A. H. Nature, 2011, 479, 88. 
42. Timko, J. M.; Moore, S. S.; Walba, D. M.; Hiberty, P. C. Cram, D. J. J. Am. 




CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTHS AND BOND 
ANGLES FOR  THE CRYSTAL STRUCTURE OF 213 
385 
  
 Table A.1  Crystal data and structure refinement for the crystal structure of 213
Empirical formula C16H11NO4S 
Formula weight 313.32 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
 Space group Cc 
Unit cell dimensions a = 9.825(9) Å a= 90°. 
b = 24.46(2) Å b= 123.934(8)°. 
c = 6.970(6) Å g = 90°. 
Volume  1390(2) Å3 
Z 4 
Density (calculated)  1.498 Mg/m3 
-1 Absorption coefficient 0.251 mm  
F(000) 648 
Crystal size  0.18 x 0.16 x 0.07 mm3 
Theta range for data collection 1.67 to 28.67°. 
Index ranges -12<=h<=12, -31<=k<=31, -9<=l<=9 
Reflections collected 7739 
Independent reflections 3170 [R(int) = 0.0309] 
Completeness to theta = 28.67° 91.80% 
 Absorption correction  Semi-empirical from equivalents
Max. and min. transmission 0.9826 and 0.9562 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3170 / 2 / 200 
Goodness-of-fit on F2 1.103 
Final R indices [I>2sigma(I)] R1 = 0.0294, wR2 = 0.0614 
R indices (all data) R1 = 0.0377, wR2 = 0.0679 
Absolute structure parameter -0.03(6) 








Table A.2 Bond lengths [Å] for the crystal structure 213 
Atoms Lengths Atoms Lengths 
S(1)-C(7) 1.727(2) C(6)-C(7) 1.386(3) 
S(1)-C(1) 1.737(2) C(6)-C(8) 1.471(3) 
O(1)-C(3) 1.227(2) C(8)-C(9) 1.494(3) 
N(1)-C(7) 1.369(3) C(9)-C(10) 1.389(3) 
N(1)-C(2) 1.395(3) C(9)-C(14) 1.390(3) 
N(1)-C(3) 1.431(3) C(10)-C(11) 1.389(3) 
C(1)-C(2) 1.330(3) C(10)-H(10) 0.95 
C(1)-H(1) 0.95 C(11)-C(12) 1.381(3) 
O(2)-C(8) 1.226(2) C(11)-H(11) 0.95 
C(2)-H(2) 0.95 C(12)-C(13) 1.387(3) 
O(3)-C(15) 1.203(2) C(12)-H(12) 0.95 
C(3)-C(4) 1.427(3) C(13)-C(14) 1.397(3) 
O(4)-C(15) 1.332(2) C(13)-H(13) 0.95 
O(4)-C(16) 1.449(3) C(14)-H(14) 0.95 
C(4)-C(5) 1.365(3) C(16)-H(16A) 0.98 
C(4)-H(4) 0.95 C(16)-H(16B) 0.98 







Table A.3 Bond angles [°] for the crystal structure 213 
Atoms Angles Atoms Angles 
C(7)-S(1)-C(1) 90.29(12) C(6)-C(8)-C(9) 119.20(16) 
C(7)-N(1)-C(2) 114.16(17) C(10)-C(9)-C(14) 120.77(18) 
C(7)-N(1)-C(3) 124.19(16) C(10)-C(9)-C(8) 119.90(17) 
C(2)-N(1)-C(3) 121.65(17) C(14)-C(9)-C(8) 119.19(18) 
C(2)-C(1)-S(1) 112.92(17) C(11)-C(10)-C(9) 119.32(18) 
C(2)-C(1)-H(1) 123.5 C(11)-C(10)-H(10) 120.3 
S(1)-C(1)-H(1) 123.5 C(9)-C(10)-H(10) 120.3 
C(1)-C(2)-N(1) 112.1(2) C(12)-C(11)-C(10) 120.47(18) 
C(1)-C(2)-H(2) 123.9 C(12)-C(11)-H(11) 119.8 
N(1)-C(2)-H(2) 123.9 C(10)-C(11)-H(11) 119.8 
O(1)-C(3)-C(4) 127.94(18) C(11)-C(12)-C(13) 120.18(18) 
O(1)-C(3)-N(1) 119.15(17) C(11)-C(12)-H(12) 119.9 
C(4)-C(3)-N(1) 112.91(18) C(13)-C(12)-H(12) 119.9 
C(15)-O(4)-C(16) 115.33(14) C(12)-C(13)-C(14) 120.04(19) 
C(5)-C(4)-C(3) 122.48(17) C(12)-C(13)-H(13) 120 
C(5)-C(4)-H(4) 118.8 C(14)-C(13)-H(13) 120 
C(3)-C(4)-H(4) 118.8 C(9)-C(14)-C(13) 119.2(2) 
C(4)-C(5)-C(6) 122.92(18) C(9)-C(14)-H(14) 120.4 
C(4)-C(5)-C(15) 116.55(15) C(13)-C(14)-H(14) 120.4 
C(6)-C(5)-C(15) 120.45(16) O(3)-C(15)-O(4) 125.20(18) 
C(7)-C(6)-C(5) 115.19(17) O(3)-C(15)-C(5) 123.44(17) 
C(7)-C(6)-C(8) 117.33(16) O(4)-C(15)-C(5) 111.34(15) 
C(5)-C(6)-C(8) 127.27(16) O(4)-C(16)-H(16A) 109.5 
N(1)-C(7)-C(6) 121.84(16) O(4)-C(16)-H(16B) 109.5 
N(1)-C(7)-S(1) 110.37(14) H(16A)-C(16)-H(16B) 109.5 
C(6)-C(7)-S(1) 127.73(16) O(4)-C(16)-H(16C) 109.5 
O(2)-C(8)-C(6) 120.24(17) H(16A)-C(16)-H(16C) 109.5 
O(2)-C(8)-C(9) 120.24(17) H(16B)-C(16)-H(16C) 109.5 
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Completeness to theta = 28.56° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 8.9145(17) Å a= 117.232(2)°. 
b = 9.6258(19) Å b= 92.157(2)°. 
c = 10.346(2) Å g = 98.263(2)°. 
 775.8(3) Å3 
2 
 1.393 Mg/m3 
-1 0.103 mm  
340 
 0.12 x 0.12 x 0.10 mm3 
2.23 to 28.56°. 
-11<=h<=11, -12<=k<=12, -13<=l<=13 
9619 
3625 [R(int) = 0.0282] 
92.10% 
 Semi-empirical from equivalents
0.9898 and 0.9878 
Full-matrix least-squares on F2 
3625 / 0 / 220 
1.033 
R1 = 0.0387, wR2 = 0.0852 
R1 = 0.0584, wR2 = 0.0935 







Table B.2 Bond lengths [Å] for the crystal structure of 216 
Bond Length Bond Length 
O(1)-C(7) 1.3425(16) C(9)-C(14) 1.3943(19) 
O(1)-C(1) 1.4046(15) C(9)-C(10) 1.4012(19) 
N(1)-C(7) 1.3646(17) C(10)-C(11) 1.386(2) 
N(1)-C(3) 1.4212(17) C(10)-H(10) 0.95 
N(1)-C(2) 1.4266(17) C(11)-C(12) 1.393(2) 
C(1)-C(2) 1.3303(19) C(11)-H(11) 0.95 
C(1)-C(17) 1.4797(19) C(12)-C(13) 1.387(2) 
O(2)-C(3) 1.2327(16) C(12)-H(12) 0.95 
C(2)-C(18) 1.4901(19) C(13)-C(14) 1.3874(19) 
O(3)-C(8) 1.2265(16) C(13)-H(13) 0.95 
C(3)-C(4) 1.4275(19) C(14)-H(14) 0.95 
O(4)-C(15) 1.2058(16) C(16)-H(16A) 0.98 
C(4)-C(5) 1.3661(19) C(16)-H(16B) 0.98 
C(4)-H(4) 0.95 C(16)-H(16C) 0.98 
O(5)-C(15) 1.3397(16) C(17)-H(17A) 0.98 
O(5)-C(16) 1.4550(16) C(17)-H(17B) 0.98 
C(5)-C(6) 1.4244(18) C(17)-H(17C) 0.98 
C(5)-C(15) 1.5044(18) C(18)-H(18A) 0.98 
C(6)-C(7) 1.3836(18) C(18)-H(18B) 0.98 






Table B.3 Bond angles [°] for the crystal structure of 216 
Bond Angle Bond Angle 
C(7)-O(1)-C(1) 107.01(10) C(9)-C(10)-H(10) 120 
C(7)-N(1)-C(3) 123.09(11) C(10)-C(11)-C(12) 120.02(13) 
C(7)-N(1)-C(2) 107.76(11) C(10)-C(11)-H(11) 120 
C(3)-N(1)-C(2) 128.85(11) C(12)-C(11)-H(11) 120 
C(2)-C(1)-O(1) 110.09(11) C(13)-C(12)-C(11) 120.33(13) 
C(2)-C(1)-C(17) 134.33(13) C(13)-C(12)-H(12) 119.8 
O(1)-C(1)-C(17) 115.58(11) C(11)-C(12)-H(12) 119.8 
C(1)-C(2)-N(1) 105.93(11) C(12)-C(13)-C(14) 119.74(13) 
C(1)-C(2)-C(18) 129.50(12) C(12)-C(13)-H(13) 120.1 
N(1)-C(2)-C(18) 124.47(12) C(14)-C(13)-H(13) 120.1 
O(2)-C(3)-N(1) 120.13(12) C(13)-C(14)-C(9) 120.51(13) 
O(2)-C(3)-C(4) 126.89(13) C(13)-C(14)-H(14) 119.7 
N(1)-C(3)-C(4) 112.98(12) C(9)-C(14)-H(14) 119.7 
C(5)-C(4)-C(3) 122.95(13) O(4)-C(15)-O(5) 124.47(12) 
C(5)-C(4)-H(4) 118.5 O(4)-C(15)-C(5) 122.79(12) 
C(3)-C(4)-H(4) 118.5 O(5)-C(15)-C(5) 112.69(11) 
C(15)-O(5)-C(16) 114.42(11) O(5)-C(16)-H(16A) 109.5 
C(4)-C(5)-C(6) 122.94(12) O(5)-C(16)-H(16B) 109.5 
C(4)-C(5)-C(15) 116.48(12) H(16A)-C(16)-H(16B) 109.5 
C(6)-C(5)-C(15) 120.57(12) O(5)-C(16)-H(16C) 109.5 
C(7)-C(6)-C(5) 113.83(12) H(16A)-C(16)-H(16C) 109.5 
C(7)-C(6)-C(8) 123.37(12) H(16B)-C(16)-H(16C) 109.5 
C(5)-C(6)-C(8) 121.80(12) C(1)-C(17)-H(17A) 109.5 
O(1)-C(7)-N(1) 109.08(11) C(1)-C(17)-H(17B) 109.5 
O(1)-C(7)-C(6) 126.65(12) H(17A)-C(17)-H(17B) 109.5 
N(1)-C(7)-C(6) 124.13(12) C(1)-C(17)-H(17C) 109.5 
O(3)-C(8)-C(6) 119.47(12) H(17A)-C(17)-H(17C) 109.5 
O(3)-C(8)-C(9) 120.76(12) H(17B)-C(17)-H(17C) 109.5 
C(6)-C(8)-C(9) 119.73(11) C(2)-C(18)-H(18A) 109.5 
C(14)-C(9)-C(10) 119.40(12) C(2)-C(18)-H(18B) 109.5 
C(14)-C(9)-C(8) 121.24(12) H(18A)-C(18)-H(18B) 109.5 
C(10)-C(9)-C(8) 119.19(12) C(2)-C(18)-H(18C) 109.5 
C(11)-C(10)-C(9) 119.99(13) H(18A)-C(18)-H(18C) 109.5 
C(11)-C(10)-H(10) 120 H(18B)-C(18)-H(18C) 109.5 
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 Table C.1  Crystal data and structure refinement for the crystal structure of 221
Empirical formula  C20H13NO5 
Formula weight 347.31 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
 Space group P21/n 
Unit cell dimensions a = 7.7120(5) Å a= 90°. 
b = 21.3499(14) Å b= 102.9940(10)°. 
c = 9.7403(6) Å g = 90°. 
Volume   1562.68(17) Å3 
Z 4 
Density (calculated)  1.476 Mg/m3 
-1 Absorption coefficient 0.108 mm  
F(000) 720 
Crystal size 0.34 x 0.29 x 0.15 mm3 
Theta range for data 
1.91 to 28.57°.




Reflections collected 18868 
Independent reflections 3753 [R(int) = 0.0222] 






Max. and min. transmission 0.9840 and 0.9643 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3753 / 0 / 236 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0352, wR2 = 0.0864 
R indices (all data) R1 = 0.0394, wR2 = 0.0897 







Table C.2 Bond lengths [Å] for the crystal structure of 221 
Atoms Lengths Atoms Lengths 
O(1)-C(7) 1.3610(13) C(8)-C(9) 1.4284(15) 
O(1)-C(6) 1.3928(13) C(8)-C(12) 1.5008(15) 
N(1)-C(7) 1.3706(14) C(9)-C(10) 1.3689(15) 
N(1)-C(5) 1.4133(13) C(9)-C(19) 1.5039(15) 
N(1)-C(11) 1.4144(14) C(10)-C(11) 1.4412(15) 
C(1)-C(6) 1.3776(16) C(10)-H(10) 0.95 
C(1)-C(2) 1.3970(17) C(12)-C(13) 1.4867(15) 
C(1)-H(1) 0.95 C(13)-C(14) 1.3987(16) 
O(2)-C(11) 1.2252(14) C(13)-C(18) 1.3998(15) 
C(2)-C(3) 1.3971(18) C(14)-C(15) 1.3916(16) 
C(2)-H(2) 0.95 C(14)-H(14) 0.95 
O(3)-C(12) 1.2185(14) C(15)-C(16) 1.3932(18) 
C(3)-C(4) 1.3956(16) C(15)-H(15) 0.95 
C(3)-H(3) 0.95 C(16)-C(17) 1.391(2) 
O(4)-C(19) 1.2023(14) C(16)-H(16) 0.95 
C(4)-C(5) 1.3865(15) C(17)-C(18) 1.3863(17) 
C(4)-H(4) 0.95 C(17)-H(17) 0.95 
O(5)-C(19) 1.3435(13) C(18)-H(18) 0.95 
O(5)-C(20) 1.4593(13) C(20)-H(20A) 0.98 
C(5)-C(6) 1.3840(16) C(20)-H(20B) 0.98 
C(7)-C(8) 1.3600(15) C(20)-H(20C) 0.98 
395 
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Completeness to theta = 28.53° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 






a = 11.4291(7) Å a= 90°. 
b = 9.6320(6) Å b= 104.9580(10)°. 
c = 16.5114(11) Å g = 90°. 
  1756.07(19) Å3 
4 
 1.352 Mg/m3 
-1 0.101 mm  
752 
0.34 x 0.31 x 0.10 mm3  
1.95 to 28.53°. 
-15<=h<=14, -12<=k<=12, -22<=l<=21 
20933 




0.9899 and 0.9899 
Full-matrix least-squares on 
F2  
4214 / 0 / 239 
1.04 
R1 = 0.0349, wR2 = 0.0859 
R1 = 0.0446, wR2 = 0.0920 







Table D.2 Bond lengths [Å] for the crystal structure 212 
Bond Length Bond Length 
O(1)-C(2) 1.3350(13) C(7)-C(8) 1.3945(16) 
O(1)-C(1) 1.4478(14) C(7)-C(12) 1.3964(16) 
N(1)-C(15) 1.3084(14) C(8)-C(9) 1.3891(17) 
N(1)-C(17) 1.3937(14) C(8)-H(8) 0.95 
C(1)-H(1A) 0.98 C(9)-C(10) 1.3873(19) 
C(1)-H(1B) 0.98 C(9)-H(9) 0.95 
C(1)-H(1C) 0.98 C(10)-C(11) 1.386(2) 
O(2)-C(2) 1.2032(14) C(10)-H(10) 0.95 
C(2)-C(3) 1.5126(15) C(11)-C(12) 1.3850(18) 
O(3)-C(6) 1.2152(13) C(11)-H(11) 0.95 
C(3)-C(4) 1.5068(15) C(12)-H(12) 0.95 
C(3)-H(3A) 0.99 C(14)-H(14A) 0.98 
C(3)-H(3B) 0.99 C(14)-H(14B) 0.98 
O(4)-C(13) 1.2088(14) C(14)-H(14C) 0.98 
C(4)-C(5) 1.3501(15) C(16)-C(17) 1.3534(16) 
C(4)-C(13) 1.4928(15) C(16)-C(19) 1.4803(16) 
O(5)-C(13) 1.3379(13) C(17)-C(18) 1.4926(16) 
O(5)-C(14) 1.4509(14) C(18)-H(18A) 0.98 
C(5)-C(15) 1.4514(15) C(18)-H(18B) 0.98 
C(5)-C(6) 1.5286(14) C(18)-H(18C) 0.98 
O(6)-C(15) 1.3552(13) C(19)-H(19A) 0.98 
O(6)-C(16) 1.3818(13) C(19)-H(19B) 0.98 






Table D.3 Bond angles [°] for the crystal structure of 212
Atoms Angles Atoms Angles 
C(2)-O(1)-C(1) 115.68(9) C(12)-C(7)-C(6) 118.97(10) 
C(15)-N(1)-C(17) 104.80(9) C(9)-C(8)-C(7) 120.20(11) 
O(1)-C(1)-H(1A) 109.5 C(9)-C(8)-H(8) 119.9 
O(1)-C(1)-H(1B) 109.5 C(7)-C(8)-H(8) 119.9 
H(1A)-C(1)-H(1B) 109.5 C(10)-C(9)-C(8) 119.87(12) 
O(1)-C(1)-H(1C) 109.5 C(10)-C(9)-H(9) 120.1 
H(1A)-C(1)-H(1C) 109.5 C(8)-C(9)-H(9) 120.1 
H(1B)-C(1)-H(1C) 109.5 C(11)-C(10)-C(9) 120.14(12) 
O(2)-C(2)-O(1) 123.87(10) C(11)-C(10)-H(10) 119.9 
O(2)-C(2)-C(3) 125.36(10) C(9)-C(10)-H(10) 119.9 
O(1)-C(2)-C(3) 110.76(9) C(12)-C(11)-C(10) 120.30(12) 
C(4)-C(3)-C(2) 110.81(9) C(12)-C(11)-H(11) 119.9 
C(4)-C(3)-H(3A) 109.5 C(10)-C(11)-H(11) 119.9 
C(2)-C(3)-H(3A) 109.5 C(11)-C(12)-C(7) 119.95(12) 
C(4)-C(3)-H(3B) 109.5 C(11)-C(12)-H(12) 120 
C(2)-C(3)-H(3B) 109.5 C(7)-C(12)-H(12) 120 
H(3A)-C(3)-H(3B) 108.1 O(4)-C(13)-O(5) 123.56(10) 
C(5)-C(4)-C(13) 117.36(10) O(4)-C(13)-C(4) 124.59(10) 
C(5)-C(4)-C(3) 124.33(10) O(5)-C(13)-C(4) 111.85(9) 
C(13)-C(4)-C(3) 118.17(9) O(5)-C(14)-H(14A) 109.5 
C(13)-O(5)-C(14) 115.54(9) O(5)-C(14)-H(14B) 109.5 
C(4)-C(5)-C(15) 125.81(10) H(14A)-C(14)-H(14B) 109.5 
C(4)-C(5)-C(6) 122.97(9) O(5)-C(14)-H(14C) 109.5 
C(15)-C(5)-C(6) 111.16(9) H(14A)-C(14)-H(14C) 109.5 
C(15)-O(6)-C(16) 104.70(8) H(14B)-C(14)-H(14C) 109.5 
O(3)-C(6)-C(7) 123.25(10) N(1)-C(15)-O(6) 113.68(9) 
O(3)-C(6)-C(5) 118.73(10) N(1)-C(15)-C(5) 124.45(10) 
C(7)-C(6)-C(5) 117.87(9) O(6)-C(15)-C(5) 121.84(9) 
C(8)-C(7)-C(12) 119.53(11) C(17)-C(16)-O(6) 107.88(9) 





O(6)-C(16)-C(19) 116.99(10) H(18A)-C(18)-H(18C) 109.5 
C(16)-C(17)-N(1) 108.94(10) H(18B)-C(18)-H(18C) 109.5 
C(16)-C(17)-C(18) 129.67(11) C(16)-C(19)-H(19A) 109.5 
N(1)-C(17)-C(18) 121.38(10) C(16)-C(19)-H(19B) 109.5 
C(17)-C(18)-H(18A) 109.5 H(19A)-C(19)-H(19B) 109.5 
C(17)-C(18)-H(18B) 109.5 C(16)-C(19)-H(19C) 109.5 
H(18A)-C(18)-H(18B) 109.5 H(19A)-C(19)-H(19C) 109.5 
C(17)-C(18)-H(18C) 109.5 H(19B)-C(19)-H(19C) 109.5 





X-RAY CRYSTAL STRUCTURES, CRYSTAL DATA, STRUCTURE 
REFINEMENT, BOND LENGTH AND BOND ANGLES  







Figure E.1 X-ray crystal structures of two independent molecules of 218 
403 
  


















Completeness to theta = 28.52° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 8.8520(9) Å 
b = 18.193(2) Å 
c = 18.818(2) Å 
  2768.1(5) Å3 
4 
 1.338 Mg/m3 
-1 0.104 mm  
1176 
 0.34 x 0.32 x 0.08 mm3 




12851 [R(int) = 0.0325] 
91.50% 
Semi-empirical from equivalents 
0.9917 and 0.9656 
Full-matrix least-squares on F2 
12851 / 0 / 737 
1.04 
R1 = 0.0483, wR2 = 0.1135 
R1 = 0.0711, wR2 = 0.1257 
 0.820 and -0.384 e.Å-3 
a= 113.8890(10)°. 
b= 91.0220(10)°. 








Table E.2 Bond lengths [Å] for the crystal structure of 218. 
Atom Length Atom Length 
O(1)-C(8) 1.358(2) O(10)-C(21) 1.451(2) 
O(1)-C(1) 1.408(2) C(10)-C(11) 1.393(3) 
N(1)-C(8) 1.347(2) C(10)-C(15) 1.397(2) 
N(1)-C(2) 1.413(2) O(11)-C(33) 1.357(2) 
N(1)-C(3) 1.447(2) O(11)-C(26) 1.410(2) 
C(1)-C(2) 1.328(3) C(11)-C(12) 1.387(3) 
C(1)-C(24) 1.481(2) C(11)-H(11) 0.95 
O(2)-C(9) 1.223(2) O(12)-C(34) 1.223(2) 
N(2)-C(33) 1.344(2) C(12)-C(13) 1.384(3) 
N(2)-C(27) 1.415(2) C(12)-H(12) 0.95 
N(2)-C(28) 1.447(2) O(13)-C(41) 1.207(2) 
C(2)-C(25) 1.483(2) C(13)-C(14) 1.386(3) 
O(3)-C(16) 1.207(2) C(13)-H(13) 0.95 
C(3)-C(20) 1.526(2) O(14)-C(41) 1.331(2) 
C(3)-C(4) 1.542(2) O(14)-C(42) 1.447(2) 
C(3)-H(3) 1 C(14)-C(15) 1.391(3) 
O(4)-C(16) 1.331(2) C(14)-H(14) 0.95 
O(4)-C(17) 1.449(2) O(15)-C(43) 1.215(2) 
C(4)-C(5) 1.501(2) C(15)-H(15) 0.95 
C(4)-C(22) 1.525(2) O(16)-C(43) 1.345(2) 
C(4)-H(4) 1 O(16)-C(44) 1.447(2) 
O(5)-C(18) 1.213(2) O(17)-C(45) 1.202(2) 
C(5)-C(6) 1.365(2) C(17)-H(17A) 0.98 
C(5)-C(18) 1.475(2) C(17)-H(17B) 0.98 
O(6)-C(18) 1.346(2) C(17)-H(17C) 0.98 
O(6)-C(19) 1.445(2) O(18)-C(45) 1.326(2) 
C(6)-C(7) 1.443(2) O(18)-C(46) 1.460(2) 
C(6)-C(16) 1.510(2) O(19)-C(47) 1.200(2) 
O(7)-C(22) 1.204(2) C(19)-H(19A) 0.98 
C(7)-C(8) 1.386(2) C(19)-H(19B) 0.98 
C(7)-C(9) 1.500(2) C(19)-H(19C) 0.98 
O(8)-C(22) 1.329(2) O(20)-C(47) 1.328(2) 
O(8)-C(23) 1.458(2) O(20)-C(48) 1.455(2) 
O(9)-C(20) 1.197(2) O(21)-C(52) 1.224(3) 
C(9)-C(10) 1.494(2) C(21)-H(21A) 0.98 
O(10)-C(20) 1.319(2) C(21)-H(21B) 0.98 
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Table E.3 Bond angles [°] for the crystal structure of 218
Atom Angle Atom Angle 
C(8)-O(1)-C(1) 107.93(13) C(6)-C(7)-C(9) 116.08(15) 
C(8)-N(1)-C(2) 109.28(14) C(22)-O(8)-C(23) 116.05(14) 
C(8)-N(1)-C(3) 125.92(14) N(1)-C(8)-O(1) 107.54(14) 
C(2)-N(1)-C(3) 124.81(14) N(1)-C(8)-C(7) 131.91(16) 
C(2)-C(1)-O(1) 108.67(15) O(1)-C(8)-C(7) 120.53(15) 
C(2)-C(1)-C(24) 134.37(17) O(2)-C(9)-C(10) 119.99(15) 
O(1)-C(1)-C(24) 116.93(15) O(2)-C(9)-C(7) 119.56(15) 
C(33)-N(2)-C(27) 109.50(14) C(10)-C(9)-C(7) 120.24(15) 
C(33)-N(2)-C(28) 125.31(14) C(20)-O(10)-C(21) 116.04(15) 
C(27)-N(2)-C(28) 125.18(14) C(11)-C(10)-C(15) 119.18(16) 
C(1)-C(2)-N(1) 106.57(15) C(11)-C(10)-C(9) 119.01(16) 
C(1)-C(2)-C(25) 131.46(16) C(15)-C(10)-C(9) 121.55(16) 
N(1)-C(2)-C(25) 121.89(16) C(33)-O(11)-C(26) 107.92(13) 
N(1)-C(3)-C(20) 109.52(14) C(12)-C(11)-C(10) 120.34(18) 
N(1)-C(3)-C(4) 111.99(13) C(12)-C(11)-H(11) 119.8 
C(20)-C(3)-C(4) 113.73(14) C(10)-C(11)-H(11) 119.8 
N(1)-C(3)-H(3) 107.1 C(13)-C(12)-C(11) 120.08(19) 
C(20)-C(3)-H(3) 107.1 C(13)-C(12)-H(12) 120 
C(4)-C(3)-H(3) 107.1 C(11)-C(12)-H(12) 120 
C(16)-O(4)-C(17) 114.51(14) C(12)-C(13)-C(14) 120.29(18) 
C(5)-C(4)-C(22) 116.76(14) C(12)-C(13)-H(13) 119.9 
C(5)-C(4)-C(3) 112.52(14) C(14)-C(13)-H(13) 119.9 
C(22)-C(4)-C(3) 109.61(14) C(41)-O(14)-C(42) 115.01(14) 
C(5)-C(4)-H(4) 105.7 C(13)-C(14)-C(15) 119.78(19) 
C(22)-C(4)-H(4) 105.7 C(13)-C(14)-H(14) 120.1 
C(3)-C(4)-H(4) 105.7 C(15)-C(14)-H(14) 120.1 
C(6)-C(5)-C(18) 123.79(15) C(14)-C(15)-C(10) 120.31(18) 
C(6)-C(5)-C(4) 122.27(15) C(14)-C(15)-H(15) 119.8 
C(18)-C(5)-C(4) 113.39(14) C(10)-C(15)-H(15) 119.8 
C(18)-O(6)-C(19) 116.06(14) C(43)-O(16)-C(44) 115.10(14) 
C(5)-C(6)-C(7) 128.41(16) O(3)-C(16)-O(4) 124.50(16) 
C(5)-C(6)-C(16) 119.35(15) O(3)-C(16)-C(6) 122.53(15) 
C(7)-C(6)-C(16) 112.10(14) O(4)-C(16)-C(6) 112.94(14) 
C(8)-C(7)-C(6) 125.88(15) O(4)-C(17)-H(17A) 109.5 








Table E.3 (continued) 
H(17A)-C(17)-H(17B) 109.5 H(24A)-C(24)-H(24B) 109.5 
O(4)-C(17)-H(17C) 109.5 C(1)-C(24)-H(24C) 109.5 
H(17A)-C(17)-H(17C) 109.5 H(24A)-C(24)-H(24C) 109.5 
H(17B)-C(17)-H(17C) 109.5 H(24B)-C(24)-H(24C) 109.5 
C(45)-O(18)-C(46) 116.36(14) C(2)-C(25)-H(25A) 109.5 
O(5)-C(18)-O(6) 122.80(16) C(2)-C(25)-H(25B) 109.5 
O(5)-C(18)-C(5) 124.21(16) H(25A)-C(25)-H(25B) 109.5 
O(6)-C(18)-C(5) 112.85(14) C(2)-C(25)-H(25C) 109.5 
O(6)-C(19)-H(19A) 109.5 H(25A)-C(25)-H(25C) 109.5 
O(6)-C(19)-H(19B) 109.5 H(25B)-C(25)-H(25C) 109.5 
H(19A)-C(19)-H(19B) 109.5 C(27)-C(26)-O(11) 108.66(15) 
O(6)-C(19)-H(19C) 109.5 C(27)-C(26)-C(49) 134.68(17) 
H(19A)-C(19)-H(19C) 109.5 O(11)-C(26)-C(49) 116.64(15) 
H(19B)-C(19)-H(19C) 109.5 C(26)-C(27)-N(2) 106.34(15) 
C(47)-O(20)-C(48) 115.50(15) C(26)-C(27)-C(50) 131.65(16) 
O(9)-C(20)-O(10) 124.58(18) N(2)-C(27)-C(50) 121.96(16) 
O(9)-C(20)-C(3) 123.02(17) N(2)-C(28)-C(47) 109.42(14) 
O(10)-C(20)-C(3) 112.35(14) N(2)-C(28)-C(29) 111.07(14) 
O(10)-C(21)-H(21A) 109.5 C(47)-C(28)-C(29) 111.65(14) 
O(10)-C(21)-H(21B) 109.5 N(2)-C(28)-H(28) 108.2 
H(21A)-C(21)-H(21B) 109.5 C(47)-C(28)-H(28) 108.2 
O(10)-C(21)-H(21C) 109.5 C(29)-C(28)-H(28) 108.2 
H(21A)-C(21)-H(21C) 109.5 C(30)-C(29)-C(45) 116.53(14) 
H(21B)-C(21)-H(21C) 109.5 C(30)-C(29)-C(28) 112.45(14) 
O(7)-C(22)-O(8) 124.49(16) C(45)-C(29)-C(28) 109.47(13) 
O(7)-C(22)-C(4) 123.59(15) C(30)-C(29)-H(29) 105.9 
O(8)-C(22)-C(4) 111.82(14) C(45)-C(29)-H(29) 105.9 
O(8)-C(23)-H(23A) 109.5 C(28)-C(29)-H(29) 105.9 
O(8)-C(23)-H(23B) 109.5 C(31)-C(30)-C(43) 124.99(15) 
H(23A)-C(23)-H(23B) 109.5 C(31)-C(30)-C(29) 122.20(15) 
O(8)-C(23)-H(23C) 109.5 C(43)-C(30)-C(29) 112.68(14) 
H(23A)-C(23)-H(23C) 109.5 C(30)-C(31)-C(32) 128.71(15) 
H(23B)-C(23)-H(23C) 109.5 C(30)-C(31)-C(41) 118.70(15) 
C(1)-C(24)-H(24A) 109.5 C(32)-C(31)-C(41) 112.48(14) 
C(1)-C(24)-H(24B) 109.5 C(33)-C(32)-C(31) 125.59(15) 
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Table E.3 (continued) 
 
C(33)-C(32)-C(34) 117.92(15) O(15)-C(43)-O(16) 121.04(16) 
C(31)-C(32)-C(34) 116.46(14) O(15)-C(43)-C(30) 123.25(15) 
N(2)-C(33)-O(11) 107.57(14) O(16)-C(43)-C(30) 115.68(14) 
N(2)-C(33)-C(32) 132.20(16) O(16)-C(44)-H(44A) 109.5 
O(11)-C(33)-C(32) 120.22(15) O(16)-C(44)-H(44C) 109.5 
O(12)-C(34)-C(32) 119.64(16) H(44A)-C(44)-H(44C) 109.5 
O(12)-C(34)-C(35) 119.42(16) O(16)-C(44)-H(44B) 109.5 
C(32)-C(34)-C(35) 120.74(15) H(44A)-C(44)-H(44B) 109.5 
C(40)-C(35)-C(36) 119.11(16) H(44C)-C(44)-H(44B) 109.5 
C(40)-C(35)-C(34) 121.69(16) O(17)-C(45)-O(18) 124.42(17) 
C(36)-C(35)-C(34) 118.84(16) O(17)-C(45)-C(29) 123.09(16) 
C(37)-C(36)-C(35) 120.32(18) O(18)-C(45)-C(29) 112.40(14) 
C(37)-C(36)-H(36) 119.8 O(18)-C(46)-H(46A) 109.5 
C(35)-C(36)-H(36) 119.8 O(18)-C(46)-H(46B) 109.5 
C(36)-C(37)-C(38) 120.23(18) H(46A)-C(46)-H(46B) 109.5 
C(36)-C(37)-H(37) 119.9 O(18)-C(46)-H(46C) 109.5 
C(38)-C(37)-H(37) 119.9 H(46A)-C(46)-H(46C) 109.5 
C(39)-C(38)-C(37) 119.87(17) H(46B)-C(46)-H(46C) 109.5 
C(39)-C(38)-H(38) 120.1 O(19)-C(47)-O(20) 125.56(17) 
C(37)-C(38)-H(38) 120.1 O(19)-C(47)-C(28) 124.06(16) 
C(38)-C(39)-C(40) 120.08(18) O(20)-C(47)-C(28) 110.38(15) 
C(38)-C(39)-H(27) 120 O(20)-C(48)-H(48A) 109.5 
C(40)-C(39)-H(27) 120 O(20)-C(48)-H(48B) 109.5 
C(39)-C(40)-C(35) 120.39(17) H(48A)-C(48)-H(48B) 109.5 
C(39)-C(40)-H(39) 119.8 O(20)-C(48)-H(48C) 109.5 
C(35)-C(40)-H(39) 119.8 H(48A)-C(48)-H(48C) 109.5 
O(13)-C(41)-O(14) 125.13(16) H(48B)-C(48)-H(48C) 109.5 
O(13)-C(41)-C(31) 122.75(15) C(26)-C(49)-H(49B) 109.5 
O(14)-C(41)-C(31) 112.08(14) C(26)-C(49)-H(49A) 109.5 
O(14)-C(42)-H(42A) 109.5 H(49B)-C(49)-H(49A) 109.5 
O(14)-C(42)-H(42B) 109.5 C(26)-C(49)-H(49C) 109.5 
H(42A)-C(42)-H(42B) 109.5 H(49B)-C(49)-H(49C) 109.5 
O(14)-C(42)-H(42C) 109.5 H(49A)-C(49)-H(49C) 109.5 
H(42A)-C(42)-H(42C) 109.5 C(27)-C(50)-H(50A) 109.5 















































































CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTH AND BOND 
ANGLES FOR THE CRYSTAL STRUCTURE OF 238
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Completeness to theta = 
28.41° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 8.4877(8) Å a= 92.8590(10)°. 
b = 9.9860(10) Å b= 94.2390(10)°. 
c = 13.6900(13) Å g = 94.7410(10)°. 
  1151.37(19) Å3 
4 
 1.334 Mg/m3 
-1 0.095 mm  
488 
 0.30 x 0.30 x 0.05 mm3 
2.05 to 28.41°.
 
-11<=h<=11, -13<=k<=13, -17<=l<=18 
14016 
5311 [R(int) = 0.0207] 
91.70%
 
 Semi-empirical from equivalents
0.9952 and 0.9719 
Full-matrix least-squares on F2 
5311 / 0 / 311 
1.039 
R1 = 0.0462, wR2 = 0.1164 
R1 = 0.0588, wR2 = 0.1245 







Table F.2 Bond lengths [Å] for the crystal structure of 238 
Atoms Lengths Atoms Lengths 
O(1)-C(2) 1.2007(19) C(10)-C(11) 1.378(2) 
N(1)-C(5) 1.3567(18) C(10)-H(10) 0.95 
N(1)-C(4) 1.4423(18) C(11)-C(12) 1.391(2) 
N(1)-H(1) 0.88 C(11)-H(11) 0.95 
C(1)-C(2) 1.503(2) C(12)-C(13) 1.391(2) 
C(1)-H(1A) 0.98 C(12)-H(12) 0.95 
C(1)-H(1B) 0.98 C(13)-H(13) 0.95 
C(1)-H(1C) 0.98 C(14)-C(15) 1.491(2) 
O(2)-C(5) 1.2444(17) C(14)-H(14A) 0.98 
N(2)-C(18) 1.3567(18) C(14)-H(14B) 0.98 
N(2)-C(17) 1.4470(18) C(14)-H(14C) 0.98 
N(2)-H(2) 0.88 C(15)-C(17) 1.559(2) 
C(2)-C(4) 1.557(2) C(16)-C(17) 1.515(2) 
O(3)-C(7) 1.3662(16) C(16)-H(16A) 0.98 
O(3)-C(4) 1.4308(17) C(16)-H(16B) 0.98 
C(3)-C(4) 1.5148(19) C(16)-H(16C) 0.98 
C(3)-H(3A) 0.98 C(18)-C(19) 1.463(2) 
C(3)-H(3B) 0.98 C(19)-C(20) 1.342(2) 
C(3)-H(3C) 0.98 C(19)-H(19) 0.95 
O(4)-C(15) 1.2081(19) C(20)-C(21) 1.471(2) 
O(5)-C(18) 1.2401(18) C(21)-C(26) 1.385(2) 
C(5)-C(6) 1.457(2) C(21)-C(22) 1.393(2) 
O(6)-C(20) 1.3756(17) C(22)-C(23) 1.388(2) 
O(6)-C(17) 1.4304(17) C(22)-H(22) 0.95 
C(6)-C(7) 1.350(2) C(23)-C(24) 1.374(3) 
C(6)-H(6) 0.95 C(23)-H(23) 0.95 
C(7)-C(8) 1.473(2) C(24)-C(25) 1.383(3) 
C(8)-C(13) 1.393(2) C(24)-H(24) 0.95 
C(8)-C(9) 1.396(2) C(25)-C(26) 1.381(3) 
C(9)-C(10) 1.390(2) C(25)-H(25) 0.95 







Table F.3 Bond angles [°] for the crystal structure of 238 
Atoms Angles Atoms Angles 
C(5)-N(1)-C(4) 118.48(12) C(6)-C(7)-O(3) 121.37(13) 
C(5)-N(1)-H(1) 120.8 C(6)-C(7)-C(8) 126.51(13) 
C(4)-N(1)-H(1) 120.8 O(3)-C(7)-C(8) 112.09(12) 
C(2)-C(1)-H(1A) 109.5 C(13)-C(8)-C(9) 119.38(13) 
C(2)-C(1)-H(1B) 109.5 C(13)-C(8)-C(7) 119.84(13) 
H(1A)-C(1)-H(1B) 109.5 C(9)-C(8)-C(7) 120.77(13) 
C(2)-C(1)-H(1C) 109.5 C(10)-C(9)-C(8) 120.02(14) 
H(1A)-C(1)-H(1C) 109.5 C(10)-C(9)-H(9) 120 
H(1B)-C(1)-H(1C) 109.5 C(8)-C(9)-H(9) 120 
C(18)-N(2)-C(17) 119.80(12) C(11)-C(10)-C(9) 120.49(14) 
C(18)-N(2)-H(2) 120.1 C(11)-C(10)-H(10) 119.8 
C(17)-N(2)-H(2) 120.1 C(9)-C(10)-H(10) 119.8 
O(1)-C(2)-C(1) 123.13(14) C(10)-C(11)-C(12) 119.84(14) 
O(1)-C(2)-C(4) 120.57(14) C(10)-C(11)-H(11) 120.1 
C(1)-C(2)-C(4) 116.21(13) C(12)-C(11)-H(11) 120.1 
C(7)-O(3)-C(4) 113.77(11) C(13)-C(12)-C(11) 120.17(15) 
C(4)-C(3)-H(3A) 109.5 C(13)-C(12)-H(12) 119.9 
C(4)-C(3)-H(3B) 109.5 C(11)-C(12)-H(12) 119.9 
H(3A)-C(3)-H(3B) 109.5 C(12)-C(13)-C(8) 120.09(14) 
C(4)-C(3)-H(3C) 109.5 C(12)-C(13)-H(13) 120 
H(3A)-C(3)-H(3C) 109.5 C(8)-C(13)-H(13) 120 
H(3B)-C(3)-H(3C) 109.5 C(15)-C(14)-H(14A) 109.5 
O(3)-C(4)-N(1) 109.72(11) C(15)-C(14)-H(14B) 109.5 
O(3)-C(4)-C(3) 107.23(11) H(14A)-C(14)-H(14B) 109.5 
N(1)-C(4)-C(3) 111.09(12) C(15)-C(14)-H(14C) 109.5 
O(3)-C(4)-C(2) 108.45(11) H(14A)-C(14)-H(14C) 109.5 
N(1)-C(4)-C(2) 110.84(11) H(14B)-C(14)-H(14C) 109.5 
C(3)-C(4)-C(2) 109.40(12) O(4)-C(15)-C(14) 123.74(15) 
O(2)-C(5)-N(1) 121.75(13) O(4)-C(15)-C(17) 118.90(15) 
O(2)-C(5)-C(6) 123.80(13) C(14)-C(15)-C(17) 117.19(13) 
N(1)-C(5)-C(6) 114.31(12) C(17)-C(16)-H(16A) 109.5 
C(20)-O(6)-C(17) 113.25(11) C(17)-C(16)-H(16B) 109.5 
C(7)-C(6)-C(5) 119.83(13) H(16A)-C(16)-H(16B) 109.5 
C(7)-C(6)-H(6) 120.1 C(17)-C(16)-H(16C) 109.5 
C(5)-C(6)-H(6) 120.1 H(16A)-C(16)-H(16C) 109.5 
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CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTH AND BOND 
ANGLES FOR THE CRYSTAL STRUCTURE OF 255
416 
  


















Completeness to theta = 28.55° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 9.3533(5) Å a= 90°. 
b = 17.8571(10) Å b= 103.1200(10)°. 
c = 9.6942(5) Å g = 90°. 
  1576.89(15) Å3 
4 
 1.311 Mg/m3 
-1 0.093 mm  
656 
 0.51 x 0.39 x 0.22 mm3 
2.24 to 28.55°. 
-12<=h<=12, -23<=k<=23, -12<=l<=12 
18934 
3728 [R(int) = 0.0194] 
92.90% 
 Semi-empirical from equivalents
0.9798 and 0.9540 
Full-matrix least-squares on F2 
3728 / 0 / 212 
1.036 
R1 = 0.0341, wR2 = 0.0889 
R1 = 0.0372, wR2 = 0.0917 







Table G.2 Bond lengths [Å] for the crystal structure of 255 
Atoms Lengths Atoms Lengths 
O(1)-C(3) 1.3347(11) C(10)-C(11) 1.3934(14) 
O(1)-C(2) 1.4099(11) C(10)-H(10) 0.95 
N(1)-C(3) 1.3685(12) C(11)-C(12) 1.3898(16) 
N(1)-C(7) 1.4095(12) C(11)-H(11) 0.95 
N(1)-C(1) 1.4317(11) C(12)-C(13) 1.3849(18) 
C(1)-C(2) 1.3353(14) C(12)-H(12) 0.95 
C(1)-C(15) 1.4875(13) C(13)-C(14) 1.3891(15) 
O(2)-C(5) 1.2269(12) C(13)-H(13) 0.95 
C(2)-C(16) 1.4776(13) C(14)-H(14) 0.95 
O(3)-C(7) 1.2056(12) C(15)-H(15A) 0.98 
C(3)-C(4) 1.3756(13) C(15)-H(15B) 0.98 
O(4)-C(8) 1.2278(12) C(15)-H(15C) 0.98 
C(4)-C(5) 1.4434(13) C(16)-H(16A) 0.98 
C(4)-C(8) 1.4839(13) C(16)-H(16B) 0.98 
C(5)-C(6) 1.5445(13) C(16)-H(16C) 0.98 
C(6)-C(7) 1.5243(13) C(17)-H(17A) 0.98 
C(6)-C(18) 1.5285(13) C(17)-H(17B) 0.98 
C(6)-C(17) 1.5558(14) C(17)-H(17C) 0.98 
C(8)-C(9) 1.4923(13) C(18)-H(18A) 0.98 
C(9)-C(10) 1.3917(14) C(18)-H(18B) 0.98 
C(9)-C(14) 1.3986(14) C(18)-H(18C) 0.98 
418 
  
 Table G.3 Bond angles [°] for the crystal structure of 255 


























































































































































CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTHS AND BOND 
ANGLES FOR THE CRYSTAL STRUCTURE OF 260
420 
  


















Completeness to theta = 28.47° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Extinction coefficient 







a = 4.3902(6) Å a= 88.084(2)°. 
b = 12.0616(17) Å b= 85.268(2)°. 
c = 13.7392(19) Å g = 79.661(2)°. 
  713.15(17) Å3 
2 
 1.324 Mg/m3 
-1 0.098 mm  
296 
 0.57 x 0.16 x 0.11 mm3 
1.49 to 28.47°. 
-5<=h<=5, -16<=k<=15, -18<=l<=18 
8684 




0.9807 and 0.9807 
Full-matrix least-squares on F2 
3291 / 0 / 194 
1.074 
R1 = 0.0366, wR2 = 0.0979 
R1 = 0.0475, wR2 = 0.1033 
0.008(3) 




 Table H.2 Bond lengths [Å] and angles [°] for the crystal structure of 260 












































































 Table H.3  Bond angles [°] for the crystal structure of 260




























































































































CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTHS AND BOND 
ANGLES FOR THE CRYSTAL STRUCTURE OF 263
424 
  


















Completeness to theta = 27.78° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 14.6753(13) Å a= 90°. 
b = 12.3879(11) Å b= 99.8040(10)°. 
c = 7.6153(7) Å g = 90°. 
  1364.2(2) Å3 
4 
 1.516 Mg/m3 
-1 0.250 mm  
648 
 0.20 x 0.19 x 0.15 mm3 
2.16 to 27.78°. 
-18<=h<=19, -16<=k<=15, -9<=l<=9 
16049 
3167 [R(int) = 0.0328] 
98.90% 
 Semi-empirical from equivalents
0.9635 and 0.9517 
 Full-matrix least-squares
on F2  
3167 / 0 / 199 
1.15 
R1 = 0.0405, wR2 =
0.0941 
R1 = 0.0502, wR2 =
0.0978 






Table I.2 Bond lengths [Å] for the crystal structure of 263 
Atoms Lengths Atoms Lengths 
S(1)-C(10) 1.7282(19) C(6)-H(6A) 0.99 
S(1)-C(1) 1.744(2) C(6)-H(6B) 0.99 
O(1)-C(8) 1.351(2) C(7)-H(7B) 0.99 
O(1)-C(7) 1.453(2) C(7)-H(7A) 0.99 
N(1)-C(10) 1.367(2) C(8)-C(9) 1.435(3) 
N(1)-C(2) 1.403(2) C(9)-C(10) 1.400(3) 
N(1)-C(3) 1.428(2) C(9)-C(11) 1.467(3) 
C(1)-C(2) 1.340(3) C(11)-C(12) 1.497(3) 
C(1)-H(1) 0.95 C(12)-C(13) 1.397(3) 
O(2)-C(3) 1.236(2) C(12)-C(17) 1.398(3) 
C(2)-H(2) 0.95 C(13)-C(14) 1.389(3) 
O(3)-C(11) 1.239(2) C(13)-H(13) 0.95 
C(3)-C(4) 1.418(3) C(14)-C(15) 1.393(3) 
C(4)-C(8) 1.383(3) C(14)-H(14) 0.95 
C(4)-C(5) 1.508(3) C(15)-C(16) 1.391(3) 
C(5)-C(6) 1.523(3) C(15)-H(15) 0.95 
C(5)-H(5A) 0.99 C(16)-C(17) 1.388(3) 
C(5)-H(5B) 0.99 C(16)-H(16) 0.95 
C(6)-C(7) 1.508(3) C(17)-H(17) 0.95 
426 
  
 Table I.3 Bond angles [°] for the crystal structure of 263 










































































































































CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTHS AND BOND 
ANGLES FOR THE CRYSTAL STRUCTURE OF 286
428 
  


















Completeness to theta = 28.54° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 







a = 7.9468(14) Å a= 90°. 
b = 9.3410(17) Å b= 115.729(2)°. 
c = 8.2382(15) Å g = 90°. 
  550.90(17) Å3 
2 
 1.755 Mg/m3 
-1 0.194 mm  
292 
0.87 x 0.17 x 0.16 mm3  
2.74 to 28.54°. 
-10<=h<=10, -11<=k<=12, -10<=l<=11 
6794 
2561 [R(int) = 0.0230] 
93.70% 
 Semi-empirical from equivalents
0.9696 and 0.8495 
Full-matrix least-squares on F2 
2561 / 1 / 173 
1.042 
R1 = 0.0288, wR2 = 0.0613 
R1 = 0.0336, wR2 = 0.0641 
0.7(5) 







Table J.2 Bond lengths [Å] for the crystal structure of 286 
Atoms Lengths Atoms Lengths 
F(1)-C(1) 1.3402(19) C(7)-C(8) 1.522(2) 
F(2)-C(1) 1.335(2) C(7)-H(7A) 0.99 
F(3)-C(1) 1.3431(19) C(7)-H(7B) 0.99 
F(4)-C(5) 1.343(2) C(6)-C(3) 1.443(2) 
F(5)-C(5) 1.337(2) C(3)-C(4) 1.433(2) 
F(6)-C(5) 1.337(2) C(3)-C(2) 1.439(2) 
O(1)-C(2) 1.226(2) C(2)-C(1) 1.546(2) 
O(2)-C(4) 1.231(2) C(4)-C(5) 1.546(2) 
O(3)-C(6) 1.3293(19) C(8)-H(8A) 0.99 
O(3)-C(8) 1.476(2) C(8)-H(8B) 0.99 
N(1)-C(6) 1.302(2) C(9)-H(9A) 0.98 
N(1)-C(9) 1.456(2) C(9)-H(9B) 0.98 





Table J.3 Bond angles [°] for the crystal structure of 286
Atoms Angles Atoms Angles 
C(6)-O(3)-C(8) 107.93(12) F(1)-C(1)-C(2) 109.64(13) 
C(6)-N(1)-C(9) 127.03(14) F(3)-C(1)-C(2) 114.85(13) 
C(6)-N(1)-C(7) 110.91(14) O(2)-C(4)-C(3) 124.54(15) 
C(9)-N(1)-C(7) 122.06(13) O(2)-C(4)-C(5) 114.67(15) 
N(1)-C(7)-C(8) 100.80(12) C(3)-C(4)-C(5) 120.78(14) 
N(1)-C(7)-H(7A) 111.6 F(6)-C(5)-F(5) 106.86(14) 
C(8)-C(7)-H(7A) 111.6 F(6)-C(5)-F(4) 106.07(14) 
N(1)-C(7)-H(7B) 111.6 F(5)-C(5)-F(4) 108.25(13) 
C(8)-C(7)-H(7B) 111.6 F(6)-C(5)-C(4) 109.97(14) 
H(7A)-C(7)-H(7B) 109.4 F(5)-C(5)-C(4) 114.01(14) 
N(1)-C(6)-O(3) 113.22(14) F(4)-C(5)-C(4) 111.29(14) 
N(1)-C(6)-C(3) 128.78(15) O(3)-C(8)-C(7) 103.96(12) 
O(3)-C(6)-C(3) 117.97(14) O(3)-C(8)-H(8A) 111 
C(4)-C(3)-C(2) 124.96(14) C(7)-C(8)-H(8A) 111 
C(4)-C(3)-C(6) 115.34(14) O(3)-C(8)-H(8B) 111 
C(2)-C(3)-C(6) 119.02(14) C(7)-C(8)-H(8B) 111 
O(1)-C(2)-C(3) 127.71(15) H(8A)-C(8)-H(8B) 109 
O(1)-C(2)-C(1) 113.34(14) N(1)-C(9)-H(9A) 109.5 
C(3)-C(2)-C(1) 118.87(14) N(1)-C(9)-H(9B) 109.5 
F(2)-C(1)-F(1) 107.16(13) H(9A)-C(9)-H(9B) 109.5 
F(2)-C(1)-F(3) 107.38(14) N(1)-C(9)-H(9C) 109.5 
F(1)-C(1)-F(3) 106.21(14) H(9A)-C(9)-H(9C) 109.5 
F(2)-C(1)-C(2) 111.22(14) H(9B)-C(9)-H(9C) 109.5 





CRYSTAL DATA, STRUCTURE REFINEMENT, BOND LENGTHS AND BOND 
ANGLES FOR THE CRYSTAL STRUCTURE OF 287
432 
  



















Completeness to theta = 
28.67° 
 Absorption correction
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 9.1206(6) Å a= 90°. 
b= 
b = 9.5688(7) Å 
99.0520(10)°.
c = 10.2660(7) Å g = 90°. 
  884.79(11) Å3 
4 
 1.600 Mg/m3 
-1 0.162 mm  
440 
0.22 x 0.20 x 0.11 mm3  
2.78 to 28.67°. 
-12<=h<=12, -12<=k<=12, -13<=l<=13 
10655 





0.9824 and 0.9652 
Full-matrix least-squares on 
F2 
2178 / 0 / 133 
1.067 
R1 = 0.0314, wR2 = 0.0784 
R1 = 0.0384, wR2 = 0.0817 







Table K.2 Bond lengths [Å] for the crystal structure of 287 
Atoms Lengths Atoms Lengths 
F(1)-C(1) 1.3355(14) C(4)-O(3) 1.2469(14) 
F(2)-C(1) 1.3429(14) C(4)-N(1) 1.3277(15) 
F(3)-C(1) 1.3373(14) N(1)-C(7) 1.4555(15) 
O(1)-C(2) 1.4035(14) N(1)-C(5) 1.4655(15) 
O(1)-H(1) 0.84 C(7)-H(7A) 0.98 
O(2)-C(2) 1.3941(14) C(7)-H(7B) 0.98 
O(2)-H(8) 0.873(19) C(7)-H(7C) 0.98 
C(1)-C(2) 1.5339(16) C(5)-C(6) 1.5301(16) 
C(2)-C(3) 1.5296(16) C(5)-H(5A) 0.99 
C(3)-C(4) 1.5297(15) C(5)-H(5B) 0.99 
C(3)-C(6) 1.5323(16) C(6)-H(6A) 0.99 
C(3)-H(3) 1 C(6)-H(6B) 0.99 
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Symmetry transformations used to generate equivalent atoms: 
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